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Abstract
ChxlO is a homeobox transcription factor essential for the development of the 
vertebrate eye. A mutation in the human gene CHX10 causes microphthalmia and a 
similar phenotype is observed in the ocular retardation, ChxlO null mouse. Lack of 
ChxlO causes a reduction in proliferation of neural retinal progenitor cells (RPCs) in 
the developing retina, resulting in a reduction in the size of the eye. The aim of this 
study was threefold: to identify downstream targets of the ChxlO gene and discover 
more about the role of ChxlO at a molecular level, to further characterise the ChxlO'1' 
phenotype and the behaviour of the mutant RPCs, and to investigate the possibility 
that the ChxlO'A retina harbours stem cell-like cells.
Firstly, Affymetrix GeneChip technology was used to compare the gene expression 
profile of wild type retina with that of the ChxlO null retina during early 
development. Significant differential expression was observed for 34 characterised 
genes; genes involved in neuronal differentiation were down-regulated whereas 
genes involved in retinal pigmented epithelium (RPE) specification were up- 
regulated. These findings highlight a novel role for ChxlO in maintaining the neural 
retina/RPE boundary.
Secondly, experiments aimed at characterising ChxlO'1' RPCs showed that they 
exhibit altered cycling properties compared to wild type RPCs and that their 
differentiation to neural retinal cells is delayed. The data resulting from these studies 
support a model in which the transition from G1 phase of the cell cycle to S phase or 
to differentiation is disrupted in the ChxlO'f' retina. Finally, a population of 
proliferating cells was discovered in the adult ChxlO'1' retina, which showed 
neurogenic properties and formed neurospheres in culture, a point of interest in the 
context of retinal stem cell research.
The study conducted here has offered valuable clues as to how ChxlO affects retinal 
progenitor cell proliferation and differentiation at both a molecular and a cellular 
level. It is hoped this work will contribute to the current knowledge of eye 
development in general, and ChxlO’s involvement in this process in particular.
2
Acknowledgements
First and foremost, I would like to thank my primary supervisor Jane Sowden and my 
secondary supervisor Patrizia Ferretti for all their help, support and advice during the 
last four years. In addition there are several people who have given me technical 
assistance and advice as well as contributing to the work presented in this thesis. 
They are Dr. Mike Hubank, Danielle Fletcher, and Nipuma Jina, who run the 
Affymetrix GeneChip facility at ICH, Jo Sinclair in the Molecular Immunology Unit 
at ICH, who runs the flow cytometry unit and has helped with the analysis of the 
flow cytometry experiments described in Chapter 5, Brian Young at the Institute of 
Neuroscience who prepared the semithin retinal sections described in Chapter 5, 
Professor Robin Ali, Dr. James Bainbridge, and Kam Balaggan from the Institute of 
Ophthalmology, who contributed to Chapter 6 - and I would like to specifically thank 
Jim and Kam for performing the BrdU injections described therein-, Joel Rae for his 
contribution of data to the orientation of cell division experiment described in 
Chapter 5, and Deborah Ridout who provided statistical advice. Funding for this 
project was provided by a Fight for Sight studentship and I would like to thank the 
organisation for their support and interest.
On a personal note, I would like to thank everyone in the Developmental Biology 
and Neural Development units who have made my day to day life interesting and 
enjoyable. I don’t want to offend anyone by accidental omission, so I’m just going to 
say you know who you are, although I’d like to say a special thank you to Joel Rae 
for his help in the final production of this thesis. I feel privileged to have known and 
worked with you all. Special mention also goes to ‘the Coven’, Bronwen Herbert, 
Kerra Pearce, Katy Newton, Sarah Horton, Chantelle Hudson and Emily Towers, 
who have kept me sane and shared with me the ups and downs of phd-dom. I would 
especially like to thank Bronwen and Kerra for their close personal friendship in 
addition to their technical help in the labs. I would like to thank my family, and 
especially my parents, for their unstinting love and support throughout my studies 
and research. Their encouragement has contributed greatly to the completion of this 
thesis. Finally, I would like to thank Marc, whose endless love, support, and patience 
have meant the world to me.
3
Table of Contents
Abstract  .............................................................................................................2
Acknowledgements..................................................................................................3
Table of Contents.....................................................................................................4
List of Figures..........................................................................................................9
List of Tables.......................................................................................................... 13
List of Abbreviations................................................................. ............................ 15
CHAPTER 1 Introduction...............................................................................16
1.1 The importance of vision loss drives the study of eye development............... 17
1.2 Embryonic Development of the Vertebrate Eye.............................................. 19
1.2.1 Overview.......................................................................................................19
1.2.2 Genes expressed early during eye development and those causing eye 
phenotypes............................................................................................................ 27
1.2.3 Patterning of the developing eye...................................................................29
1.2.4 Neural Retina versus RPE.............................................................................30
1.3. Differentiation of Retinal Cells.......................................................................33
1.4 Microphthalmia................................................................................................37
1.5 The CHX10 gene..............................................................................................40
1.5.1 ChxlO Expression During Eye Development...............................................41
1.5.2 A Role in Specification and Differentiation of the Neural Retina................43
1.5.3 A Role in Retinal Progenitor Cell Proliferation............................................45
1.5.4 ChxlO and the Cell Cycle.............................................................................47
1.6 Retinal Stem Cells............................................................................................50
1.7 Aims ........................................................................................................55
CHAPTER 2 Materials and Methods............................................................. 58
2.1 Materials.........................................................................................................59
2.1.1. General lab reagents and solutions................ ;............................................59
2.1.2 Reagents for GeneChip Assay....................................................................61
2.1.3. Real Time PCR Reagents.............................................................................64
2.1.4 Preparation of riboprobes..............................................................................65
2.1.5 Whole mount in situ hybridisation................................................................74
4
2.1.6. Embedding and vibratome sectioning of whole mount in situ hybridized 
embryos..................................................................................................................75
2.1.7. In situ hybridisation for cryostat sections....................................................75
2.1.8. Preparation of frozen and paraffin-embedded sections................................77
2.1.9. Staining with Eosin and Haematoxylin........................................................77
2.1.10. Immunohistochemistry on frozen and paraffin-embedded sections..........77
2.1.11. Fluorescence activated cell sorting (FACS) analysis of cell cycle............80
2.1.12. Analysis of mitotic spindle orientation during cell division......................80
2.1.13 Dissociation and Numb-labelling of retinal cells.......................................80
2.1.14 Immunohistochemistry on sections of BrdU injected mice........................80
2.1.15. Dissociation and immunohistochemistry of retinal cells...........................81
2.1.16. TUNEL labelling........................................................................................81
2.1.17. Cell Culture Reagents................................................................................82
2.2 Methods.........................................................................................................83
2.2.1 Animals and timed matings.........................................................................83
2.2.2. Affymetrix GeneChip assay.......................................................................83
2.2.3 Real time PCR analysis...............................................................................92
2.2.4. Preparation of riboprobes for in situ hybridisation....................................94
2.2.5 Whole mount in situ hybridisation............................................................ 100
2.2.6. Embedding and vibratome sectioning of whole mount in situ hybridized 
embryos................................................................................................................ 101
2.2.7. In situ hybridisation for cryostat sections.................................................. 102
2.2.8. Preparation of frozen and paraffin-embedded retinal sections.................. 103
2.2.9. Staining with Eosin and Haematoxylin...................................................... 104
2.2.10. Immunohistochemistry on frozen and paraffin-embedded sections 105
2.2.11. Flourescence activated cell sorting (FACS) analysis of cell cycle 107
2.2.12. Analysis of mitotic spindle orientation during cell division.................... 108
2.2.13 Dissociation and Numb-labelling of retinal cells...................................... 109
2.2.14 Histological examination of semithin retinal sections.............................. 109
2.2.15 Immunohistochemistry on sections of BrdU injected mice...................... 110
2.2.16. Dissociation and immunohistochemistry of retinal cells......................... 112
2.2.17. TUNEL labelling...................................................................................... 113
2.2.18. Cell Culture from adult retina.................................................................. 114
5
CHAPTER 3 Identifying Genes Downstream of ChxlO............................... 116
3.1 Introduction.................................................................................................... 117
3.2 Results............................................................................................................ 121
3.2.1 Embryonic day 11.5 was selected as an appropriate time point for GeneChip 
analysis................................................................................................................. 121
3.2.2 High quality RNA was extracted and amplified from pools of retinae 123
3.2.3 Acquisition and normalisation of GeneChip data....................................... 126
3.2.4 Thirty four characterised genes show a statistically significant greater than
1.5 fold change.....................................................................................................128
3.2.5 Examining genes that show a correlation to the two most changed genes. 141
3.2.6 Functional classification of genes with altered expression......................... 142
3.3 Discussion......................................................................................................151
3.3.1 Considerations for interpreting microarray data......................................... 151
3.3.2 ChxlO seems to exert a significant effect on cell proliferation, growth and 
differentiation.......................................................................................................153
3.3.3 Changes in expression of genes involved in cell adhesion and fat metabolism 
and the immune system........................................................................................155
3.3.4 Genes selected for further study.................................................................. 157
CHAPTER 4 Analysis of Putative ChxlO Target Genes............................ 159
4.1 Introduction.................................................................................................... 160
4.2 Results............................................................................................................ 166
4.2.1 Retinoid X receptor gamma........................................................................ 166
4.2.2 Silver and dopachrome tautomerase........................................................... 172
4.2.3 Distal-less homeobox 2 ............................................................................... 179
4.2.4 Neurogenic differentiation 1 ....................................................................... 184
4.2.5 Cadherin 8 ................................................................................................... 187
4.2.6 In silico examination of ChxlO-regulated genes......................................... 190
4.3 Discussion.................................................................................................... 196
4.3.1 Retinoid signalling gene up-regulated in the ChxlO'1' retina...................... 196
4.3.2 Another homeobox transcription factor down-regulated in the ChxlO'1' retina 
  ................................................................................................................... 198
4.3.3 Neurodl is a candidate for ChxlO regulation............................................. 199
4.3.4 RPE genes up-regulated in the Chxl&' retina............................................201
4.3.5 Cadherin 8 may be involved in bipolar cell fate specification....................203
6
4.3.6 Conclusions...............................................................................................204
CHAPTER 5 ChxlO‘/' retinal progenitor cells exhibit altered properties 
during retinal development...............................................................................205
5.1. Introduction...................................................................................................206
5.2. Results...........................................................................................................209
5.2.1 Mitotic cells in the ChxlO'A mutant retina fail to amplify the size of the 
retinal progenitor cell population.........................................................................209
5.2.2 PCNA labelling confirms a lack of proliferation at the periphery..............217
5.2.3 Apoptosis does not contribute to the cell number deficit or differentiation 
delay in the early embryonic ChxlO"A retina........................................................222
5.2.4 Changes in the cell cycle.............................................................................224
5.2.5 The orientation of cell division is altered in the ChxlO'A retina..................229
5.2.6 Altered profile of cell fate determination....................................................232
5.2.7 Cell numbers are decreased in both the inner and outer nuclear layers of the 
Chxl0'/m retina...................................................................................................... 243
5.3. Discussion.................................................................................................... 247
5.3.1 A decrease in proliferation in the periphery of the ChxlO'A retina may be due 
to misspecification of neural retina......................................................................247
5.3.2 H3 labelled cells and orientation of cell division offer clues to how ChxlO'A 
RPCs proliferate...................................................................................................248
5.3.3 The cell cycle of the ChxlOA RPCs is likely to be increased in length 250
5.3.4 Conclusions.................................................................................................251
CHAPTER 6 Absence of ChxlO causes embryonic neural progenitor-like 
cells to persist in the adult retina......................................................................252
6.1. Introduction...................................................................................................253
6.2. Results...........................................................................................................256
6.2.1. Proliferation of cells in the ChxlO_A central retina persists into adulthood 256
6.2.2. Pattern of proliferation after birth..............................................................269
6.2.3. Some BrdU labelled cells differentiate and form new neurons in the adult 
ChxlO'1' retina................................................................................................  277
6.2.4. New amacrine-like cells develop in the adult Cfoc-/0'Aretina.....................284
6.2.5. Labelling of dissociated cells.....................................................................290
6.2.7. BrdU labelled cells in the adult wild type form part of the retinal vasculature 
   292
7
6.2.6. Cell death is not a common fate of cells in the ChxlO'A retina  .......292
6.2.8. Cell cultures of adult retinal cells suggest retinal progenitor-like cells are
present in the Chxl&~ central retina....................................................................295
6.3. Discussion...................................................................................................298
6.3.1 An aberrant pattern of proliferation observed in the ChxlO'1' retina during 
development continues after birth........................................................................298
6.3.2 Misspecification of the retina through the absence of ChxlO may contribute 
to the continued cycling of retinal progenitor cells..............................................300
6.3.3 RPC-like cells maintain neurogenic potential, but are unable to expand 
retinal cell numbers..............................................................................................301
6.3.4 In vivo demonstrations of stem-cell like properties of cycling cells in the
adult retina...........................................................................................  302
CHAPTER 7 Final Discussion.......................................................................303
7.1 Identification of genes previously not known to be under ChxlO control 304
7.1.1 Cell cycle proteins affected by the absence of ChxlO................................304
7.1.2 Cell differentiation factors affected by a loss of ChxlO.............................307
7.1.4 Microarray studies in the ChxlO'A mouse...................................................311
7.2 Misspecification at the border between the neural retina and RPE may 
contribute to a decrease in proliferation in the periphery of the retina................312
7.3 An altered pattern of proliferation in the ChxlO retina results in fewer retinal 
cells and a delay in their differentiation...............................................................313
7.4 Stem-cell like properties of cells proliferating in the adult ChxlffA retina.... 314
7.5 Considerations for future work......................................................................317
7.6 Final Thoughts...............................................................................................319
APPENDICES.....................................................................................................320
REFERENCES.........................   335
8
List of Figures
Figure 1.1: Overview of early eye vertebrate eye development........................................ 21
Figure 1.2: Cells of the neural retina...........................................................................24
Figure 1.3: Cascade of progressive differentiation of retinal progenitor cells to the seven
different cell types of the neural retina............................................................................36
Figure 1.4: Examples of microphthalmia in human patients.............................................38
Figure 1.5: Organisation of the ChxlO polypeptide sequence........................................ 42
Figure 1.6: ChxlO expression during retinal development.............................................44
Figure 1.7: Depiction of the cell cycle and how various cell cycle proteins interact
with or are affect by ChxlO........................................................................................... 48
Figure 1.8: Stem cells and progenitor cells in the Xenopus and mammalian eye................51
Figure 1.9: Model of cycling behaviour in wild type and Chxl&' CE cell culture.............53
Figure 2.1: Simple plasmid maps of the vectors and inserts obtained to make riboprobes for
in situ hybridisation...................................................................................................... 68
Figure 2.2: Schematic of the preparation of the cRNA targets to hybridise to the
GeneChips................................................................................................................... 87
Figure 3.1: Standard eukaryotic gene expression assay..................................................119
Figure 3.2: Differences between wild type and ChxlO' retinae during
development............................................................................................................... 122
Figure 3.3: Progression of retinal dissection................................................................. 124
Figure 3.4: Quality and quantity control of RNA samples extracted from pools of El 1.5
ChxlCf/‘ and wild type retinae...................................................................................... 127
Figure 3.5: Normalised GeneChip data from 6 chips..................................................... 130
Figure 3.6: Normalised data showing relative expression of genes between wild type
replicates and ChxlCfA replicates...................................................................................132
Figure 3.7: Normalised data showing genes with a greater than 1.5-fold or 2-fold change in
expression between the wild type and ChxlCfA replicates................................................ 134
Figure 3.8: Normalised data showing genes with a significant greater than 1.5-fold or 2-fold
change in expression between the wild type and ChxlCf ' replicates................................ 136
Figure 3.9: Normalised data showing genes with a significant greater than 1.5-fold or 2-fold
change in expression between the wild type and ChxlCfA replicates................................ 138
Figure 3.10: Normalised data showing genes that show a correlation with Rxrg.............. 144
Figure 3.11: Normalised data showing genes that show a correlation with Dlx2.............. 146
Figure 4.1: PCR amplification of a series of 10-fold dilutions is displayed on both a linear 
scale and a logarithmic scale........................................ 163
9
Figure 4.2: Quantitative real time RT-PCR chemistry....................................................164
Figure 4.3: RT-PCR amplification curves for Rxrg....................................................... 169
Figure 4.4: Fold-change data from real time PCR experiments for all six genes
examined....................................................................................................................171
Figure 4.5: Whole mount in situ hybridisation of El 1.5 and E12.5 wild type and ChxlO'A
embryos for silver........................................................................................................174
Figure 4.6: In situ hybridisation of E13.5 wild type and ChxlO' ' retinal sections for S/— 176 
Figure 4.7: Whole mount in situ hybridisation of El 1.5 and E12.5 wild type and ChxlOA
embryos for Dct.......................................................................................................... 177
Figure 4.8: In situ hybridisation of E13.5 wild type and ChxlOA retinal sections for Dct.. 178 
Figure 4.9: Whole mount in situ hybridisation of El 1.5 and E12.5 wild type and ChxlO'1'
embryos for Dlx2.........................................................................................................181
Figure 4.10: In situ hybridisation of E13.5 wild type and ChxlOA retinal sections for
Dlx.............................................................................................................................183
Figure 4.11: Whole mount in situ hybridisation of El 1.5 and E12.5 wild type and ChxlOA
embryos for Neurodl...................................................................................................186
Figure 4.12: Whole mount in situ hybridisation of El 1.5 and E12.5 wild type and ChxlO"
embryos for Cdh8.............  189
Figure 4.13: Sequence alignments of the Neurodl promoter region...............................193
Figure 4.14: Sequence alignments of the Dlx2 promoter region......................................194
Figure 5.1: IB-labelled cells in the developing ChxlOA retina at El 1.5 and E13.5.......... 211
Figure 5.2: IB-labelled cells in the developing ChxlOA retina at El 5.5 and El 8.5.......... 213
Figure 5.3: Comparison of total cell number and H3 labelled cells in wild type and ChxlOA
retina.......................................................................................................................... 216
Figure 5.4: Localisation of cells in various phases of the cell cycle in the developing
retina.......................................................................................................................... 218
Figure 5.5: PCNA labelling of wild type and ChxlOA retina at various time points during
development.....................................................................................   220
Figure 5.6: PCNA labelling of wild type and ChxlOA retina at El 8.5........................... 221
Figure 5.7: TUNEL labelling of El 1.5 wild type and ChxlOA retina.............................223
Figure 5.8: Flow cytometry data of retinal progenitor cells at El 1.5.............................. 225
Figure 5.9: Flow cytometry data of retinal progenitor cells at E13.5.............................. 227
Figure 5.10: Flow cytometry data of retinal progenitor cells........................................ 228
Figure 5.11: Examining symmetry of division of retinal progenitor cells...................... 230
Figure 5.12: Immunostaining for |33-tubulin............................................................... 234
Figure 5.13: Syntaxin labelling of wild type and ChxlOA retina at E13.5 and E15.5...... 236
Figure 5.14: VC1.1 labelling of wild type and ChxlOA retina at E13.5 and E15.5..........238
10
Figure 5.15: Recoverin labelling of wild type and ChxlO'A retina at El 8.5...................... 240
Figure 5,16. Examination of photoreceptor differentiation in the postnatal retina............ 242
Figure 5.17: Semithin sections of wild type and Chxl(XA retina stained with toluidine
blue............................................................................................................................ 245
Figure 6.1: The relative contribution of the CMZ to retinal growth has been progressively
reduced in homeothermic vertebrates and is shown in drawings of the adult eyes.............255
Figure 6.2: Two sections of wild type retina taken from mice injected with BrdU between
PI5 and P29................................................................................................................258
Figure 6.3: Section of ChxlO'A retina taken from mouse injected with BrdU between PI 5
and P29...................................................................................................................... 260
Figure 6.4: Two sections of ChxlO" retina taken from mice injected with BrdU between
PI5 and P29................................................................................................................262
Figure 6.5: Sections of wild type and ChxlO'A retina, taken from mice injected with BrdU 
between PI 5 and P29, were labelled with anti-BrdU antibody and counterstained with
Hoechst nuclear dye....................................................................................................263
Figure 6.6: Mice were injected with BrdU for two weeks before culling at 4, 5 or 8 weeks,
and labelled cells were counted in midline retinal sections and compared.......................266
Figure 6.7: Sections of Chxl(TA retina taken from mice injected with BrdU every other day
for two weeks, from three to five weeks of age and from six to eight weeks of age............ 268
Figure 6.8: H3 labelling in the wild type and Chxl(XA retina at postnatal day 20...............270
Figure 6.9: BrdU labelled cell counts of midline retinal sections from mice injected 
overnight and culled the following day or injected every other day for five days and culled
on the day after last injection.......................................................................................271
Figure 6.10: BrdU labelled cells in retinae of mice injected once and culled the following
day.............................................................................................................................273
Figure 6.11: BrdU labelled cells in retinae of mice injected every other day for five days
before culling..............................................................................................................276
Figure 6.12: Sections from wild type and Chxl(TA eyes double labelled for BrdU and
nestin.........................................................................................................................278
Figure 6.13: Sections from wild type and Chxl (7 ‘eyes labelled for CRALBP and BrdU at
four weeks of age....................................................................................................... 280
Figure 6.14: Sections from wild type and Chxl0'A eyes labelled for GFAP and BrdU at four
weeks of age........................................... ..................................................................282
Figure 6.15: Sections from wild type and Chxl0'A eyes double labelled for BrdU and p3
tubulin........................................................................................................................ 283
Figure 6.16: Sections from wild type and Chxl0~A eyes double labelled for BrdU and 
NeuN.......................................................... ..............................................................285
11
Figure 6.17: Sections from wild type eyes or ChxlO' 'eyes labelled with a variety of retinal
cell markers and BrdU.................................................................................................287
Figure 6.18: Sections from wild type and Chxli? 'eyes labelled for VC1.1 and BrdU 288
Figure 6.19: Sections from wild type and ChxlO'"eyes labelled for syntaxin and BrdU.. ..289 
Figure 6.20: Dissociated ChxlCf^retinal cells from BrdU injected mice, co-labelled for BrdU
and VC1.1, syntaxin or recoverin................................................................................. 291
Figure 6.21: Sections from wild type and ChxlO''eyes double labelled for BrdU and pi
integrin.......................................................................................................................293
Figure 6.22: Sections from wild type and ChxlO' ' eyes stained with the TUNEL detection
kit for apoptotic bodies and counterstained with Hoechst nuclear dye............................ 294
Figure 6.23: Cell cultures of dissociated wild type and ChxlO'A retinal cells................... 296
Figure 7.1: Interactions of cell cycle proteins known to interact with ChxlO or showing a
change in expression in the ChxlO'7' retina....................................................................306
Figure 7.2: Cascade of progressive differentiation of retinal progenitor cells to the seven
different cell types of the neural retina in the ChxlO'1' retina...........................................309
Figure 7.3: Mitf- and ChxlO-mediated retinal tissue specification...................................310
Figure 7.4: Model of how an arrest in G1/G0 of the cell cycle in RPCs of the ChxlO' ' retina 
might result in a smaller population of retinal cells and delayed differentiation................315
12
List of Tables
Table 1.1: List of genes known to cause microphthalmia in the mouse or in humans... 26
Table 1.2: Known loci and genes for non-syndromic simple microphthalmia................... 40
Table 1.3: Cell cycle components potentially affected by or under control o f................... 50
Table 2.1: Gene mix information from Applied Biosystems for Assays-on-Demand gene
mixes...........................................................................................................................65
Table 2.2. Enzymes and RNA polymerases used to make antisense and sense riboprobes for
the genes listed.............................................................................................................66
Table 2.3 Primary antibodies used in immunohistochemistry........................................... 78
Table 2.4 Secondary antibodies used in immunohistochemistry....................................... 79
Table 2.5: Washing and staining protocol for Affymetrix GeneChips............................... 91
Table 3.1: Number of retinae collected per GeneChip used in this study and the somite range
for each pool of retinae collected..................................................................................126
Table 3.2: Table of 40 genes/ESTs that showed a statistically significant greater than 1.5-
fold change in expression between the wild type and Chxl&' retina...............................140
Table 3.3: Table of 8 genes that showed a statistically significant greater than 2-fold change
in expression between the wild type and ChxlO A retina..............................................  141
Table 3.4: Table of transcripts that show an expression correlation with either Rxrg or
Dlx2...........................................................................................................................147
Table 3.5: Functional characterisation of the fifty six genes that show a change in expression
in the ChxlCf  ^retina compared to the wild type.............................................................148
Table 4.1: Number of retinae collected per pool of tissue used in the real time RT-PCR study
and the somite range for each....................................................................................... 166
Table 4.2: Relative change in expression of Rxrg in ChxlCfA retinae compared to wild type
retinae for each set of retinal pools collected for real time PCR.......................................167
Table 4.3: Relative change in expression of Si and Dct in ChxlCf ' retinae compared to wild
type retinae for each set of retinal pools collected for real time PCR.............................172
Table 4.4: Relative change in expression of Dlx2 in ChxlCfA retinae compared to wild type
retinae for each set of retinal pools collected for real time PCR.......................................180
Table 4.5: Relative change in expression of Neurodl in ChxlO' ' retinae compared to wild
type retinae for each set of retinal pools collected for real time PCR.............................185
Table 4.6: Relative change in expression of cadherin 8 in ChxlCfA retinae compared to wild 
type retinae for each set of retinal pools collected for real time PCR................................188
13
Table 4.7: Summary of promoter searches of differentially expressed genes....................191
Table 4.8: The six differentially expressed mouse genes obtained from the microarray study,
their human homologues, and the chromosome location of their human homologues 195
Table 4.9: Summary of expression data obtained for six genes in the wild type and ChxlO'A
retinae........................................................................................................................ 195
Table 5.1. Comparison of thickness , by nuclei, of retinal tissues from wild type and ChxlO "A
mice........................................................................................................................246
Table 6.1: BrdU injection schedules employed to examine cell proliferation in the postnatal 
wild type and Chxl&' retina........................................................................................269
14
List of Abbreviations
Abbreviation Full Title
ANOVA Analysis of variance
bHLH Basic helix-loop-helix
BMP Bone morphogenetic protein
BrdU Bromodeoxyuridine
CB Ciliary body
CDS Coding sequence
CE Ciliary epithelium
CHX10 C. elegans ceh-10 homeo domain containing homolog
CMZ Ciliary marginal zone
CNS Central nervous system
CRALBP Cellular retinaldehyde-binding protein
DAPI 4 ’ 6-diamidino-2-pheny lindole
DEPC Diethylpyrocarbonate
EGF Epidermal growth factor
EST Expressed sequence tags
EtOH Ethanol
FACS Flourescence activated cell sorting
FEVR Familial exudative vitreoretinopathy
FGF Fibroblast growth factor
GAPDH Gly ceraldehy de-3 -phosphate dehydrogenase
GCL Ganglion cell layer
GFAP Glial fibrilary acidic protein
GFP Green flurorescent protein
GO Graves’ ophthalmopathy
H3 Histone H3
INL Inner nuclear layer
ISH In situ hybridisation
IVT In vitro transcription
MeSH Medical subject heading
Mitf Microphthalmia-associated transcription factor
NBL Neuroblastic layer
NeuN Neuronal nuclear antigen
NMD Nonsense-mediated mRNA decay
NNOl Nanophthalmos 1
NR Neural retina
OMIM Online Medelian Inheritance in Man
ONL Outer nuclear layer
PBS Phosphate buffered saline
PCNA Proliferating cell nuclear antigen
PI Propidium iodide
PKC Protein kinase C
PNA Peanut agglutinin
pRB Protein retinoblastoma
RA Retinoic acid
RGCs Retinal ganglion cells
RPC Retinal progenitor cell
RPE Retinal pigmented epithelium
RT-PCR RT-PCR
SAGE Serial analysis of gene expression
TUNEL TdT-mediated dUTP digoxigenin nick end labelling
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CHAPTER 1 
Introduction
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1.1 The importance of vision loss drives the study of eye development
The World Health Organization (WHO) estimated in 1996 that approximately 38 
million people worldwide were blind and more than 110 million had low vision. 
With the world's population estimated at 5.3 billion at the time, this translated 
roughly into an overall blindness rate of 7 per 1000. (Schaumberg and Dana, 1996). 
By 2002, the WHO reported that the number of people with visual impairment 
worldwide was in excess of 161 million (Resnikoff et al., 2004). Normal vision 
provides a key source of information about one’s environment, and any loss of vision 
soon becomes debilitating. As such a large number of people are affected by vision 
loss, a great deal of effort is being made to examine the causes and possible solutions 
to blindness. The causes of blindness are wide-ranging, from genetic abnormalities to 
vitamin insufficiencies. In this study, microphthalmia, a form of congenital blindness 
characterised by small eyes, is being examined. Congenital blindness is usually either 
caused by genetic factors (e.g. mutations in single genes or chromosome 
abnormalities) or is prenatally acquired because of environmental factors such as 
maternal drug use, irradiation poisoning or maternal disease (Warburg, 1993). 
Simple, non-syndromic microphthalmia results from genetic alterations at various 
chromosomal loci (see section 1.4).
The well-characterised physiology and anatomy of the eye facilitates research into its 
developmental aberrations. A large number of patients and murine models with eye 
malformations are available for genetic and biological analysis because a) the eye is 
not essential for viability, b) gene mutations affecting the eye and retina generally 
produce readily recognised phenotypes and c) the importance of normal vision to 
humans means that virtually any significant dysfunction of the retina is brought to 
clinical attention (Freund et al., 1996). Thus, more mutations affecting the eye have 
been documented in humans than in any other species. Genetic abnormalities of the 
eye were found to be involved in 2% of the 2811 phenotypes recorded in a 1985 
analysis of McKusick’s Mendelian Inheritance in Man (Costa et al., 1985), making it 
the fourth most common system affected by genetic disease in humans (Freund et al., 
1996).
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In addition, the retina is an ideal developmental system for study. The eye is 
effectively a highly specialised extension of the brain (Chow and Lang, 2001) and 
the retina in particular is recognised as an ‘approachable part of the brain’ (Dowling, 
1987; Freund et al., 1996). This accessibility exists even in utero, and has enabled 
the use of the eye as a model system for the study of mechanisms of development in 
general, and central nervous system development in particular, in a variety of 
vertebrates (Cepko et al., 1996; Chow and Lang, 2001; Dyer and Cepko, 2001; 
Harris, 1997; Jean et al., 1998). Relatively few types of cells (only seven main 
classes of cells are present in the vertebrate retina) proliferate, differentiate and 
organise themselves into functional structures in the developing eye, so the eye 
represents the various processes of development, including tissue induction, 
formation of highly specialised structures and neurogenesis, in an easily accessible 
system. Thus, a great deal of information is available on the process of eye 
development, several aspects of which will be examined below.
However, many questions remain to be answered about the molecular basis of retinal 
development and it is clear that elucidating the regulatory mechanisms that underlie 
eye and retinal development will be a difficult task. The human and mouse genome 
projects, together with knowledge of eye development in other model organisms 
such as Drosophila melanogaster, will eventually make it possible to understand 
how the eye is made in cellular and molecular detail. In the coming years, the main 
goals of basic and applied developmental research of the eye will be: 1) to identify 
all of the regulatory molecules which control eye formation and to determine their 
relationship to genetic eye diseases; 2) to understand the function of these molecules, 
as well as the relationship between them (i.e. which molecules control which and 
when); and 3) to identify and characterise the retinal stem cells and progenitor cells 
which give rise to the mature retina.
The medical benefits of this work will, in the long run, be enormous. First, it will be 
possible to make specific molecular diagnoses in many patients with congenital eye 
defects, and to provide their families with accurate genetic counselling. Second, and 
in the longer term, it may be possible to prevent the retinal cell death associated with 
various eye defects by using gene therapy or pharmacological approaches. Finally 
knowledge of retinal stem cells and progenitor cells is likely to make feasible the
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replacement of damaged retinal or other ocular tissue, by cell transplantation 
approaches using cells derived from the eye or elsewhere in the patient’s nervous 
system, or from other stem cell sources, such as embryonic stem cells or bone 
marrow.
1.2 Embryonic Development of the Vertebrate Eye
1.2.1 Overview
The vertebrate eye develops from an area of the neuroectoderm (specifically the 
forebrain) that evaginates towards the surface ectoderm early in development, around 
22 days of human embryonic development and embryonic day 8 (E8) in mouse. This 
forms the optic pit. By the time the evaginating tissue abuts the surface ectoderm, 
around 4 weeks in the human embryo (Sadler, 1990) and by E9 in the mouse (Chow 
and Lang, 2001; Freund et al., 1996; Jean et al., 1998); Figure 1.1 A), it has formed 
the optic vesicle, the anterior part of which will become the neural retina, and the 
posterior part of which will become the retinal pigmented epithelium (RPE) and 
optic stalk. The vesicle induces changes in the ectoderm necessary for lens formation 
and the surface ectoderm thickens. As development progresses, during embryonic 
weeks 5 and 6 in the human, and by E10 in the mouse (Chow and Lang, 2001; 
Freund et al., 1996; Jean et al., 1998; Sadler, 1990), the optic vesicle and the surface 
ectoderm begin to invaginate, forming the optic cup and lens placode. The interior 
layer of the optic cup will differentiate to become the neural retina and the outer 
layer of the cup will become the RPE, with the most posterior part of the optic cup 
forming the optic stalk, which will develop into the optic nerve. The invaginating 
lens placode will pinch off from the surface ectoderm to form the lens. The 
invagination is not restricted to the central portion of the optic cup, but also involves 
part of the ventral surface, forming the choroid (or optic) fissure (Figure 1 .IB). 
Formation of this fissure allows the hyaloid artery to reach the inner chamber of the 
eye (Figure 1.1B). From week 6 to week 11 in the human and E l0 to E ll in the 
mouse, the inner layer of the optic cup, the neural retina, thickens as retinal 
progenitor cells proliferate, whilst the outer layer of the cup, the RPE, becomes a 
thin, pigmented cellular layer (Chow and Lang, 2001; Freund et al., 1996; Jean et al.,
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Figure 1.1: Overview of early eye vertebrate eye development. A: the eye first 
develops from evaginations of the forebrain which form the optic vesicle. This 
abuts an area of the surface ectoderm which becomes the lens placode. Both the 
optic vesicle and lens placode then invaginate to form the optic cup. B: The optic 
cup invaginates such that it becomes a two layered structure, the interior of which 
will differentiate to become the neural retina. Invagination also occurs in the 
ventral portion of the optic cup, forming the choroid fissure, allowing the hyaloid 
artery to reach the inner chamber of the eye. C: As development progresses, the 
inner layer of the optic cup thickens and differentiates into the neural retina, whilst 
the outer layer becomes a relatively thin pigment layer, the retinal pigmented 
epithelium (RPE). The choroid fissure fuses ventrally around the optic nerve, 
completing formation of the optic cup which will grow into a mature eye. Figure 
adapted from: Sadler, 1990.
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1998; Sadler, 1990). The choroid fissure fuses ventrally, completing formation of the 
optic cup (Sadler, 1990), which continues to grow into a mature eye.
The initial thickening of the inner layer of the optic cup between E10 and El 1 in the 
mouse results from the proliferation of retinal progenitor cells (RPCs). This 
proliferation continues throughout development, until about postnatal day 11 (PI 1), 
but at the same time, from about E l0.5 onwards, a number of cells begin to leave the 
cell cycle and become post-mitotic, and differentiate into one of seven retinal cell 
types (Freund et al., 1996; Marquardt and Grass, 2002). Therefore, some RPCs are 
continuing to proliferate at the same time as others are differentiating into mature 
retinal neurons. RPCs differentiate in a conserved order to form a stratified tissue 
composed of six major classes of neuronal cells, and one class of glial cells. These 
are arranged in three cellular strata: the ganglion cell layer (GCL), composed of 
ganglion cells, the inner nuclear layer (INL), composed of amacrine, horizontal, and 
bipolar retinal neurons as well as Muller glial cells, and the outer nuclear layer 
(ONL), composed of rod and cone photoreceptors. Two acellular plexiform layers 
separate these three layers (Jean et al., 1998; Marquardt and Grass, 2002); Figure 
1.2A).
RPCs in the neuroblastic multi-potential retina become post-mitotic at different 
overlapping times, depending on what type of cell they will differentiate to (Young, 
1985). As retinogenesis proceeds, the proportion of cells of each type which 
differentiate from RPCs changes continuously. Because the interval between 
cessation of mitosis and the onset of overt differentiation is not a constant, the order 
of cell differentiation could not be determined by microscopic assessment of 
morphological specialisation. Instead, Young (Young, 1985) determined the day of 
final mitosis (or birth-date) of each retinal cell type by autoradiographic analysis of 
nuclear labelling in the mature retina in animals injected with tritiated thymidine 
during the period of RPC proliferation. Figure 1.2B, left, depicts a summary of the 
time-course of multiplication and differentiation of the neural retina in the mouse 
that resulted from this study. It was determined that ganglion cells are the first to 
become post-mitotic, followed by horizontal cells and amacrine cells in the INL, and 
cone photoreceptors in the ONL. Rod photoreceptors soon follow, and last to be bom 
are the bipolar cells and Muller glial cells of the INL (Figure 1.2B, right, summarises
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Figure 1.2: Cells of the neural retina. A: Diagrammatic representation and 
semithin section, stained with toluene blue, of the wild type adult mouse retina, 
depicting the rod and cone photoreceptors of the outer nuclear layer, the 
horizontal, amacrine, bipolar and Muller glial cells of the inner nuclear layer, and 
the retinal ganglion cells of the retinal ganglion cell layer. The cell layers are 
separated by two acellular plexiform layers. B: Left: summary of the time-course 
of multiplication and differentiation of neural retinal cells as elucidated by Young, 
1985. Retinal progenitor cells of the developing retina exit the cell cycle and 
differentiate to the various different types of retinal cells in a conserved order, 
starting with the earliest bom ganglion cells, horizontal cells and cone 
photoreceptors at El 1, to the last bom bipolar cells and Miiller glial cells up to 11 
days after birth. (G.C. - ganglion cells, H.C. - horizontal cells, adapted from 
Young, 1985). Right: summary of the time of birth of each retinal cell type. 
Figure adapted from Marquardt and Gruss, 2002.
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the time of birth for each cell type) (Cepko et al., 1996; Marquardt and Gruss, 2002; 
Young, 1985). In the mouse, retinal differentiation is complete around postnatal day 
11 or PI 1, when there are no more proliferating retinal progenitor cells present 
(Cepko et al., 1996; Young, 1985).
The timing and mechanisms of the commitment of an RPC to become a specific cell 
type are largely unknown. Seminal lineage studies using intracellular injection of 
either tracers or retroviruses in various species including Xenopus and mouse, have 
demonstrated that the embryonic RPC is multipotent, i.e. each RPC has the potential 
to form any of the six major classes of mature neurons as well as Muller cells (Holt 
et al., 1988; Turner et al., 1990; Turner and Cepko, 1987; Wetts and Fraser, 1988). 
These studies also show that the multipotency of RPCs appears to extend to the last 
cell division, suggesting they are committed to a specific cell fate only after they exit 
the cell cycle (Holt et al., 1988; Turner and Cepko, 1987). Further studies indicated 
that at a given time during development, an RPC can generate only a subset of cell 
types (Austin et al., 1995; Belliveau et al., 2000; Belliveau and Cepko, 1999), 
leading to the development of the competence model: RPCs pass through a series of 
competence states, thought to be intrinsically defined, during each of which they are 
competent to produce only a subset of retinal cell types in response to environmental 
factors (Cepko et al., 1996)
Some of the general principles underlying development, and formation of the retina 
in particular, are now well established. Two major classes of regulatory factors, 
signalling molecules (often secreted factors) and transcription factors, control 
developmental processes (Harris, 1997; Jean et al., 1998). Secreted factors activate 
signalling pathways that often result in the expression of particular transcription 
factors. Transcription factors then intrinsically direct the expression of cell-specific 
markers while restricting fate choice (Harris, 1997). Many examples of these factors 
are known to be important during embryonic development of the vertebrate eye. A 
comprehensive review of the numerous genes involved in vertebrate eye 
development is beyond the scope of this overview, but a number of them should be 
addressed, with regards to the work discussed in this study. Table 1.1 displays a list 
of genes whose products are essential for eye formation, as an aberrant ocular 
phenotype can be observed if these genes are affected by a mutation, either in mouse
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Gene Phenotype Reference
ChxlO, Reduction in retinal proliferation, microphthalmia (Burmeister et al.,
CHX10 1996)
Pax6 No eyes visible and no nasal cavities develop in 
homozygotes, heterozygotes have small eyes and are blind
(Hill et al., 1991)
Rx,RX Failure to develop eyes (Zhang et al., 2001)
Pitx3 Bilateral microphthalmia due to failure of lens morphogenesis (Rieger et al., 2001)
Mitf Microphthalmia (Hodgkinson et al., 
1993)
Cyclin Severe retinopathy caused by impaired development of all (Fantl et al., 1995)
D1 layers of the retina
Hesl Premature and accelerated differentiation, resulting in a small 
eye
(Tomita et al., 1996)
Lhx2 Anophthalmia due to failure of optic cup and lens placode 
formation
(Porter et al., 1997)
Gasl Remnant mutant eyes are ingressed from the surface with 
minimal RPE and lens, and disorganised eyelid, cornea and 
NR
(Lee et al., 2001)
Gli3 Variable ocular phenotypes from normal optic cup and lens (Franz and Besecke,
pit to persistent optic vesicle with no evidence of lens 1991; Hui and Joyner,
development 1993)
Otx2, Missing forebrain and hindbrain structures in mice, (Matsuo et al., 1995;
OTX2 micro/anopthalmia in humans Ragge et al., 2005a)
Pax 2 Defects in optic nerve development, coloboma (Favor et al., 1996)
Foxgl Ventrally rotated ellipsoid eyes, defective nasal retina (Freund et al., 1996)
Hesxl Anophthalmia (Dattani et al., 1999)
Msxl,2 Double null: arrest in eye development, Msx2 overexpression: (Rauchman et al.,
microphthalmia 1997; Wu et al., 2003)
Bmp7 Anophthalmia (Wawersik et al., 
1999)
SOX2 Anophthalmia (Fantl et al., 1995; 
Ragge et al., 2005b)
SIX6 Bilateral anophthalmia and pituitary anomalies (Gallardo et al., 2004)
Table 1.1 List of genes known to cause microphthalmia in the mouse or in humans 
(capitalised italics).
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or chick, or in the human. Many of them are expressed early during eye 
development, and their absence often leads to a loss of entire parts of the eye. In 
addition, expression of a large number of other genes has been observed in the 
developing eye, at various time points and in various areas, contributing to patterning 
of the eye. Finally, a number of genes are involved specifically in retinal 
development, in particular in specification of the various cell types of the retina. 
These genes are summarised in Figure 1.3.
1.2.2 Genes expressed early during eye development and those causing eye 
phenotypes
Many of the genes in Table 1.1, such as Pax6, Rx, Hesxl, Six3 and Otxl and Otx2, 
are expressed very early in eye development, and are thought to be involved in initial 
specification of the eye. The majority of them are anterior neural plate transcription 
factors, a group of genes whose expression is required for specification of the eye 
field (Chow and Lang, 2001). Pax6, in particular, has been studied in great detail and 
is thought to be a master regulator of eye development. It is a paired class homeobox 
gene that has maintained an extremely high level of conservation throughout 
evolution (Haider et al., 1995) and orthologues have been identified in vertebrates 
(Hirsch and Harris, 1997; Krauss et al., 1991; Li et al., 1997; Martin et al., 1992; 
Walther and Gruss, 1991), Drosophila (Quiring et al., 1994) and squid (Tomarev et 
al., 1997). In the murine eye, Pax6 is first expressed in the optic pit at E8, and by E9, 
expression is seen in the neural epithelium of the optic vesicle, the optic stalk and the 
prospective lens ectoderm and it continues to be expressed in all these cell types 
through to E l2. The essential requirement for this gene can be deduced from the 
malformation of eyes when over- or under-expressed in a variety of species (Schedl 
et al., 1996) and its ability to induce ectopic eyes in Drosophila (Quiring et al., 
1994), squid (Tomarev et al., 1997), and Xenopus (Chow and Lang, 2001) when 
misexpressed.
In mice, null mutations of Hesxl, a member of the paired-like family of transcription 
factors, lead to variable anterior CNS defects and pituitary dysplasia, as well as 
anophthalmia or microphthalmia (Dattani et al., 1999). It is expressed early in the 
mouse gastrula and anterior neural plate. Six3 and Six6 are closely-related members
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of the SIX-homeodomain family. Severe brain defects and microphthalmia in 6 cases 
of holoprosencephaly suggest a role for SIX3 in the developing anterior neural plate 
and eye (Wallis et al., 1999). In Medaka fish, misexpression of Six3 results in 
conversion of the midbrain and prospective cerebellum to RPE-containing, optic cup 
like structures, and in the appearance of ectopic Rx, Pax6 and endogenous Six3 
expression (Loosli et al., 1999). Six3 is expressed in the eye field at early gastrula 
stage whilst both Six3 and Six6 are expressed throughout optic vesicle at later stages. 
Expression of both continues in optic stalk and neural retina. Misexpression studies 
suggest importance of Six6 in retinal determination. In chick RPE cells, Six6 
misexpression leads to expression of ChxlO (C. elegans ceh-10 homeo domain 
containing homolog) and visinin, two neural retinal markers normally excluded from 
the RPE (Toy et al., 1998).
Another gene expressed early during eye development is the paired-like homeobox 
gene Rx. Its role in the early events of eye development has been established based 
on its expression pattern and gain/loss of function studies (Mathers et al., 1997; 
Zhang et al., 2000). First expressed throughout the anterior plate, and following 
neurulation, it is expressed most abundantly in the optic vesicles and later throughout 
the neural retina. By postnatal day 6.5 in the mouse, Rx is restricted to photoreceptor 
cells and the inner nuclear layer, and by 13.5, it is no longer detectable (Bailey et al., 
2004). Rx misexpression in Xenopus can expand endogenous Pax6, Six3, and Otx2 
expression in the optic region at late neurula stages (Zhang et al., 2001). Mice 
homozygous for the Rx gene are anophthalmic as optic vesicles fail to develop 
(Voronina et al., 2004).
Otx2, a member of the orthodenticle-related family of transcription factors, is 
expressed in the optic vesicle, and eventually becomes restricted to the RPE 
(Bovolenta et al., 1997; Simeone et al., 1993). In Otx2'/' mutants, forebrain and 
midbrain structures are completely missing, due to a defect in neural induction, 
making it difficult to determine its precise role in the developing eye. However, in 
chimeric embryos in which the neuroectoderm is made up of Otx2'/' cells, the 
expression of the forebrain/eye markers Six3 and Hesxl is initiated but not 
maintained, suggesting that Otx2 is not required cell-autonomously for the induction 
of anterior neural tissue, but is required for its maintenance and regional specification
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(Rhinn et al., 1998). In the human, mutations in OTX2 cause a range of severe ocular 
malformations, including bilateral anophthalmia (Ragge et al., 2005a).
1.2.3 Patterning of the developing eye
As eye development progresses, a number of genes are involved in patterning of the 
optic vesicle and subsequently the optic cup, and their expression patterns are 
restricted to various fields of the eye cup. In addition, a variety of genes are required 
for specification of the lens, which develops from the overlying ectoderm. 
Misexpression of a number of these genes, such as Pax2, Lhx2, Msxl and 2, Chxl O 
and Mitf \ result in abnormal eye phenotypes (Table 1.1), but many genes expressed 
later in development appear more robust, i.e. show no abnormal eye phenotype upon 
misexpression, perhaps due to redundancy.
Pax2 and Vox2 are both expressed early in the ventral half of the optic cup (Barbieri 
et al., 2002; Dressier et al., 1990; Nomes et al., 1990; Schulte et al., 1999), whereas 
Xbr-1 and Tbx5 are restricted to the dorsal half (Gibson-Brown et al., 1998; Isaac et 
al., 1998; Papalopulu and Kintner, 1996; Sowden et al., 2001). Misexpression of 
Vax2 in the chick dorsal neural retina leads to the ectopic expression of the ventral 
markers Pctx2, Ephb2, Ephb3 and the downregulation of the dorsal markers Tbx5, 
Ephrinb2 and Ephrinb3 (Schulte et al., 1999). By contrast, Tbx5 misexpression in the 
ventral retina leads to the down-regulation of both Vax2 and Pax2 and the ectopic 
induction of EphrinB2 and EphrinB3 (Koshiba-Takeuchi et al., 2000). These 
experiments suggest that Vax2 and Tbx5 play important roles in specifying ventral 
and dorsal fates and also highlight the potential role of ephrin signalling in the 
determination of dorsal/ventral polarity in the neural retina (Chow and Lang, 2001). 
It has been suggested that the developing retina is in fact divided into four domains 
along the dorso-ventral axis, with EphrinB2 expression localised to the dorsal-most 
domain, Tbx5 expression extending through to the two dorsal domains, and Vax 
expression localised to the ventral-most domain (Peters and Cepko, 2002).
Experiments in zebrafish and mice have provided evidence suggesting that retinoic 
acid (RA) also plays a role in establishing ventral polarity within the developing 
optic cup. RA-soaked beads induced a secondary choroidal fissure in any region of
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the zebrafish optic cup, and RA treatment also resulted in an enlarged optic stalk and 
in the expansion of Pax[b], the zebrafish homologue of Pax2, in dorsal region of the 
eye (Hyatt et al., 1996). In retinoid-responsive transgenic reporter mice, the 
importance of RA for morphological changes involved in choroidal fissure formation 
was also demonstrated, however it could not ventralise the retina as observed in 
zebrafish (Schulte et al., 1999). RA receptor loss-of-function mutants also highlight 
the importance of RA in the ventral retina, for example, Rxra'1' mice are 
characterised by a reduction in size of the ventral retina and by the failure of the 
optic fissure to close (Kastner et al., 1994).
Segregation of gene expression can also be observed along the anterior (nasal)- 
posterior (temporal) axis of the developing eye. Expression of BF-l/Foxgl, a 
winged-helix transcription factor, is restricted to the anterior half and BF-2/Foxdl, 
another winged-helix transcription factor, is restricted to the posterior half (Hatini et 
al., 1994). The two may regulate each other perhaps in the same manner as Pax6 and 
Pax2. In addition, two homeodomain factors of the hmx family, Sohol and Gh6, are 
expressed in the anterior neural retina. Misexpression studies in chick have shown 
that either Sohol or Gh6 can down-regulate expression of EphA3, which is normally 
restricted to the posterior neural retina (Schulte and Cepko, 2000).
Induction and development of the lens requires the expression of a variety of genes, 
including Pax6 (Ashery-Padan et al., 2000; Collinson et al., 2000; Quinn et al.,
1996), bone morphogenetic protein genes Bmp4 and Bmp7 (Furuta and Hogan, 1998; 
Wawersik et al., 1999), fibroblast growth factor (FGF) signalling (McAvoy et al.,
1991), members of the Group B1 Sox family of transcription factors (Chow and 
Lang, 2001), and forkhead transcription factors Foxe3 and Lensl (Blixt et al., 2000; 
Brownell et al., 2000; Kenyon et al., 1999).
1.2.4 Neural Retina versus RPE
Of particular interest is how the two layers of the optic cup, both derived from the 
neuroectoderm, become specified such that that anterior layer develops into the 
neural retina, and the posterior layer into the RPE. A variety of genes, as well as an
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interaction with the surrounding tissue, are involved in specifying and segregating 
the two domains.
The earliest known transcription factor expressed specifically in the presumptive 
retinal region upon close contact with the surface ectoderm (with which the 
presumptive retina interacts to achieve correct development) is encoded by the 
paired-like homeobox gene ChxlO (Burmeister et al., 1996; Liu et al., 1994b). 
Explant studies support the idea that ChxlO expression in the presumptive neural 
retina occurs in response to inductive signals from the presumptive lens ectoderm 
(Nguyen and Amheiter, 2000). Interaction with the surface ectoderm appears to be a 
requirement for retinal development, as it does not develop if the surface ectoderm is 
removed (Hyer et al., 1998; Nguyen and Amheiter, 2000). Along with ChxlO, other 
genes that appear to play an important role during this period of close contact include 
Lhx2, a LIM homeodomain-containing transcription factor, whose loss of function in 
knock out mice results in anophthalmia (Porter et al., 1997), and members of the 
fibroblast growth factor (FGF) family (Hyer et al., 1998; Nguyen and Amheiter, 
2000). Both FGF1 and FGF2 are expressed in the surface ectoderm and their ectopic 
expression leads to a thickening of the presumptive RPE that retains Pax6 and ChxlO 
expression, normally restricted to the neural retinal layer, and lacks expression of the 
helix-loop-helix transcription factor Mitf (microphthalmia associated transcription 
factor) and pigmentation, both normally associated with the developing RPE 
(Nguyen and Amheiter, 2000).
In addition, further genes are implicated in the correct development of the retina e.g. 
Msxl, Msx2 and Dlxl. Both Msxl (formerly known as Hox7.1) and Msx2 (Hox 8.1) 
are expressed in the mouse embryo during early stages of mouse development in a 
distinct spatial and temporal manner (Monaghan et al., 1991). Their expression 
pattern indicates that the inner layer of the optic cup is differentiated into three 
distinct compartments even before cellular differentiation becomes obvious. It is 
suggested that both Msxl and Msx2 are involved in regulation of the development of 
the iris, ciliary body and retina. The Msxl and Msx2 double knock out mouse shows 
an arrest in eye development* whilst overexpression of Msx2 leads to microphthalmia 
(Rauchman et al., 1997; Wu et al., 2003). Dlxl is expressed in prospective retina at 
E11.5toE14.5. Expression is restricted to the neural retinal layer, while more ventral
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parts of the eye epithelium, the prospective ciliary body and iris, are not labelled. 
Within the differentiating neural retina, labelling seems stronger in the neuroblastic 
layer (in more compacted cells). Dlxl can be used as a molecular marker of the 
prospective neural retina prior to its morphological differentiation (Dolle et al.,
1992).
RPE specification, on the other hand, is dependent on signals from the extraocular 
mesenchyme and the transcription factor Mitf. In mice, Mitf is initially expressed 
throughout the dorsal optic vesicle, but is down-regulated in the presumptive retinal 
region soon after the initiation of ChxlO expression (Bora et al., 1998), after which it 
becomes restricted to the presumptive RPE. In chick optic vesicle explants, it was 
observed that initiation of Mitf expression does not occur and that expression of 
ChxlO expands throughout the entire explant, suggesting that extraocular 
mesenchyme is required for both RPE development and for inhibition of neural 
retina development (Chow and Lang, 2001; Fuhrmann et al., 2000). The ability of 
exogenously applied activin A to rescue Mitf expression and RPE development 
makes it a good candidate for secreted mesenchymal factor that induces RPE 
(Fuhrmann et al., 2000).
When Mitf is rendered non-functional (at least 17 mutant alleles are known for this 
gene (Graw, 1996)), the RPE hyperproliferates, remains unpigmented and displays 
areas developing into a second retina, presumably through a process of 
transdifferentiation (Bumsted and Barnstable, 2000; Nakayama et al., 1998; Nguyen 
and Amheiter, 2000). It has been speculated that formation of the secondary 
transdifferentiated neural retina in Mitf mutants depends on signals such as Bmp7 
which are expressed on the dorsal side of the optic cup. Bmp7 mutants are 
anophthalmic, suggesting that BMP signalling plays an important role in the 
development of the neural retina (Wawersik et al., 1999).
The specification of the two layers of the optic cup is the result of an early inductive 
decision: neural retina versus RPE. Although morphologically distinct from an early 
stage as well as biochemically identifiable (ChxlO, Pax6 and Msx2 are preferentially 
expressed in the presumptive neural retina, for example), this determination is 
nevertheless extremely plastic. For example, regulation can occur as late as optic cup
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stages when the inner and outer layers are interchanged. Even after the RPE has 
begun to differentiate, most vertebrates can regenerate neural retina from the RPE if 
the retina is removed or damaged (Saha et al., 1992). RPE has been shown to 
transdifferentiate in response to FGF in vitro and its ability to do so is restricted to a 
specific period during development (Pittack et al., 1991). The fact that removal of the 
neural retina can result in a transformation of the RPE into neural retina indicates 
that these two layers interact during normal development. In addition, it is known 
that the RPE plays a critical role in later development of the neural retina; contact 
with the RPE is required for photoreceptor differentiation specifically, and laminar 
organisation in general (Reh, 1992). What factors the RPE and neural retina provide 
for each other is not yet resolved and needs further experimentation.
1.3. Differentiation of Retinal Cells
Birthdating and morphological studies have demonstrated that the various cell layers 
of the presumptive neural retina undergo their final mitosis and begin to differentiate 
in a precise and stereotypical fashion (Cepko et al., 1996; Young, 1985). Studies 
suggest that retinal cell determination involves cell-cell interactions together with an 
intrinsic timing mechanism that regulates the differing ability of cells to respond to 
inductive stimuli, mechanisms that are paralleled in embryonic lens and mesoderm 
induction (Cepko et al., 1996; Marquardt and Grass, 2002).
The timing and mechanisms of the commitment of a retinal progenitor cell to become 
a specific cell type are largely unknown, but it appears that progenitors usually 
become committed to a specific fate only after they exit the mitotic cycle (Cepko et 
al., 1996). Commitment of a retinal progenitor cell to a specific cell fate appears to 
depend on both intrinsic properties (regulating their competence to differentiate to a 
particular cell fate) and signals from the microenvironment. Identification of the 
environmental cues necessary to initiate the differentiation pathways for each 
specific retinal cell type is still ongoing. Nevertheless it is clear that the cornerstones 
of developmental regulation - in the eye as in other tissues -  are the signalling events 
within and between cells, and the endogenous control by transcription factors of the 
competence of cells to respond to signals (Freund et al., 1996). Thus transcription 
factors may serve to make post-mitotic retinal cells competent to respond to
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appropriate environmental stimuli, and initiate the production of signals by the cells 
that modify the microenvironment, thereby influencing the developmental program 
of neighbouring cells (Cepko et al., 1996; Freund et al., 1996).
The three successive processes that make up retinogenesis - proliferation of 
progenitors, neurogenesis, and gliogenesis - rely on changing states of RPCs over 
time. Whilst it has been proven that a single RPC can generate all 7 types of retinal 
cell, at any specific point in development, discrete populations of RPCs co-exist, 
which display differing preferences for various cell fates (Lillien, 1998). These 
inherent differences are mediated by a range of basic helix-loop-helix (bHLH) 
transcription factors, which function as cell-intrinsic regulators (Marquardt and 
Grass, 2002). These factors lie broadly within two distinct functional groups -  
repressors and activators (Hatakeyama and Kageyama, 2004). Repressors such as 
He si and Hes5 (homologues of Drosophila hairy and enhancer o f split genes) inhibit 
neuronal differentiation, instead promoting maintenance of progenitor cell status and 
also gliogenesis. In the mature mouse retina, Hesl is expressed only in CRALBP- 
positive (Furukawa et al., 2000) cells, the latest bom of the retinal cell types 
(Furukawa et al., 2000), indicative of the fact that the expressing cells have resisted 
or not been susceptible to all previous signals to differentiate. Activators, such as 
Mashl and Math5 (homologues of Drosophila proneural genes achaete-scute and 
atonal) override repressor activity and promote neural differentiation (Tomita et al., 
2000).
As well as maintaining progenitor cells or promoting differentiation, bHLH factors 
have been shown to contribute to the specification of many neuronal types from 
precursor cells during neurogenesis. The activating bHLH factor Neurodl, for 
instance, has a regulatory role in several processes in the developing rodent neural 
retina (Morrow et al., 1999a). In retinal explants from Neurodl-null mice, an 
increased Muller glial cell population was observed, and misexpression of Neurodl 
blocked gliogenesis, indicating a role for Neurodl in the regulation of the neuronal 
versus glial cell fate decision. A role in intemeuron development was also suggested 
after the observation that lack of Neurodl promoted bipolar cell differentiation at the 
expense of amacrine cells, and conversely the amacrine intemeuron population was 
expanded at the expense of bipolar cells under forced Neurodl expression (Inoue et
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al., 2002). The fact that Neurodl expression remains within a subset of mature 
photoreceptors and that in retinal explants from Neurodl-null mice a subset of 
photoreceptors underwent apoptosis also suggests Neurodl is required for the 
survival of retinal neurons (Morrow et al., 1999a).
Although activating bHLH factors promote neurogenesis and play a role in 
determining cell fate, they cannot alone specify retinal neuron subtypes. For instance, 
the bHLH genes Math3 and Neurodl are expressed by differentiating amacrine 
intemeurons and in the double knock out mice, amacrine cells are completely absent 
(Inoue et al., 2002). In addition, an increase in the numbers of ganglion and Muller 
glial cells is observed in the double mutant retina, suggesting an alteration in the fate 
adopted by a distinct population of cells. However, retinal culture studies showed 
that induced expression of either Math3 or Neurodl is not sufficient to cause an 
increase in the amacrine cell population, although gliogenesis was inhibited. 
Misexpression of Pax6 with Math3, however, increased amacrine and horizontal cell 
genesis and Pax6 with Neurodl increased amacrine cell genesis alone (Inoue et al., 
2002). These results indicate that a combination of bHLH and homeobox genes is 
required to confer specific cell fates.
Current research suggests that homeodomain transcription factors determine layer 
specificity, while bHLH transcription factors regulate neuronal fate within the 
specified layers (Hatakeyama and Kageyama, 2004). In the example above, Pax6 
specifies the INL, but without further signalling, cells do not mature. Neurodl is 
required to specify an identity from the three available cell types in the INL. Various 
combinations of transcription factors required for cell fate have been elucidated, as 
shown in Figure 1.3. Misexpression of the repressing bHLH factor He si during 
retinal development inhibits neuronal differentiation, instead promoting progenitor 
cell status (Tomita et al., 1996). This is in agreement with the suggested function of 
Hesl, which is to maintain cells in a progenitor state such that there is sufficient time 
for expansion of the retinal cell population and also a sufficient supply of RPCs 
remaining at late stages of development for generation of all retinal cell types. Those 
cells that do not stop expression of Hesl adopt the last-born cell fate (Muller glia, 
Figure 1.3)(Tomita 1996).
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Figure 13: Cascade of progressive differentiation of retinal progenitor cells to 
the seven different cell types of the neural retina. RPCs express Hesxl, Pax6 
and ChxlO. At particular points in development, subpopulations of RPCs 
express combinations of bHLH and homeobox transcription factors required for 
differentiation into a particular cell type. RPC = retinal progenitor cell, RGC =  
retinal ganglion cell, INL = inner nuclear layer, ONL = outer nuclear layer.
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As time progresses, many other genes involved in specifying and/or maintaining 
identity of cells of the neural retina, such as Crx in photoreceptors (Furukawa et al.,
1997), Brn3b (Liu et al., 2000b) in retinal ganglion cells and protein kinase C (PKC) 
in bipolar cells, are being identified (some of which are depicted in Figure 1.3). It is 
clear that, from the moment the eye field becomes specified, a complex network of 
transcription factors and signalling molecules controls the highly organised process 
of producing the correct cell types in the correct ratios in the correct areas of the 
retina. Mutations in one or more of these factors cause a variety of eye phenotypes, 
one of which is microphthalmia.
1.4 Microphthalmia
Microphthalmia, a cause of congenital blindness, is an ocular malformation 
characterised by a small eye, specifically a short total axial length (TAL) (Weiss et 
al., 1989). Examples of microphthalmic eyes are shown in Figure 1.4. It may or may 
not be accompanied by other ocular abnormalities, such as cataracts, microcomea, 
sclerocomea, and retinal or optic-nerve coloboma (a gap in structure of the eye). 
There are thought to be over 150 causes of microphthalmia, ranging from a variety of 
genetic mutations to disruption of the intrauterine environment (Bateman, 1984; 
Warburg, 1993) and it may manifest itself as a part of a syndrome. Severity of the 
disease often ranges from mild to clinical anophthalmia (Kubo et al., 2005), even 
within a single family, suggesting variable gene expression (Warburg, 1993). There 
are more than 100 inherited conditions inducing microphthalmos and coloboma; 
approximately 50 different autosomal dominant, 67 autosomal recessive, and 16 X- 
linked syndromes with microphthalmia and coloboma, and this wide spectrum of 
genetic microphthalmia conditions is reflected in the volume and variety of entries 
regarding microphthalmia entered onto the Online Mendelian Inheritance in Man 
(OMIM) database. In some disorders, ocular manifestations are isolated signs, 
(Pearce, 1986), but it is more common that systemic features are part of the 
symptomology. A variety of deletions and translocations, occurring in a variety of 
chromosomes, may give rise to microphthalmia or coloboma (Warburg, 1993). The 
reported prevalence of these conditions has varied between 0.22 and 3.48 per 10000, 
partly due to a great variability in the inclusion criteria used in different registers
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Normal eye
Microphthalmic eye
Figure 1.4: Examples of microphthalmia in human patients. A: an example of 
bilateral microphthalmia. Photo from Ferda et al, 2000. B : Comparison of a 
normal eye versus a microphthalmic eye. Photos kindly provided by Dr. Bart 
Leroy, Dept, of Ophthalmology, Ghent University Hospital, Ghent, Belgium.
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(Bermejo and Martinez-Frias, 1998; Busby et al., 1998; Castilla, 1994; Kallen et al., 
1996; Morrison et al., 2002; Stoll et al., 1992; Warburg, 1993). For example, in some 
studies, a distinction was made between isolated microphthalmia or anophthalmia 
and those that were associated with a syndrome (Bermejo and Martinez-Frias, 1998; 
Castilla, 1994), whilst others grouped all ocular malformations together (Busby et al., 
1998; Kallen et al., 1996; Morrison et al., 2002).
Microphthalmos appears to be a fairly common ocular malformation in all races. The 
high incidence, which would be unusual for a disorder caused by a single gene 
suggests multiple etiologies (Bateman, 1984). Thus, nonsyndromic simple 
microphthalmia is clinically and genetically heterogeneous, and may be inherited in a 
number of manners. A number of families have been studied in which simple 
microphthalmos seems to be inherited in an autosomal dominant (Fryns, 1995; 
Othman et al., 1998; Pearce, 1986; Vingolo et al., 1994), autosomal recessive 
(Bateman, 1984; Bessant et al., 1998; Ghose et al., 1991; Kohn et al., 1988; 
Warburg, 1993; Zlotogora et al., 1994), and X-linked manner (Graham et al., 1991; 
Hoefnagel et al., 1963).
For all of the above forms, one or more loci have been identified. Two loci have been 
identified in families in which the disease is inherited in an autosomal dominant 
manner: one shows linkage to chromosome 15ql2-ql5 (Morle et al., 2000), and 
another is the NNOl locus, on chromosome 11 (Othman et al., 1998). In a family 
with autosomal recessive inheritance of the disease, a locus for isolated 
microphthalmia was mapped to chromosome 14q32 (Bessant et al., 1998), and in a 
family with X-linked inheritance of clinical anophthalmos, a gene is localised to the 
Xq27-28 (Graham et al., 1991). Another locus (Male et al., 2002) was identified 
through the association of microphthalmia and anophthalmia with chromosome 
rearrangements involving distal 3q (Male et al., 2002; Yokoyama et al., 1992), whilst 
another locus has been inferred by the co-segregation of a translocation, t(2:16), with 
the phenotype, suggesting a gene on the 16pl3.3 band is responsible (Yokoyama et 
al., 1992).
Although a number of loci have been identified, very few genes have been shown to 
cause microphthalmia. The first to be identified was CHX10 (Ferda et al., 2000).
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Table 1.2 summarises the known loci and genes for non-syndromic simple 
microphthalmia.
Known Loci Reference
15q 12-q 15 (Mode et al., 2000)
HP (Othman et al., 1998)
14q32 (Bessant et al., 1998)
Xq27-q28 (Graham et al., 1991)
16pl3.3 (Yokoyama et al., 1992)
3q26.33-q28 (Male et al., 2002)
Known Genes
CHX10 (Ferda et al., 2000)
SOX2 (Fantes et al., 2003; Ragge et al., 2005b)
RX (Voronina et al., 2004)
OTX2 (Ragge et al., 2005a)
Table 1.2: Known loci and genes for non-syndromic simple 
microphthalmia
1.5 The CHX10 gene
In a recent study, a locus for isolated human microphthalmia has been mapped on 
chromosome 14q24.3, and the gene at this locus identified as human homeobox 
transcription factor CHX10 (Ferda et al., 2000). As described above, CHX10 is 
known to be an important gene for neural retinal specification. A point mutation in 
the DNA recognition helix of the homeodomain renders the CHX10 protein unable 
to bind to DNA and thus abolishes its function. This was the first human 
microphthalmia gene to be identified -  three others, the RX (Voronina and Mathers,
2000), SOX2 (Fantes et al., 2003) and OTX2 (Ragge et al., 2005a) genes, have been 
recently discovered -  and accounts for approximately 2% (2/117) of the patients with 
nonsyndromic microphthalmia examined (Ferda et al., 2000).
The discovery of CHX10 as a gene for human microphthalmia can be attributed to 
the similarity that was observed between human microphthalmia and a mouse mutant 
with an effective null mutation in the homologous gene ChxlO. In 1962 a mutant 
mouse with small eyes, a soft and irregular lens, and a thin and undifferentiated 
retina was described, and designated ocular retardation, or (Truslove, 1962). A 
second allele of the mutation, o / ,  was discovered in 1973 (Theiler et al., 1976), 
demonstrating recessive inheritance with complete penetrance. Its phenotype has 
been described in detail by a number of authors, and includes a reduction in the size
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of the eye with an uneven retina in which most of the cell layers are disorganised 
(Burmeister et al., 1996; Robb et al., 1978; Theiler et al., 1976).
ChxlO co-segregates with the o/  locus, and this ocular retardation allele is an 
effective null allele of ChxlO. A point mutation near the midpoint of ChxlO mRNA, 
leading to a premature stop codon, is thought to result in a truncated form of the 
protein, which is quickly degraded (Burmeister et al., 1996). The similarity between 
this phenotype and that of human microphthalmia led to the cloning of the human 
CHX10 gene (Liu et al., 1994b), and the identification of mutations in this gene 
giving rise to a recessively inherited form of the disease (Ferda et al., 2000).
The murine ChxlO gene encodes a 361 amino acid polypeptide with a predicted mass 
of 39 kDa. The homeodomain is situated between residues 148 and 207. Like many 
other homeobox transcripts, the ChxlO mRNA has a long 3’ untranslated region (Liu 
et al., 1994b). The ChxlO homeodomain is 58-65% identical to a series of paired 
(prd)-like homeodomains, and the deduced protein contains an octapeptide between 
residues 33 and 39, much like several other putative transcription factors with prd- 
like homeodomains (Figure 1.5; (Liu et al., 1994b). It has been speculated that 
conserved homeodomain sequence also indicates a conserved function. One example 
of this is the Drosophila eyeless gene, highly related in protein sequence to 
mammalian Pax-6 genes (Quiring et al., 1994). Both are expressed in the developing 
eye of their respective embryos and eye formation is severely affected by their 
mutation. In the same way, ChxlO is thought to be related in function to the prd-like 
homeodomain genes goldfish vsx-1 and C. elegans ceh-10. In addition to a high level 
of sequence identity in the homeodomain, all three express a second domain, termed 
the CVC domain. The function of this domain is unclear but may serve as a DNA or 
protein binding site (Svendsen and McGhee, 1995).
1.5.1 ChxlO Expression During Eye Development
ChxlO expression in the eye is observed as early as embryonic day 9.5 (E9.5) 
(Burmeister et al., 1996). At this stage of eye development, the optic vesicle, an 
evagination from the diencephalon, is in contact with the surface ectoderm (Chow 
and Lang, 2001). ChxlO expression is restricted to the anterior (outermost) region of
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NTF
32-39 117-138 148-207 208-264
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Figure 1.5: Organisation of the ChxlO polypeptide sequence. The octapeptide is 
found close to the N-terminus in ChxlO and related homeodomain proteins, a 
serine/threonine region is located N-terminal to the homeodomain, and a 
potential nuclear localisation signal overlaps the N-terminus of the 
homeodomain. The CVC domain lies C-terminal to the homeodomain, and there 
is a small region high in acidic amino acids in the C terminus.
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the optic vesicle, which will form the future neuroretina (Liu et al., 1994b); Figure 
1.6A). At E10, invagination of the optic vesicle is initiated, creating the optic cup, 
composed of two layers. The overlying ectoderm thickens to form the lens placode, 
from which the lens and cornea will develop. ChxlO remains expressed in the 
presumptive neuroretina, the inner layer of the optic cup (Figure 1.6A). The outer 
layer of the optic cup will form the retinal pigmented epithelium (RPE). Expression 
of ChxlO persists in the presumptive neuroretina until the onset of differentiation 
(around E ll), after which it is maintained in dividing neural progenitors of the 
neuroblastic layer only (Figure 1.6B-E). By the time retinal differentiation is 
complete (around postnatal day 11 or PI 1) (Young, 1985); (Cepko et al., 1996) and 
there are no more proliferating retinal progenitor cells, ChxlO expression is restricted 
to the inner nuclear layer (INL) of the retina, specifically to the bipolar cells, 
although a recent study using a novel multifunctional BAC transgenic reporter 
identified the expression of ChxlO in a subset of Muller glial cells, also located in the 
INL (Rowan and Cepko, 2004). This expression in the INL is maintained in the 
mature retina.
Although ChxlO is a transcription factor, its downstream target or targets have yet to 
be identified. Examination of the mouse mutant ChxlO'A has provided some clues to 
the function of this transcription factor, but a clear picture is yet to be established. In 
a broader sense, the mutant is one of several models of microphthalmia that are 
providing information about the various genes involved in eye development. Thus, 
examination of the mutant and elucidation of downstream targets may not only 
provide clues to the function of ChxlO itself, but also provide more information 
about genes required for eye development, necessary to understand and treat 
microphthalmia and other retinal disorders.
1.5.2 A Role in Specification and Differentiation of the Neural Retina
Based on its expression pattern, a number of roles for the ChxlO gene have been 
proposed: as it is expressed at an early stage, and throughout the presumptive neural 
retina, ChxlO may specify the presumptive neuroretina in the early optic vesicle and 
optic cup, most likely in combination with other transcription factors, such as
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optic pit optic vesicle optic cup formation optic cup
early lens
Figure 1.6: ChxlO expression during retinal development. A: Schematic 
representation of early eye development, with expression of ChxlO depicted in 
purple. ChxlO is first observed throughout the anterior part of the optic vesicle 
at E9.5 in the mouse. ChxlO expression then continues to be expressed in 
proliferating retinal progenitor cells of the neural retina. B-E: As development 
progresses, and cells of the neural retina begin to differentiate, ChxlO becomes 
restricted to the proliferating neuroblastic layer of the developing retina. B and 
D : Haematoxylin and eosin staining of mouse El 8.5 and human 13 week retina 
respectively. C  and E: In situ hybridisation at the same time points showing 
ChxlO expression in neural progenitors of the proliferative neuroblastic layer 
(NBL). GCL = ganglion cell layer. In situ data kindly provided by Dr. A. 
Rutherford, a former member of the Sowden lab.
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microphthalmia-associated transcription factor (Mitf), the transcription factor 
necessary for specifying the RPE (Liu et al., 1994b). As it is initially present in all 
RPCs, and then becomes restricted to bipolar cells in the INL, ChxlO may also have 
a specific role later in eye development, during bipolar cell differentiation. It may 
determine the identity of cells in the INL and/or boundaries of the INL (Burmeister 
et al., 1996; Liu et al., 1994b) and in the mature retina, the differentiated cells of the 
neuroretina, particularly the bipolar cells, may be maintained by ChxlO expression 
(Burmeister et al., 1996; Liu et al., 1994b).
Such roles in differentiation are consistent with observations regarding other 
homeobox genes. As described earlier, homeobox genes are frequent determinants of 
pattern formation, and in many cases, their activity may extend over a region of the 
embryo containing a variety of cell types, such as the layers of the retina, rather than 
being restricted to a single developing cell type (Krumlauf, 1993a; Krumlauf, 1993b; 
Liu et al., 1994b; Morata, 1993). Misexpression studies of bHLH genes Mash-1 and 
Math3, and the homeobox gene ChxlO, support the idea that ChxlO is important for 
the specification of the cells of the INL. ChxlO seems to provide the inner nuclear 
layer specific identity, while the bHLH genes regulate neuronal versus glial fate of 
the INL retinal neurons, thus leading to the differentiation of bipolar cells 
(Hatakeyama et al., 2001). Both sets of genes are necessary for the differentiation of 
bipolar cells, but they play different roles. In the ChxlO'/_ mutant, differentiation of 
neural retinal cells other than bipolar cells also seems to be indirectly affected, with a 
delay in the differentiation of some of the other cells such as the photoreceptors, and 
a decrease in size of the inner and outer segments of photoreceptor rods (Burmeister 
et al., 1996). Thus, ChxlO may play a role (direct or indirect) in differentiation of all 
retinal cell types.
1.5.3 A Role in Retinal Progenitor Cell Proliferation
ChxlO is also thought to be important in undifferentiated precursors. The primary 
role of ChxlO in these RPCs seems to be to promote proliferation, as has been 
concluded from studies of the ChxlO'A mutant mouse. Using bromodeoxyuridine 
(BrdU) incorporation as an assay for cell proliferation, it was observed that by El 1.5, 
there was an 83% reduction in BrdU incorporation in the periphery of the retina, and
45
that total cell number throughout the retina was decreased by 30-50% (Burmeister et 
al., 1996). The apparent decrease in proliferation in the periphery was observed 
between E l0.5 and E l8.5. It was suggested that this might account for the fact that 
the volume of the mutant retina is only one half that of controls at E l0.5 and one 
tenth that of controls at E l8.5 (Burmeister et al., 1996). These data suggest that 
ChxlO influences RPC division during much or all of retinal formation.
In another study, it was observed that the phenotype is partly ameliorated when 
expressed on a different background (Mus musculus castaneus instead of 129/SV) 
(Bone-Larson et al., 2000). However, one prominent feature of the original mutant 
phenotype was not rescued: the periphery of the modified Chxl0'A retina showed 
both incomplete growth and a lack of differentiated cells. Since this aspect of the 
ocular retardation phenotype was not ameliorated, it is likely that ChxlO plays a 
fundamental role in the central-to-peripheral gradient of retinal development. Thus, 
again a decrease in proliferation in the periphery of the retina was observed, with 
relatively few changes in the central retina. A decrease in proliferation is one of three 
developmental mechanisms proposed to explain the resulting phenotype (a decrease 
in only peripheral proliferation, but a reduction in cell number throughout the entire 
retina). There are a number of other possibilities that may account for the reduction 
in cell number observed in the above study. The first is an increase in cell death, but 
this is unlikely, as cell death has been shown to decrease in Chxl0'A mutants (Robb 
et al., 1978; Theiler et al., 1976). A second possibility is that the population of 
progenitors selected to continue along a neurogenic line could be reduced at the 
outset of ocular morphogenesis. Even at a normal rate of proliferation, (which seems 
to be occurring in the central retina according to the above study) a small reduction 
in the number of progenitors can lead to the reduction in cell numbers observed 
throughout the retina (Bone-Larson et al., 2000). This possibility has yet to be 
explored.
However, even though an apparent decrease in cell proliferation, as assayed by BrdU 
incorporation, is observed only in the periphery of the mutant retina, a change in cell 
proliferation seems to be the most likely explanation of the mutant phenotype. One 
suggestion that would be consistent with the observed data is that ChxlO prolongs 
Gl, an observation made in studies using 3H-thymidine injections to estimate the
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percentage of mitotic figures present in the developing wild type and ChxlO null 
mutants (Konyukhov and Sazhina, 1966). In this way, apparently normal 
proliferation in the central retina, as assayed by BrdU incorporation, may still give 
rise to a smaller retina. That a homeobox gene such as ChxlO might regulate cell 
proliferation is in agreement with recent proposals of a similar function for some 
Hox genes during development (Condie and Capecchi, 1993; Condie and Capecchi, 
1994; Dolle et al., 1993; Duboule, 1995). For example, it was shown that disruption 
of the Hoxd-13 gene induces localised heterochrony -  retardation in morphogenesis 
during development - leading to mice with neotenic limbs (Dolle et al., 1993).
1.5.4 ChxlO and the Cell Cycle
It is reasonable to speculate that if ChxlO plays a role in proliferation, it may play a 
role in control of the cell cycle. Some evidence for this is coming to light. A 
relatively well-known mechanism for cell cycle exit is the dephosphorylation of the 
negative cell cycle regulators protein retinoblastoma (pRB), p i07 and p i30 and their 
subsequent binding to E2F family proteins that encourage proliferation (Figure 1.7). 
A loss of pRB results in the formation of retinoblastoma tumours. Despite their 
ubiquitous expression during embryogenesis, however, the specific loss of pRB or 
pi 07 together with p i30 disrupts the normal development of only a very limited 
spectrum of tissues (Wiggan et al., 1998). Previously such disruptions have been 
attributed to deregulation of E2F activity and consequent failure to exit cells cycle to 
allow differentiation.
It has been suggested that the tissue specific effects of losing specific pRB-family 
proteins (including effects in the retina) may also be a consequence of deregulation 
of the activity of other novel pRB-associated factors that are involved in determining 
cell fate. This led to the discovery of an interaction between the pRB-family proteins 
and a class of homeoprotein domain-containing developmental factors, including 
Mhox, Pax3, and ChxlO in vitro. As with the interaction with E2F, the consequence 
of these interactions is repression of activated transcription by these proteins 
(Wiggan et al., 1998). Thus, it can be postulated that activated unphosphorylated 
pRB may bind to ChxlO and repress either its transcription of cell differentiation 
genes, or its repression of cell cycle genes -  it is unknown which action ChxlO
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Figure 1.7: Depiction of the cell cycle and how various cell cycle proteins 
interact with or are affected by ChxlO. Upon exit from the cell cycle, pRB is 
thought to bind to E2F and ChxlO to promote differentiation. P27Kipl is 
upregulated upon exit from the cell cycle, and its overexpression inhibits 
proliferation. Cells continuing into the cell cycle, require expression of cyclin 
Dl, whose absence results in a hypoblastic retina. As pRB is phosphorylated, 
E2F and ChxlO are released and can bind to DNA to promote 
proliferation/repress differentiation.
DNA
ChxlO
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exerts. This interaction, illustrated in Figure 1.7, provides a potential mechanism for 
integrating the process of cellular proliferation and differentiation -  two processes in 
which ChxlO appears to be involved.
Just as deregulation of pRB gives rise to retinal abnormalities relating to 
proliferation, a number of other cell cycle components have been shown to be 
involved in retinal disease or abnormalities. A study of the knockout mouse for 
cyclin D l, a cell cycle component necessary for pRB phosphorylation by cyclin 
dependent kinase and expressed ubiquitously during embryogenesis, reveals that 
only a few tissues, including the retina, are sensitive to its absence. Nullizygous mice 
revealed a striking reduction in thickness and organisation of the retinal layers (Fantl 
et al., 1995). Comparison of cell numbers in the two nuclear layers confirmed that a 
reduction in thickness was most marked for the outer layer and accompanied by 
disorganisation of nuclear polarity. A reduction in thickness and organisation of the 
surface ganglion cell layer was also seen (Fantl et al., 1995). A lack of cyclin D1 
seems to affect only proliferation, and it would therefore be interesting to see if 
cyclin D1 has any relationship with ChxlO.
Another interesting cell cycle component, which might have some relationship with 
ChxlO, is the cyclin-dependent kinase inhibitor p27Kipl (Figure 1.7). In vitro analyses 
show that p27K,pl accumulation in retinal cells correlates with cell cycle withdrawal 
and differentiation, and when overexpressed, it inhibits proliferation of the 
progenitor cells (Reh and Levine, 1998). Results from another recent publication 
suggest that p27Klpl is abnormally present in progenitors of the ChxlO'f' mutant 
mouse, and that its deletion rescues the mutant phenotype (Green et al., 2003). It was 
suggested that ChxlO influences p27Klpl at a post-transcriptional level, through a 
mechanism that is largely dependent on cyclin Dl. Additionally, deletion of the 
p27Kipl gene restores normal development of cyclin Dl deficient mice (Geng et al.,
2001). Thus, these cell cycle regulators may play an important role in ChxlO 
regulation of neural retinal progenitor proliferation. Table 1.3 summarises how 
ChxlO is thought to interact with various cell cycle proteins.
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Cell Cycle Role in Cell Cycle Phenotype upon deletion Relationship with
Component ChxlO?
pRb Negative cell cycle regulator, Retinoblastoma tumours - Yes
binds E2F to cause exit of uncontrolled proliferation (Wiggan et al.,
cell cycle 1998)
Cyclin Dl Activates cyclin dependent Severe retinopathy - Suspected
kinases cdk4 and cdk6, impaired development of (Green et al.,
drives cell cycle progression all retinal layers 2003)
P27Kipl Inhibits cyclin dependent Normal period of Yes
kinases, required for timing histogenesis of (Green et al.,
of cell cycle withdrawal photoreceptors and Muller 
glia is extended
2003)
Table 1.3: Cell cycle components potentially affected by or under control of ChxlO
1.6 Retinal Stem Cells
The role of ChxlO in proliferation of neural retinal progenitor cells is of great interest 
because of the profound reduction in volume of the retina observed in the 
microphthalmia phenotype. There is however, an additional reason why this role is of 
interest: contrary to past belief, there is a possibility that a RPC- or stem cell-like 
cells may exist in adult warm-blooded vertebrates, which may be a source of new 
strategies in treating retinal degenerative disease. There is some evidence that both 
birds and mammals may have a source of proliferating retinal progenitors in the 
equivalent of the frog and fish ciliary marginal zone (CMZ) (Figure 1.8A, B) 
(Ahmad et al., 2000; Fischer and Reh, 2000; Perron and Harris, 2000b; Tropepe et 
al., 2000). It has long been clear that amphibian and fish eyes grow postnatally, with 
cells from the ciliary marginal zone at the periphery of the retina exiting a pool of 
progenitors, differentiating and migrating and integrating within the retina (Reh and 
Levine, 1998; Wetts et al., 1989) (Figure 1.8A and B). An upregulation of these 
proliferating cells is observed upon retinal damage (Reh and Levine, 1998). Until 
recently, no such mechanism was believed to exist in birds or mammals. However, a 
proliferating marginal zone of retinal progenitors equivalent to the frog CMZ has 
recently been identified in chickens (Fischer and Reh, 2000). These cells show many 
similarities with embryonic RPCs: they expressed both Pax6 and ChxlO, a pattern of
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Figure 1.8: Stem cells and progenitor cells in the Xenopus and mammalian eye. 
(A) Schematic diagram of a section of the adult Xenopus retina. The ciliary 
marginal zone (CMZ, pink) is located at the periphery of the retina (red). (B) The 
box in A is magnified in B. The retinal stem cell-containing region is located at the 
peripheral edge of the CMZ. More centrally, progenitors mature progressively and 
new neurons are added to the retina at the most central region of the CMZ. (C) 
Schematic diagram of a section of an adult mouse retina. (D) The box in C is 
magnified in D. Stem cells have been isolated from the pigmented ciliary 
epithelium (purple), a forward continuation of the retinal pigmented epithelium 
overlying the ciliary body. This, in turn, is overlaid by a non-photosensitive 
forward continuation of the neural retina (red), the non-pigmented ciliary 
epithelium. Figure adapted from Perron and Harris, 2000.
Pigmented
ciliary
epithelium
(purple)
pigmented
ciliary
epithelium
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Figure 1.9: Model of cycling behaviour in wild type and C h x l O CE cell 
culture. In the wild type CE (A), a stem cell-like cell gives rise to progenitor cells 
that can cycle and/or produce differentiating cells. ChxlO expression in 
progenitors regulates a feedback mechanism (blue arrow), limiting the number of 
stem cell divisions and therefore the number of colonies observed, however 
cycling of progenitors results in a large colony. In the ChxlO'1' retina, progenitor 
cells do not express ChxlO, and without its inhibiting effects, the population of 
stem cell-like cells expands (blue arrow), resulting in relatively more 
neurosphere colonies than in the wild type CE. However, lack of ChxlO also 
decreases proliferation of progenitors (red arrow), resulting in relatively smaller 
colonies.
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expression seen only during embryonic retinal progenitor proliferation, as Pax6 and 
ChxlO are expressed in different cells in the differentiated retina. Proliferation was 
observed with both BrdU and proliferating cell nuclear antigen (Kurki et al., 1988) 
labelling. Such undifferentiated cells were shown to integrate into the retina, 
although they showed no change in proliferation upon retinal damage. Similar cells 
have been identified in quail and opossum although no such cells were identified in 
mouse (Kubota et al., 2002).
The cells described above may be classified as neural stem cells based on the 
following definition of neural stem cells:
a) They are derived from embryonic stem cells or from the nervous system.
b) They generate neural cells.
c) They have some capacity for self-renewal.
d) They can give rise to cells other than themselves through asymmetric division 
(Gage, 2000).
It remains difficult to deduce the difference between stem cells and progenitor cells 
derived from them, which may have similar properties but only undergo a limited 
number of divisions and give rise to fewer cell types. In a culture system, a small 
number of cells from the pigmented ciliary epithelium of the ciliary body of both 
embryos and adult mice grew from single cells into small spheres, which showed 
multipotentiality and self-renewing properties (Tropepe et al., 2000). These 
pigmented cells were therefore designated stem cells, and the non-pigmented cells 
arising from the resulting neurospheres were designated neural retinal progenitors, as 
they showed no capacity to self-renew, but expressed ChxlO and were multipotential 
(Tropepe et al., 2000). A similar experiment using cells isolated from the pigmented 
ciliary epithelium of the adult rat eye also led to the designation of a number of cells 
as “retinal progenitor cells with stem cell like properties” -  they were shown to self- 
renew and were multipotential (Ahmad et al., 2000). These cells were thought to be 
quiescent in vivo, with only a fraction dividing, and responding to treatment with 
fibroblast growth factor 2 (FGF2) in vitro.
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Embryonic neural retinal progenitor cells, from human foetuses at 6-13 weeks after 
conception, have also been cultured and maintained for over 300 days and passaged 
more than 10 times. These cultures were expanded with addition of epidermal growth 
factor (EGF) and FGF2 (Kelley et al., 1995a). This expansion of primary cultures of 
human retinal progenitors was thought to have potential for providing a source for 
transplantation to treat degenerative conditions of the retina such as macular 
degeneration and retinitis pigmentosa. Whilst this is still true, the above-mentioned 
experiments suggest that there may now be an additional source in adults, one that 
may be exploited by encouraging proliferation rather than by transplantation.
The role ChxlO plays in these putative stem cells is of great interest. In the above- 
mentioned experiment using mouse retinal cell cultures, it was observed that the 
number of spheres arising from the pigmented ciliary epithelium in ChxlO*A mouse 
increased compared to controls, but the spheres were also smaller. It was postulated 
that the presumptive stem cells observed give rise to Chx 10-expressing neural retinal 
progenitor cells, which in turn exerted a form of feedback on the stem cells. Without 
the presence of ChxlO, this feedback would be decreased, leading to a larger number 
of stem cells, but the colonies would be smaller due to the lack of proliferation as a 
result of ChxlO absence (Figure 1.9). Although this is an interesting premise, an 
important question that arises is whether presumptive stem cell and neural retinal 
progenitor cell are one and the same, as is suggested by other studies, in which such 
cells are labelled as neural retinal progenitor cells with stem cell-like properties. The 
peripheral region of the eye is of particular interest, as it is where the presumptive 
stem cells are located, as well as the area of the eye where proliferation seems most 
affected in the Chxl0'f' mutant eye.
1.7 Aims
In this study, I wished to achieve the following objectives:
1. To identify downstream targets of ChxlO and potential genes involved in 
microphthalmia through use of microarray technology. By this method I aimed to 
discover the molecular basis of the phenotype i.e. learn more about the genetic
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pathway in which ChxlO is involved, how it might control retinal size, and identify 
new candidate genes for microphthalmia.
2. To further characterise the cellular defect observed in the ChxlO null phenotype, 
and in particular examine how the behaviour of RPCs may be altered.
3. To explore the possibility that dividing cells exist in the adult mutant and wild 
type retina and to test the hypothesis that lack of ChxlO causes a persistence of stem 
cell-like cells in the adult retina. This should lead to a greater understanding of the 
biology of stem cells and clearer view of the potential of stem cell therapy in retinal 
disease.
I have used the ChxlO'A (ChxlO null) mouse as a model for microphthalmia, as 
similar phenotypes are observed in mice and humans when a mutation occurs in their 
respective ChxlO genes (Ferda et al., 2000). With use of gene microarrays, which 
allows the investigation into the expression of thousands of genes, differential gene 
expression was studied in order to discover what genes are up- or down-regulated as 
a result of ChxlO absence. As ChxlO is a transcription factor, it is possible that it 
may have one or more direct downstream targets, which could be identified using 
this approach.
To explore how ChxlO affects cell proliferation during development and in the adult 
retina/ciliary margin, a series of immunocytochemistry experiments were undertaken 
on sections of eyes from both wild type and mutant mice at different time points 
during development and in the adult. Cell cycle markers including histone 3 (H3) and 
proliferating cell nuclear antigen (Kurki et al., 1988) were used in conjunction with 
neural/retinal cell markers in order to ascertain whether the lack of ChxlO has any 
effect on their expression. In addition, flow cytometry experiments were conducted 
to examine RPCs in various stages of the cell cycle.
To explore how ChxlO affects cell proliferating in the adult retina/ciliary margin, a 
BrdU study was initiated to identify and localise any cycling cells in vivo. In 
addition, cell cultures of dissected wild type and ChxlO_/' retina were set up to 
examine whether adult retinal or ciliary margin cells could proliferate in vitro.
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It is hoped the results presented here will give a greater understanding of the role of 
ChxlO in proliferation and differentiation of neural retinal progenitors, which might 
be the basis for future strategies to address such 
conditions as microphthalmia or neural retinal degenerative diseases.
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CHAPTER 2 
Materials and Methods
58
2.1 Materials
2.1.1. General lab reagents and solutions
2.1.1.1 General Reagents
AnalaR grade reagents obtained from either British Drug Houses (BDH) or Sigma 
Aldrich were used except where indicated otherwise.
Glassware, solutions and media were autoclaved at 15psi, 121 °C for 20 minutes as 
required.
Distilled water (dH20): Water was purified using a MilliRo 15 Water Purification 
System (Millipore, SA), or further purified using a Milli-Q Plus Ultra Pure Water 
System (Millipore), and sterilised by autoclaving as necessary.
A 1:1000 dilution of diethylpyrocarbonate (DEPC, Sigma) was added to solutions 
stated to be DEPC-treated, left at 37° C overnight, and subsequently autoclaved.
2.1.1.2. General Solutions
Phosphate buffered saline 0.16M sodium chloride, 0.003M potassium chloride,
(PBS): 0.008M disodium hydrogen phosphate, 0.001M
potassium dihydrogen phosphate, as PBS tablets from 
Oxoid, 1 tablet per 100 mis.
PBST: PBS with 0.1% Tween-20
4%PFA: 16 g paraformaldehyde was dissolved in 350 ml
DEPC-treated PBS, heated to 65°C on stirrer until 
solution was clear. The solution was then adjusted to 
400 ml.
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0.5 M EDTA: 186.lg of disodiumethylene-diaminetetraacetate.2H20 
was added to 800 ml (IH2O, adjusted to pH 8.0 with 
NaOH pellets, adjusted to pH 7.5 with HC1 if required, 
made up to 1L with (IH2O and autoclaved.
1M Tris (also referred to 121 g Tris base (Trizma base, Sigma) was dissolved in
2.1.1.3 Other general materials
TESPA (3-aminopropyltriethoxysilane, Sigma) coated slides:
Slides (1 mm Superfrost, VWR) were loaded into glass holders and dipped 
successively in troughs containing:
10%HCl/70%EtOH in DEPC H20  
DEPC H20
95% EtOH in DEPC H2O for 30 seconds each.
Slides were left to dry in a 65°C oven. Slide holders were then dipped 
successively in troughs containing:
2% TESPA in acetone,
2 x 100% acetone,
DEPC H2O for 30 seconds each.
Slides were left to dry in a 37°C oven.
as TrisHCl): 800 ml (IH2O and the pH adjusted by adding 
concentrated HC1. Solution was allowed to cool to 
room temperature before making final pH adjustment. 
The solution was made up to 1L with dH2 0  and 
autoclaved.
5M NaCl:
1M MgCl2.
292.2 g of NaCl were dissolved in 800 ml dH20. The 
solution was adjusted to 1L and autoclaved.
203.3g ofMgCl2.6H20  was dissolved in 800 ml dH20. 
The solution was adjusted to 1L and autoclaved.
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2.1.2 Reagents for GeneChip Assay
2.1.2.1. RNA preparation
Tri Reagent:
Isopropanol:
Sigma
Sigma
Pellet Paint NF Co-Precipitant: Novagen
2.1.2.2. RNA gel electrophoresis
Agarose: Gibco
Formaldehyde: Sigma
Ethidium bromide: Sigma
0.24-9.5 kb RNA ladder: Gibco
lOx MOPS buffer: 0.2M 3-(N-morpholino) propanesulfonic acid
(MOPS), 50 mM sodium acetate trihydrate, 10 
mM EDTA
RNA denaturing loading buffer: For 3.72 ml: 24 mg Orange G (Sigma), 300 pi
glycerol, 450 pi lOx MOPS, 720 pi 
formaldehyde, 2.25 ml formamide
2.1.2.3 Agilent 2100 Bioanalyser Reagents
RNA 6000 Nano LabChip(R) Kit: Molecular Probes, Inc.
RNA Nano Chips
Electrode Cleaners
RNA 6000 Nano Reagents 
and Supplies:
RNA 6000 ladder:
Molecular Probes, Inc.
RNA Nano Dye Concentrate 
RNA 6000 Nano Marker 
RNA 6000 Nano Gel Matrix 
Spin filters 
Ambion
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2.1.2.4. Target cRNA preparation
-First cycle of amplification -  cDNA synthesis:
T7-oligo(dT) promoter primer,
HPLC-purified: Affymetrix
200U/pl Superscript II, 5x first strand buffer, 0.1M DTT, lOmM dNTP mix, 5x 
second strand buffer, DNA ligase (E. coli), DNA polymerase I (E. coli), RNase H, 
T4 DNA polymerase: Invitrogen
RNasin (recombinant): Promega
Glycogen: Roche
5M ammonium acetate: 385g ammonium acetate was dissolved in 800
ml dH20
-First cycle - IVT for cRNA amplification:
MegaScript T7 kit: Ambion
RNeasy Mini Kit: Qiagen
-Second cycle of amplification and labelling -  cDNA synthesis:
Random primers: Invitrogen
Reagents as in first cycle cDNA synthesis 
GeneChip Sample Cleanup 
Module: Affymetrix
-Second cycle -  IVT for cRNA amplification and labeling:
ENZO BioArray High Yield RNA Transcript Labelling kit -  Affymetrix GeneChip 
Sample Cleanup Module: Affymetrix
62
2.1.2.5. Fragmentation
5x Fragmentation buffer composed of: 200 mM Tris-acetate pH 8.1, 150 mM 
magnesium acetate, 500 mM potassium acetate.
2.I.2.6. Hybridisation
Hybridisation
Herring sperm DNA: 
Acetylated BSA: 
GeneChips: U74Av2: 
Hybridisation buffer:
12x MES stock:
Control Kit: Affymetrix 
Control oligonucleotide B2 
20x Eukaryotic hybridisation controls 
Promega 
Gibco 
Affymetrix
2-(N-Morpholino)ethanesulfonic acid (MES) 
stock (see below), NaCl (Ambion), EDTA, 
10% Tween-20, H2 O. Final lx concentration: 
lOOmM MES, 1 M [Na+], 20 mM EDTA, 
0.01% Tween-20.
MES free acid monohydrate, MES sodium salt, 
H2O. Final concentration: 1.22 M MES, 0.89 M 
[Na+]
2.1.2.7. Washing and staining
SAPE stain solution (per array):
Antibody solution (per array):
600 pi 2x stain buffer (see below), 540 pi 
water, 2 pg/pl acetylated BSA, 10 pg/ml of 
streptavidin phycoerythrin (SAPE, Molecular 
Probes)
300 pi 2x stain buffer, 266.4pl water, 2 mg/ml 
acetylated BSA, 0.1 mg/ml normal goat IgG 
(Sigma), 3 pg/ml biotinylated goat anti- 
streptavidin antibody (Vector laboratories)
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2x stain buffer: MES stock buffer, NaCl, 10% Tween-20, H2O,
Antifoam (Sigma). Final lx concentration: 100 
mM MES, 1M [Na+], 0.05% Tween-20, 
0.005% Antifoam
Stringent wash buffer: MES stock buffer, NaCl, 10% Tween-20, H2O.
Final concentration: 100 mM MES, 0.1M 
[Na+], 0.01% Tween-20
Non-stringent wash buffer: 20x SSPE buffer (Sigma), 10% Tween-20,
water, Antifoam. Final concentration: 6x SSPE, 
0.01% Tween-20, 0.005% Antifoam
2.1.3. Real Time PCR Reagents
2.I.3.I. Preparation of RNA 
See 2.1.2.1
2.1.3.2. Reverse Transcription
Random hexamers, dNTPs: Amersham Biosciences
Rnase inhibitor: Invitrogen
PCRII buffer, MgCl2 and MLV-RT:
Applied Biosciences
2.I.3.3. Real time PCR
TaqMan Universal PCR Mastermix:
Applied Biosystems 
96-well optical plates, optical tubes and caps:
Applied Biosystems
Gene mixes (in Table 2.1): Applied Biosystems, Assays-on-Demand™ Gene 
Expression Products
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Gene ABI assay ID Sequence Surrounding Probe Exon/Exon
boundaries
Rxrg Mm00436410_ml AGCTCCCAGCTAAATGTGGTCAACA 2/3
Si Mm00498996_ml CATCATCAATGGGAGCCAGGTGTGG 3/4
Dct Mm00494456_ml TG CAAATG CACAGGAAACTTTGCTG 1/2
Dlx2 Mm00438427_ml A AA CTCAGGTCAAAATCTG GTTCCA 2/3
Cdh8 Mm00483238_ml CTGAGATCAG GAACCACAGTCAGAT 8/9
Gapdh Mm99999915_gl TGAACGGATTTGGCCGTATTGGGCG Exon 1, 
boundaries
no
Table 2.1: Gene mix information from Applied Biosystems for Assays-on-Demand gene 
mixes
Gene mix Neurodl: Applied Biosystems, Assays-by-Design™ Gene Expression 
Service
Sequence on which primers and probe were based:
5’-tcgatagccattcgcatcatgagcgagtcatgagtgcccagcttaatgccatctttcacgattagaggc 
Forward primer: 5’-tcgatagccattcgcatcatgag
Reverse primer: 5’-gcctctaatcgtgaaagatggcatt
MGB probe: 5’-c:tgggcactcatgactc (binds to same strand as reverse
primer)
Eukaryotic 18s rRNA Endogenous Control:
Applied Biosystems, MGB probe and two 
unlabelled primers, non-primer limited
2.1.4 Preparation of riboprobes
Plasmids with the cDNA inserts used for probe synthesis together with the enzymes 
(all from Promega) used to linearise and transcribe them for antisense and sense 
probes are listed in Table 2.2. Simple plasmid maps are shown in Figure 2.1. All 
vectors had ampicillin resistance.
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Gene Source Antisense Sense
Rxrg Prof. R. Evans, Howard Hughes Medical 
Institute, The Salk Institute for Biological 
Studies, La Jolla, California and Prof. D. 
Mangelsdorf, Southwestern Medical Centre, 
University o f Texas, Dallas, Texas
(after subcloning) 
Hindlll, T3
BamHI, T7
Si Dr. W. Pavan, National Institutes of Health, 
Genetic Disease Research Branch, 
Department o f Health and Human Services, 
Bethesda, MD
Kpnl, T3 Information 
not supplied
Dct Dr. W. Pavan, National Institutes o f Health, 
Genetic Disease Research Branch, 
Department o f Health and Human Services, 
Bethesda, MD
Hindlll, T7 Information 
not supplied
Dlx2 Prof. J. Rubenstein, University of 
California, San Francisco, California
Hindlll or EcoRI, 
T3
Notl, T7
Neurodl Prof. M. Tsai, Baylor College o f Medicine, 
Houston, Texas
Hindlll, T7 EcoRV, Sp6
Cdh8 Dr. M Takeichi, Riken Centre For 
Developmental Biology, Kobe
Bglll, T3 Xbal, T7
Table 2.2. Enzymes and RNA polymerases used to make antisense and sense riboprobes for 
the genes listed.
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Figure 2.1: Simple plasmid maps of the vectors and inserts obtained to make riboprobes for in situ hybridisation. A: Original 
vector/insert received for Rxrg (left) and final vector/insert used for riboprobe synthesis (right). B-F: Plasmid maps for 
vectors/inserts of Dlx2, Neurodl, silver, Dct and Cdh 8 respectively, including vector names and sizes, insert sizes, enzyme 
restriction sites, and polymerases required to make sense and antisense probes where known.
1.67 kb RXRg insert
Hindlll
77
Hindlll 
BamHI
Subcloned
4.5 kb pCMX vector
1.4 kb RXRg insert
Hindlll
Hindlll
3 kb pBSKII+ vector
Determined sense/antisense direction 
using restriction digests
B. EcoRI
560bp
Hindlll Notl
homeobox
1.7 kb Dlx-2 insert
E61 vector
Hindlll
EcoRV
Sp6
300 bp Neurodl insert
4.2 kb pCRII vector
O n
^  Antisense: cut with H indlll for full length, or EcoRI for a Antisense: cut with H indlll and use T7
560 bp probe without the homeobox and use T3 Sense: cut with EcoRV and use Sp6
Sense: cut with Notl and use T7
D. E.
HindlllKpnl
Silver insert
1.2kp Dct insert77
Anti sense: cut with 
H indlll and use T7
Antisense: cut with 
Kpnl and use T3 2.75 kb pBS vectorModified Bluescript3 vector
Cadherin 8 insert
1.1 KbBgl II
Xbal
77
EcoRI
pBSKII+ vector
Antisense: cut with Bgl II and use T3 
Sense: cut with Xbal and use T7
2.1.4.1. Transforming chemically competent cells
E.coli DH5a cells: 
LB Broth:
LB agar:
LB agar plates:
Treatment with ampicillin:
Invitrogen
Invitrogen, 20g of Lennox L LB broth base per 
1L of dfhO, autoclave.
Invitrogen, 32g of Lennox L agar per 1L of 
dLLO, autoclave.
LB agar was melted in microwave, poured into 
cell culture plates, and allowed to cool to solid 
form. Plates were stored at 4°C and used within 
a week of preparing.
0.05g ampicillin (Sigma) was dissolved per ml 
of dLLO. 1 ml of this solution was added per 1L 
of LB broth or LB agar (0.05 mg/ml)
2.1.4.2. Isolating plasmid DNA
Glycerol: Sigma
QIAprep® Miniprep from Qiagen, contains:
Buffer P1 50mM Tris-Cl, pH 8.0; 1 OmM EDTA; 1 OOpg/ml RnaseA
Buffer P2 200mM NaOH, 1% SDS
Buffer N3 3MKAcpH5.5
Buffer PE Concentrate (Qiagen)
Buffer EB 1 OmM Tris Cl, pH 8.5
2.1.4.3. Linearising plasmid DNA
lOx restriction enzyme reaction buffers, restriction enzymes (as shown in Table 2.2):
Promega /Roche
TE buffer: Qiagen, 10 mM Tris-Cl, pH 8.0,1 mM EDTA
3M sodium acetate: 408. lg of sodium acetate was dissolved in 800
ml dH20. The pH was adjusted to 5.2 with
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glacial acetic acid. The solution was made up to 1L
with CIH2 O and autoclaved.
2.1.4.3.1 DNA Agarose Gel Electrophoresis
Agarose: Gibco
Ethidium bromide, 10 mg/ml: Sigma
5x Loading buffer: Bioline
Hyperladders I and IV: Bioline
Tris-acetate/EDTA (TEA) electrophoresis buffer:
Working solution lx: 0.04M Tris-acetate 0.001M EDTA
Stock solution 50x: 242g Tris base
57.1 ml glacial acetic acid 
100 ml EDTA pH 8.0 per 1L 
Tris-borate/EDTA (TBE) electrophoresis buffer:
Working solution lx: 0.045M Tris-borate
0.001M EDTA 
Stock solution 5x: 54 g Tris base
27.5 g boric acid
20ml 0.5M EDTA pH 8.0 per 1L
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2.1.4.3.2. Subcloning of Rxrg plasmid
1 Ox NEBuffer 2, BSA (1 OOx): NEB (New England Biolabs)
lOx NEBuffer BamHI, BSA (lOOx): NEB
Calf Intestinal Alkaline Phosphatase (CIP) 10,000U/ml:
NEB
Qiaquick Gel Extraction Kit: Qiagen
Buffer QG: Qiagen, composition undisclosed
Buffer PE: Concentrate (Qiagen)
Buffer EB: lOmM Tris Cl, pH 8.5
Low DNA Mass ladder: Invitrogen
T4 DNA ligase 2,000,000U/ml and lOx ligation reaction buffer:
NEB
E. coli TOP 10 one shot cells, S.O.C. medium:
Invitrogen
PCR mastermix:
dNTPs: Bioline,
5U/pl Taq polymerase, lOx Buffer, 50mM MgCL solution:
Bioline
T7 and T3 primers: Genosys (Sigma)
Primer sequences:
T7 (5’ to 3’) GTAATACGACTCACTATAGG
T3 (5’ to 3’) AATTAACCCTCACTAAAGGG
2.I.4.4. Production of Riboprobe
5x polymerase buffer, DTT, RNase inhibitor:
Promega/Roche 
DIG labelling mix: Roche
Polymerases (T3, T7, Sp6): Promega/Roche
10 M ammonium acetate: 770g ammonium acetate was dissolved in 800
ml dH20, the solution was adjusted to 1L.
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2.1.5 Whole mount in situ hybridisation
Proteinase K: 
Glycine: 
Glutaraldehyde: 
Sheep Serum:
Anti DIG antibody: 
NBT/BCIP:
SSC:
10% SDS:
Hybridisation mix:
Solution 1:
Solution2:
TBST:
NTMT:
Sigma
BDH
Sigma
Sigma
Roche
Roche
20x SSC (3 M sodium chloride, 0.3 M sodium citrate) was 
made up by dissolving 175.3 g of sodium chloride and 88.2 g 
of sodium citrate into 900 ml of DEPC-treated water. The pH 
was adjusted to 7.0 with concentrated sodium hydroxide 
solution and made up to a litre with DEPC-treated water. For 
SSC pH 4.5, citric acid was used to adjust the pH.
25g sodium dodecyl sulphate (SDS) was dissolved in 200 ml 
DEPC-treated H2O and heated to 68° C to dissolve. pH is 
adjusted to 7.2 with HC1. The solution was made up to 250 ml 
with DEPC-treated H2O.
50 ml whole mount hybridisation mix was made up at a time 
and stored in 10 ml aliquots at -20°C. 25 ml formamide, 12.5 
ml 20x SSC pH 4.5, 5 ml 10% SDS, 250 pi 10 mg/ml yeast 
tRNA (Sigma) and 250 pi 10 mg/ml heparin (Sigma) were 
mixed and made up to 50 ml with DEPC-treated water.
50% formamide, 5x SSC pH 4.5, 1% SDS in DEPC treated 
H20
50% formamide and 2x SSC pH 4.5 in DEPC treated H2O 
250 ml TBST was made from 25 ml sterile lOx TBST stock,
2.5 ml Tween-20 (to give a 1% concentration), 24 mg 
levamisol and distilled water. lOx TBST stock contained 8% 
w/v NaCl, 0.2% w/v KC1, and 0.25 M Tris HC1 (pH 7.5).
50 ml NTMT was made up from 1 ml 5M NaCl, 5 ml Tris pH
9.5, 2.5 ml 1M MgCh, 1% Tween-20 and 24 mg levamisol in 
DEPC H20.
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2.1.6. Embedding and vibratome sectioning of whole mount in situ hybridized
embryos
25% glutaraldehyde solution: Sigma
Gelatin/albumin embedding mixture:
200 ml embedding mixture was made by adding 0.9 g gelatin 
(300 Bloom; Sigma) to 20 ml PBS and heating to dissolve with 
continuous stirring. A further 160 ml PBS was added once the 
mix had dissolved. The solution was cooled to room 
temperature. 56 g albumin grade II (Sigma) was stirred in by 
mixing overnight with a stirrer. 36 g sucrose was added and 
stirring was continued until dissolution. The embedding 
mixture was stored at -20°C in 5 ml aliquots.
2.1.7. In situ hybridisation for cryostat sections
Anti Digoxigenin (Dig) antibody: Roche
Nitro blue tetrazolium chloride/5-Bromo-4-chloro-3-indolyl phosphate NBT/BCIP:
Roche
Histoclear: National Diagnostics
Yeast tRNA: 50 mg yeast tRNA (Sigma) was dissolved in 5 ml DEPC-
treated distilled water to give a concentration of 10 mg/ml.
Dextran sulphate: 5 g dextran sulphate (Sigma) was dissolved in DEPC-treated
water by vigorous vortexing to give a 50% solution.
Salts solution: 10 times Salts solution (2 M sodium chloride, 0.05 M sodium
dihydrogen orthophosphate monohydrate, 0.05 M di-sodium 
hydrogen orthophosphate anhydrous, 0.05 mM EDTA, 0.1 M 
Tris pH 7.5) was made up with: 57g sodium chloride, 3.45g 
sodium dihydrogen orthophosphate monohydrate, 3.55g di­
sodium hydrogen orthophosphate anhydrous, 50 ml 0.5 mM 
EDTA, 50 ml 1 M Tris (pH 7.5), made up to 500 ml with 
DEPC-treated water and autoclaved.
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Cryosection 
hybridisation 
buffer (CSHB):
Washing Solution: 
MABT:
M-block:
Staining buffer:
50 ml made up from, 25 ml formamide, 10 ml 50% dextran 
sulphate, 5 ml 10 mg/ml tRNA, 5 ml lOx Salts, 250 pi 
Denhardts solution (Sigma), 4.75 ml DEPC-treated water, 
final concentration 50% formamide, 10% dextran sulphate, 
0.5% Denhardts solution, 0.1% tRNA, lx Salts, stored in 10 
ml aliquots at -20°C
lx SSC, 50% formamide, and 0.1% Tween-20 in DEPC H2O 
Made from a sterile 5 times MABT stock, diluted in distilled 
water and mixed with Tween-20 to give a 0.1% concentration. 
5 times MABT (0.5 M maleic acid, 0.75 M sodium chloride) 
was made up with 58.1 g maleic acid dissolved into 900 ml 
distilled water. Sodium hydroxide was added to raise the pH to
7.5, causing the maleic acid to first come out of solution, and 
then go back into solution. 43.8 g of sodium chloride was 
added, the pH checked again and the solution made up to 1 
litre with distilled water.
50 ml M-block was made up and stored at -20°C in 10 ml 
aliquots: a) a 10% Blocking Reagent (Roche Molecular 
Biochemicals) solution was made up in MABT and stored at 
-20°C in 10 ml aliquots. 10 ml 10% Blocking Reagent was 
added to 10 ml heat-inactivated (by heating to 56°C for 30 
minutes) sheep serum and made up with 5 times MABT stock 
and Tween-20 to give 50 ml blocking solution in 1 times 
MABT (M-block).
2% 5M NaCl, 5% 1M MgCl2, 10% 1M Tris pH 9.5, 0.1% 
Tween-20 in DEPC H20.
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2.1.8. Preparation of frozen and paraffin-embedded sections
OCT compound: BDH
Isopentane: Sigma
20% sucrose: 20g of sucrose (Sigma) were dissolved per 100
ml DEPC treated PBS and filter sterilised. 5 ml 
aliquots were stored at -20°C until use.
2.1.9. Staining with Eosin and Haematoxylin
Ehrlich’s haematoxylin: VWR
Eosin (1 % aqueous): Raymond Lamb
Vecta-Mount mounting medium (Vector Laboratories)
Histoclear: National Diagnostics
2.1.10. Immunohistochemistry on frozen and paraffin-embedded sections
2.1.10.1. Primary antibodies
All primary antibodies used in immunohistochemistry are listed in Table 2.3 
Rhodamine conjugated anti peanut agglutinin (PNA): Vector laboratories
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Antibody Host Subtype Working
Cone.
Source
Anti-phosphohistone 
3 (H3)
Rabbit
Polyclonal
IgG 1:100 Upstate
Anti-proliferating 
cell nuclear antigen 
(PCNA)
Mouse
Monoclonal
IgG2a 1:100 Santa Cruz
Anti-numb Mouse
Monoclonal
IgG, 1:500 BD Transduction 
Laboratories
Anti-bm3b (Pou4f) Goat
Polyclonal
HH OQ o 1:100 Santa Cruz
Anti-p3 tubulin Mouse
Monoclonal
IgG, 1:1000 Promega
Anti- blue “S” cone 
opsin
Chicken 1:5000 Tiansen Li, Harvard 
Medical School, Boston 
(Zhao et al., 2003)
Anti-rhodopsin Goat
Polyclonal
IgG 1:50 Santa Cruz
Anti recoverin Rabbit
Monoclonal
1:100 Chemicon
Anti syntaxin Mouse
Monoclonal
IgG, 1:100 Sigma
Anti-VCl.l Mouse
Monoclonal
IgM 1:100 Sigma
Anti-
bromodeoxyuridine
(BrdU)
Rat
Monoclonal
IgG2a 1:100 Oxford Biotech 
(Immunologicals Direct)
Anti nestin Mouse
Monoclonal
IgG, 1:10 Developmental Studies 
Hybridoma Bank
Anti-NeuN Mouse
Monoclonal
IgG, 1:50 Chemicon
Anti-pl integrin Mouse IgG, 1:100 Transduction
Laboratories
Anti CRALBP Rabbit 1:1000 Jack Saari, University of 
Washington, Seattle 
(Bunt-Milam and Saari, 
1983)
Anti GFAP Rabbit
Monoclonal
1:100 DAKO
Anti PKC Mouse
Monoclonal
1:100 Amersham Biosciences
Anti Calbindin Rabbit
Polyclonal
1:50 Santa Cruz
Table 2.3 Primary antibodies used in immunohistochemistry
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2.1.10.2. Secondary antibodies
Secondary Antibody Working
Cone.
Source
Fluorescein (FITC)-conjugated 
AfFmipure goat anti-rabbit IgG
1:100 Jackson Immunoresearch 
Laboratories
Cy3-conjugated Affinipure goat anti 
mouse IgG
1:100 Jackson Immunoresearch 
Laboratories
Cy3-conjugated Affinipure rabbit anti 
goat IgG
1:100 Jackson Immunoresearch 
Laboratories
FITC-conjugated Affinipure donkey 
anti-goat IgG
1:100 Jackson Immunoresearch 
Laboratories
Rhodamine Red-X-conjugated 1:100 Jackson Immunoresearch
Affinipure donkey anti rabbit IgG Laboratories
Alexa Fluor 594-conjugated goat anti­
chicken IgG
Molecular Probes 
(Invitrogen)
Fluorescein-labelled affinity purified 
goat anti-rat IgG
1:100 Insight Biotechnology 
(KPL)
Rhodamine (TRITC)-conjugated 
Affinipure goat anti rabbit IgG
1:100 Jackson Immunoresearch 
Laboratories
Table 2.4 Secondary antibodies used in immunohistochemistry
2.1.10.3. Blocking sera and detergents, other reagents
Foetal Calf Serum (also used for cell culture):
Sigma 
DAKO 
Santa Cruz 
Sigma
Citifluor Ltd.
Cell Marque
Hoechst 33258 (Sigma) diluted at 1.2 
mg/ml in water
0.01M citric acid buffer: 2.1 g of citric acid monohydrate added to
950 ml dl-LO, adjusted to pH 6.0 with 
NaOH, and made up to 11 with dH20.
Normal Goat Serum:
Normal Donkey Serum:
Bovine Serum Albumin (BSA): 
Citifluor glycerol/PBS solution: 
Declere:
Hoechst nuclear dye:
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2.1.11. Fluorescence activated cell sorting (FACS) analysis of cell cycle
Leibovitz’s L I5 Medium with L-Glutamine:
Gibco
0.05% trypsin/0.53 mM EDTA: Gibco
Hypotonic buffer containing propidium iodide:
(50 pg/ml propidium iodide in 0.1% sodium citrate and 0.1% 
Triton X-100). A sodium citrate/Triton X-100 stock solution 
was made by dissolving 250 mg of sodium citrate and 250 pi 
of Triton X-100 in 250 ml H2O. 50 pi of 20x propidium 
iodide stock solution (1 mg/ml) could then be added to every 
ml of sodium citrate/Triton X 100 solution used.
2.1.12. Analysis of mitotic spindle orientation during cell division
Vectashield mounting medium containing DAPI:
Vector Laboratories
2.1.13 Dissociation and Numb-labelling of retinal cells (see also 2.1.10 and
2.1.11)
DMEM/F-12 (1:1) with Glutamax I:
Gibco
Hanks Balanced Salt Solution (HBSS):
Gibco
Anti-numb and other: see tables 2.3 and 2.4
2.1.14 Immunohistochemistry on sections of BrdU injected mice
2.1.14.1. Preparation of BrdU injected mouse eyes
BrdU: Sigma
Camoy’s fixative: 60% EtOH, 30% chloroform, 10% acetic acid
2.1.14.2. Primary antibodies 
See Table 2.3
2.1.14.3. Secondary antibodies 
See Table 2.4
2.1.14.4. Blocking sera and detergents, other reagents 
See 2.1.10
Histoclear: National Diagnostics
0.1M sodium borate (pH 8.5): 19.04 g added to500 ml H2O, pH adjusted with
HC1
2.1.15. Dissociation and immunohistochemistry of retinal cells (See also 2.1.10, 
2.1.13)
DMEM/F-12 (1:1) with Glutamax I:
Gibco
Dispase: Gibco
2.1.16. TUNEL labelling
In situ Cell death Detection kit: Roche
Proteinase K solution: 915 pi dH20
50 pi 1 M Tris
25 pi 200 mM EDTA
10 pi 1 mg/ml Proteinase K
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2.1.17. Cell Culture Reagents
Media:
NSA medium: Euroclone
Leibovitz’s L I5 Medium with L-Glutamine:
Gibco
DMEM/F-12 (1:1) with Glutamax I:
Gibco
N-2 Supplement (containing insulin, human transferrin, progesterone, 
putrescine and selenite): Gibco
Dispase: Gibco
0.05% trypsin/0.53 mM EDTA: Gibco
Penicillin/streptomycin solution: Sigma
Epidermal growth factor, human, recombinant (EGF):
Promega
Fibroblast growth factor, basic, human, recombinant (FGF-2):
Promega
Fetal Calf Serum: Sigma
Poly-l-lysine (PLL) and laminin coated coverslips were prepared as follows:
Sterile coverslips in culture wells were coated with lOOjul of 20 
pg/ml of PLL (Sigma, 20 pi of a 1 mg/ml stock solution made up 
to 1 ml with distilled water), for 30 minutes, after which the PLL 
was siphoned out and the coverslips were allowed to air dry in the 
hood for 30 minutes. Coverslips were then coated with 100 pi of 
50pg/ml of laminin (Sigma, stock solution 1 mg/ml, 50 pi of 1 
mg/ml stock solution made up to 1 ml with PBS) for 30 minutes 
after which the laminin was siphoned out and the coverslips 
allowed to air dry.
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2.2 Methods
2.2.1 Animals and timed matings
129/Sv wild type and ChxlO'f' (Mus musculus colony with a homozygous mutation of 
ChxlO on a 129/Sv background) colonies were housed in the animal housing facility 
at the Institute of Child Health in accordance with Home Office Licensing 
stipulations and all procedures involving animals were carried out under Home 
Office Licensing approval and in accordance with the Animals (Scientific 
Procedures) Act 1986. Timed matings were set up on the evening of a given day and 
if vaginal plugs were subsequently found, the following morning was designated 
embryonic day 0.5 (E0.5). On required day of embryonic development, pregnant 
mice were sacrificed by cervical dislocation. Embryos were removed from the uterus 
for use in all experiments described, e.g. for fixing and producing sections, or further 
dissection. When required, eyes from the sacrificed mother were proptosed and 
removed using bent forceps.
El 1.5 ChxlO'1'/ p27Kipl'/' double null mice embryos were received from Edward 
Levine (Department of Ophthalmology and Visual Sciences, Department of 
Neurobiology and Anatomy, University of Utah, Salt Lake City, UT, USA). ChxlO'A 
/ p27Kipl'/' double null mice were generated by inter-crossing ChxlO'f' and p27Kipl'f' 
mice. ChxlO"A and p27Kipl'/' animals were on a 129/Sv background. Genotyping of 
mouse-tail DNA was performed as described by Green et al (Green et al., 2003).
2.2.2. Affymetrix GeneChip assay
2.2.2.I. Preparation of RNA
Retinal dissection
Eyes were dissected using no.5 Watchmaker’s forceps from embryonic day
11.5 (El 1.5) day old 129/Sv (wild type) and ChxlO'A (mutant) embryos in 
cold DEPC-treated PBS. In all cases, somites were counted, by adding all 
somites from the hind limb to the tail to 27, the number of somites known to
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have developed from the head to the hind limb. The mesenchyme was 
removed from the outside of the eyes, and the RPE was subsequently teased 
away to leave only the neural retina and the lens. To ensure purity of the 
material, the dissected tissue was moved to a new dish of PBS with every 
step. Eyes from one litter were placed together in a 0.5 ml microfuge tube and 
placed in a -80°C freezer until the day of RNA extraction.
RNA extraction
Without letting the tissue thaw, TRI Reagent was added to the tissue, in a 
volume of roughly ten times the amount of tissue. The tissue was triturated 
and allowed to stand for 5 minutes at room temperature to allow complete 
dissociation of nucleoprotein. 0.2 ml of chloroform was added per ml of TRI 
Reagent and the sample was vortexed and allowed to stand for 10 minutes at 
room temperature. The resulting mixture was centrifuged at 13,000 rpm 
(approx. ll,000x g) for 15 minutes in a Heraeus Biofuge 13R refrigerated 
centrifuge at 4° C. The upper aqueous phase of the mixture, containing RNA, 
was transferred to a fresh tube. 0.5 ml of isopropanol was added per ml of 
TRI Reagent used, and this was left to precipitate overnight at -20° C. In 
some cases 0.5 pi of pellet paint was added to aid visualisation. The 
precipitate was centrifuged at 13,000 rpm (approx. 16,000x g) for 30 minutes 
and an RNA pellet was formed in the bottom of the tube. The supernatant was 
removed, and the pellet was allowed to air dry for 5-10 minutes and 
resuspended in an appropriate amount of distilled water.
The extracted RNA was tested for quality and quantity on a formamide RNA gel 
and/or on an Agilent 2100 Bioanalyser.
2.2.2.2. RNA gel electrophoresis
A 1% w/v agarose gel was prepared by dissolving 0.95g of agarose in 9.5 ml lOx 
MOPS buffer and 5 ml formaldehyde. 16 pi RNA denaturing loading buffer and 1 pi 
of 1 mg/ml ethidium bromide was added to 3 pi samples and 0.24-9.5kb ladder and 
incubated at 70° C for 5 minutes. The samples were loaded onto the gel and run at
84
maximum current and 100 V. Gels were visualized on an Alpha Innotech 
Corporation Multilmage Light Cabinet using Alphalmager 1220 software.
2.2.2.3. Agilent 2100 Bioanalyser
The Agilent 2100 Bioanalyser system comprises of the Chip Priming Station, the 
IKA vortex mixer, the 2100 Bioanalyser itself and the 2100 Expert Software. RNA 
samples were analysed according to the manufacturer’s protocol.
Reagents were allowed to equilibrate to room temperature. RNA 6000 Nano dye 
concentrate was vortexed and spun down. 1 pi of dye was added to 65 pi of filtered 
gel matrix and vortexed thoroughly to produce a gel-dye mix. 9 pi of gel-dye mix 
was added to the gel-dye mix well of the RNA Nano Chip. The chip was placed on 
the correctly adjusted chip priming station and the plunger of the syringe was 
depressed and held in place for 30 seconds. After releasing the plunger and opening 
the priming station, 9 pi of gel-dye mix was added to the other two gel-dye wells of 
the chip. 5 pi of RNA 6000 Nano Marker was added to the ladder well and each of 
the sample wells. The RNA 6000 ladder and samples were heat denatured at 70° C 
for 2 minutes. 1 pi of ladder was added to the ladder well, and 1 pi of sample RNA 
was added to the sample wells. The chip was placed on the vortex mixer and 
vortexed for 1 minute at the IKA vortexer set point (2400 rpm). The chip was then 
placed on the Bioanalyser and the analysis program was initiated.
2.2.2.4. Preparation of cRNA target (schematic shown in Figure 2.2)
-First cycle of amplification, first strand cDNA synthesis
The total RNA samples were mixed with the T7-oligo(dT) promoter primer and 
incubated at 70°C for 6 minutes, then cooled to 4°C for 2 minutes. RTPr emi x l  was 
prepared from DEPC-treated water, 5x first strand buffer, DTT, 0.1M, dNTP mix, 
lOmM, RNase inhibitor, 40 U/pl, and Superscript II, 200 U/pl, and added to the 
denatured RNA and primer mixture. These were incubated for 1 hour at 42°C. The 
samples were heated at 70°C for 10 minutes to inactivate the Superscript II, then 
cooled to 4°C.
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Figure 2.2: Schematic of the preparation of the cRNA targets to hybridise to the 
GeneChips. This consists of two rounds of cDNA synthesis and in vitro transcription 
in order to amplify the total RNA extracted from the tissue. The first cycle is the 
amplification step: total RNA is converted to cDNA and subsequently to cRNA 
through in vitro transcription using unlabelled ribonucleotides. The second cycle 
results in the production of labelled cRNA target: the cRNA from the first cycle is 
converted to cDNA and subsequently converted to labelled cRNA through in vitro 
transcription using biotinylated ribonucleotides. Figure from www.affymetrix.com.
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-First cycle, second strand cDNA synthesis
SS_Premix_l was prepared from DEPC-treated water, 5x second strand buffer, 
dNTP mix, E. coli DNA ligase, 10 U/pl, E. coli DNA polymerase, 10 U/pl, and 
RNase H, 2 U/pl. This was added to the first strand reaction and incubated at 16°C 
for 2 hours. 1 pi of T4 DNA polymerase (5 U/pl) was added to each sample and 
these were further incubated at 16°C for 10 minutes.
-First cycle double-stranded cDNA cleanup by ethanol precipitation
DEPC-treated water, glycogen, 0.6 volumes of 5M ammonium acetate and 2.5 
volumes of cold absolute ethanol were added to the reaction and mixed. The cDNA 
was precipitated at -20°C for 30 minutes to 2 hours and subsequently centrifuged at
13,000 rpm (approx. 16,000x g) for 20 minutes at 4°C. The supernatant was removed 
and the pellets washed with 70% cold ethanol. After centrifuging at 13,000 rpm for 5 
minutes at 4°C, the ethanol was removed and the pellets dried in a Speed Vacuum for 
5-10 minutes.
-First cycle, IVT for cRNA amplification using Ambion MEGAscript T7 kit
DEPC-treated water, premixed NTPs, lOx reaction buffer and lOx enzyme mix were 
added to the dried double-stranded cDNA pellets at room temperature and mixed. 
These were incubated at 37°C for 5-6 hours.
-First cycle, cRNA cleanup with RNeasy columns
The samples were adjusted to a volume of 100 pi with RNase-free water, and 350 pi 
Buffer RLT was added to each sample, followed by 250 pi ethanol. Each sample was 
applied to an RNeasy mini spin column and centrifuged for 15 seconds at 10,000 rpm 
(approx. 9,000x g). The flowthrough was discarded. 500 pi Buffer RPE was added 
and the column was centrifuged for 15 seconds at 10,000 rpm. 500 ml Buffer RPE 
was added and the column was centrifuged for 2 minutes at maximum speed to dry
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the RNeasy membrane. The column was transferred to a new collection tube and 30 
pi of RNase-free water was pipetted onto the membrane. This was centrifuged for 1 
minute at 10,000 rpm to elute. This was followed by a second elution with 20 pi of 
water. One pi of this was used to examine IVT yield on the Agilent 2100 
Bioanalyser.
-Second cycle, first strand cDNA synthesis
Random primers were added to the cDNA samples and incubated at 70°C for 10 
minutes. The samples were cooled on ice for 2 minutes. RT_Premix_2 was prepared 
from the same reagents as RTPr emi x l  and added to the denatured RNA and 
primer mixture. This was incubated at 42°C for 1 hour. To remove the RNA 
template, RNase H was added and the samples were incubated for 20 minutes at 
37°C, then heated at 95°C for 5 minutes to inactivate the RNase H. The samples were 
chilled on ice for 2 minutes.
-Second cycle, second strand synthesis
T7-01igo(dT) promoter primer was added to the chilled samples and incubated at 
70°C for 6 minutes. The samples were then cooled to 4°C. SS_Premix_2 was 
prepared from DEPC-treated water, 5x second strand buffer, dNTP mix, and E. coli 
DNA polymerase I and added to the samples. The samples were incubated at 16°C 
for 2 hours, T4 DNA polymerase was then added and the samples were incubated at 
16°C for a further 10 minutes.
-Second cycle, double-strand cDNA cleanup using the GeneChip sample cleanup 
module
600 pi of cDNA binding buffer was added to each of the samples and mixed. These 
were each applied to a cDNA cleanup spin column and centrifuged for 1 minute at
10,000 rpm (approx. 9,000x g). 750 pi wash buffer was then applied to each spin 
column and the columns were centrifuged for 1 minute at 10,000 rpm. The cap of 
each spin column was opened and the columns were centrifuged for 5 minutes at
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maximum speed to allow complete drying of the membrane. Each spin column was 
transferred to a 1.5 ml collection tube and 14 pi of cDNA elution buffer was pipetted 
directly onto the membrane. This was incubated for 1 minute at room temperature 
and centrifuged for 1 minute at maximum speed to elute.
-Second cycle, IVT for cRNA amplification and labelling with ENZO BioArray 
High Yield Transcript Labelling Kit
DEPC-treated water, lOx HY reaction buffer, lOx biotin-labelled ribonucleotides, 
lOx DTT, lOx RNase inhibitor mix and 20x T7 RNA polymerase were added to the 
double-stranded cDNA sample and incubated at 37°C for 4-5 hours.
-Second cycle, labelled cRNA target cleanup using GeneChip sample cleanup 
module
60 pi water, 750 pi IVT cRNA binding buffer and 250 pi ethanol were added to the 
samples and each sample was applied to a spin column. The columns were 
centrifuged for 15 seconds at 10,000 rpm (approx. 9,000x g). 500 pi IVT cRNA 
wash buffer was applied to each column and the columns were spun for 15 seconds 
at 10,000 rpm. 500 pi 80% of ethanol was then applied to each column, and the 
columns centrifuged for 15 seconds at 10,000 rpm. The cap of each spin column was 
opened and the columns were centrifuged for 5 minutes at maximum speed. The 
columns were transferred to a 1.5 ml collection tube and 11 pi of RNase-free water 
was pipetted directly onto the membrane. The columns were centrifuged for 1 minute 
at maximum speed to elute. One pi of this sample was used to examine IVT yield 
and quality on the Agilent 2100 Bioanalyser.
2.2.2.5. Fragmentation
2 pi of 5x fragmentation buffer is added for every 8 pi of RNA + H2O and incubated 
at 94°C for 35 minutes. This was put on ice following incubation.
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2.2.2.6. Hybridisation
A hybridisation cocktail was prepared with 15 pg fragmented cRNA, 5 pi control 
oligonucleotide B2, 15 pi 20x Eukaryotic hybridisation controls, 3 pi herring sperm 
DNA, 3 pi acetylated BSA, 150 pi 2x hybridisation buffer, and water to make up to 
300 pi (per chip). This was heated to 99°C for 5 minutes. After this, the hybridisation 
cocktail is transferred to a 45°C heat block for 5 minutes. The probe array cartridges 
(GeneChips) are filled with lx hybridisation buffer and incubated at 45°C for 10 
minutes. The hybridisation cocktail was spun at maximum speed in a 
microcentrifuge for 5 minutes to remove any insoluble material from the mixture. 
The buffer solution was removed from the probe array cartridges and filled with 
clarified hybridisation cocktail. This was placed in a rotisserie box rotating at 60 rpm 
in a 45°C oven. This was left to hybridise for 16 hours.
222.1. Washing and staining
The GeneChip cartridges were inserted into the designated modules of the GeneChip 
Fluidics Station 400, which automates the introduction of the nucleic acid target to 
the probe array cartridge and controls the delivery of reagents. The washing and 
staining program was set up follows:
Post hyb wash 1: 10 cycles o f 2 mixes/cycle with non-stringent wash buffer at 25° C
Post hyb wash 2: 4 cycles of 15 mixes/cycle with stringent wash buffer at 50°C
Stain: Stain the probe array for 10 minutes in SAPE solution at 25°C
Post stain wash: 10 cycles o f 4 mixes/cycle with non-stringent wash buffer at 25°C
2nd Stain: Stain the probe array for 10 minutes in antibody solution at 25°C
3rd Stain: Stain the probe array for 10 minutes in SAPE solution at 25°C
Final Wash: 15 cycles o f 4 mixes/cycle with non-stringent wash buffer at 30°C.
Table 2.5: Washing and staining protocol for Affymetrix GeneChips
The probe arrays were removed from the fluidics station modules and checked for 
bubbles or air pockets. If bubbles were present, the chips were refilled either by hand 
or on the fluidics station. The probe arrays were then scanned in the HP GeneArray 
scanner.
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2.2.3 Real time PCR analysis
2.2.3.I. Preparation of RNA
Retinal dissection and extraction of RNA as described in 2.2.2.1.Quality and quantity 
of RNA was tested on a spectrophotometer and by electrophoresis on a formamide 
gel as described in 2.2.2.2.
2.23.2. Reverse transcription
1 pg of RNA in 10 pi dH20 was added to 5 pi of RT mix 1 (2 pi of 50 pM random 
hexamers, 2 pi of dNTPs at 2.5 mM each, and 1 pi of 20U/pl RNase inhibitor) on ice 
and incubated at 70°C for 10 minutes. The mixture was placed on ice for a further 1 
minute after which 5 pi of RT mix 2 (2 pi lOx PCRII buffer, 2 pi of 25 mM MgC^, 
and 1 pi of 50U/pl MLV-RT) was added. This was incubated at 42°C for 1 hour. For 
non-RT controls, dfLO was added to RT mix 2 instead of MLV-RT.
2.2.3.3. Real time PCR
Enough gene mix was made for the number of wells/reactions required per gene.
Per reaction:
25 pi TaqMan universal PCR mastermix
2.5 pi 20x Gene mix (details section 2.1.1.3)
20.5 pi dH20
2 pi cDNA (or H2O for non-template controls) was added to each, making a 
total reaction of 50 pi per well. In some experiments, all amounts were 
halved with no significant changes to the results.
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The 96-well plate or optical tubes were briefly spun and placed in the ABI 7000 
Sequence detector. The standard conditions for PCR were set as follows:
2 min at 50° C 
10 min at 95° C 
40 cycles of: 15 sec at 95° C 
60 sec at 60° C
using the 9600 emulation (the ramping of the block is controlled to mimic the 
performance of the ABI 7000 Sequence detector predecessor, the 9600)
2.2.3.4. Data analysis
The threshold line for each experiment was set at the level where all runs were in the 
linear range of amplification. A threshold cycle (Ct) was determined for each 
amplification. Using the CTs, relative differences in starting material between the 
wild type and ChxlO’A retinae could be determined. The method used here is the 
AACt method and is as follows:
Subtraction of Gapdh Ct from Sample Ct to normalise against Gapdh:
Sample Ct -  Gapdh Ct = ACt Sample 
Set one of samples as a reference (e.g. wild type) and subtract reference ACt from 
other sample ACts (e.g. ChxlO"A):
ACtfChxlO'7'] -  ACt [wild type] = AACt
Amount of Chxlff relative to wild type is then calculated:
_ 2-a a c t
This will produce the fold-change difference between the reference sample, in this 
case the wild type sample, and the other samples, in this case the ChxlO"A sample. 
This method is based on the assumption that the targets all have a 100% 
amplification efficiencies leading to a doubling of DNA product per cycle, or 2n 
amount of DNA after n cycles. This assumption is made here because the primers
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and probes for the PCR study were produced as kits by Applied Biosystems (Assays- 
on-Demand), which have been optimised to 100% efficiency.
Only one set of primers and probes was made through the Assays-by-Design system, 
where a sequence is sent to Applied Biosystems and primers and probes are designed 
based on this sequence. To test whether the efficiency of this primer/probe set, 
Neurodl, is also optimal, dilutions of cDNA were run for Gapdh and Neurodl. Data 
points were plotted and the slope of the Neurodl line matched that of the Gapdh line, 
indicating the same efficiencies.
2.2.4. Preparation of riboprobes for in situ hybridisation
2.2.4.1. Chemically competent cells were transformed with plasmid DNA
E. coli DH5a cells were removed from -80°C freezer and thawed on ice. 100 pi of 
cells were transferred to a microfuge tube and 1 pi of plasmid DNA (see Table 2.2) 
was added directly to the competent cells and mixed in by gentle tapping. The tube 
was incubated on ice for 30 minutes, then heat shocked for 45 seconds in a 37°C 
waterbath. The tube was then placed on ice for 2 minutes. 900 pi of pre-warmed LB 
broth was added to the tube and the vial was shaken for 1 hour at 225 rpm in a 37°C 
shaking incubator. Two volumes (50 and 200 pi) from each transformation were 
spread on separate LB agar plates treated with ampicillin. The plates were inverted 
and incubated overnight in a 37°C oven. The following day, 1-2 colonies would be 
selected and grown in 5 ml LB broth with ampicillin overnight in a 37°C shaking 
incubator.
2.2.4.2. Isolating plasmid DNA
The following day, glycerol stocks of the transformed cells were made by adding 300 
pi of autoclaved 80% glycerol to 700 pi bacteria to be kept at -80°C for future use. 
The rest of the cells were spun down in a Sorvall RC5B Plus centrifuge at 4°C at 600 
rpm (approx. 30x g) for 15 minutes.
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Plasmid DNA was isolated using the Qiagen QIAprep Miniprep Kit according to 
manufacturer’s protocol:
lml of a total 5ml overnight culture was harvested by centrifugation at 13000 rpm 
(approx. 15,000x g) for 1 minute. Bacterial cell pellets were resuspended in 250pl of 
buffer PI, with subsequent of addition of 250pl of P2.These were then inverted 4-6 
times to mix. 350pl of N3 was then added and samples inverted 4-6 times to mix. 
Precipitates were harvested by centrifugation at 13,000 rpm for 10 minutes. 
Supernatants were bound to Qiagen spin miniprep columns by centrifugation at
13,000 rpm for 1 minute and washed with 750pl of PE using centrifugation as above. 
The columns were centrifuged to remove excess PE and DNA eluted from the 
column by incubation with 50pl of buffer EB for 1 minute, followed by 
centrifugation at 13,000 rpm for 1 minute.
2.2.4.3. Linearising plasmid DNA
A digest was set up with a final volume of 30 pi: 8-10 pg of plasmid, 3 pi of 
appropriate lOx restriction enzyme reaction buffer, 1 pi of restriction enzyme, made 
up to 30 pi with DEPC H2O. This was allowed to digest overnight. 1 pi of digest was 
run on a 1% agarose gel to confirm digestion. The rest was made up to 400 pi with 
dP^O and 400 pi of phenol/choloroform was added. The mixture was vortexed for a 
few seconds and spun at full power on a microfuge for 5 minutes. The top layer was 
transferred to a new microfuge tube and 400 pi of chloroform was added. The 
mixture was again vortexed and spun. The top layer was again transferred to a new 
microfuge tube and 40 pi of 3M sodium acetate (pH5.3) and 1 ml of EtOH was 
added. The mixture was left to precipitate overnight at -20°C. The mixture was then 
spun for 40 minutes at full speed (approx. 16,000x g) on a microfuge and washed 
with 70% EtOH and another spin for 10 minutes. The pellet was air dried for 5-10 
minutes and diluted in TE buffer at approx 1 pg/pl, taking into account a roughly 
30% loss from the original 8-10 pg digested. 1 pi of the linearised DNA was tested 
for quality and quantity on an agarose gel and/or a spectrophotometer.
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2.2.4.3.1 DNA Agarose Gel Electrophoresis
The appropriate amount of electrophoresis grade agarose was added to the 
appropriate volume of TAE buffer (e.g. a 1% gel was made up of lg of agarose per 
100 ml dfLO) and placed in a microwave at full power for a few minutes depending 
on the volume (the mixture was not allowed to boil, and heated until the agarose was 
fully dissolved). A 1:10000 dilution of 10 mg/ml ethidium bromide was added to the 
gel and the gel poured in a mould and allowed to cool. When gel was cooled, the gel 
was placed in a gel tank with lx TAE (used when running 1>1 kb DNA fragments or 
when running a gel for gel extraction) or TBE buffer (used when running <1 kb 
fragments).
1 pi of 5x loading buffer was added per 4 pi of sample DNA and samples were 
loaded onto the gel. One of the wells was loaded with a molecular weight marker, 
e.g. hyperladder I or IV. The gel was run at maximum current and 100V. Gels were 
visualized on an Alpha Innotech Corporation Multilmage Light Cabinet using 
Alphalmager 1220 software, unless stated otherwise.
2.2.4.3.2 Spectrophotometry
2 pi of sample DNA was diluted in 48 pi of appropriate buffer or water in Eppendorf 
cuvettes. A cuvette with 50 pi buffer or water was first placed in the Eppendorf 
Biophotometer and used to set a reference. The appropriate dilution was entered onto 
the Biophotometer and the samples were measured one by one for DNA quality and 
quantity. The spectrophotometer measures absorbance at 230, 260, and 280 nm, and 
calculates DNA concentration and 260/280 and 260/230 ratios, taking into account 
the dilution factor, giving and indication of amount and purity.
2.2.4.3.3. Subcloning of Rxrg plasmid
The plasmid obtained for Rxrg was received in an expression vector. As antisense 
probe could not be produced from this plasmid (see Figure 2.1) a 1.4 Hindlll 
fragment was subcloned into the Bluescript pSKII+ plasmid. Cmx-Rxrg plasmid and
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pSKII+ plasmid (available in the lab from glycerol stocks) were isolated and 
linearised as follows:
30 pi of pSKII+ at 0.09 mg/ml, 1.5 pi Hindlll, 3 pi 1 Ox NEBuffer 2, and 0.4 
pi BSA were incubated at 37° C for 1 hour, then 4 pi lOx NEBuffer BamHl 
and 2 pi BamHl were added and the mixture further incubated at 37° C for 1 
hour. 2.5 pi CIP (about 1:10) was added to the pSKII+ digest at 37° C for 1 
hour.
5 pi Cmx-Rxrg plasmid at 0.37 pg/pl, 1 pi Hindlll, 1 pi lOx NEBuffer 2, 0.2 
pi BSA and 3 pi H2O were incubated at 37° C for 1 hour, then 1.5 pi lOx 
NEBuffer BamHl,l pi BamHl and 7 ml H2O were added and the mixture 
further incubated at 37° C for 1 hour.
Both vector and Rxrg insert were run on a 1.5% agarose gel, which was visualised on 
a BioRad ChemiDoc imager using BioRad QuantityOne software. The vector and 
insert were excised from the gel and gel purified using a Qiagen QIAquick Gel 
Extraction Kit according to the manufacturer’s protocol:
3 volumes of Buffer QG were added to 1 volume of gel (lOOmg = approx 100 
pi) in a colorless tube. This was incubated at 50° C until gel was completely 
dissolved (approx 10 min), while vortexing every 2-3 min. 1 volume of 
isopropanol was added per volume of gel and the sample was applied to the 
QIAquick spin column and centrifuged for 1 minute. The flow-through was 
discarded. 0.75 ml Buffer PE was added to the spin column and sample was 
centrifuged for 1 min. The column was placed in a clean collection tube and 
20 pi dH20 was applied to the centre of the spin column membrane. The 
column was allowed to stand for 1 min, then centrifuged for 1 min.
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2 j j .1 of the linearised plasmids were run on a 2% gel with a low DNA mass ladder to 
determine their relative concentrations. The insert and plasmid were incubated in a 
2:1 or 5:1 ratio of insert:vector using the following equation:
ng insert -  (ng vector x kb inert)/ kb vector = ratio insert:vector
and made up to 8 pi with dFLO and incubated at 45°C for 5 minutes. The mixture 
was put on ice and 1 pi of concentrated T4 DNA ligase and 1 pi of lOx ligation 
buffer was added and the mixture was incubated for 1 hour at 25°C.
4 pi of the ligation mix was added to 50 pi of TOPlO-One shot cells and was mixed 
by gentle tapping and incubated on ice for 20 minutes. Cells were heat shocked for 
45 seconds at 45°C and returned to ice for a further 2 minutes. 250 pi of prewarmed 
S.O.C. medium was added and the tube incubated for 1 hour in a shaking incubator 
at 37°C. 150 pi of the cells were plated out on LB plates with ampicillin together 
with appropriate control plates. Plates were incubated overnight at 37°C. Controls 
included a ligation mix with the cut vector and cells without ligation mix.
The following PCR mastermix was made up:
1:20 dNTPs 25mM each final cone, 1:10 lOx buffer, 1:40 MgCL solution, 
1:200 BIOTaq polymerase, and 1:200 T7 and T3 primers (100 pM stock) . 
The 31 colonies resulting from the 2:1 ratio ligation were picked up with a 
pipette tip, and each tip was dipped into an aliquot of PCR mix and kept. The 
PCR was set up on an Eppendorf Mastercycler as follows:
5 min 95° C 
Followed by 25 cycles of:
15 sec 95° C 
15 sec 52° C
1.5 min 72° C
Followed by:
10 min 72° C
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The pipette tips that had been dipped into those colonies found to contain the insert 
were subsequently dipped into 5 ml ampicillin treated LB broth and treated as above 
to isolate the cDNA.
2.2.4.4. Production of riboprobe
A reaction mixture containing the following was prepared on ice:
9 pi DEPC H20  
4 pi 5x polymerase buffer 
2 pi DTT
2 pi DIG labelling mix 
1 pi linearised DNA 
1 pi RNase inhibitor 
1 pi Polymerases (T3, T7 or Sp6)
The mixture was spun briefly on a microfuge and incubated at 37°C for 1 hour to 
overnight.
To precipitate the probe, 130 pi of DEPC H20 , 50 pi 10M ammonium acetate, and 
400 pi 100% EtOH was added and the mixture placed at -20°C overnight. The 
mixture was then spun for 30 minutes, washed with 70% EtOH for 10 minutes and 
resuspended in 20 pi DEPC H20. 1 pi was used to run an RNA gel (see 2.2.2.2). 20 
pi formamide was added to the probe together with 1 pi RNase inhibitor and the 
probe was stored at -20°C until used. DIG-labelled probes were used for whole 
mount ISH and section ISH usually by diluting 1 pi of probe in 150 pi of 
hybridization buffer (approx. 1 pg/ml). Probes were tested for specificity of binding 
to mRNA either by comparing hybridization of sense and Antisense probes or by 
reproduction of wild type expression pattern reported elsewhere.
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2.2.5 Whole mount in situ hybridisation
Mouse embryos for whole mount ISH (El 1-El2) were harvested and fixed overnight 
in 4% PFA in PBT. They were subsequently washed 3 x 15 minutes in PBT and 
dehydrated through a series of methanols: 20 minutes each in 25%, 50%, and 75% 
v/v methanol in PBT and 2 x 20 minutes in 100% methanol. Embryos could be 
stored at -20°C for several weeks in 100% methanol at this point.
To begin the procedure embryos were rehydrated through methanols and washed 
twice for 10 minutes in PBT. The embryos were then permeabilised in proteinase K 
in PBT at room temperature. Strength and length of treatment depended on embryos 
and probes, and required optimisation. Approximate concentrations and times are 
shown below:
10 pg/ml for 15 minutes for E l2.5 embryos 
10 jug/ml for 8 minutes for El 1.5 embryos
The reaction was stopped by incubating embryos with 2 mg/ml of freshly made 
glycine/PBT for 10 minutes. Embryos were then washed 2 x 5  minutes in PBT. The 
embryos were subsequently post-fixed in 4% PFA and 0.2% glutaraldehyde (0.2% of 
a 25% glutaraldehyde solution) in PBT for 20 minutes and washed 2 x 1 0  minutes 
PBT. Embryos were bleached in 6% H2 O2 in PBT for 1 hour, then washed again 2 x 
10 minutes in PBT. The embryos were then placed in 1 ml hybridisation mix without 
probe and transferred to 2 ml microfuge tubes. The hybridization mix was replaced 
with another 1 ml of hybridisation mix and the embryos were incubated (pre­
hybridised) overnight in a 70°C waterbath.
The following day, embryos were transferred to prewarmed fresh hybridisation mix 
containing probe at chosen dilution (~1 pg/ml), and incubated at 70°C overnight.
The hybridisation mix was removed and saved for re-use, and embryos were washed 
2 x 30 minutes in Solution 1 at 70°C. The embryos were then washed 2 x 30 minutes 
in Solution 2 at 65°C.
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After washing 3 x 5  minutes in TBST at room temperature, embryos were pre­
blocked with 20% sheep serum (heat inactivated at 70°C) in TBST for 1 hr at room 
temperature or 2-3 hr at 4°C. Embryos were then incubated with a 1:1000 dilution of 
anti-DIG antibody in above block at 4°C overnight.
The following day, the antibody was recovered for reuse and the embryos washed 
with TBST at 40 minute intervals as many times as possible at room temperature (at 
least 5), then overnight at 4°C
Embryos were then washed 3 x 10 minutes in NTMT, after which NBT/BCIP in 
NTMT (18 pl/ml) was added. Vials containing embryos were wrapped in foil and 
developed by rocking in a light tight box. Embryos were examined every 10-20 
minutes until staining was complete. Embryos were then washed 2 x 1 0  minutes in 
PBT and stored in the dark with 0.018% thimerosol in PBT. Embryos were examined 
on a Leica MZFLIII dissecting microscope and digital images were captured using a 
Jenoptik ProgRes C14 camera and Improvision Openlab software.
2.2.6. Embedding and vibratome sectioning of whole mount in situ hybridized 
embryos
Embryos were washed in PBS and transferred to 2-5 ml gelatin/albumin embedding 
mixture and incubated 30 minutes to overnight. Each embryo was coated in 
embedding mix and placed on the side of an embedding mould. With instruments 
and microscope readied, 0.1 volume of 25% glutaraldehyde was added to 1 volume 
of embedding mixture and mixed thoroughly and swiftly by pipetting. Embryo was 
immediately placed in mixture and orientated under microscope (setting occurred 
within 2 minutes). Blocks were placed at 4°C for 1 hour to overnight to set. Blocks 
could be kept wrapped in cling film or in PBS for several weeks at 4°C.
For vibratome sectioning, blocks were trimmed and superglued to vibratome mount. 
Blocks were cut in a bath of DEPC PBS and 30-50pm sections were cut and placed 
on TESPA coated slides. Slides were mounted with 50% glycerol in PBT and stored 
in a flat slide holder at 4°C. Slides were examined on a Zeiss Axioplan 2 using DIC
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and digital images were captured using a Leica DC500 camera and Adobe Photoshop
software.
2.2.7. In situ hybridisation for cryostat sections
Slides with cryosectioned tissue were removed from -80°C and laid out for 15 
minutes at room temperature to thaw. Preparation of cryo-sectioned retina is 
described in 2.2.8. RNA probes to be hybridised were diluted to an appropriate 
concentration (~1 ng/pl), usually around 1 part in 100 (this is best determined 
empirically), in cryostat section hybridisation buffer, allowing 75-100 pi for each 
slide. Probe mixes were incubated at 70°C for 5 minutes to denature the RNA. 75- 
100 pi mix was then added to each of the thawed out slides. Probe mix was evenly 
spread across the slides with no bubbles over the sections. 20 x 40 mm coverslips 
were washed in 100% ethanol, dried, and carefully placed on the slides so as to cover 
the sections entirely. Slides were placed on a slide moat (Grant Instruments Ltd., 
Shepreth, UK) heated to 65°C and humidified with DEPC-treated distilled water and 
left overnight.
Slides were removed from the slide moat, placed in coplin jars (maximum 5 slides 
per coplin jar) and immersed in preheated Washing Solution within a glass trough in 
a 65°C water bath for 1 hour. Slides were then carefully transferred into new coplin 
jars containing preheated Washing Solution. Any coverslips that had not fallen off 
the slides were gently nudged off using a 200 pi pipette tip. After 30 minutes, the 
Washing Solution was replaced (in a fume hood) and slides were washed a further 30 
minutes at 65°C. The slides were transferred in a fume hood to fresh coplin jars 
containing MABT and washed 2 x 30 minutes at room temperature. Slides were then 
removed one by one from the coplins, their edges dried with a tissue and the sections 
encircled using a grease pen, and placed in a humidified incubation chamber. 200- 
300 pi M-block was immediately applied to each slide. The slides were incubated for 
a minimum of 1 hour at room temperature. Anti-digoxygenin antibody tagged with 
alkaline phosphatase was diluted 1:1000 in M-block and applied to the slides. The 
slides were then incubated overnight at 4°C.
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The slides were removed from 4°C and transferred back into coplin jars to be washed 
4 x 5  minutes in MABT. The slides were placed in fresh coplins to be washed 2x10  
minutes in Staining Buffer. They were then returned to the incubation chamber. 200- 
300 pi of Staining Buffer with 18 pl/ml NBT/BCIP stock solution were applied to 
each slide and incubated at room temperature protected from light for 1-24 hours 
until satisfactorily developed. The length of time necessary for development is 
related to the strength of the probe during hybridisation. The reaction can be slowed 
by placing at 4°C. Labelling was checked under a dissecting microscope and slides 
were washed in distilled water. Slides were dehydrated in 100% butanol for 5 
minutes and washed 2 x 5  minutes in Histoclear. Slides were immediately mounted 
with Vectamount™ and left to dry at room temperature. Slides were examined on a 
Zeiss Axioplan 2 using DIC and digital images were captured using a Leica DC500 
camera and Adobe Photoshop software.
2.2.8. Preparation of frozen and paraffin-embedded retinal sections
2.2.8.1. Frozen sections
Cryo-sections were used fore a variety of experiments, for in situ, immunostaining, 
and DAPI staining. Sections were prepared of mouse embryos and adult eyes. Tissue 
required for sectioning was fixed in 4% paraformaldehyde overnight. After a brief 
wash in PBS, the tissue was placed in 20% sucrose solution and again left overnight. 
After another brief wash in PBS, the tissue was placed in a polystyrene or foil mould 
containing O.C.T. compound. The mould was placed in a container of isopentane, 
which in turn was placed in liquid nitrogen. The O.C.T. compound was allowed to 
freeze completely and either sectioned straight away or placed in a -80° C freezer 
until sectioned. The block was sectioned using a Bright cryostat (model OTF with a 
5040 microtome) and Bright solid microtome knife (B1009DR) in 7 pm thick 
sections. The sections were collected onto slides which were coated with 2% 
TESPA. The slides were kept at room temperature overnight to allow them to dry, 
and stored at -80° C until used.
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2.2.8.2. Paraffin-embedded sections
Tissue required for sectioning was fixed in 4% paraformaldehyde overnight. The 
tissue was partially dehydrated through a succession of ethanol (EtOH)/PBS 
solutions from 30% to 50% to 70% to 90% to 100% EtOH for 5-30 minutes 
depending on size of tissue. If not fully processed immediately, the process was 
stopped at the 70% EtOH/PBS stage and the tissue kept in 70% EtOH/PBS at room 
temperature until required for embedding. The tissue was then cleared in a 1:1 
solution of ethanol and Histoclear, and subsequently placed in a 60°C oven in 100% 
Histoclear. The tissue was then transferred successively to a wash of 1:1 
Histoclear:paraffin wax, and two washes of paraffin wax. The tissue was taken out of 
the oven and positioned and the wax allowed to cool and harden overnight. The wax 
blocks were sectioned on a Microm microtome (HM325) at 7pm, and the sections 
collected onto a film of CIH2O on TESPA-coated slides. Slides were placed on a 
heated surface where sections were allowed to flatten over the warmed water’s 
surface. The water was pipetted off and the slides were allowed to dry in a 37°C 
incubator overnight and stored at room temperature until use.
2.2.9. Staining with Eosin and Haematoxylin
2.2.9.1. Frozen sections
Slides were removed from -80°C and allowed to thaw for about 10 minutes at room 
temperature. The sections were incubated in distilled water to remove O.C.T. 
compound, then placed in Ehrlich’s haematoxylin solution for 5 minutes. They were 
then washed in distilled water for 1 minute and placed in a trough to be washed for 5 
minutes under running tap water. Slides were then immersed in 10% hydrochloric 
acid, 70% ethanol in distilled water for 10 seconds only and returned to the trough 
and the running tap water for a further 5 minutes. This was followed by immersion in 
1% eosin solution for 5 minutes and a further five minutes in the trough with running 
tap water. Slides were then dehydrated through a series of alcohol solutions: 2 
minutes in 70% ethanol (in distilled water), 2 minutes in 95% ethanol, and 2 x 5  
minutes in 100% ethanol. After 2 x 5  minute washes in Histoclear, slides were 
immediately mounted with coverslips using Vecta-Mount mounting medium and
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allowed to dry at room temperature. Slides were examined on a Zeiss Axioplan 2 
Imaging microscope and digital pictures were captured using a Jenoptik ProgRes 
C14 camera and Improvision Openlab software.
2.2.9.2. Paraffin-embedded sections
Sections were deparaffinized in Histoclear for ten minutes and rehydrated through 
graded concentrations of EtOH as follows:
100% EtOH -  3 minutes
90%, 70%, 50%, 25% EtOH -  1 minute each
Distilled H2O -  5 minutes
They were then placed in Ehrlich’s haematoxylin for 5 minutes and the protocol was 
followed as described above for frozen sections.
2.2.10. Immunohistochemistry on frozen and paraffin-embedded sections
2.2.10.1. Anti-phosphohistone H3 on frozen sections
Slides of retinal sections were taken from the -80°C freezer and laid out to thaw for 
15 minutes. After three washes with PBS, a grease pen was used to draw around the 
sections. The sections were then treated with blocking solution (10% foetal calf 
serum (FCS), 1% bovine serum albumin (BSA), and 0.1% Tween-20 in PBS) for 1 
hour. Anti-phosphohistone 3 antibody (1:100) was made up in blocking solution and 
the sections were incubated with the primary antibody overnight at 4°C. After three 
washes with PBS, the sections were incubated with FITC-conjugated anti-rabbit 
secondary antibody (1:100) and Hoechst nuclear dye (1:1000), made up in blocking 
solution, for 1 hour. The sections were then washed three times in PBS and mounted 
with Citifluor. Slides were examined on a Zeiss Axiophot and digital images were 
captured using a Hamamatsu Orca camera and Improvision Openlab software. 
Alternatively, slides were examined using a Zeiss Axioplan 2 Imaging microscope
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and digital images were captured using a Jenoptik ProgRes C14 camera and
Improvision Openlab software.
Statistical analysis: The total number of retinal cells (Hoechst-stained) and the 
number of mitotic cells (H3-labelled) were counted on nine midline retinal sections 
from three eyes from mutant and wild type animals at all time points (El 1.5, E l3.5, 
E l5.5 and El 8.5). An H3 labelling index was obtained by dividing the number of 
H3-labelled cells by the total number of cells in each section. Two-way analysis of 
variance was performed using SPSS 11 to check for an interaction between mutant 
and wild type mice and the various time points. After an interaction was found, the 
significant simple main effects were further analysed by pairwise comparisons using 
the Sidak adjustment for multiple comparisons (p<0.05 was considered significant). 
Refs: http://web.uccs.edu/lbecker/SPSS/glm sme.htm: (Becker and Coolidge, 1991; 
Rosnow and Rosenthal, 1989).
2.2.10.2. Anti-proliferating cell nuclear antigen (PCNA) on paraffin-embedded 
sections
Sections from embryonic eyes were deparaffinized in Histoclear for ten minutes and 
rehydrated through graded concentrations of EtOH as follows:
100% EtOH -  3 minutes
90%, 70%, 50%, 25% EtOH -  1 minute each
Distilled H2O -  5 minutes
The slides were heated in a microwave at 540W in 0.01 M citric acid buffer (pH 6.0) 
for 10 minutes and cooled 10 minutes under running tap water before being rinsed 
two times in PBS. Sections were incubated with blocking solution (10% FCS, 1% 
BSA and 0.1%Tween-20 in PBS) for 30 minutes. Slides were subsequently incubated 
with mouse anti PCNA primary antibody (diluted 1:100 in blocking solution) at 4°C 
overnight. After 3 x 5  minute washes with PBS, slides were incubated with Cy3- 
conjugated anti mouse secondary antibody (diluted 1:100 in blocking solution) for 40 
minutes, together with 1:1000 Hoechst nuclear dye. Slides were then washed again 2 
x 5 minutes in PBS and mounted with Citifluor. Slides were examined on a Zeiss
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Axiophot and digital images were captured using a Hamamatsu Orca camera and
Improvision Openlab software.
2.2.10.3. Immunohistochemistry using retinal cell markers on frozen sections
Sections were thawed for 15 minutes, rinsed in PBS for a further 15 minutes and then 
blocked with 10% fetal calf serum, 1% BSA and 0.1% Tween-20 in PBS for 30 
minutes, 10% normal goat serum and 0.2% Triton X-100 in PBS for two hours (for 
PNA), 2% normal donkey serum and 0.1% Tween-20 in PBS for 30 minutes (for 
anti-bm3b), 10% normal goat serum, 3% BSA and 0.1% Tween-20 in PBS for 30 
minutes (for anti-blue cone opsin), or 4% normal donkey serum and 1% Triton X- 
100 in PBS for two hours (for anti-rhodopsin). The sections were incubated with 
mouse anti-p3 tubulin (1:100), mouse anti-syntaxin (1:100), mouse anti-vc 1.1, 
(1:100), rabbit anti-recoverin (1:100), goat anti-bm3b (1:100), rhodamine- 
conjugated PNA (1:10), chicken anti-blue cone opsin antibody (1:5000), or goat anti- 
rhodopsin antibody (1:50) at 4°C overnight. PNA treated sections were then 
incubated with Hoechst nuclear dye (1:1000) for 40 minutes and mounted with 
Citifluor. Anti-p3 tubulin, anti-syntaxin, and anti-vc 1.1 treated sections were 
incubated with Cy3-conjugated anti-mouse antibody (1:100). Anti-recoverin, anti- 
bm3b, anti-blue cone opsin and anti-rhodopsin treated sections were incubated with 
rhodamine Red-X-conjugated anti-rabbit (1:100), Cy3-conjugated anti-goat (1:100), 
Alexa594-conjugated goat anti-chicken (1:100) and FITC-conjugated donkey anti­
goat (1:100) antibodies respectively for two hours. The sections were then treated 
with Hoechst nuclear dye for 40 minutes and mounted with Citifluor. Slides were 
viewed using a Zeiss Axiophot and digital images were captured using a Hamamatsu 
Orca camera and Improvision Openlab software. Alternatively, slides were viewed 
using a Zeiss Axioplan 2 Imaging microscope and digital images were captured 
using a Jenoptik ProgRes C14 camera and Improvision Openlab software.
2.2.11. Fluorescence activated cell sorting (FACS) analysis of cell cycle
Retinal dissection from El 1.5 embryos occurred as described in 2.2.2.1 but in 
Leibovitz’s L I5 medium. In addition, retinae were dissected in a similar manner
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from E13.5, E15.5, and E18.5 embryos, with a further step in which the lens was 
separated from the retina, leaving a clean retina. Retinae from littermates were 
pooled. They were treated with 0.05% trypsin/0.53 mM EDTA for 10 minutes at 
37°C, and the reaction was subsequently quenched with a small amount of fetal calf 
serum. The tissue was triturated gently to form a single cell suspension. The cells 
were centrifuged for 1 minute at 8000 rpm (approx. 6,000x g) and washed with PBS 
and counted on a haemocytometer. The cells were then briefly centrifuged and 
resuspended in 70% ethanol and kept at 4°C until used for analysis (1-14 days). Cells 
were briefly centrifuged and resuspended in 300 pi hypotonic buffer containing 
propidium iodide (50 pg/ml propidium iodide (Sigma) in 0.1% sodium citrate and 
0.1% Triton X-100). The samples, containing 5xl05 to lxlO6 cells, were immediately 
run on a Beckman Coulter Epics XL flow cytometer. 30,000 events were collected 
and, with Expo 32 software (Beckman Coulter), gated using doublet discrimination. 
In this way, only single cells in the cell cycle were selected for analysis. The data 
were subsequently modelled using Multicycle software (Phoenix Flow Systems), 
using an appropriate modelling system.
Statisical analysis: 3 pools of wild type and 3 pools of ChxlO‘A retinae were 
collected at El 1.5 and run on the flow cytometer. The data were averaged and means 
and standard deviations calculated, after which student t-tests were performed.
2.2.12. Analysis of mitotic spindle orientation during cell division
Frozen sections of embryonic mouse retinae were laid out to thaw at room 
temperature for 15 minutes. They were then washed twice in PBS and mounted with 
Vectashield mounting medium containing DAPI. Slides were viewed using a Zeiss 
Axioplan 2 Imaging microscope and digital images were captured using a Jenoptik 
ProgRes C14 camera and Improvision Openlab software. The angle between a line 
running through the mitotic spindle of the dividing cell and a tangent to the closest 
part of the ventricular surface was measured. Vertical mitotic spindles (line through 
spindle 90° +/- 45° to ventricular surface) were classified as asymmetric cell divisions 
and horizontal spindles (line through spindle 0° +/- 45° to the ventricular surface) as 
symmetric.
108
Statistical analysis: Chxl(y/', ChxlOv7 p27Kipl+/~ and ChxlO^V p27Kipl~/' and wild 
type 129/Sv mice were analysed blind. The percentage of vertical divisions was 
determined per eye (at least 4 eyes were analysed per genotype) and the mean and 
standard error was calculated for each genotype. Genotypes were analysed for 
significant differences using pairwise 2-tailed Mann Whitney U tests.
2.2.13 Dissociation and Numb-labelling of retinal cells
Retinae were dissected as described in 2.2.2.1 but in DMEM/F-12 medium, then 
washed with Hanks balanced salt solution (HBSS). The tissue was centrifuged for 5 
minutes at 900 rpm (approx. 80x g) and the supernatant replaced with 0.5 ml of 1 
mM EDTA in HBSS. The cells were subsequently placed in culture incubator for 20- 
30 minutes, at 37°C with 5% CO2 . The tissue was then mechanically dissociated by 
trituration and washed with HBSS by centrifuging the cells for 5 minutes at 900 rpm 
for three minutes and replacing the supernatant. This was repeated in order to 
resuspend cells in DMEM/F-12. After cell counting using a haemocytometer, cells 
were plated on poly-l-lysine and laminin coated coverslips at 6-12 x 104 cells/ml. 
The cells were placed in a cell culture incubator at 37°C with 5% CO2 and left 
overnight. The cells were subsequently fixed for .10 minutes in 4% PFA. The 
coverslips were then washed three times in Leibovitz’s LI5 medium. Cells were 
treated with blocking solution (10% NGS and 0.1% Triton X-100 in PBS) for 20 
minutes. Anti-Numb antibody was diluted 1:500 in 5% NGS and 0.1% Triton X-100 
and applied to the cells for 1 hour. The coverslips were washed three times in 
Leibovitz’s LI5 medium, after which Cy3-conjugated anti-mouse antibody, diluted 
1:50 in blocking solution, was applied for 30 minutes. The coverslips were then 
washed three times in Leibovitz’s LI5 medium and once in dH20. Each coverslip 
was then mounted onto a glass slide using CITIFLUOR.
2.2.14 Histological examination of semithin retinal sections
For histological examination, retinal tissue was fixed in 3% glutaraldehyde (pH 7.4), 
0.1M sodium cacodylate, and 5 mM calcium chloride; rinsed; and transferred to 1% 
osmium tetroxide for 2 hours before being processed and embedded in resin
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(Agar 100, DDSA, MNA, DMP30) using standard procedures. Semithin sections 
were cut on a microtome (Ultracut E; Leica, Cambridge, UK) with glass knives and 
stained with 1% toluidine blue in 1% borax. Observations were made in four P12 
Chxl0_/‘ and four 129/Sv mice. For each retina, replicate counts of the number of 
cells in the inner and outer nuclear layers were made from 1-pm semithin sections. 
For each retina, sections were prepared at 20-pm intervals at four positions across the 
central retina. Observations were restricted to the central retinal zone, avoiding the 
peripheral region where the cell layers are thinner. For the mutant, the analysis was 
performed on the thickest region of central retina in each section.
2.2.15 Immimohistochemistry on sections of BrdU injected mice
2.2.15.1. Preparation of BrdU injected mouse eyes
Animals were given an intraperitoneal injection with lOOpg/g of body weight of 
BrdU diluted at 10 mg/ml in 0.1M Tris pH7. Tissue was prepared either the 
following day or 1 day to 3 weeks after the last injection when injecting every other 
day over a period of time (See injection schedules Chapter 6). Animals were given a 
terminal anaesthetic and perfused with saline to remove blood. The eyes were 
removed and fixed in Camoy’s fixative: 60% EtOH, 30% chloroform, 10% acetic 
acid for no longer than 15 minutes. The eyes were embedded in wax as described in 
section 2.2.8.2, going from Camoy’s fixative straight to 90% EtOH. The wax blocks 
were sectioned and treated as described in section 2.2.8B. Alternatively, animals 
were perfused with 4% paraformaldehyde rather than saline, and required no further 
fixing.
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2.2.15.2. Anti-BrdU immunolabelling on paraffin-embedded sections
Sections were deparaffinized in Histoclear for ten minutes and rehydrated through 
graded concentrations of EtOH as follows:
100% EtOH -  3 minutes
90%, 70%, 50%, 25% EtOH -  1 minute each
Distilled H2O -  5 minutes
The slides were heated in a microwave at 540W in 0.01 M citric acid buffer (pH 6.0) 
for 6 minutes and cooled 10 minutes under running tap water before being rinsed two 
times in PBS. Alternatively, sections were treated with Declere (1:20 Declere:dH20) 
for 4 minutes at full power and 15 minutes at 540W in the microwave and rinsed 
with PBS, replacing the deparaffinising, rehydrating and citric acid buffer steps. The 
sections were then incubated in 0.1 M HC1 for 30 minutes at room temperature. They 
were subsequently incubated in 2M HC1 for 30 minutes at 37° C, followed by a 10 
minute incubation in 0.1M sodium borate (pH 8.5) at room temperature. After three 
washes in PBS, non-specific binding sites were blocked with 10% FCS and 1%BSA 
in PBS for 1 hour at room temperature. This was followed by incubation with rat 
anti-BrdU antibody (1:100 in blocking solution) at 4°C overnight in a humid 
chamber. After three washes in PBS, the slides were incubated with the FITC- 
labelled anti-rat secondary antibody (1:100 in blocking solution) for 40 minutes. 
After three washes with PBS, the slides were mounted with Citifluor. Slides were 
viewed using a Zeiss Axiophot and digital images were captured using a Hamamatsu 
Orca camera and Improvision Openlab software. Alternatively, slides were viewed 
using a Zeiss Axioplan 2 Imaging microscope and digital images were captured 
using a Jenoptik ProgRes C14 camera and Improvision Openlab software.
Statistical analysis: BrdU labelled cells were counted on midline retinal sections 
from 3-7 eyes from treated mutant and wild type animals at 4 weeks and 8 weeks of 
age. Student t-tests were performed between mutant and wild type counts at the two 
time points to determine significance (p<0.05).
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2.2.15.3. Retinal cell markers on BrdU injected paraffin-embedded sections
For double labelling of BrdU and nestin, p3 tubulin, pl-integrin, NeuN, Bm3b 
(Pou4f2), rhodopsin, blue cone opsin, recoverin, CRALBP (cellular retinaldehyde- 
binding protein), GFAP, protein kinase C (PKC), syntaxin, or VC 1.1, sections were 
treated as above, but after the blocking step, sections were incubated with either 
mouse anti-nestin antibody (1:10), anti-p3 tubulin (1:1000), anti-pl-integrin (1:100), 
anti-NeuN (1:50), anti-PKC (1:100), anti-syntaxin (1:100), or anti-VCl.l (HNK-1) 
antibody (1:100), goat anti-Bm3b (1:100) or anti-rhodopsin antibody (1:50), chicken 
anti-blue cone opsin antibody (1:5000), and rabbit anti-calbindin (1:50) antibody, 
anti-recoverin antibody (1:100), anti-CRALBP antibody (1:1000) or anti-GFAP 
antibody (1:100) at 4°C overnight. Incubation with primary antibody was followed 
by a 1 hour incubation with the appropriate species-specific secondary antibody: 
Cy3-conjugated anti-mouse antibody (1:100), Cy3-conjugated anti-goat antibody 
(1:100), Alexa-594-conjugated anti-chicken antibody (1:100), or rhodamine 
(TRITC)-conjugated anti-rabbit antibody (1:100, GFAP) or rhodamine Red-X- 
conjugated anti rabbit antibody (1:100, calbindin, recoverin and CRALBP). After 
washing in PBS, the slides were then incubated with anti-BrdU antibody (1:100) for 
two hours, followed by 3 x 5 minute washes in PBS and incubation in FITC- 
conjugated anti-rat secondary antibody for 40 minutes. After three washes with PBS, 
the slides were mounted with Citifluor. Slides were viewed using a Zeiss Axiophot 
and digital images were captured using a Hamamatsu Orca camera and Improvision 
Openlab software. Alternatively, slides were viewed using a Zeiss Axioplan 2 
Imaging microscope and digital images were captured using a Jenoptik ProgRes C14 
camera and Improvision Openlab software.
2.2.16. Dissociation and immunohistochemistry of retinal cells
To immuno-label neuronal sub-types of dissociated retinal cells, wild type (n=5) and 
ChxlO 'A mutant mice (n=12) were injected with BrdU at P25, P27, and P29 and 
tissue was prepared 3 weeks after the first injection. Retinae were dissected as 
described in 2.2.2.1 but in DMEM/F-12 medium, then treated with 2 units/ml dispase 
for 10-20 minutes and triturated to dissociate cells. Cells were spun onto slides using 
a Shandon cytospin (500 rpm for 5 mins), air dried for 10 minutes and fixed for 10
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minutes with 4% paraformaldehyde. Slides were treated with 2M HC1 for 10 
minutes, sodium borate for 10 minutes and incubated with 10% FCS and 1% BSA in 
PBS blocking solution for 20 minutes. Immunohistochemistry was performed as 
described above for double labelling studies, with the following alterations: primary 
antibody incubations and anti-BrdU antibody incubations were performed for one 
hour, secondary antibody incubations were performed for 30 minutes. Slides were 
viewed using a Zeiss Axioplan 2 Imaging microscope and digital images were 
captured using a Jenoptik ProgRes C14 camera and Improvision Openlab software.
2.2.17. TUNEL labelling
The terminal deoxynucleotidyl transferase (TdT) -mediated deoxyuridine 
triphosphate (dUTP) nick end labeling (TUNEL) assay was performed using the In 
situ Cell death Detection kit. This procedure was performed on both frozen and 
paraffin-embedded sections. Frozen sections were laid out to thaw for 10-15 minutes 
and washed in dH^O for five minutes. Paraffin-embedded sections were 
deparaffinized in Histoclear for ten minutes and rehydrated through graded 
concentrations of EtOH as follows:
100% EtOH -  3 minutes
90%, 70%, 50%, 25% EtOH -  1 minute each
Distilled H2O -  5 minutes
Alternatively, sections were treated with Declere (1:20 Declere:dH20) for 4 minutes 
at full power and 15 minutes at 540W in the microwave and rinsed with PBS, 
replacing the deparaffinising and rehydrating step.
All sections were then permeabilised by incubating with Proteinase K solution (100 
pl/section) for 15 minutes at room temperature. After washing 2 x 5  minutes in PBS, 
sections were incubated with the TUNEL reaction mixture (5 pi enzyme solution and 
45 pi labelling solution per section) for 1 hour at 37°C. Sections were rinsed and 
washed 3 x 5  minutes in PBS and mounted with Citifluor. Slides were viewed using 
a Zeiss Axiophot and digital images were captured using a Hamamatsu Orca camera
113
and Improvision Openlab software. Alternatively, slides were viewed using a Zeiss
Axioplan 2 Imaging microscope and digital images were captured using a Jenoptik
ProgRes C14 camera and Improvision Openlab software.
2.2.18. Cell Culture from adult retina
Retinae were dissected from adult wild type 129/Sv and ChxlO"A mutant eyes in 
Leibovitz’s LI5 medium. The retinal tissue was placed in a small amount of dispase 
(2.5 U/ml) at 37°C for ten minutes, and subsequently broken up mechanically. The 
tissue was then placed in small amount of trypsin/EDTA for 10 minutes at 37°C. 
10% FCS in medium was added to neutralise the trypsin, and the samples were 
centrifuged at 1000 rpm (approx. 200x g) for 5 minutes. The supernatant was 
removed and replaced with NSA (used initially but then replaced by DMEM/F-12) or 
DMEM/F-12 medium containing 10 pl/ml N2 supplement, 10 ng/ml FGF-2, 20 
ng/ml EGF, and a penicillin/streptomycin solution (50 U/ml penicillin, 50 pg/ml 
streptomycin). The tissue was triturated to fully dissociate the cells and the cells were 
examined on a haemocytometer to assess their numbers. Cells were plated at roughly
100,000 cells per well in a 24-well plate. Medium (half the amount of medium 
already present in the well) was added to the wells every five to seven days and cells 
and medium transferred to larger wells as necessary. Cells were incubated at 37°C 
with 5% C02.
After 28 days, cultures which had formed neurospheres were passaged. Neurospheres 
were spun down in a microfuge and fresh medium was added. The cells were then 
mechanically dissociated by triturating. Cells were subsequently replated in 24-well 
plates in the medium described above. This procedure was repeated on day 56, in one 
case on day 86. Cells generally did not survive a second passage, and in one case a 
third passage.
On some occasions, at the same time as passaging, some of the passaged cells were 
plated with differentiating medium, DMEM/F-12 medium containing 10 pl/ml N2 
supplement, 10% FCS and penicillin/streptomycin solution, but without the growth 
factors. Cells were plated onto poly-L-lysine and laminin coated cover slips in 24 
well plates. Medium was replaced with fresh medium every other day.
114
Images of cells were captured using a Zeiss inverted stereo microscope, with a 
Yashica 108 Multiprogram camera and Kodak Ektachrome 160T film. Film was then 
processed and scanned into digital images using an Epson FilmScan 200 and Adobe 
Photoshop.
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CHAPTER 3 
Identifying Genes Downstream of ChxlO
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3.1 Introduction
From the time it was first characterised in some detail (Liu et al., 1994b), ChxlO has 
been regarded as a putative transcription factor, due to the presence of a 
homeodomain sequence. More specifically, it is thought to belong to the paired class 
of homeodomain transcription factors, as it is 58%-65% identical to a series of 
paired-like homeodomains and like several other putative transcription factors with 
prd-like homeodomains, contains an HSIDGILG octapeptide in addition to its 
homeodomain (Liu et al., 1994b). However, little is known about the genes it may 
regulate. It has been shown that ChxlO acts as both a transcriptional activator and 
repressor (Dorval et al., 2005; Ferda et al., 2000), but thus far, although its DNA 
binding site has been determined (Ferda et al., 2000), no direct targets have been 
identified. Identifying ChxlO target genes and elucidating the genetic pathway in 
which ChxlO is involved may lead to the identification of other genes involved in 
microphthalmia. Characterisation of genes that control retinal proliferation and 
differentiation will provide increased understanding of the underlying molecular 
mechanisms and in the longer term may lead to the development of novel therapeutic 
strategies.
In order to identify possible downstream targets of the ChxlO transcription factor, the 
Affymetrix GeneChip Expression Probe Array system was used to examine 
differential gene expression between ChxlO'A and wild type retinal tissue. Microarray 
studies have become a widely used tool for examining gene expression in recent 
years. Before their introduction, existing expression monitoring technologies 
included differential colony (plaque) hybridisation of cDNA clones (Yamamoto et 
al., 1983), the use of subtractive hybridisation (Hubank and Schatz, 1994; Kavathas 
et al., 1984), and a more recent differential display method (Liang and Pardee, 1992); 
(Paraoanu et al., 2005; Welsh et al., 1992). In addition, sequencing of cDNA libraries 
by EST was used to identify unknown genes expressed in given cells or tissues 
(Adams et al., 1991). However, using hybridisation gels is cumbersome and 
insensitive and whilst the sequencing of cDNA libraries is more direct, it is not 
designed to quantify expressed genes, requires some effort and is not sensitive in the 
presence of less abundant messages (Constantine and Harrinton, 2001; Yamamoto et 
al., 2001).
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Serial analysis of gene expression (SAGE) is an efficient variation of cDNA 
sequencing, which allows for quantitative and simultaneous analysis of a large 
number of transcripts in any particular cell or tissue (Velculescu et al., 1995; 
Yamamoto et al., 2001), but requires relatively complicated procedures for sample 
preparation, requires large amounts of sequencing and is not very sensitive 
(Constantine and Harrinton, 2001). So more recently, array based methods involving 
spotting or printing clones or cDNAs onto various surfaces have been developed. 
The advantage of this is that it is parallel, but to monitor many genes, large numbers 
of cDNAs or PCR products must be prepared, purified, quantitated, catalogued and 
spotted onto a support. If derived from a cDNA library, low abundance cDNAs are 
unlikely to be spotted and the library must be normalised to reduce redundant 
spotting of genes from highly expressed genes (Constantine and Harrinton, 2001). 
Once prepared, the arrays can be used for comparative hybridisations using cDNA 
prepared from different sources.
A further refinement has been the development of GeneChip Expression Probe 
Arrays, which are synthesised in situ on a glass support using light-directed, solid- 
phase combinatorial chemistry. Labelled cRNA targets derived from the mRNA of 
an experimental sample are hybridised to DNA oligonucleotide probes attached to 
the solid support of the chip. By monitoring the amount of label associated with each 
DNA location, it is possible to infer abundance of each mRNA species represented 
(www.affymetrix.com, Figure 3.1). The direct, combinatorial synthesis of 
oligonucleotides based on sequence information offers several advantages: because 
oligonucleotide probes for each gene or EST are specifically chosen and synthesised 
in known locations on the arrays, hybridisation patterns and signal intensities can be 
interpreted in terms of specific gene or EST identity and relative amounts of mRNA 
without additional sequencing or characterisation (Constantine and Harrinton, 2001; 
Lockhart et al., 1996; Wodicka et al., 1997). Use of specifically chosen 
oligonucleotide probes allows for the sensitive, quantitative detection of alternatively 
spliced mRNAs and the differentiation of closely related members of gene families. 
This procedure eliminates the necessity of preparing and handling clones, PCR
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Figure 3.1: Standard eukaryotic gene expression assay. The target, biotin labelled 
cRNA, is produced from total RNA extracted from the relevant tissue. The target 
is fragmented and hybridised to the nucleic acid probes attached to the GeneChip 
expression array. By monitoring the amount of label associated with each DNA 
location, after washing, staining and scanning, it is possible to infer the 
abundance of each mRNA species represented. (Adapted from a figure on 
www.affymetrix.com)
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products and cDNAs. In contrast to many of the spotting methods where a single 
clone is used to analyse each mRNA, GeneChip Arrays use approximately sixteen 
pairs of specific unique 25mer oligonucleotide probes to analyse each transcript. This 
method allows users to achieve quantitative and reproducible transcript detection 
over a wide range of mRNA expression levels (Constantine and Harrinton, 2001).
Using GeneChip arrays, it is possible to make a global analysis by simultaneously 
monitoring the activities of thousands of genes (www.affymetrix.com). Although the 
end goal in this experiment is to focus on a small number of genes, whole genome 
analysis provides an efficient tool to sort through the activities of thousands of genes, 
and to recognise key players. I hoped this system would allow me to identify 
candidate ChxlO target genes based on their differential expression between the 
ChxlO'A and wild type retina; an approach that should be more wide-ranging than 
choosing and examining genes already known to be involved in eye development 
generally. In this study, I have used as the set of probes the murine U74Av2 
GeneChip, an array with oligonucleotides representing all sequences (~6000) in the 
mouse UniGene database (Build 74) that have been functionally characterised. In 
addition, ~6000 EST clusters are also represented. At the time, this was the most 
complete murine array available, as chips with the recently fully characterised 
murine genome have only been produced after completion of this experiment. A list 
of forty genes/ESTs showing a significant 1.5-fold difference in expression and eight 
genes showing a significant at least two-fold difference in expression between the 
ChxlO'A retina and the wild type retina was produced from this study. In addition, 
thirty genes/ESTs showed a more than 1.5-fold change in expression similar to the 
two most changed genes. Several of these genes are involved in regulation of 
transcription, cell fate determination, and/or the cell cycle, offering clues to the 
molecular pathways in which ChxlO is involved.
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3.2 Results
3.2.1 Embryonic day 11.5 was selected as an appropriate time point for 
GeneChip analysis
cRNA derived from total RNA collected from pools of wild type and ChxlO'1' El 1.5 
retinae was used as the target for the GeneChip probes. ChxlO is first expressed in 
retinal progenitor cells of the presumptive neuroretina at E9.5 in the optic vesicle. 
However, the invagination of the optic vesicle and formation of the optic cup, 
including increased initial proliferation of the neuroretina relative to the RPE, occurs 
normally in the ChxlO'A retina, and its appearance at E l0.5 is grossly normal 
(Burmeister et al., 1996), indicating that ChxlO is not essential for this process. 
Instead it seems most important in proliferation and regulation of retinal progenitor 
cells later in development.
To explore this idea further, the total number of cells in midline sections from both 
wild type (n = 9) and ChxlO'1' (n = 9) eyes at various time points during development 
were counted to examine the relative change in total cell number between the two. At 
E10.5, when the optic cup has just been formed and the initial thickening of the 
presumptive neuroretina is occurring, no significant difference was observed 
between the number of retinal cells per midline sections counted in the wild type 
retina and those counted in the ChxlO'/_ retina (2-way ANOVA and post hoc multiple 
comparisons using the Sidak adjustment, p < 0.97, Figure 3.2A). Only a 1.7% 
reduction in average number of total cells per section was observed. At E11.5 this 
reduction increases to 24%, although the difference in cell number is not yet 
significant (p < 0.23, Figure 3.2A). As development progressed, the wild type eye 
showed a much larger increase in cell number compared to the ChxlO'1' retina, with 
the difference between the wild type and ChxlO'A becoming larger and showing 
higher significance than at El 1.5 (p < 0.001 from 13.5 onwards, asterisks Figure 
3.2A). A previous study reported a 30-50% reduction in cell number between the 
wild type and ChxlO'A retina and a reduction in proliferation in the peripheral but not 
the central retina at El 1.5 (Burmeister et al., 1996). On haematoxylin and eosin 
stained frozen sections of El 1.5 retinae, some differences can be observed between 
the wild type and Chxl0'A retina. Although the presumptive neural retina has
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Figure 3.2: Differences between wild type and ChxlO'' retinae during 
development. (A) Change in total cell number during development. Difference in 
the total number of cells between wild type and ChxlO'/' midline retinal sections 
at various time points during development. The total number of cells in 9 midline 
retinal sections from wild type and ChxW '' eyes per time point were counted. At 
E l0.5, no significant difference is observed between wild type and ChxlOr' cell 
counts (p < 0.97, 2-way ANOVA and post hoc multiple comparisons using Sidak 
adjustment). At El 1.5, a 24% reduction in total RPC number is observed in the 
Chxl0_/' retina, but this difference is not yet significant (p < 0.23). As 
development progresses, the difference in cell number increases, as the number of 
cells in the wild type retina increases to a greater extent than the number of cells 
in the ChxlO‘/  retina, and the difference between the wild type and ChxlO'/' cell 
numbers is highly significant (* p < 0.001). Error bars = 1 standard deviation, n = 
nine midline sections taken from three eyes. (B) Haematoxylin and eosin stained 
frozen section of an El 1.5 wild type (+/+) retinal section and an El 1.5 ChxlO' ' (- 
/-) retinal section. The periphery of the ChxlO'/~ retina is thinner than that of the 
wild type (arrows).
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thickened in comparison to the presumptive retinal pigmented epithelium in both 
genotypes, the periphery of the ChxlO'1 retina does seem to be thinner than that of 
the wild type (Figure 3.2B, arrows). As changes between wild type and 
ChxlO"A retinae are becoming apparent at El 1.5, the effects of ChxlO absence should 
be reflected in differential gene expression at this time point.
Another consideration in choosing this time point was the importance of achieving a 
clean dissection and the ability to extract RNA successfully from small amounts of 
material. Whilst it is difficult to separate the RPE from the retina at E9.5, at El 1.5 
the RPE is relatively well formed and easy to tease away from the neural retina. 
After dissecting the eye from the embryo and removing the RPE, a clean retina and 
lens are left (Figure 3.3). Even at El 1.5, it was technically difficult to remove the 
lens cleanly from the retina at this stage, and thus the lens was left in place in all 
dissections. ChxlO is not expressed in the lens, but possible indirect effects on the 
gene expression in the lens must be kept under consideration when comparing gene 
expression from the GeneChip data. The initial aim was to collect enough RNA to 
hybridise to the chips without the need for an amplification step, a total of 5 pg RNA 
per chip. Pilot experiments showed that roughly 5 pg of total RNA can be extracted 
from the retinae of about 35-40 El 1.5 embryos -  thus requiring the need to dissect 
210-240 embryos to collect enough RNA for six chips (3 wild type replicates and 3 
ChxlO’/' replicates). Setting up timed matings and dissecting the material is a time- 
consuming task, and the numbers of embryos required would have increased 
significantly if an earlier time point was chosen, where the retinae are far smaller.
3.2.2 High quality RNA was extracted and amplified from pools of retinae
An important step in performing GeneChip analysis is acquiring sufficient high 
quality RNA to convert to cRNA to hybridise to the chips. As discussed above, the 
initial aim of this study was to extract sufficient RNA from embryonic retinae to 
avoid the necessity of amplification, a potential source of bias. However, this proved 
to be technically difficult. In a preliminary experiment, enough dissections were 
performed to acquire the minimum 5 pg of RNA required per chip as recommended 
by Affymetrix. However, after cDNA synthesis and in vitro transcription, the
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Figure 3.3: Progression of retinal dissection. A and B depict whole wild type (A) 
and Chxl0~A (B) embryos at El 1.5. Eyes were teased away from both the wild 
type (C) and ChxlO" (D) embryos, shown in each panel from the front (left) and 
back (right). The lens is outlined with red dashed lines, the optic fissure indicated 
by a blue arrow and the optic stalk outlined in dashed yellow lines. The retinal 
pigmented epithelium is subsequently teased away, leaving a clean wild type (E) 
or ChxlO" (F) retina. Again both panels depict views from the front (left) and 
back (right) of the retina, with the lens outlined in red dashed lines and the optic 
stalk outlined in yellow dashed lines. Scale bars: 1 mm.
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resulting cRNA produced was not sufficient to fragment and hybridise to the 
GeneChips. It became clear that in this study, 5 pg of RNA per chip would not be 
sufficient to produce enough material for hybridisation, and that realistically, to 
perform triplicate hybridisations, the study would require an amplification step.
The Affymetrix standard labelling protocol of a single round of cDNA synthesis and 
subsequent in vitro transcription is effectively already a linear amplification step. 
Based on a protocol first described by Eberwine and colleagues (Van Gelder et al., 
1990), it has been shown to faithfully maintain relative mRNA levels when starting 
with 1 pg of poly(A)+ or 10 pg of total RNA (Lockhart et al., 1996; Mahadevappa 
and Warrington, 1999). Aplication of additional rounds of amplification from much 
smaller amounts of RNA have since been shown to give reproducible results for a 
single RNA sample (Luo et al., 1999), and to allow detection of differences between 
samples consistent with those detected without amplification (Wang et al., 2000). A 
technical note produced by Affymetrix examines the use of an additional round of 
cDNA synthesis and in vitro transcription protocol as a method for amplifying small 
amounts of starting material. The protocol produces a good cRNA yield from as little 
as 1 ng of RNA. A comparison of hybridisation to GeneChips indicated the amplified 
transcripts are a close match to those produced from a single round of cDNA 
synthesis and IVT, although when amplifying from as little as 1 ng of RNA, some 
transcripts are lost. Linearity of amplification was tested by spiking samples with 
predetermined amounts of exogenous poly (A)+ transcripts and was shown to be 
preserved, when amplifying as little as 100 ng of RNA (GeneChip Eukaryotic Small 
Sample Target Labelling Technical Note,
http://www.malaria.mr4.org/MArray/Affy_small_technote.pdf). The protocol does 
exhibit a 3’ bias compared to the standard protocol however, but it was generally 
found to produce similar results to the standard protocol when amplifying 10 ng of 
RNA or more, and thus this protocol was chosen for use in this study (for schematic, 
see Chapter 2.2.2.4). For each chip, 100-600 ng of RNA was amplified.
High quality RNA was extracted from pools of retinae dissected from embryos that 
were in the 40-47 somite range (Table 3.1). Collecting tissue from a large number of 
individuals should reduce the possibility that observed gene expression is specific to 
any one individual, and limiting the somite range should allow observation of gene
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expression at a fairly specific window during development. The quality of the 
extracted RNA was tested initially using formaldehyde RNA gels, and all samples 
were tested for quantity and quality on an Agilent 2100 Bioanalyser. The Bioanlayser 
is a microfluidics based platform for the analysis of DNA, RNA, proteins and cells 
and is often used in the context of gene expression analysis via microarray 
technology (www.agilent.com). RNA is injected into microchannels and separated 
according to molecular size, after which the fragments are detected by fluorescence. 
The system calculates the ratio of ribosomal bands in total RNA samples and shows 
the percentage of ribosomal impurities in as little as 5 ng of mRNA, as well as giving 
a good estimation of concentration. Figure 3.4 is an example of quality control on 
RNA extracted from both wild type, and ChxlO'1' , retinae.
Chip Tissue Collected Somite Range
129/Sv 1 80 retinae from 45 individuals 40-45
129/Sv 2 59 retinae from 30 individuals 42-47
129/Sv 3 29 retinae from 15 individuals 41-43
ChxlO-'-1 82 retinae from 41 individuals 41-47
ChxlO'' 2 30 retinae from 15 individuals 41-44
Chxl&' 3 30 retinae from 15 individuals 41-45
Table 3.1: Number of retinae collected per GeneChip used in this 
study and the somite range for each pool of retinae collected.
3.2.3 Acquisition and normalisation of GeneChip data
cRNA from three independent pools of wild type and ChxlO'*' retinae were 
hybridised to separate U74v2 chips, producing a total of six chips, three replicates of 
each type. All were stained with the single dye phycoerythrin and scanned twice by 
the HP GeneArray scanner for fluorescence. The data for all three replicates of each 
type were pooled and analysed using Genespring 5.1 and later Genespring 6 
software. The data was normalised in two consecutive steps, in order to eliminate 
variations between the three hybridisations. Firstly, the data was normalised per chip. 
Because global expression is being examined, it is expected that in general, 
fluorescence of all six chips should be of a similar intensity -  whilst a proportion of 
the transcripts may be up- or down-regulated in some of the chips compared to 
others, most of the transcripts are expected to be expressed at similar levels. Thus the
thfluorescence signal of all chips is normalised to the 50 percentile. Secondly, the 
data is normalised per gene. On every chip, sixteen probe pairs are present per
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RNA ladder RNA ladder ChxlO" RUA ChxlO--RNA  Wild type
3 |il 1:2 dilution sample 1 sample 2 RNA sample
9 kb 
7  kb
4 .4  kb
2.37 kb
1.35 kb
19 24 29 34 39 44 49 54 59 64 69
Time (seconds)
1= ChxlO "  RNA sample 1 
RNA Area 125.29 L =  RNA ladder
RNA Concentration(ng/ul) 189.11 2 =  ChxlO- -R N A  sample 2
rRNA Ratio [28S / 1 8S] 1.75 3 =  Wild type RNA sample
Figure 3.4: Quality and quantity control of RNA samples extracted from pools of 
El 1.5 ChxlO'A and wild type retinae. (A) Samples were run on an RNA gel to 
check for the presence of RNA. In this case, samples from one pool of wild type 
and two pools of ChxlO'/' retinae were tested. The presence of RNA is indicated 
by the typical 18S and 28S ribosomal RNA bands. A rough estimate of quantity 
could be acquired based on the brightness of the bands as compared to the 
brightness of the ladder bands at various dilutions. 3 ql of ladder contains 
approximately 500 ng of each component. (B) The RNA was also tested on an 
Agilent Bioanalyser 2100, producing a graph and gel equivalent, again clearly 
depicting 18S and 28S bands for the first mutant sample tested on the gel in A. 
Peaks were in the correct proportion (1.75, 1.7-2 is considered optimal) and a 
smooth baseline indicated no contamination by DNA. An estimate of the quantity 
of RNA present was also produced (RNA concentration ng/ i^l). (C) ‘Gels’ 
produced by the Bioanalyser for the RNA ladder and other two samples tested on 
the gel in A.
transcript (gene/EST), and their fluorescent signal is expected to be the same. Thus 
for every chip, the data is normalised to the median expression of every sequence.
The normalised data could then be displayed per chip, where expression of five chips 
could be compared to any one chip (Figure 3.5A; Figures 3.5-3.9 show consecutive 
steps of analysing data and producing gene lists). For each chip, small numbers of 
genes show very low or very high expression, whilst the majority of genes show an 
average expression and are therefore grouped in between the two extremes. A more 
useful display of the normalised data, however, was graphing the data by type, with 
all three replicates of the ChxlO'1' chips averaged and compared to the averages of all 
the wild type chips (Figure 3.5B). The graph is produced on a linear scale of signal 
intensity, thus giving a relatively direct representation of the extent to which a gene 
is expressed in the wild type retina compared to the ChxlO'/_ retina. A number of 
genes are expressed highly in the wild type retina and down-regulated in the ChxlO'1' 
retina (green diagonal lines Figure 3.5B), while others showed increased expression 
in the ChxlO"A retina compared to the wild type (purple diagonal lines Figure 3.5B). I 
went on to examine the fold change differences between gene expression and 
performed statistical tests to narrow down which of the -12000 transcripts 
represented on the chips were statistically significantly up- or down-regulated in the 
ChxlO''' retina compared to the wild type.
3.2.4 Thirty four characterised genes show a statistically significant greater than 
1.5 fold change
The data was organised into a two-dimensional plot of the hybridisation signal for 
ease of comparison (Figure 3.6A). Values of the majority of the transcripts fall along 
the central diagonal line and in between the parallel lines. Subsequent analysis of the 
data continued by eliminating all transcripts that were given an Absent signal for 
either set of RNA. A restriction was set for transcripts that were Present in at least 
two out of three wild type chips or two out of three ChxlO'1' chips. Thus, only the 
genes that were expressed by either the wild type or ChxlO''' retinae were displayed, 
narrowing down the number of genes to analyse to 7218 (Figure 3.6). Genes were 
then restricted to those that showed at least a 1.5-fold difference in expression 
between the wild type and ChxlO''' retina -  a total of 293 genes (Figure 3.7A, for a
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Figure 3.5: Normalised GeneChip data from 6 chips.
(A) Normalised data is displayed per chip (SV 1-3 are the wild type replicates, 
ORJ 1-3 are the ChxlO'/' replicates). All expression data is compared to SV1, thus 
the expression data for this sample is coloured according to the legend on the right: 
genes that show the least expression are represented with a purple colour at the 
bottom of the graph(low signal intensity), and genes that show high expression are 
represented with a green colour at the top of the graph (high signal intensity). The 
colour of each gene is maintained in the other samples, but their position on the 
graph (signal intensity) is higher or lower compared to the SV 1 sample (see also 
Figure 3.8).
(B) Normalised data is displayed as a graph, in which the signal intensities of the 
three wild type replicates (SV, left) and the three ChxlQrA replicates (ORJ, right) 
are averaged. Expression of the ChxlO'/' replicates is compared to that of the wild 
type replicates, and thus the lines are coloured according to wild type expression: 
green for highly expressed transcripts with high signal intensity at the top of the 
graph, and purple for transcripts with lower signal intensity.
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Figure 3.6: Normalised data showing relative expression of genes between wild
type replicates and ChxlO'A replicates.
(A) Normalised data for all genes represented on the GeneChip is displayed as a 
two-dimensional plot of the average hybridisation signal intensities of the three 
wild type replicates (SV, x-axis) and the three ChxlOr/~ replicates (ORJ, y-axis). 
Values for the expression of the majority of the genes fall along the central 
diagonal line, representing equal expression in the two genotypes. Parallel lines 
indicate a two-fold change in expression.
([B) The 7218 genes that are detected as ‘Present’ in at least two out of three wild 
type replicates or two out of three ChxlO'/~ replicates are displayed as a two- 
dimensional plot of the average hybridisation signal intensities of the three wild 
type replicates (SV, x-axis) and the three ChxlO‘/  replicates (ORJ, y-axis). Values 
for the expression of the majority of the transcripts fall along the central diagonal 
line, representing equal expression in the two genotypes. Parallel lines indicate a 
two-fold change in expression.
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Figure 3.7: Normalised data showing genes with a greater than 1.5-fold or 2-fold
change in expression between the wild type and ChxlO'/' replicates.
(A) Signal intensity of 293 of the 7218 genes expressed in either the wild type or 
ChxlOr/' retinae are up- or down-regulated more than 1.5-fold times in the ChxlOr1' 
retina compared to the wild type. Data is displayed as a two-dimensional plot of 
the average hybridisation signal intensities of the three wild type replicates (SV, x- 
axis) and the three ChxlO^ replicates (ORJ, y-axis). The central diagonal line 
represents equal expression in the two genotypes. Parallel lines indicate a two-fold 
change in expression.
(B) 43 of the 7218 genes expressed in either the wild type or ChxlO'/' retinae are 
up- or down-regulated more than 2-fold times in the ChxlO'/~ retina compared to 
the wild type.
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Figure 3.8: Normalised data showing genes with a statistically significant greater 
than 1.5-fold or 2-fold change in expression between the wild type and ChxlO‘/  
replicates.
(A) 40 of the 293 genes showing a greater than 1.5-fold change in expression 
between the wild type and ChxlOrA retina passed the parametric analysis of 
variance test for significance. Data is displayed as a two-dimensional plot of the 
average hybridisation signal intensities of the three wild type replicates (SV, x- 
axis) and the three ChxlOr1' replicates (ORJ, y-axis). The central diagonal line 
represents equal expression in the two genotypes. Parallel lines indicate a two-fold 
change in expression.
(B) 8 of the 43 genes showing a greater than 2-fold change in expression between 
the wild type and ChxlOrA retina passed the parametric analysis of variance test for 
significance.
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Figure 3.9: Normalised data showing genes with a statistically significant greater 
than 1.5-fold or 2-fold change in expression between the wild type and ChxlOr1' 
replicates.
(A) Normalised data of the 40 genes/ESTs showing a statistically significant 
greater than 1.5-fold change is displayed per chip (SV 1-3 are the wild type 
replicates, ORJ 1-3 are the ChxlOr1' replicates). All expression data is compared to 
SV1, thus the expression data for this sample is coloured according to the legend 
on the right: genes that show the least expression are represented with a purple 
colour at the bottom of the graph (low signal intensity), and genes that show high 
expression are represented with a green colour at the top of the graph (high signal 
intensity). The colour of each gene is maintained in the other samples, but their 
position on the graph (signal intensity) is higher or lower compared to the SV1 
sample.
(B) Normalised data of the 8 genes showing a statistically significant greater than 
2-fold change is displayed per chip.
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list see Appendix 1). A similar restriction was set to test the 7218 genes expressed in 
either the wild type or ChxlO'A retina for a greater than two-fold change in 
expression, which was the case for 43 genes (Figure 3.7B). Already the values of a 
large proportion of the remaining transcripts fall outside the parallel lines, indicating 
a more than two-fold difference in expression between wild type and ChxlO'A retina.
Statistical analysis was performed on these two sets of genes using the log ratio of 
the signal intensity to examine whether their differential expression was statistically 
significant. An analysis of variance (ANOVA) parametric test was performed in 
which variances were not assumed to be equal. The p values for the Welch t-test 
were given a cut-off value of 0.05. 40 genes showed a statistically significant greater 
than 1.5 fold change in expression between the wild type and ChxlO'1' retina (Figure 
3.8A, Table 3.2). It should be noted that of the 293 genes that showed a greater than
1.5-fold differential expression, about 14 genes would be expected to pass the 
restriction by chance. The same tests were performed on those genes that showed a 
two-fold change in expression and 8 genes showed a statistically significant greater 
than two-fold change in expression between the wild type and ChxlO_/' retina (Figure 
3.8B, Table 3.3). Of the 43 genes tested, about 3 genes would be expected to pass the 
restriction by chance. The values for all the remaining transcripts are now outside the 
parallel lines, indicating the significant difference of expression of these transcripts 
in the wild type retina compared to the ChxlO’A retina. The log ratio of the intensity 
signals of these genes could then be specifically observed per chip (Figure 3.9). This 
comparison between chips gives some idea of the consistency and reproducibility of 
the microarray study. The two labelled genes are clearly expressed at a different level 
in all three wild type retinal samples compared to the three ChxlO'A retinal samples.
Of the forty transcripts listed in Table 3.2, four are EST clones that have as yet not 
been further characterised. In addition, there is some redundancy, as there are two 
transcripts representing C. elegans ceh-10 homeo domain containing homolog 
{ChxlO) and two transcripts representing protein kinase C, beta 1 {Pkcbl). Thus a 
total of thirty four characterised genes show a significant, more than 1.5-fold change, 
in expression between the wild type retina and the ChxlO'1' retina. Fifteen of these 
are up-regulated in the ChxlO"A retina, and eighteen are down-regulated. Eight show 
a significantly greater than two-fold change (Table 3.3).
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Gene Title Trend Fold-
change
Genbank Accession 
Number
Apolipoprotein E (Apoe) + 4.70 D00466
Biglycan (Bgri) + 2.18 X53928
Brain and kidney protein (Bk) + 2.26 AW046243
Cyclin E2 (Ccne2) - 2.44 AF091432
Cadherin 8 (Cdh8) - 6.00 X95600
C. elegans ceh-10 homeo domain containing - 2.61 L34808
homolog {ChxlO)*
C. elegans ceh-10 homeo domain containing - 2.69 AV246437
homolog (ChxlO)*
Claudin 1 (Cldnl) - 2.75 AI604314
Cytochrome P450, family 1, subfamily b, - 3.41 X78445
polypeptide 1 (C yp lb l)
Dopachrome tautomerase (Dct) + 4.80 X63349
Distal-less homeobox 2 (Dlx2) - 13.83 M80540
Fibroblast growth factor 9 (Fgf9) - 2.75 U33535
Forkhead box C2 (Foxc2) - 2.29 X74040
Frizzled homolog 4 (Drosophila) (Fzd4) + 2.07 AW 122897
Growth arrest specific 2 (Gas2) - 2.14 M21828
GATA-binding protein 3 (Gata3) - 2.27 X55123
G protein-coupled receptor 175 (Gprl75) + 2.50 AI842363
Heparan sulfate (glucosamine) 3-O-sulfotransferase + 2.32 AF019385
1 (Hs3stl)
Insulin-like growth factor binding protein 5 (IgfbpS) + 2.41 LI2447
Indolethylamine N-methyltransferase (Inmt) + 3.26 M88694
Insulinoma-associated 1 (Insml) - 2.14 AF044669
Myeloblastosis oncogene (Myh) - 2.31 Ml 2848
Neurogenic differentiation 1 (Neurodl) - 8.29 U28068
Pleckstrin homology-like domain, family A, - 3.04 U44088
member 1 (Phldal)
Phospholipase D3 (Pld3) + 2.12 AF026124
Protein kinase C, beta 1 (Prkcbl)* + 2.56 X53532
Protein kinase C, beta 1 (Prkcbl)* + 2.50 X59274
Renin binding protein (Renbp) + 2.46 AA600645
Retinoid X receptor gamma (Rxrg) + 17.93 X66225
Silver (Si) + 3.54 U14133
Stathmin-like 2 (Stmn2) - 2.21 AI839868
Transducin-like enhancer of split 1, homolog of - 2.48 U61362
Drosophila E(spl) (Tlel)
Tenascin C (Tnc) - 2.30 X56304
Transient receptor potential cation channel, + 3.34 AF047714
subfamily M, member (Trpml)
Thyroid stimulating hormone receptor (Tshr) - 5.76 U02602
UDP-glucose ceramide glucosyltransferase (Ugcg) + 2.30 D89866
EST + 2.50 AA717225
EST + 2.09 AA691628
EST + 1.84 AA763466
EST - 2.09 AI153421
Table 3.2: Table of 40 genes/ESTs that showed a statistically significant greater than 1.5- 
fold change in expression between the wild type and ChxlO_/' retina. Trend indicates whether 
the gene is up- (+) or down-regulated (-) in the ChxlO"A retina compared to the wild type. * 
Indicates a gene that is represented twice.
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Gene Title Trend Fold-change Genbank Accession Number
Silver (Si) + 3.54 U14133
Thyroid stimulating hormone receptor - 5.76 U02602
(Tshr)
Dopachrome tautomerase (Dct) + 4.80 X63349
Cadherin 8 (CdhS) - 6.00 X95600
Distal-less homeobox 2 (Dlx2) - 13.83 M80540
Apolipoprotein E (Apoe) + 4.70 D00466
Neurogenic differentiation 1 - 8.29 U28068
(Neurodl)
Retinoid X receptor gamma (Saga et + 17.93 X66225
al., 1999)
Table 3.3: Table of 8 genes that showed a statistically significant greater than 2-fold change 
in expression between the wild type and Chxl&' retina. Trend indicates whether the gene is 
up- (+) or down-regulated (-) in the ChxlO A retina compared to the wild type.
3.2.5 Examining genes that show a correlation to the two most changed genes
The lists of genes/ESTs above were obtained through a series of relatively stringent 
steps. One of the problems of analysing the volume of data obtained from a 
microarray experiment is that various approaches will result in different lists of genes 
showing changes in expression. There is no correct or definitive list. It is important 
to be aware that taking one approach to analysing the GeneChip data may lead to the 
exclusion of differentially expressed genes that are important to the study because of 
stringent analysis conditions. Whilst the approach described above is used as a 
standard method in the microarray facility at the Institute of Child Health, UCL, at 
which this study was performed, it is important try to ensure no genes have been 
unnecessarily eliminated.
Statistical tests will not necessarily pinpoint only those genes that are important to a 
particular study. They simply exclude genes that do not exhibit a sufficiently 
different change in expression. In order to examine the data a little further, a 
common procedure is to look for genes whose pattern of altered expression correlates 
with some of the most significantly altered genes. The 293 genes that showed a 1.5- 
fold change in expression were analysed for a correlation with the two most changed 
genes: retinoid X receptor gamma (.Rxrg), the gene most increased in expression, and 
distal-less homeobox 2 (Dlx2\ the gene most decreased in expression in the ChxlO'A 
retina. Twenty one transcripts showed an increase in expression similar to that of
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Rxrg (Figure 3.10) and twenty three transcripts showed a decrease in expression 
similar to that of Dlx2 (Figure 3.11).
Of the twenty one transcripts showing an increase in expression, eighteen did not 
pass the statistical analysis performed earlier, and thus are not observed in Table 3.2. 
Upon examination of the data per chip (Figure 3.10C), it is clear that the reason for 
this is that these samples showed variable levels of expression. Whilst overall it is 
clear that there is a difference between the wild type and ChxlOv' expression of the 
genes, the difference would not have been clear-cut enough to pass the statistical 
analysis. Similarly, of the twenty three transcripts that show a decrease in expression, 
another twelve failed the statistical analysis, excluding them from the list in Table 
3.2. The transcripts that failed the statistical analysis are listed in Table 3.4. Eight of 
the transcripts represent ESTs, and twenty two of the transcripts represent 
characterised genes.
3.2.6 Functional classification of genes with altered expression
One of the challenges of analysing microarray data is extracting meaningful 
information from often very large lists of genes. In order to assign some meaning to 
the fifty six characterised genes that show a change in expression, ontology 
information from Netaffix, the Affymetrix online analysis facility 
(www.affymetrix.com), and the Mouse Genome Informatics website 
(www.informatics.jax.org) were used to assign the expressed genes to a functional 
class, based on the biological processes they are involved in. A number fit into more 
than one category, due to having either more than one function or because of an 
overlap between functional classes themselves. The results are listed in Table 3.5, 
giving an initial glance at what types of genes show a difference in expression.
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Figure 3.10: Normalised data showing genes that show a correlation with Rxrg
{A) 21 genes show a correlation in expression to Rxrg. Data is displayed as a graph, in 
which the log ratio of signal intensities of the three wild type replicates (SV, left) and the 
three Chxlfr/m replicates (ORJ, right) are averaged. Expression of the ChxlOr/_ replicates 
is compared to that of the wild type replicates, and thus the lines are coloured according 
to wild type expression: green for highly expressed genes with high signal intensity at 
the top of the graph, and purple for genes with lower signal intensity.
(B) 18 of the 21 genes showing a correlation in expression to Rxrg did not pass the 
statistical analysis performed on the 293 genes showing a change in expression between 
the wild type and ChxlO'A retinae.
(C) Normalised data of the genes in (B) is displayed per chip (SV 1-3 are the wild type 
replicates, ORJ 1-3 are the ChxlO-/- replicates). All expression data is compared to SV1, 
thus the expression data for this sample is coloured according to the legend on the right: 
genes that show the least expression are represented with a purple colour at the bottom 
of the graph (low signal intensity), and genes that show high expression are represented 
with a green colour at the top of the graph (high signal intensity). The colour of each 
gene is maintained in the other samples, but their position on the graph (signal intensity) 
is higher or lower compared to the SV 1 sample.
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Figure 3.11: Normalised data showing genes that show a correlation with Dlx2
(A) 23 genes show a correlation in expression to Dlx2. Data is displayed as a graph, in 
which the log ratio of signal intensities of the three wild type replicates (SV, left) and the 
three ChxlOr1' replicates (ORJ, right) are averaged. Expression of the ChxlO~/~ replicates 
is compared to that o f the wild type replicates, and thus the lines are coloured according 
to wild type expression: green for highly expressed genes with high signal intensity at 
the top of the graph, and purple for genes with lower signal intensity.
(B) 12 of the 23 genes showing a correlation in expression to Dlx2 did not pass the 
statistical analysis performed on the 293 genes showing a change in expression between 
the wild type and ChxlO‘/  retinae.
(Q  Normalised data of the genes in (B) is displayed per chip (SV 1-3 are the wild type 
replicates, ORJ 1-3 are the ChxlO-/- replicates). All expression data is compared to SV1, 
thus the expression data for this sample is coloured according to the legend on the right: 
genes that show the least expression are represented with a purple colour at the bottom 
of the graph (low signal intensity), and genes that show high expression are represented 
with a green colour at the top of the graph (high signal intensity). The colour of each 
gene is maintained in the other samples, but their position on the graph (signal intensity) 
is higher or lower compared to the SV 1 sample.
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Gene Title Trend Fold-
Change
Genbank
Accession
Number
Adenylosuccinate synthetase like 1 (Adssll) + 1.91 M74495
Basic helix-loop-helix domain containing, + 2.95 Y07836
class B2 CBhlhb2)
CCR4-NOT transcription complex, subunit + 3.31 AI931748
7 (Cnot7)
Cellular retinoic acid binding protein I - 2.29 X15789
(Crabpl)
DNA segment, Chr 2, ERATO Doi 93, - 1.94 C77278
expressed (D2Ertd93e)
DNA segment, Chr 6, Wayne State - 2.07 AA733372
University 176, expressed (D6Wsul76e)
Enolase 2, gamma neuronal (Eno2) + 2.28 AC002397
Famesyl diphosphate synthetase (Fdps) - 1.83 AW045533
Fragile histidine triad gene (Fhit) + 1.80 AF047699
Forkhead box G1 (Foxgl) - 3.57 U36760
Glutathione S-transferase, theta 2 (Gstt2) + 2.06 X98056
Leukotriene B4 12-hydroxy dehydrogenase + 1.84 AA596710
CUb4dh)
N-acetyl galactosaminidase, alpha (Naga) + 2.18 AJ223966
Polo-like kinase, pseudogene 1 (Plk-psl) - 2.67 U73170
Protein kinase C, alpha (Prkca) - 2.35 M25811
Sphingomyelin phosphodiesterase, acid­ + 2.42 Y08135
like 3A (iSmpdl3a) .
Small proline-rich protein 2F (Sprr2f) - 2.03 AJ005564
Signal transducer and activator of + 3.02 L47650
transcription 6 (Stat6)
ST8 alpha-N-acetyl-neuraminide alpha-2,8- - 2.25 X80502
sialyltransferase 3 (St8sia3)
Transmembrane protein 30B (Tmem30b) + 2.13 AA619554
Transmembrane 4 superfamily member 8 + 2.18 AI843488
(:Tm4sf8)
Vascular endothelial growth factor B + 1.84 U43836
(Vegfb)
EST + 2.51 AA607758
EST + 2.08 AA656550
EST + 2.07 AI839150
EST + 2.00 AV303935
EST + 1.96 AI020029
EST - 4.18 AW214136
EST - 3.51 AW 122834
EST - 2.33 AA867778
Table 3.4: Table of transcripts that show an expression correlation with either Rxrg or Dlx2. 
Trend indicates whether the transcript is up- (+) or down-regulated (-) in the ChxlO'A retina 
compared to the wild type. Up-regulated genes correlate with Rxrg, down-regulated genes 
with Dlx2.
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Classification Genes
Carbohydrate metabolism Eno2, Naga, Renbp, Smpdlia
Cell adhesion Cdh8, Cldnl
Cell Cycle/Proliferation Ccne2, Crabpl, Fgf9, Foxgl, Gas2, Myb, Vegfb
Cell differentiation/cell fate 
determination
Bhlhb2, ChxlO, Crabpl, Dlx2, Fgf9, Foxgl, GATA 3, 
Neurodl, Tlel
Cell growth/ 
regulation of cell growth
Apoe, Gas2, IgfbpS, Myb, Prkcbl, Stat6, Vegfb
Cell signalling Fgf9, Foxc2, Fzd4, Prkca, Prkcbl, Stat6, Stmn2, Tlel, Tshr
Electron transport Cyplbl
Glutathione metabolism Gstt2
Lipid metabolism/transport Apoe, Fdps, Pld3, Ugcg
Melanin Biosynthesis Dct, Si
Nucleotide biosynthesis Adssll
Protein biosynthesis Phldal, St8sia3
Regulation of transcription Bhlhbl, ChxlO, Cnot7, Foxc2, Dlx2, Myb, Neurod 1, Rxrg, 
St at 6, Tlel
Unclassified Bgn, Bk, D2Ertd93, D6Wsul76e, Fhit, Gprl75, Hs3stl, 
Inmt, Insml, Ltb4dh, Plk-psl, Sprr2, Tmem30B, Tm4sf8, 
Tnc, Trpml
Table 3.5: Functional characterisation of the fifty six genes that show a change in expression 
in the ChxlO'A retina compared to the wild type. Genes in bold type are up-regulated, those 
in normal type are down-regulated.
A few of the genes exhibiting changes in expression are involved in cell metabolism 
and thus may reflect some physical differences between the wild type and ChxlO'/m 
eye. Nine genes are involved in carbohydrate, lipid, and glutathione metabolism, and 
all but one {Fdps, involved in lipid metabolism) of those are up-regulated in the 
ChxlO'A retina. A further three are important for protein and nucleotide biosynthesis. 
Phldal and St8sia3, involved in protein biosynthesis, are both down-regulated, 
whilst Adssll, involved in nucleotide biosynthesis, is up-regulated in the ChxlO'1' 
retina. In addition, two genes whose products are play a part in melanin biosynthesis, 
Si and Dct show an increase in expression in the ChxlO'A retina compared to the wild 
type. A further two genes, Cldnl and Cdh8, are involved in cell adhesion, and are 
both down-regulated in the ChxlO'1' retina, as is Cyplbl, which has a function in 
electron transport.
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However, the majority of the genes whose expression is affected by a lack of ChxlO 
seem to be important for proliferation and cell cycle regulation, cell growth, 
differentiation and cell fate determination, or cell signalling. Twelve genes are 
transcription factors or involved in transcriptional regulation, and eight of these play 
roles in cell fate determination and differentiation. A further three are involved in 
regulation of cell growth and/or in cell proliferation. In addition, gene products of 
two of the genes, Gas2 and Ccne2 are part of the cell cycle machinery, and both are 
down-regulated in the Chxlff/' retina. Altogether, eleven genes are involved in either 
cell growth or cell proliferation; nine are involved in cell differentiation or cell fate 
determination, and nine in cell signalling.
A number of the differentially expressed genes are known to play a part in various 
disorders affecting the eyes. Fzd4 is involved in retinal angiogenesis and familial 
exudative vitreoretinopathy (FEVR) is a hereditary ocular disorder characterised by 
failure of peripheral vascularisation that has been linked to the Fzd4 locus (Robitaille 
et al., 2002). Cyplbl is affected in primary congenital glaucoma. A cytochrome 
P450-dependent arachidonate metabolite that inhibits Na+K+-ATPase in the cornea is 
thought to cause ocular drainage abnormalities (Schwartzman et al., 1987). Optic 
atrophy and blindness are characteristics of Naga deficiency (Schindler et al., 1988), 
a disorder characterised by neurologic abnormalities and progressive psychomotor 
deterioration (van Diggelen et al., 1988). Foxc2 is also associated with eye 
abnormalities: Foxc2+/' mice have anterior segment abnormalities similar to those 
reported in humans with Axenfeld-Rieger anomaly (Smith et al., 2000). Foxcl and 
Foxc2 are expressed in the mesenchyme from which ocular drainage structures 
derive. Mutations in the human homologue of Foxcl, FOXC1/FKHL7, cause 
dominant anterior segment defects and glaucoma and various families (Smith et al., 
2000). Tshr expression is detectable in normal orbital adipose tissues, with increased 
levels found in orbital tissues from patients with Graves' ophthalmopathy (GO), and 
in orbital preadipocyte cultures following differentiation (Bhattacharyya et al., 2005).
In addition, a number of the other genes are known to be expressed in the retina. 
Foxgl is normally expressed in most, if not all, nasal RGCs but not in most temporal 
RGCs (Pratt et al., 2004). Studies show that the gene product of Foxgl is involved in 
brain development, specifically in negative regulation of neuron differentiation and
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regulation of the mitotic cell cycle (Hanashima et al., 2002; Vyas et al., 2003; Xuan 
et al., 1995). Foxgl is also involved in axon midline choice point recognition (Pratt 
et al., 2004) and dorsal/ventral pattern formation (Vyas et al., 2003). The gene 
showing the most significant change, Rxrg, has been shown to be important in 
photoreceptor development, and is expressed in retinal progenitor cells during eye 
development in the rat (Azadi et al., 2002; Kelley et al., 1995b; Ying et al., 2000). 
Both Dlx2 and Neurodl, transcription factors that are involved in cell fate 
determination, have been shown to be present in the developing eye. Dlx2 is 
expressed quite early during retinal development in retinal progenitor cells, whilst 
Neurodl is expressed a little later in development and is thought to be important for 
regulating neural versus glial fate (de Melo et al., 2003; Morrow et al., 1999a).
A significant number of the differentially expressed genes are expressed in the retinal 
pigmented epithelium (RPE) of the eye. As the RPE was removed from the retinae in 
the GeneChip study, this was intriguing. Two of the genes, Si and Dct, involved in 
melanin biosynthesis from tyrosine, are specific to the melanocytes present in the 
RPE (Baxter and Pavan, 2003; Steel et al., 1992). In addition, the RPE is thought to 
be the source of Apoe, specific alleles of which are related to age-related macular 
degeneration (Anderson et al., 2001). Trpml is expressed in the normal eye and in 
melanosomal cell lines (Duncan et al., 1998) and its promoter contains 4 consensus 
binding sites for microphthalmia-associated transcription factor (Mitf), a gene 
required for determining RPE cell fate (Hunter et al., 1998). Fg/9 is also known to be 
expressed in a subpopulation of RPE cells as well as in photoreceptors and other 
neurons of the retina. It is thought to be an autocrine/paracrine factor in the outer 
retina (Alizadeh et al., 2003). Moreover, activation of FGF receptors in the 
presumptive RPE by ectopic expression of FGF9 in transgenic mice has been shown 
to result in a second retina (Zhao and Overbeek, 1999), indicating it may form part of 
the FGF signalling network thought to regulate RPE versus neural retinal fate.
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3.3 Discussion
3.3.1 Considerations for interpreting microarray data
The purpose of this study was to examine differential expression between the wild 
type and the ChxlO'A El 1.5 retina in order to ascertain whether the expression of any 
genes are affected by the absence of ChxlO. As ChxlO is a transcription factor, it 
would be logical to assume it will exert some effect, either directly or indirectly, on a 
number of other genes expressed at a similar point in development as ChxlO. Such 
genes could then become the basis of further study to examine their own role in the 
genetic pathway of retinal development as well as their possible roles in the causes of 
microphthalmia. In the past, potential candidates would have been picked for study 
based on the knowledge that they are expressed at a similar time point to ChxlO and 
important for eye development. However, GeneChip technology is an excellent tool 
for carefully targeting potentially interesting genes, as it is possible to examine a list 
of genes known to be affected by ChxlO. It is possible, for example, to observe 
differentially expressed genes that would not normally be considered for further 
study as their role in eye development might be unknown.
A few limits must be taken into consideration upon analysis, however. To date, much 
of the interest of researchers in microarrays has been directed towards identifying 
individual genes, the regulated expression of which can explain particular biological 
phenomena (Schulze and Downward, 2001). This is also the case in this study, where 
changes in expression of certain genes may lead to clues as to how the ChxlO'1' 
phenotype may result from the absence of ChxlO. The problem is that microarray 
experiments, whether based on oligonucleotides or cDNA, are highly capable of 
generating long lists of genes with altered expression, but they provide few clues as 
to which of these changes are important in establishing a given phenotype. A given 
stimulus could potentially lead to changes in the mRNA levels of hundreds of genes, 
particularly in mammalian systems (Schulze and Downward, 2001). It is important to 
avoid the temptation to look for genes that conform to existing ideas of how the 
system might work.
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In most cases, careful analysis of the published literature is required before direct 
experimental investigation of gene function is undertaken. This is complicated by the 
lack of unified gene ontology. For the examination of human expression arrays, the 
use of advanced sophisticated literature-searching tools, such as Medminer or high- 
density array-pattem interpreter (HAPI) which correlates gene accession numbers 
with MeSH (medical subject heading) keywords, can be very useful for known 
genes. Functional annotation of new sequences and expressed sequence tags remains 
a challenge, but is crucial for the interpretation of genome-wide expression data 
(Schulze and Downward, 2001). In this study, a dedicated Affymetrix data analysis 
website, Netaffix, and the Mouse Genome Informatics website were used as the first 
point of call to examine the function of genes that show a change in expression, and 
further information was retrieved from the Online Inheritance in Man (OMIM) 
website and research articles about the genes concerned.
The approach to data analysis undertaken in this study mirrors those undertaken in a 
variety of microarray studies. The use of commercial, and specifically Affymetrix, 
microarrays is becoming a common phenomenon. They have been used to examine 
such wide-ranging subjects as the effects of short- and long-term caloric restriction 
on the liver of aging mice (Cao et al., 2001), the development of the mouse 
hippocampus (Mody et al., 2001), the regulation of gene expression by Bm3a in 
developing sensory ganglia (Eng et al., 2004), and gene expression in the eye of a 
mouse model for Batten Disease (Chattopadhyay et al., 2004). In all cases, a cut-off 
in the change in expression levels is chosen below which changes are unlikely to 
signify an important contribution to the study. In this study, the cut-off point chosen 
was a 1.5-fold change. Rather than suggesting that all genes that show a greater than
1.5-fold change in expression are responding to the absence of ChxlO, it suggests 
that any genes that show a less than 1.5-fold change in expression are more likely to 
be showing a natural variation in expression rather than a response to ChxlO 
absence. In other studies, the cut-off point ranged from 1.5- (Cao et al., 2001) to 3- 
fold (Mody et al., 2001) changes in expression. Similar to the study performed by 
Eng et al, the genes showing changes in expression were then sorted into functional 
groups, based on literature and ontology resources. This is a relatively subjective 
area of the analysis, and is approached in different manners in different studies, but
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an attempt at classification is always made (Cao et al., 2001; Chattopadhyay et al., 
2004; Eng et al., 2004; Mody et al., 2001).
One final problem that limits the usefulness of microarrays in the analysis of 
individual pathways is the fact that regulation of mRNA levels is only one aspect of 
biological control. Protein levels are also controlled at several post-transcriptional 
steps, and protein activity is controlled by post-translational modification (Schulze 
and Downward, 2001). Thus, whilst a valuable tool in identifying potentially novel 
genes and proteins involved in biological processes for which little information 
exists, this is by no means an all-encompassing, definitive approach.
3.3.2 ChxlO seems to exert a significant effect on cell proliferation, growth and 
differentiation
Strikingly, many of the identified genes are involved in cell proliferation or 
regulation of cell growth. As the Chxl0~A retina is significantly smaller than the wild 
type retina, this is an encouraging result. It is interesting that a 2.4-fold decrease in 
cyclin E2 (Ccne2) is observed in ChxlO'A retina, as expression of another cyclin, 
cyclin Dl, has previously been shown to be decreased in the ChxlO"A retina (Green et 
al., 2003). Cyclins A, D and E are required for mammalian cells to traverse G1 and 
enter S phase. Cyclin E controls the initiation of DNA synthesis by activating CDK2; 
the KIP1 and CIP1 proteins bind and inhibit the cyclin E-CDK2 complex (Gudas et 
al., 1999; Lauper et al., 1998). It has been suggested that cyclin Dl is necessary for 
proliferation to progress in the ChxlO'/' retina, as it may be required for ChxlO"A 
dependent-modulation of p27Kipl. It is possible that Cyclin E may play a similar role.
Gas2 is another cell cycle gene that shows a decrease in expression. It tends to be 
expressed during growth arrest and is a component of the microfilament system 
(Brancolini et al., 1992). When expressed in mammalian cells, human Gas2 localised 
at the actin cytoskeleton, along the stress fibres and at the plasma membrane 
(Collavin et al., 1998). Its decrease in expression in the ChxlO'A retina is another 
indication that the small size of the ChxlO'1 retina may in some way arise from a 
mis-regulation of the cell cycle.
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Not all genes with a function in proliferation that showed a change in expression are 
necessarily known to be expressed in the eye. For example, the Myb gene encodes 
proteins that are critical for hematopoietic cell proliferation and development, and 
there is evidence that disrupting Myb function might be an effective therapeutic 
strategy for controlling leukemic cell growth (Ratajczak et al., 1992). Detailed 
analysis of hematopoiesis in Myb homozygous mutant mice revealed distinct blocks 
in T-cell, B-cell, and red blood cell development, as well as a 10-fold increase in the 
number of hematopoietic stem cells. Cell cycle analysis showed that twice as many 
hematopoietic stem cells were actively cycling in mutant mice compared with 
wildtype mice (Sandberg et al., 2005). Vegfb, a growth factor expressed in muscle 
and in the heart, can promote angiogenesis (Olofsson et al., 1996; Silvestre et al.,
2003). Cellular retinoic acid-binding protein (Crabpl) is assumed to play an 
important role in various retinoic acid-mediated differentiation and proliferation 
processes (OMIM entry *180230; Vogel). Foxgl has been shown to be involved in 
the regulation of the cell cycle in the brain (Vyas et al., 2003). To see a change in 
such genes in this study is interesting because of their known roles in proliferation 
generally or specifically in other cell types. It would be of interest if these roles are 
retained in the developing eye.
In addition to changes in expression of genes important for proliferation and growth, 
a number of the changed genes are involved in cell differentiation or signalling. 
ChxlO itself is shown to be down-regulated in the ChxlO'A retina, with both sets of 
probe pairs for this gene showing a similar fold-change in expression (Table 3.2). It 
is interesting that ChxlO shows a change in expression, but not entirely surprising. 
The ChxlO mRNA is detected in the Chxl0f/' retina (Rutherford et al., 2004), but the 
mRNA contains a premature stop codon and is likely to be degraded by a process 
such as nonsense-mediated mRNA decay (NMD), in which the cell is rid of non­
functional mRNAs arising from mutations and processing errors (Weischenfeldt et 
al., 2005). Thus a decrease in the ChxlO mRNA transcript is reflected in the 
microarray study. Five genes, Neurodl, Dlx2, Fgf9, Foxgl, and Rxrg, are expressed 
specifically in the eye. As stated in section 3.2.6, both Dlx2 and Neurodl are 
expressed early in retinal development and play roles in cell fate determination (de 
Melo et al., 2005; Morrow et al., 1999a) and Fgf9 is also known to be expressed in a 
subpopulation of RPE cells as well as in photoreceptors and other neurons of the
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retina (Alizadeh et al., 2003). Foxgl is normally expressed in most, if not all, nasal 
RGCs but not in most temporal RGCs (Pratt et al., 2004) and Rxrg has been shown to 
be important in photoreceptor development, and is expressed in retinal progenitor 
cells during eye development in the rat (Azadi et al., 2002; Kelley et al., 1995b; Ying 
et al., 2000). In addition, Cnot7, another gene showing differential expression, is a 
transcriptional cofactor, known to co-regulate Rxrb by binding to its AF-1 domain in 
testicular somatic cells. Rxrb malfunctions in the absence of Cnot7 (Nakamura et al.,
2004).
A number of transcription or signalling factors that are known to play a role in other 
cell types have also shown a change in expression. It’s been shown that expression of 
individual Tie genes correlated with immature epithelial cells that are progressing 
toward that terminally differentiated state, suggesting a role during epithelial 
differentiation. In both normal tissues and tissues resulting from incorrect or 
incomplete maturation events, Tie expression was elevated and coincided with Notch 
expression, implicating these molecules in the maintenance of the undifferentiated 
state in epithelial cells (Liu et al., 1996). Bhlhb2 is a transcription factor involved in 
the regulation of chondrocyte differentiation via the cAMP pathway (Shen et al., 
1997). The gene product of Prkca is involved in the induction of positive 
chemotaxis, neutrophil chemotaxis, the positive regulation of inflammatory response, 
and the induction of apoptosis by intracellular signals (Cataisson et al., 2003). As 
with the cell proliferation genes expressed in tissues other than the eye, changes in 
these genes may indicate novel roles for them in the retina, or conversely, previously 
unidentified roles for Chx 10.
3.3.3 Changes in expression of genes involved in cell adhesion and fat 
metabolism and the immune system
Two of the differentially expressed genes are involved in cell adhesion, Cdh8 and 
Cldnl. Cadherins mediate calcium-dependent cell-cell adhesion and cadherin 8 has 
been shown to be expressed during retinal development and in the adult eye (Honjo 
et al., 2000). Claudin 1 is associated with tight junctions (Furuse et al., 1998). Cldnl 
is a member of a superfamily of epithelial membrane proteins (EMPs), which may 
have multiple potential functions, including maintenance and regulation of cell
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polarity and permeability, perhaps through mechanisms involving tight junctions 
(Swisshelm et al., 1999). It is interesting that these two genes show a difference in 
expression, as ChxlO'1' retinal progenitor cells may have different adhesive properties 
to those of the wild type.
Four genes involved in adipocyte metabolism or differentiation, Foxcl, Tpra40, 
GATA3, and Tshr, have shown a change in expression. Cederberg et al identified 
Foxc2 as a key regulator of adipocyte metabolism. In mice over-expressing Foxc2 in 
white adipose tissue (WAT) and brown adipose tissue (BAT), the intra-abdominal 
WAT depot was reduced and has acquired a brown fat-like histology, whereas 
interscapular BAT was hypertrophic (Cederberg et al., 2001). Tshr expression is 
increased in orbital tissues from patients with Graves' ophthalmopathy (GO), and in 
orbital preadipocyte cultures following differentiation (Bhattacharyya et al., 2005). 
The orbit of the Chxl(T/' eye contains what appear to be large deposits of fatty tissue, 
described as hypertrophied Harderian and lachrymal glands in one study (Truslove, 
1962), and thus it would be of interest to examine whether changes in adipocyte 
metabolism or differentiation are an effect of ChxlO absence.
Three of the differentially expressed genes are normally associated with the immune 
system: Prkcbl'A mice are immuno-deficient, showing characteristics similar to X- 
linked immunodeficiency (Leitges et al., 1996). GATA3 is expressed in T cells and 
participates in T cell receptor activation. GAT A3 is necessary and sufficient for Th2 
cytokine gene expression (Zheng and Flavell, 1997), and is critical for the expression 
of the IL5 gene in Th2 cells (Zhang et al., 1997). Tong showed that murine GATA2 
and GATA3 are specifically expressed in white adipocyte precursors and that their 
down-regulation sets the stage for their terminal differentiation. Constitutive GATA2 
and GATA3 expression suppressed adipocyte differentiation and trapped cells at the 
preadipocyte stage (Tong et al., 2000). Stat6 activates 1L4 and is involved in Th2 
cell differentiation. As yet there is no indication that ChxlO plays any significant part 
in the immune system, but it could be an interesting subject for research.
Thus, the microarray data provide an interesting overview of the mechanisms 
potentially controlled by ChxlO. A few genes controlling cell proliferation have 
changed in expression, but more strikingly, a large number of transcription factors,
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particularly ones that control various aspects of cell differentiation, have changed in 
expression in the ChxlO^' retina. Although cell proliferation and differentiation are 
often intricately linked, it seems ChxlO may be exerting its effects more through cell 
differentiation mechanisms than through changes in the cell cycle.
Whilst encouraging, it is important to remember, however, the data obtained from 
this experiment are not necessarily the definitive list of genes whose expression is 
altered in the developing eye by a lack of ChxlO. It is important to note, for example 
that three genes previously shown to be up- or down-regulated in the ChxlO'A retina, 
retinoid related orphan receptor B (Chow et al., 1998), Foxn4 (Gouge et al., 2001) 
and cyclin Dl (Green et al., 2003) and that were present on the microarray, did not 
show any significant difference in expression in this study. The analysis of the data is 
to some extent subjective, depending on such factors as correctly, linearly amplified 
high quality RNA, the type of parametric tests selected to analyse the microarray 
data, the restrictions I’ve chosen to impose on the data, and even the type of chips 
available at the time. The amplification step used in this study was chosen based on 
its success in previous studies, but there is no guarantee that no targets were lost as a 
result of the amplification strategy. The statistical analysis used here is also quite 
stringent, thus producing a relatively small list of differentially expressed genes. To 
some extent I have tried to look at some genes that did not pass the statistical 
analysis based on their correlation with other differentially expressed genes, but it is 
possible that genes that are in fact regulated by ChxlO did not pass the analysis. It is 
important to consider that a different approach to the analysis of the raw data may 
have produced different results.
3.3.4 Genes selected for further study
Once a set of genes has been identified, their function has to be modulated in such a 
way as to directly determine their degree of involvement. The gene list produced in 
this study seems to present a plausible snapshot of gene expression at El 1.5 in the 
wild type and ChxlO'A retina. Many of the genes in the list are known to be expressed 
in the eye at this time point and examination of the literature available regarding 
these genes has produced some idea of how ChxlO affects retinal development. 
However, it is important to verify whether these genes are indeed differentially
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expressed and whether they are directly regulated by ChxlO. Ideally, all genes would 
be examined further, but time constraints have led me to choose some of the most 
interesting and most significantly changed genes to examine initially.
Some of the genes that show the most significant changes in expression, such as Rxrg 
or Dlx2, are genes that would not immediately be considered as potential candidates 
for ChxlO regulation, as they have not been studied in detail in the developing retina 
and thus their potential importance is as yet unknown. These genes, along with 
Neurodl, seem to play a large part in cell differentiation and cell fate determination, 
processes ChxlO appears to exert a large effect upon. In addition, a number of genes 
that show differential expression are normally expressed in the RPE (Dct, Si, Apoe, 
Fgf9). This pattern of expression change suggests that perhaps one way in which 
ChxlO regulates retinal development is through the specification of the retina in 
favour of the RPE.
Thus, of the list of genes in Tables 3.2 an 3.3 ,1 have chosen to examine in further 
detail the expression of retinoid X receptor (Saga et al., 1999), dopachrome 
tautomerase (Dct), silver (Si) -  the three most up-regulated genes-, distal-less 
homeobox 2 (Dlx2), neurogenic differentiation 1 (Neurodl) and cadherin 8 (Cdh8) -  
the three most down-regulated genes, with the exception of silver, which was 
selected in preference to Apoe because of its early RPE expression and close 
association with Dct. All six are shown to be significantly up- or down-regulated 
more than 2-fold in the ChxlO'A retina compared to the wild type retina and five of 
these genes may be part of a ChxlO'A regulated retinal versus RPE specification 
system as discussed above. This study will form the subject of the following chapter.
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CHAPTER 4 
Analysis of Putative ChxlO Target Genes
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4.1 Introduction
The aim of the microarray study described in the previous chapter was to identify 
genes that are regulated by ChxlO and in this way discover the molecular basis for 
the ChxlO"A microphthalmic phenotype. The expression of a number of genes has 
been shown to be either up- or down-regulated in the El 1.5 ChxlO’A retina compared 
to the wild type. As discussed, the nature of these genes and their various functions 
give some indication as to how ChxlO might control various aspects of eye 
development. However, before any conclusions can be drawn, it is important to 
verify whether these are genuine changes in expression, and to compare their patterns 
of expression to begin to determine whether these changes are likely to result from 
direct transcriptional regulation by ChxlO, or as an indirect effect of its function. 
Ideally, all 54 characterised genes that showed a change in expression would be 
examined further to verify their expression in the wild type and ChxlO'1' retina and 
tested for regulation by ChxlO. However, as is the case with many microarray 
experiments, examining all the genes that show a change in expression in further 
detail is a daunting and time consuming task and was beyond the scope of this thesis. 
A more realistic approach taken here was to choose a small number of genes that are 
potentially interesting and by analysis of these, validate the broader set of data from 
the microarray.
The microarray experiment has yielded a list of eight genes statistically significantly 
up- or down-regulated by more than 2-fold in the absence of ChxlO. I have chosen to 
study six of these in further detail. The three genes shown to be most significantly 
up-regulated in the absence of ChxlO are retinoid x receptor gamma (.Rxrg), silver 
(Si,) and dopachrome tautomerase (Dct). Their up-regulation suggests that these 
three genes are normally repressed in the presence of ChxlO. In addition, I further 
examined three genes that were down-regulated in the absence of ChxlO: distal-less 
2 (Dlx2), neurogenic differentiation 1 {Neurodl), and cadherin 8 (Cdh8). Their 
down-regulation in expression suggests that these three genes are normally activated 
in the presence of ChxlO. Whether any of these genes are directly regulated by 
ChxlO remains to be seen, but in at least an indirect manner, it seems ChxlO may 
play a dual role as an activator and a repressor.
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Rxrg showed the greatest change in expression in the ChxlO'1' retina compared to the 
wild type. Retinoic acid is of vital importance for'proper function of the retina and 
retinoic acid activity is mediated by interaction with nuclear retinoic acid receptors 
and retinoid X receptors (Janssen et al., 1999). Retinoid X receptors respond to 9-cis- 
retinoic acid and also serve as heterodimeric partners for the vitamin D receptor, 
thyroid hormone receptors, and retinoic acid receptors, A, B and G (Mangelsdorf et 
al., 1992). A lack of ChxlO causes it to be up-regulated nearly 18-fold, suggesting a 
link between ChxlO and retinoic acid signalling. The other two up-regulated genes I 
have selected are dopachrome tautomerase {Dct) and silver {Si). Both of these genes 
are normally expressed in the developing retinal pigmented epithelium (RPE) and are 
thought to be important for the specification of melanocytes (Baxter and Pavan, 
2003). Their expression in the Chxl&' retina is therefore unusual and hints at a role 
for ChxlO in specification of the neural retina by repression of RPE genes.
Two of the genes that are down-regulated, Dlx2 and Neurodl, are known to be 
involved in development of the forebrain. Their role in retinal development is less 
well studied, but as with Si and Dct, the Dlx2 and Neurodl proteins seem to be 
involved in cell fate specification, both in the CNS and in the developing retina (Liu 
et al., 2000a; Miyata et al., 1999; Qiu et al., 1995). The final gene chosen for 
examination is cadherin 8 {Cdh8), an integral membrane protein that mediates 
calcium-dependent cell adhesion. It has been proposed that cadherins are involved in 
the sorting and aggregation of early neurons during central nervous system 
development and in the formation of brain nuclei and cortical laminae (Korematsu 
and Redies, 1997). A similar role during early retinal development is as yet unclear.
In order to confirm the differential expression of the genes obtained from the 
microarrays, real time RT-PCR (RT-PCR) was used. Because differences in gene 
expression between the wild type and ChxlO'A retina were mostly within a ten-fold 
change of each other (excepting Rxrg and Dlx2), it was important to use a sensitive 
method to verify these changes. Traditional end-point RT-PCR using agarose gels is 
only semi-quantitative, showing at best only a 10-fold change, as ethidium bromide 
is not very sensitive and agarose gel resolution poor. Real-time RT-PCR can 
accurately detect a 2-fold difference in expression. In addition, real time PCR allows 
one to measure the product of amplification during the early exponential phase of
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amplification, when product is doubling with every cycle, whilst end-point RT-PCR 
only allows measurement of product at the end of the 
plateau stage of amplification, when products can be highly variable 
(http://www.appliedbiosystems.com/support/tutorials/pdf/rtpcr_vs_tradpcr.pdf). This 
is illustrated in Figure 4.1 where PCR amplification of a series of 10-fold dilutions is 
displayed on both a linear scale and a logarithmic scale. As the sample is diluted, it 
takes more cycles before the amplification is detectable. If the reactions were stopped 
at, for example, 33 cycles, as would be the case in traditional end-point PCR, the 
blue, red and purple reactions would indicate the same amount of product even 
though the reactions shown by the purple and red lines differ by a factor of 100 in the 
amount of cDNA. The logarithmic graph illustrates the importance of examining the 
product in the much earlier, exponential phase of amplification. The orange threshold 
line is set at the point where the reactions show a series of equally spaced curves in 
order of dilution. On the linear graph this is at the very beginning of the upturn of the 
curve and not in what appears to be the linear region of the curve. In real time PCR, 
it is possible to measure the cycle number at which the increase in fluorescence (and 
therefore cDNA) is logarithmic.
The measured fluorescence is a result of the chemistry of real time PCR. A number 
of approaches are available. The one used in this study is the TaqMan probe system. 
In addition to forward and reverse primers, a TaqMan probe is designed to hybridise 
to a given sequence between the forward and reverse primer sequences. The TaqMan 
probe is a linear oligonucleotide probe that contains a 5’ reporter fluorophore and a 
3’ quencher at the ends of the probe. When the probe is intact, the quencher dye 
absorbs the fluorescence of the reporter dye due to their close proximity to each 
other. When the probe is hybridised to the target, it is hydrolysed by the exonuclease 
activity of the Taq DNA polymerase, resulting in the separation of the reporter dye 
from the quencher and an increase in the fluorescence emission (Figure 4.2).
In addition to using RT-PCR, I used whole mount in situ hybridisation (ISH) to 
examine the expression of the differentially expressed genes in the El 1.5 and E12.5 
wild type and ChxlO'A mouse and retina. Frozen sections of retinae at later time 
points were also examined through ISH. The ISH studies were designed to give a
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Figure 4.1: PCR amplification of a series of 10-fold dilutions is displayed on both a 
linear scale and a logarithmic scale. As the sample is diluted, it takes more cycles 
before the amplification is detectable. If the reactions were stopped at, for example, 
33 cycles, blue, red and purple reactions would indicate the same amount of product 
even though the reactions shown by the purple and red lines differ by a factor of 100 
in the amount of cDNA. The orange threshold line is set at the point where the 
reactions show a series of equally spaced curves in order of dilution on the 
logarithmic (bottom) scale and the threshold cycle (Ct) is shown for each sample. 
On the linear graph (top) this is at the very beginning of the upturn of each curve 
and not in what appears to be the linear region of the curve. In real time PCR, it is 
possible to measure the cycle number at which the increase in fluorescence (and 
therefore cDNA) is logarithmic. Figure adapted from online real time per tutorial by 
Dr. Margaret Hunt at Unifersity of South Carolina School of Medicine 
(http://pathmicro.med.sc.edu/pcr/realtime-home.htm)
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Figure 4.2: Quantitative real time RT-PCR chemistry. In addition to forward and reverse primers, a TaqMan probe is 
designed to hybridise to a given sequence between the forward and reverse primer sequences. The TaqMan probe is a 
linear oligonucleotide probe that contains a 5’ fluorophore and a 3’ quencher at the ends of the probe. When the probe is 
intact, the quencher dye absorbs the fluorescence of the reporter dye due to their close proximity to each other. When the 
probe is hybridised to the target, together with the primers, it is hydrolysed by the exonuclease activity of the Taq DNA 
polymerase as the DNA strand is being synthesised , resulting the separation of the reporter dye from the quencher and an 
increase in the fluorescence emission upon completion of strand synthesis.
visual confirmation of expression changes in the wild type and ChxlO'A retinae, as 
well as allowing the observation of specific areas of expression within the embryo 
and the retina. In addition, they served to test whether patterns of expression 
overlapped with ChxlO and therefore whether RPC expression of ChxlO is likely to 
directly regulate their expression
Finally, I performed in silico studies of the above genes. In order to examine whether 
these genes might be direct targets of the ChxlO transcription factor, I have 
examined their promoter regions for ChxlO binding sites. Potential ChxlO binding 
sites found close to the start of the CDS of a given gene were further examined for 
conservation through sequence alignment with other species. In addition, I have 
compared the chromosome positions of the human homologues of these genes, as 
well as other genes identified in the previous chapter, with known microphthalmia 
loci in order to discover whether any of these genes might be a cause of 
microphthalmia.
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4.2 Results
4.2.1 Retinoid X receptor gamma
The most dramatic change in expression observed in the microarray study was that of 
retinoid X receptor gamma. Expression of this gene was increased 17.9-fold in the 
ChxlOf /‘ retina compared to the wild type. In order to verify this change in expression 
by RT-PCR, for Rxrg as well as for the other genes examined in this chapter, total 
RNA from three pools of El 1.5 wild type and ChxlO'A retinae were collected in 
addition to one pool for a pilot experiment (Table 4.1). This approach mirrors the 
conditions used for the microarray study.
Pool Tissue Collected Somite Range
129/Sv pilot 16 retinae from 8 individuals 40-44
129/Sv 1 30 retinae from 15 individuals 41-44
129/Sv 2 36 retinae from 19 individuals 41-45
129/Sv 3 35 retinae from 18 individuals 42-46
Chxl&' pilot 26 retinae from 13 individuals 41-48
ChxlO'' 1 30 retinae from 15 individuals 41-45
ChxlO" 2 36 retinae from 18 individuals 42-46
chxitr'- 3 34 retinae from 17 individuals 41-47
Table 4.1: Number of retinae collected per pool of tissue used in 
the real time RT-PCR study and the somite range for each pool
A pilot study was conducted using primers and probe for the two most changed 
genes, Rxrg and Dlx2, in order to test sensitivity, as RT-PCR is a relatively new 
approach as yet untested in our laboratory. Reverse transcription, using 1 pg of RNA, 
was performed once using the pilot RNA samples and a single PCR run performed, 
using for each gene, with the housekeeping gene, glyceraldehyde-3-phosphate 
dehydrogenase (Gapdh) as a control. Reverse transcription was performed twice on 
RNA samples in pool 1, and RT-PCRs run using cDNA from both RTs. Reverse 
transcription was performed once for samples in pools 2 and 3. 18s RNA was used as 
a control in addition to Gapdh for pools 2 and 3. H2O non-template controls were 
used for every gene to check for possible contamination. This applies to all genes 
tested through RT-PCR described below.
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The real time PCR results are depicted as amplification graphs in Figure 4.3. In all 
cases, the amplification products from the ChxlO'A retina were detectable at earlier 
cycles than those from the wild type retina, with any replicates showing very close 
correlation. This indicates that there was more of the target cDNA present in the 
ChxlO'*' retina than in the wild type 129/Sv retina. An example of a control Gapdh 
amplification curve is also shown on Figure 4.3. There was little detectable 
difference in Gapdh amplification curves between the wild type and ChxlO'A retina 
for Pool 1, RT1, suggesting that the difference in Rxrg amplification product 
between the wild type and the ChxlO'1' retina is due to a difference in Rxrg 
expression rather than a difference in loading. The threshold was set within the lower 
part of the linear range for every experiment (horizontal green lines, Figure 4.3). As 
the product of amplification doubles with every cycle number, the difference 
between the threshold cycles (Ct, where the fluorescence passes the threshold) of the 
wild type and ChxlO'f' samples, after normalisation against Gapdh, allows 
calculation of the fold-change in expression between the two (see AACt method 
described in Chapter 2). The fold-change values for Rxrg expression in the ChxlO'1' 
retina compared to the wild type retina are as detailed in Table 4.2. ChxlO'1' pool 1 
was compared to wild type pool 1, ChxlO’A pool 2 compared to wild type pool 2, etc. 
All are normalised against Gapdh expression.
Pool Increase/Decrease Fold-change
Pilot Increase 6.2
Pool 1 RT1 Increase 13.9
Pool 1 RT2 Increase 7.1*
Pool 2 Increase 10.7* (8.8-13.1)
Pool 3 Increase 12* (10.3-14.2)
Table 4.2: Relative change in expression of Rxrg in ChxlO'' retinae compared to wilt 
type retinae for each set of retinal pools collected for real time PCR. * Indicates result 
of fold-change calculation based on average of Cts of duplicate runs. Numbers in
parentheses indicate a range of fold-changes, based on calculations including a standard 
deviation between duplicate runs.
The above table indicates that there is an increased amount of expression of Rxrg in 
the ChxlO*A retina compared to the wild type retina. The fold changes are slightly 
variable, but it seems Rxrg expression is increased roughly 10-fold in the ChxlO'1' 
retina. These data correspond with the microarray data, where a 17.9-fold increase in 
Rxrg expression was observed in the ChxlO‘A retina compared to the wild type. Pools 
2 and 3 were also normalised against 18s RNA with similar results. However, some
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Figure 4.3: RT-PCR amplification curves for Rxrg. Amplification curves depicted as cycle number versus Delta Rn (baseline corrected 
normalised fluorescence). Amplification curves shown for the pilot experiment and for cDNA from all 3 cDNA pools. For Pools 2 and 3, 
the PCRs were run as duplicates. ChxlO^ amplification curves are consistently to the left of the wild type curves. An amplification curve is 
also shown for GAPDH, to which the products were normalised. H20  controls were used in all experiments, with fluorescence above the 
threshold level considered as contamination. An H20  control run can be seen on the GAPDH graph.
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contamination was observed in the H2O control for 18s rRNA and thus Gapdh was 
used as the control throughout the study.
For Pools 2 and 3, standard deviations of duplicate runs were taken into account to 
produce a range of fold-change (see chapter 2 for calculation method) and thus these 
data provide the most complete reflection of the fold-change difference in expression 
of the five experiments. Figure 4.4 summarises the fold-changes observed for all six 
genes tested (see below). The RT-PCR results for Rxrg are clearly consistent 
between runs, and this reproducibility suggests the RT-PCR results are very accurate.
I also wished to examine Rxrg expression through in situ hybridisation. In order to 
produce riboprobes for the ISH study, I was kindly supplied with a CMX-mRxrg 
expression vector containing the mouse Rxrg cDNA by Professor Evans 
(Mangelsdorf et al., 1992) (See Chapter 2 for details of plasmids received for in situ 
hybridisation). The Rxrg cDNA was excised from the CMX vector and inserted into 
the pSKII+ vector, in order to prepare riboprobes for ISH experiments. Rxrg 
expression was previously reported in various areas of the wild type embryo using 
35S-labelling probes in ISH, including the myotomes at all segmental levels of trunk 
and tail and facial muscle primordia, the central nervous system, including the 
forebrain and striatum, and in sensory and endocrine tissues, including the otic 
epithelium and retina by Dolle et al (Dolle et al., 1994). These data were not 
reproduced here, in repeated whole mount and section ISH experiments, even after 
replicated synthesis of probes as described in Chapter 2, although restriction digests 
confirmed the identity of the cDNA as RXRg. Further experiments will be necessary 
to generate effective riboprobes by subcloning regions of the Rxrg cDNA. In 
addition, the failure to reproduce the staining pattern of Dolle et al. may reflect the
i f
lower sensitivity of DIG labelling compared to S labelling. Although it was not 
possible to confirm the expression change in the ChxlO'1' retina by ISH in this study, 
nevertheless, the RT-PCR data obtained here confirm the significant change in 
expression of this gene in the ChxlO"A retina as observed in the previous chapter.
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Figure 4.4: Fold-change data from real time PCR experiments for all six genes 
examined. The fold-changes calculated for each experiment, based on the AACt 
method, are given for each gene, as listed along the X-axis. An increase in 
expression in the Chxl0'/' retina compared to the wild type is depicted by a positive 
fold-change value, whilst a decrease in expression is depicted by a negative fold- 
change value. Very little variation was found between repeated experiments for all 
but one gene, N eurodl, from which highly varied results were obtained. Fold- 
changes per gene were either all positive or all negative, and their change in 
expression correlated with the mircroarray data obtained in Chapter 3.
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4.2.2 Silver and dopachrome tautomerase
Two other genes that show a significant increase in expression in the ChxlOf1' retina 
compared to the wild type are silver (Si, also known as melanocyte protein mel 17, 
Pmell7) and dopachrome tautomerase (Dct or tryosinase-related protein 2, TyrpT). 
They showed an increase of 3.5- and 4.8-fold respectively. Both genes play roles in 
melanin biosynthesis and are present in melanocytes from early development 
onwards. Most melanocytes originate in the neural crest and migrate from there to 
populate specific regions of the developing mouse embryo, including the skin and 
hair follicles, the inner ear and the Harderian gland and choroid of the eye (Steel et 
al., 1992). Melanocytes that form the retinal pigmented epithelium (RPE) of the eye, 
in contrast, develop from locally derived neuroectoderm (Steel et al., 1992). It was 
surprising that genes normally associated with the RPE were being up-regulated in 
the ChxlO'A retina. The presence of RPE-specific genes in the ChxlO'A retina may 
indicate some disruption in the specification of the retina and/or RPE.
Real time RT-PCR was performed as described in section 4.2.1. Amplification 
curves obtained from the RT-PCR study are provided in Appendix 2. The 
comparative Ct method was used to calculate the fold-change in gene expression in 
the ChxlO^' retina compared to the wild type and the normalised results summarised 
in Table 4.3. The amplification for Pool 1 RT1 failed for Dct, and thus no change in 
expression is noted for this run. As for Rxrg, standard deviations of duplicate runs 
were taken into account to produce a range of fold-change for Pools 2 and 3 (see 
chapter 2 for calculation method) and thus these data provide the most complete 
reflection of the fold-change difference in expression of the four experiments.
Si Dct
Pool Increase/Decrease Fold-change Increase/Decrease Fold-change
Pool 1RT1 Increase 4.6 - -
Pool 1RT2 Increase 3.4 Increase 6.3*
Pool 2 Increase 5.5* (4.8-6.2) Increase 5.4* (4.6-6.4)
Pool 3 Increase 3.6* (2.7-4.9) Increase 4.2* (2.8-6.3)
Table 4.3: Relative change in expression of Si and Dct in ChxlO’' retinae compared to wild 
type retinae for each set of retinal pools collected for real time PCR. * Indicates result of 
fold-change calculation based on average of Cts of duplicate runs. Numbers in parentheses 
indicate a range of fold-changes, based on calculations including a standard deviation 
between duplicate runs.
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The above table indicates that there is an increased amount of expression of both Si 
and Dct in the Chxl&~ retina compared to the wild type retina. As with Rxrg, the 
fold changes are slightly variable (see Figure 4.4 for comparison), but it seems 
expression of Si is increased roughly 4-fold and of Dct roughly 5-fold in the ChxlO'A 
retina. These data correspond well with the microarray data, where a 3.54 and 4.8- 
fold increase in Si and Dct expression respectively were observed in the ChxlO'A 
retina compared to the wild type. These figures fall into the fold-change ranges 
produced for Pools 2 and 3, and the results were reproducible across several runs. 
Pools 2 and 3 were also normalised against 18s RNA with similar results.
In addition to RT-PCR, silver and dopachrome tautomerase expression were also 
examined using in situ hybridisation. Figure 4.5A-D shows whole mount ISH 
staining for silver at both El 1.5 and E12.5 in wild type and ChxlO'A embryos. At 
El 1.5 melanocytes can be observed migrating away from the neural crest (Figure 
4.5A, B, arrows). An abundant presence of silver mRNA was also observed in the 
retinal pigmented epithelium of the eye (Figure 4.5A, inset). At E12.5, the silver 
expression can be observed in the limbs of both the wild type, and ChxlO*A , embryos 
(Figure 4.5C, D). Again, the RPE was darkly stained in both genotypes, but it was 
difficult to tell if there was any difference in expression between the two, either in 
the RPE or the retina (Figure 4.5C, D insets).
30 pm vibratome sections of the retinae of the treated embryos were examined 
(Figure 4.5E-H) in order to assess whether any differences in silver expression could 
be observed between the wild type and ChxlO'A retinae. A few individual 
melanocytes can be observed just outside the RPE of all sections. At both El 1.5 and 
E l2.5 the wild type RPE shows high silver expression, whilst silver mRNA was 
faintly detected in the retina at El 1.5 but not at E12.5 (Figure 4.5E, G). In the 
ChxlO"A eye, the RPE is also exhibits high silver expression, and expression seems 
more extensive, especially around the periphery of the RPE and retina (Figure 4.5F, 
H, arrows). The border between the RPE and retina is obscured by heavy staining. 
The retina itself shows a greater presence of silver mRNA at both time points 
compared to the wild type retina, suggesting increased silver expression in the retina 
as well as the RPE.
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Figure 4.5: Whole mount in situ hybridisation of El 1.5 and El 2.5 wild type and ChxlO'L 
embryos for silver. A-D: El 1.5 (A,B) and E12.5 (C, D) wild type and ChxlO" embryos 
with staining of melanocytes migrating from the neural crest along the length of the body 
(A,B arrows). Inserts show magnified eyes. E-H: 30 pm vibratome sections of whole mount 
ISH from El 1.5 (E,F) and E12.5 (G,H) wild type (E,G) and ChxlO" (F,H) embiyos. Very 
dark staining is observed in the RPE of all eyes. Some staining is observed in the wild type 
El 1.5 retina, but little staining is observed in the E12.5 wild type retina. In the Chxl0~/' 
eyes, staining is extended into the periphery of the retina at both ages (F,H arrowheads), 
and the rest of the retina is also lightly stained. Scale bar = 1 mm for A-D, 100 pm for E-H
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In situ hybridisation of much thinner (14 pm) frozen sections at El 3.5, clearly show 
silver expression being restricted to the RPE of the wild type retina (Figure 4.6A), 
whereas in the ChxlO'A retina, silver expression is observed both in the RPE and in 
the periphery of the neural retina (Figure 4.6B and C). Especially in the ventral 
retina, silver expression seems to have extended from the boundary of the RPE and 
the neural retina toward the central retina.
A pattern similar to silver expression can be observed after whole mount ISH for Dct 
(Figure 4.7). Again, melanocytes can be observed migrating from the neural crest 
and around the eye (Figure 4.7A-D, arrows and insets, and G). However, Dct is not 
expressed in the limbs at E12.5 like silver is (compare Figure 4.7 C, D with Figure 
4.7 C, D). The ChxlO"A eye seems more darkly stained than the wild type at both 
ages (Figure 4.7A-D, insets). 30 pm vibratome sections of the treated embryos 
confirmed this observation. In the wild type sections at both El 1.5 and E12.5 the 
wild type RPE shows significant Dct expression, whilst the retina does not seem to 
express any significant amount of Dct (Figure 4.7E-H). In contrast, in the ChxlO'A 
eye, the retina itself shows more Dct expression at both time points (Figure 4.7F, H). 
Dct mRNA is also abundant in the RPE and as with silver, expression seems to 
extend into the periphery of the retina. In addition, it seems that expression is more 
extensive in the ventral retina and RPE (Figure 4.7F, H, arrows). A similar 
observation could be made upon close examination of silver expression, especially 
after in situ hybridisation on frozen sections; however, the difference seems more 
marked in Dct whole mount in situ hybridisation sections compared to those 
examined for silver expression.
In situ hybridisation of E l3.5 frozen sections with Dct probe show a remarkable 
similarity to those hybridised with silver probe. Again, expression is restricted to the 
RPE of the wild type eye (Figure 4.8A) whilst it is extended into the periphery of the 
retina in the ChxlO*A eye (Figure 4.8B and C). Again, staining seems to be more 
extensive in the ventral retina than in the dorsal retina.
The observed expression in the wild type embryos closely matches Si and Dct 
expression described in the literature (Baxter and Pavan, 2003), and thus 
hybridisation appears to be specific. However, the silver expression observed in the
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Figure 4.6: In situ hybridisation of E13.5 wild type and Chxlfr^ retinal sections for 
Si. A: E l3.5 wild type retinal section with Si staining restricted to the retinal 
pigmented epithelium. No Si staining is observed in the retina. B and C: E13.5 
C hxlfl7' retinal sections with Si staining observable in the retinal pigmented 
epithelium as well as in the periphery of the retina, especially in the ventral 
peripheral retina (arrows). Scale bar = 100 pm for all.
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Figure 4.7: Whole mount in situ hybridisation of El 1.5 and E12.5 wild type and ChxlO' 
embryos for Dct. A-D: El 1.5 (A,B) and E12.5 (C, D) wild type and ChxlO" embryos 
with staining of melanocytes migrating from the neural crest along the length of the body. 
Inserts show magnified eyes, with darker staining in mutant eyes. E-H: 30 pm vibratome 
sections of whole mount ISH from El 1.5 (E,F) and E12.5 (G,H) wild type (E,G) and 
ChxlO-' (F,H) embryos. Very dark staining is observed in the RPE of all eyes. No 
staining is observed in the wild type retinae. In the ChxlO" eyes, staining is extended 
into the periphery of the retina, especially in the ventral retina, at both ages (F,H 
arrowheads), and the rest of the retina is also stained. Scale bar = 1 mm for A-D, 100 pm 
for E-H. 1 7 7
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Figure 4.8: In situ hybridisation of El 3.5 wild type and ChxlO''" retinal sections for 
Dct. A: E l3.5 wild type retinal section with silver staining restricted to the retinal 
pigmented epithelium. No Dct staining is observed in the retina. B and C: E13.5 
ChxlOrA retinal sections with Dct staining observable in the retinal pigmented 
epithelium as well as in the periphery of the retina, especially in the ventral 
peripheral retina (arrows). Scale bar = 100 pun for all.
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limbs of the E l2.5 retina is not reported in other literature. The data were also highly 
reproducible as at least three embryos of each genotype were treated with each 
probe, with similar results. The above in situ hybridisation and real time RT-PCR 
data indicate that both Si and Dct are indeed up-regulated in the ChxlO'1' retina at 
El 1.5 and suggest that normal specification of the neural retina and the boundary 
between the RPE and the NR at the periphery of the optic cup is disrupted in the 
absence of ChxlO. These data correspond with the microarray data discussed in the 
previous chapter.
4.2.3 Distal-less homeobox 2
After Rxrg, the gene that shows the most dramatic change in expression between the 
wild type and ChxlO'1' retina is distal-less homeobox 2 (Dlx2), which shows a 13.8- 
fold reduction in expression in the Chxl&' retina compared to the wild type. Dlx2 is 
thought to play a large role in forebrain specification and development but little is 
known about the role of Dlx2 in retinal development. I examined the expression of 
Dlx2 during early retinal development using real time RT-PCR and in situ 
hybridisation.
Real time RT-PCR was performed as described in section 4.2.1. Amplification 
curves obtained from the Dlx2 RT-PCR study are supplied in Appendix 2. In contrast 
to the data observed for Rxrg, the amplification products from the wild type retina 
were detectable at earlier cycles than those from the ChxlO'A retina. This indicates 
that there was more of the target cDNA present in the wild type retina than in the 
ChxlO'1' retina. The comparative Ct method was used to calculate the fold-change in 
gene expression in the Chxl Of'' retina compared to the wild type and the normalised 
results summarised in Table 4.4. Standard deviations of duplicate runs were taken 
into account to produce a range of fold-change for Pools 2 and 3.
179
Pool Increase/Decrease Fold-change
Pilot Decrease 7.7
Pool 1 RT1 Decrease 11.0
Pool 1 RT2 Decrease 4.5*
Pool 2 Decrease 6.1* (3.6-10.6)
Pool 3 Decrease 4.6* (2.6-8.3)
Table 4.4: Relative change in expression of Dlx2 in ChxlO" retinae compared to 
wild type retinae for each set of retinal pools collected for real time PCR.
* Indicates result of fold-change calculation based on average of Cts of duplicate 
runs. Numbers in parentheses indicate a range of fold-changes, based on 
calculations including a standard deviation between duplicate runs.
The RT-PCR data indicate that there is indeed a decreased amount of Dlx2 
expression in the Chxl Of retina compared to the wild type retina. Expression is 
decreased roughly 7-fold in the ChxlO"A retina. A seven-fold change in expression 
falls into the fold-change ranges calculated for the last two runs. These ranges are 
relatively large as compared to the genes described earlier (Figure 4.4 provides a 
comparison). This is because the standard deviations between replicates are slightly 
larger, represented by the greater difference between replicates on the amplification 
curves. The microarray data indicate there is a 13.83 fold decrease in Dlx2 
expression in the Chxl&' retina compared to the wild type, which suggests that the 
microarray study may have been more sensitive to changes in expression compared 
to the RT-PCR method. The biggest change in expression observed using RT-PCR 
was an eleven-fold decrease for Pool 1 RT1. However, the results do not show a 
particularly large variation between runs, and thus the RT-PCR data confirm to a 
large extent the data obtained from the microarray study. Pools 2 and 3 were also 
normalised against 18s RNA with similar results.
Figure 4.9 summarises whole mount in situ hybridisation results for Dlx2 at El 1.5 
and E l2.5. High expression can be observed in the forebrain and branchial arches of 
both wild type, and ChxlO'A , embryos at El 1.5 (Figure 4.9A, B). The expression in 
the forebrain remains high at E l2.5 for both genotypes, but is decreased in the 
branchial arches of E12.5 embryos (Figure 4.9C, D). High magnification views of 
the eyes of all embryos are also shown in Figure 4.9 (insets). Very little presence of 
Dlx2 mRNA can be observed in any of the eyes, with exception of the E l2.5 wild 
type eye (Figure 4.9C, inset), where some expression can be seen within the area 
enclosed by the RPE. This suggests Dlx2 expression begins at around E l2.5 in the
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E12.5
Figure 4.9: Whole mount in situ hybridisation of El 1.5 and E12.5 wild type and ChxlO* 
■ embryos for Dlx2. A-D: El 1.5 (A,B) and El 2.5 (C, D) wild type and ChxlO'' embryos 
with Dlx2 expression in the branchial arches (arrows) and the forebrain (arrowheads). 
Inserts show magnified eyes, with staining visible in the wild type E12.5 retina 
(arrowhead). E-H: 30 pm vibratome sections of whole mount ISH from El 1.5 (E,F) and 
E12.5 (G,H) wild type (E,G) and ChxlO" (F,H) embryos. Faint radial staining can be 
observed across the central area of the wild type retina at El 1.5 (E, arrow). By E12.5, 
Dlx2 staining is extended in the central area of the wild type retina, predominantly into 
the dorsal retina and to a lesser extent the ventral retina (G, arrows). No staining is 
observed in the Chxlfr ' retina at any time. Scale bar = 1 mm for A-D, 100 pm for E-H .
E12.5
wild type retina, but that little or no Dlx2 is expressed in the ChxlO'A retina at the 
same time point.
Examination of 30 pm vibratome sections of the embryos confirms this observation 
(Figure 4.9E-F). Very little Dlx2 expression can be detected in the El 1.5 wild type 
retina, suggesting that Dlx2 is only beginning to be expressed in the central retina at 
this time point (Figure 4.9E, arrow). This observation is in accordance with the 
literature, which indicates that Dlx2 staining in the wild type retina begins centrally 
and extends radially across the retina (de Melo et al., 2003; Eisenstat et al., 1999). 
No expression is observed in the Chxl0'f' retina (Figure 4.9F). The pattern of 
expression observed at El 1.5 in the wild type retina is expanded at E12.5, and 
extends further into the dorsal area of the retina than the ventral area (Figure 4.9G, 
arrows). No expression is observed in the periphery. No expression is observed in the 
ChxlO‘A E l2.5 retina, indicating that if Dlx2 is expressed at this time point in the 
ChxlO'A retina, it is at a very low level in comparison to the wild type (Figure 4.9H).
This also seems the case at E l3.5. In situ hybridisation of El 3.5 frozen sections for 
Dlx2 show clear presence of Dlx2 mRNA in the wild type retina (Figure 4.10A, B). 
Dlx2 seems to be expressed in a punctuate pattern throughout the neuroblastic layer 
of the whole retina by this time point, with exception of the far periphery. In contrast, 
no Dlx2 expression can be detected in the ChxlO'A retina (Figure 4.10C), suggesting 
that the absence of ChxlO seems to inhibit Dlx2 expression for at least a day, from 
E12.5 to E13.5.
Dlx2 sense probes did not result in any staining, and the published literature is 
consistent with the data obtained here, suggesting the anti-sense probe is specific for 
Dlx2 (de Melo et al., 2003; Eisenstat et al., 1999; Qiu et al., 1997). In addition, at 
least three embryos of each genotype were treated for each probe, with reproducible 
results. The above ISH data, combined with the real time RT-PCR data indicate that 
Dlx2 is indeed down-regulated in the ChxlO'A retina during early development, 
confirming the change in Dlx2 expression observed in the microarray experiment.
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Figure 4.10: In situ hybridisation of E13.5 wild type and C hxl0"A retinal sections 
for Dlx. A and B: E l3.5 wild type retinal section with Dlx expression observable 
throughout the retina (arrows), box in A is magnified in B. C: E l3.5 ChxlO'/' retinal 
section with no Dlx staining in the retina. Scale bar = 100 pm for A and C, 50 pm 
for B.
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4.2.4 Neurogenic differentiation 1
Another gene that showed significant down-regulation in the microarray experiment 
is Neurodl. Expression of this gene was decreased 8.3-fold in the El 1.5 ChxlO'f' 
retina compared to the wild type in the microarray study. Neurodl is a homolog of 
the Drosophila atonal gene and is widely expressed during development in the 
mammalian brain and the pancreas (Liu et al., 2000a). It plays a significant role in 
retinal cell specification and possibly in proliferation, and is therefore a very good 
candidate for ChxlO regulation.
Real time RT-PCR was performed as described in section 4.2.1. Amplification 
curves from the Neurodl RT-PCR study are provided in Appendix 2. In contrast to 
the RT-PCR studies performed for the other genes, the results for Neurodl were 
highly variable. The normalised results are summarised in Table 4.5 and depicted in 
Figure 4.4. Standard deviations of duplicate runs were taken into account to produce 
a range of fold-change for Pools 2 and 3. Amplification of cDNA from Pool 1 
initially indicated a 57.3-fold decrease in Neurod expression in the ChxlO'1' retina 
compared to the wild type. A smaller difference was observed after a second RT and 
PCR run from Pool 1 (Table 4.5).
cDNA from Pools 2 and 3 were run simultaneously. The difference between the wild 
type and ChxlO‘f  cDNAs is far greater in Pool 3 and in Pool 2. Even though the 
replicates showed a high correlation, the cDNA for Pools 2 and 3 were run again to 
examine whether this change could have been caused by some outside factor. Again 
a large difference between wild type and ChxlO’A was observed. As a final 
confirmation, the RT was performed again for Pools 2 and 3 and run on the PCR. 
Again a large difference between the two was observed.
Because the same results were produced three times within Pools 2 and 3, even after 
a second round of RT was performed from the starting material, it seems the 
variation between the two is a result of a genuine difference in Neurodl mRNA 
present in the two pools of ChxlO'A retinae (the wild type pools consistently show a 
Ct of just under 30 cycles, suggesting no difference in starting material). The non-
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template H2O controls used did not indicate any contamination. Pools 2 and 3 were 
also normalised against 18s RNA with similar results.
Pool Increase/Decrease Fold-change
Pool 1 RT1 Decrease 57.3
Pool 1 RT2 Decrease 19.56
Pool 2 Decrease 6.5* (5.7-7.3)
Pool 2 2nd run Decrease 6.6
Pool 2 RT2 Decrease 8.3
Pool 3 Decrease 88.3* (73.3-106.5)
Pool 3 2nd run Decrease 97.7
Pool 3 RT2 Decrease 109.1
Table 4.5: Relative change in expression of Neurodl in ChxlO" retinae compared 
to wild type retinae for each set of retinal pools collected for real time PCR.
* Indicates result of fold-change calculation based on average of Cts of duplicate 
runs. Numbers in parentheses indicate a range of fold-changes, based on 
calculations including a standard deviation between duplicate runs.
Despite the variability, the RT-PCR data indicate that there is indeed a decreased 
amount of Neurodl expression in the ChxlO'A retina compared to the wild type 
retina. However, it is unclear to what extent Neurodl is down-regulated in the 
Chxl O’'' retina. In the microarray experiment, an eight-fold difference in expression 
was observed. A similar change in expression is observed when comparing ChxlO''' 
Pool 2 to wild type Pool 2. However, a much greater apparent decrease in expression 
is observed for Pools 1 and 3.
To further examine Neurodl expression in the wild type and ChxlO''' retinae, whole 
mount in situ hybridisation was performed on El 1.5 and E12.5 embryos (Figure 
4.11 A-D). At El 1.5, Neurodl seems to be strongly expressed in the somites and otic 
vesicle in both genotypes (Figure 4.11 A, B arrows). Extensive expression is also 
observed in the brain. By E12.5, the same pattern of expression is observed, but 
staining is not as dark, suggesting that perhaps Neurodl is becoming down-regulated. 
This is especially true for the brain regions (Figure 4.11C, D). No apparent 
expression was observed in the eyes of any of the embryos at either time point 
(Figure 4.11 A-D, insets). Staining for Neurodl was reproducible (at least three 
embryos of each genotype tested) and specific, as a similar pattern was not observed 
when using the Neurodl sense probe and previous findings confirm that expression 
should be observed in areas containing differentiating neurons of the central and 
peripheral nervous system, for example in the otic vesicle (Kim et al., 2001).
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Figure 4.11: Whole mount in situ hybridisation of El 1.5 and El2.5 wild type and 
ChxlO-^ embryos for Neurodl. A-D: El 1.5 (A,B) and E12.5 (C, D) wild type and 
ChxlO"A embryos with Neurodl staining in otic vesicles and somites (A-D arrows). 
Inserts show magnified eyes. E-H: 30 pm vibratome sections of whole mount ISH 
from El 1.5 (E,F) and E12.5 (G,H) wild type (E,G) and Chxl Or1' (F,H) embryos. No 
apparent staining can be observed in the retinae of El 1.5 wild type and ChxlO’/' eyes. 
At E l2.5 some faint staining can be observed in the wild type central retina (.H, 
arrow), whilst no apparent staining is observed in the ChxlOr1' retina. Scale bar = 1 
mm for A -D, 100 pm for E -H . i ^
30 pm vibratome sections of the embryos treated for whole mount ISH confirm an 
apparent lack of Neurodl expression in the wild type and ChxlO'A retinae at El 1.5 
(Figure 4.1 IE, F). By E12.5 however, some expression can be observed in the wild 
type retina (Figure 4.11G). This is not observed in the ChxlO'^ retina (Figure 4.11H), 
however, suggesting Neurodl expression is not yet expressed at this time point in the 
ChxlO'/‘ retina or that its expression is severely down-regulated. Kim et al report that 
Neurodl expression in the retina cannot be observed until E l3 (Kim et al., 2001) and 
Morrow et al report it is not strongly observed until E l7 (Morrow et al., 1999a), 
which may account for the lack of strong staining in the retina at any time point 
examined here.
4.2.5 Cadherin 8
The microarray data suggest that the integral membrane protein cadherin 8 is down- 
regulated 6-fold in the El 1.5 ChxlO'A retina compared to the wild type. Cadherins 
mediate calcium-dependent cell-cell adhesion and are thought to play an important 
role in the development and maintenance of various tissues (Korematsu and Redies, 
1997). As with the genes described above, I have examined cadherin 8 expression of 
the developing retina using real time RT-PCR and in situ hybridisation.
Real time RT-PCR was performed as described in section 4.2.1 and amplification 
curves are provided in Appendix 2. The results are summarised in Figure 4.4 and 
Table 4.6. The replicates observed here generally show a close correlation. Standard 
deviations of duplicate runs were taken into account to produce a range of fold- 
change for Pools 2 and 3. Because of the greater difference between replicates in 
Pool 3 (and therefore a greater standard deviation), the fold-change range for Pool 3 
is also higher than that of Pool 2. However, the change in expression of cadherin 8 in 
the ChxlO'A retina compared to the wild type seems consistent and reproducible. As 
was the case for Dlx2, the microarray data suggest a larger difference in expression 
(6-fold versus 2-fold) than the RT-PCR study, suggesting again that the microarray 
experiment may be more sensitive to gene expression changes. Pools 2 and 3 were 
also normalised against 18s RNA with similar results.
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Pool Increase/Decrease Fold-change
Pool 1 RT1 Decrease 1.8
Pool 1 RT2 Decrease 1.8
Pool 2 Decrease 1.6* (1.4-1.8)
Pool 3 Decrease 2.3* (1.2-4.7)
Table 4.6: Relative change in expression of cadherin 8 in ChxlO" retinae compared to wild 
type retinae for each set of retinal pools collected for real time PCR. 
* Indicates an average of a duplicate run.
Whole mount in situ hybridisation of El 1.5 wild type and ChxlO‘/_ embryos indicates 
that there is Cdh8 expression in various areas of the embryo at this time point, 
including the brain and the anterior limb bud (Figure 4.12A, B), as well as along the 
somites. By E l2.5, expression is observed in a similar pattern, although expression 
seems to have decreased in the anterior limb buds and appeared in the posterior limb 
buds in both genotypes (Figure 4.12C, D). There is more extensive Cdh8 staining in 
the E12.5 ChxlOT  ^embryo, but it is difficult to assess whether this staining is real as 
staining in the brain regions is often a result of trapping in the ventricles and can also 
be observed when using sense probes. Cdh8 expression has been reported in various 
areas of the CNS by El 1.5, including various areas of the forebrain and developing 
grey matter structures (Korematsu et al., 1998); (Korematsu and Redies, 1997).
In 30 pm vibratome sections of the El 1.5 wild type embryo, some expression can be 
observed in the central and dorsal area of the retina (Figure 4.12E, arrow), but does 
not extend into the periphery of the retina. In contrast, no apparent expression can be 
observed in the same area in the Chxl OfA retina, suggesting expression of cadherin 8 
may be down-regulated in the El 1.5 C h x lO retina. At E l2.5, Cdh8 mRNA can still 
be detected in the wild type retina, but seems to be localised more to the dorsal area 
of the retina, rather than the central retina, as was the case at El 1.5 (Figure 4.12G). 
Again, no expression is observed in the ChxlO'1 retina (Figure 4.12H). The in situ 
hybridisation, performed on at least three embryos of each genotype, and real time 
RT-PCR data suggest Cdh8 is down-regulated in the ChxlO'A retina compared to the 
wild type, mirroring the data obtained from the microarray experiment.
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Figure 4.12: Whole mount in situ hybridisation of El 1.5 and E12.5 wild type 
and Chxl0'/' embryos for Cdh8. A-D : El 1.5 (A,B) and E12.5 (C, D) wild type 
and Chxl OrA embryos with Cdh8 staining in brain, somites and limbs. Inserts 
show magnified eyes. E-H: 30 pm vibratome sections of whole mount ISH 
from El 1.5 (E,F) and E12.5 (G,H) wild type (E,G) and ChxlO’/' (F,H) embryos. 
Cdh8 staining is observed in the central retina of the El 1.5 wild type eye (E, 
arrow), whereas no staining is observed in the ChxlO~/' retina at the same age. 
There is no apparent staining in the E l2.5 ChxlO'7* retina. Scale = 1 mm for A- 
D, 100 pm for E-H.
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4.2.6 In silico examination of ChxlO-regulated genes
The expression of the genes discussed above all appear to be affected by the absence 
of ChxlO. Whether ChxlO exerts a direct or indirect effect is yet unclear. One way in 
which to examine this more closely is by searching for ChxlO binding sites in the 
promoter regions of these genes. If such sites are present, this may indicate ChxlO 
binds to the promoters of these genes in order to activate or repress them directly. 
The preferred ChxlO binding site, identified through a binding site selection assay 
(Ferda et al., 2000) is TAATTAGC, where TAAT is a conserved homeobox binding 
motif, and TAGC are thought to confer further specificity for the ChxlO gene (Ferda 
et al., 2000).
For all six genes, the 10 kb region upstream of the first codon of the coding sequence 
(CDS) was searched for the consensus sequence of the ChxlO binding site 
(TAATTA). The CDS was entered into a BLAST search of nucleotide databases, and 
a genomic clone was located. Nucleotides upstream of the CDS were subsequently 
analysed for the ChxlO binding site. If no genomic clone could be located, an 
alternative method was used. A link to the ‘map viewer’ on the NCBI Entrez 
database (http://www.ncbi.nlm.nih.gov/mapview) allowed targeting of the beginning 
of the CDS and examination of the genomic sequence around it, based on genomic 
contigs. As the consensus site is palindromic, the sites identified on one strand of 
DNA are effectively also sites on the complementary strand. A summary of the 
results is displayed in Table 4.7.
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Gene Search type Genbank 
accession 
number of 
genomic clone 
or contig
Number of 
ChxlO binding 
sites found on 
sense strand
Location of ChxlO binding 
sites (bp upstream from 
CDS)
Rxrg Map Viewer NT078306 3 3393
6136
8664
Dct BLAST AC108833 3 6842
7913
6842
Si BLAST AC 117232 1 7498
Dlx2 BLAST AL928931 4 103
1738
1902
9254
Neurodl BLAST AL928696 8 844,1258 
1320,1512 
4887, 6617 
6901,10724
Cdh8 Map Viewer NT078586 2 485
5943
Table 4.7: Summary oi' promoter searches of differentially expressed genes. Two types of
searches were employed (BLAST or Map Viewer) using the CDS of the genes indicated. 
Genomic clones or contigs were examined for ChxlO binding sites and their location 
determined.
Of the six genes examined, Neurodl contains the largest number of ChxlO binding 
sites, 4 of which are within 2 kb of the CDS start site, suggesting that this would be 
the most likely candidate gene to whose promoter region ChxlO might be able to 
bind. Cdh8 and Dlx2 each have a ChxlO binding site consensus sequence within 500 
bp of their CDS start codon and in addition Dlx2 has two ChxlO consensus binding 
sites within 2 kb of its CDS start codon. Although both Rxrg and Dct have three 
ChxlO consensus binding sites, these are all more than 2 kb from the CDS start site, 
and the same is true for the Si consensus binding site. This makes them less likely 
candidates for direct ChxlO regulation than the other three.
In order to investigate the ChxlO binding sites further, sequence alignments with 
homologues from other species were made to discover whether any of the ChxlO 
consensus binding sites within roughly 5 kb of a starting site, occurred within 
conserved areas of the upstream coding region of these genes. The rat, human, dog 
and chicken homologues of the genes and their upstream regions were compared
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using Zpicture (http://zpicture.dcode.org) and MultAlin
(http://prodes.toulouse.inra.fr/multalin/multalin.html). Z-picture allows one to 
visualise areas of homology between species (Figures 4.13A and 4.14A). Multiple 
sequence alignments with hierarchical clustering were produced by entering such 
areas of homology into the MultAlin website (Figures 4.13B and 4.14B).
Of the five potential ChxlO binding sites within 5 kb of the Neurodl start codon, one 
was conserved in all species examined, the site 4.9 kb upstream of the CDS. The site 
closest to the start codon, 844 bases upstream, is conserved in human, rat and dog. 
The site 1.5 kb upstream of the CDS is conserved in the human and the rat. The other 
two potential ChxlO binding sites were only conserved in the rat (Figure 4.13).
The Dlx2 potential ChxlO binding sites at 1.7 and 1.9 kb upstream were also 
conserved in human, rat and dog (Figure 4.14). The site 103 upstream was situated in 
the 5’ UTR and thus unlikely to be a real ChxlO binding site. No comparison could 
be made with chicken as no appropriate homologue was found.
The cadherin 8 site 485 upstream of the start site was not conserved in other species 
and neither was the Rxrg site 3.3 kb upstream of the start site.
Another aim of the study is to identify genes that may be involved in 
microphthalmia. Several microphthalmia loci have been identified for various forms 
of microphthalmia including 15ql2-ql5 (Morle et al., 2000), NN01 locus on lip  
(Othman et al., 1998), 14q32 (Bessant et al., 1998), Xq27-28 (Graham et al., 1991), 
and 16pl3.3 (Yokoyama et al., 1992). To assess whether any of the six genes 
discussed above may map to microphthalmia loci, I examined the chromosome 
positions of their human homologues. Table 4.8 summarises these results.
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Neurodl
■ intergene , 
intron 
■coding 
UTR 
■repeat i 100%hgl7  chr2:l- vs -mm 5 ehr2:7950%
galGal2 chr
- vs -
mm5 chr2:79
m3 chr3:<2
- vs -
mmS chr2:79
canFaml chr
- vs -
mmS eh r2 :7 9
t  *
10.5kb
844b 1.5kb
14.0kb
4^  kb Upstream o f CDS
B
Neurodl 4.9 
mouse 
human 
dog 
rat 
chicken 
Consensus
kb upstream
GCTTGCGGCA TAATCTfT.AAT 
GCTTGCGGCA TAATCITAAT: 
GCTTGCGGCA TAATCI T.AAT: 
GCTTACGGCA TAATCITAAT 
GTTTGCGGCA TTATCTTAAT 
GcTTgCGGCA TaATClTAAT
F\GATAATT
^GATAATT
^GATAATT
\GATAATT
^AATAATT
^gATAATT
Neurodl 84 4b upstream
mouse CTCCCTTTA AAAGATGGAG 
rat. CTCGCTTTA AAAGATGGAG 
human CTCCCTTTA AAAGATTGAG 
dog CTCTCTTTAA AAAGATTGAG 
Consensus .ctcccTTtA AAAGATgGAG
TAATTA 
TAAT T A 
TAATTA 
TAATT7V 
ThATTA
:a a t
:a a t
TAAT
TGAT
^aAT
GATTCATATT
GATTCATATT
GATTCATATT
GATTCATATT
GATTCATATT
GATTCATATT
GGTCAGCGAC
GGTCAGCGAC
GGTCAGCGAT
GGTCAGCGAT
GGTCAGCGAC
GCACCTGCGA
GCACCTGCGA
GCACCTGCGA
GCACCTGCGA
GCACCTGCGA
GCACCTGCGA
Neurodl 1.5 kb upstream
mouse ATTCTCGGG AGAGTAAAAA ATAGGAATCA [TAATT^JCCT- -GTTGTTAAA
rat ATTCTCGGG AGAATAAAAA ATAGGAATCG
human TATTCTGGGG CAAAAAAATG AAAGAACT-G
Consensus .ATTCTcGGG agAatAAAaa AtAGgAaTcg
CT- -GTTGTTAAA 
TAATTAjCCTT TGTTGTTAGT 
TAATTA TCT. .GTTGTTAaa
Figure 4.13: Sequence alignments o f  the Neurodl promoter region. (A) Zpicture 
visualisation o f  the Neurodl gene. Each o f  the human (h g l7 ), chicken (galGal2), rat 
(m 3) and dog (canFam l) sequences is compared to the m ouse (mm5) sequence and 
each comparison then compared to the others. The positions o f  the three potential 
ChxlO binding sites shown in B are depicted with arrows. (B ) Sequence alignments o f  
three potential ChxlO binding sites in the Neurodl promoter region.
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Dlx2
|  intcrgcne 
intron 
■coding 
UTR 
■repeat
-viirii
100%
h gl7  chr2:l
- vs -
mm5 chr2:71
50%
rn3 chr3:53
- vs -
mm5 chr2:71
canFaml chr
- vs -
mm5 chr2:71
lO.Okb 13.3kb
1.7kbl.9kb Upstream of CDS
B
Dlx2 1.7 kb upstream
mouse AAAAGAACAA AATAGtTAJVTT AkAAGCCACA AAA 
rat AAAAGAACAA AATAGIAATT A 
dog AAAAGAACAA AATAG 
human
IAATT A 
AAAAGAACAA AATAGIAATT A
Consensus AAAAGAACAA AATAGIAATT AAAGCCACA AAA
\AAGCCACA AAA 
^AAGCCACA AAA 
\AAGCCACA AAA
Dlx2 1.9 kb upstream
mouse AAAAAGCAAG TGTG TAATTA AAACTCCAGC ATT
human AAAAAGCAAG TGTG TAATTA AAACTCCAGC ATT
rat AAAAAGCAAG TGTG TAATTA AAACT C CAGA ATT
dog AAAAAGCAAG TGTG TAATTA AAACTCCAGC ATC
Consensus AAAAAGCAAG TGTG TAATTA AAACTCCAGC ATt
Figure 4.14: Sequence alignments of the Dlx2 promoter region. (A) Zpicture 
visualisation of the Dlx2 gene. Each of the human (hgl7), rat (m3) and dog 
(canFaml) sequences is compared to the mouse (mm5) sequence and each 
comparison then compared to the others. The positions of the two potential 
ChxlO binding sites shown in B are depicted with arrows. (B) Sequence 
alignments of two potential ChxlO binding sites in the Dlx2 promoter region.
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Mouse Gene Human homologue Location of Human 
Homologue
Retinoid X receptor gamma RETINOID X RECEPTOR GAMMA Iq22-q23
Dopachrome tautomerase DOPACHROME TAUTOMERASE 13q31-q32
Silver HOMOLOG OF MOUSE SILVER 12ql3-ql4
Distal-less homeobox 2 DISTAL-LESS HOMEOBOX 2 2q32
Neurogenic differentiation 1 NEUROGENIC DIFFERENTIATION 1 2q32
Cadherin 8 CADHERIN 8 16q21-q22.1
Table 4.8: The six differentially expressed mouse genes obtained from the microarray study, 
their human homologues, and the chromosome location of their human homologues
None of the chromosome locations of the six human genes correspond to known 
microphthalmia loci. However, the human homologues of the other genes identified 
in Chapter 1 were also examined. Of these, GAS2 was localised on Ilpl5.2-pl4.3 
which coincides with the location of the NNOl locus at lip . TRPM1 is localised to 
15ql3-ql4, which also coincides with the microphthalmia locus at 15ql2-ql5. 
Finally, both BIGLYCAN and RENBP are localised to Xq28, within the Xq27-q28 
locus to which a form of X-linked clinical anophthalmia was shown to be localised. 
It would be interesting to examine whether any cases of microphthalmia segregate to 
the loci of the genes listed in Table 4.8. Interestingly, both Dlx2 and Neurodl are 
located in the same position, which would make this a particularly interesting locus 
to examine for microphthalmia.
In summary, the data obtained from the various approaches described in this and the
previous chapter is brought together below in the Table 4.9.
Gene Microarray 
(E l 1.5)
RT-PCR 
(E l 1.5)
In situ hybridisation 
(E11.5-E12.5)
Possible ChxlO binding sites
Rxrg t 17.9x t lOx Not done (technical 
fa ilure-p i 70)
Unlikely (only >2kb from 
start)
Si t  3.5x |  4x RPE but also peripheral 
neural retina in Chxl Of1'
Unlikely (only >2kb from 
start)
Dct t 4.8x t 5x RPE but also peripheral 
neural retina in ChxlO'''
Unlikely (only >2kb from 
start)
Dlx2 1 13.8x I 7x Absent in ChxlO"A (weak 
stain in El 1.5 +/+; 
stronger by E12.5)
Possibly: 3 <2kb from start 
2 conserved in 3 species 
1 in 5’ UTR - unlikely
Neurodl 1 8.3x |  6-109x Absent in ChxlO'1' (weak 
stain in E l2.5 +/+)
Yes: 4 < 2kb from start 
1 conserved: 5 species 
1 conserved: 4 species 
1 conserved: 3 species
Cdh8 |6 .0 x I 2x Absent in ChxlO''' 
(stained in +/+)
Possibly: <500 bp from start 
but not conserved
Table 4.9: Summary o f expression data obtained for six genes in the wild type and ChxlO'1' retinae
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4.3 Discussion
4.3.1 Retinoid signalling gene up-regulated in the C h x lO retina
The studies described above have provided new information on how early retinal 
development is regulated. It has been hypothesised that ChxlO is important for 
retinal progenitor cell proliferation and the cell fate determination of bipolar cells 
(Burmeister et al., 1996). However, three of the genes examined here, Rxrg, Dlx, and 
Neurodl, are involved in retinal cell fate determination and two are involved in RPE 
specification (Budd and Jackson, 1995). The picture emerging from the studies in 
this and the previous chapter is that the lack of retinal progenitor cell proliferation in 
the ChxlO_A retina may be a result of misspecification of retinal progenitor cells, 
rather than directly related to cell cycle machinery.
Whilst it has been established that retinoic acid is an important signalling molecule 
both for development and vision (Brickell and Tickle, 1989; Hyatt and Dowling, 
1997; Morriss-Kay, 1993; Rando, 1994), only a few studies have examined the 
expression of Rxrg in the developing retina. Dolle et al report the presence of Rxrg 
transcripts in the neuroblastic layer of the developing mouse retina and Kelley et al 
report the presence of Rxrg transcripts in amacrine and ganglion cells as well as in 
progenitor cells in the developing retina of the rat (Dolle et al., 1994; Kelley et al., 
1995b). Five chicken retinoid receptor genes were examined throughout chicken 
retinal development. Of these, Rxrg was observed as early as day 4 of embryonic 
development in the central retina, with expression spreading to more peripheral 
regions by day 8. The first few Rxrg expressing cells were observed in the 
neuroblastic layer of the developing retina, but with increasing iforg-expressing cell 
numbers, expression became localised to the ventricular layer. By day 10, when 
photoreceptors and ganglion cells have been generated and begun to establish their 
definitive layers, Rxrg positive cells became restricted to the photoreceptor layer and 
continued to do so post-hatching (Hoover et al., 1998).
Thus Rxrg is expressed in retinal progenitor cells and subsequently restricted to a 
subset of retinal cells, specifically the photoreceptors. In another study, thyroid 
hormone beta 2 receptor and retinoid receptor (which form heterodimers with TR-b2)
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mRNAs were examined in long term neonatal mouse retinal cultures. Long term 
cultures lacked green cone photoreceptors and showed a loss of TR-b2 and Rxrg 
mRNA, indicating these proteins are involved in determination of green cone identity 
(Azadi et al., 2002). Rxrg is also detected in the nuclei and outer segments of cone 
photoreceptor cells of the mature human retina (Janssen et al., 1999). In contrast, 
Kelley et al have shown that 9-cis RA can promote rod differentiation and propose 
that a balance between TR and RXR activation determines whether photoreceptors 
differentiate into cones or rods in the mammalian retina, with predominant RXR 
activation biasing toward rod differentiation (Kelley et al., 1994; Kelley et al., 
1995b). Thus retinoic acid promotion of differentiation of photoreceptors may be 
mediated through Rxrg. A similar role of Rxrg was suggested in developing 
myotomes, where it is expressed from an early age. Retinoic acid has a 
differentiating effect on myogenic cells and Rxrg is thought to mediate this effect 
(Dolle et al., 1994).
Rxrg expression has been studied in most detail in the central nervous system, where 
it is expressed in two domains early during development, in the developing 
hypothalamus and the neostriatum (Dolle et al., 1994). In fact, Rxrg and Rxrgl (one 
of two Rxrg isoforms) knock outs have been created to examine how the striatum 
was affected, as Rxrg and other retinoid receptors are expressed at high levels in this 
area and thought to be important for regulation of brain functions (Krezel et al., 
1998; Saga et al., 1999). Interestingly, Rxrg expression in the developing 
hypothalamus is similar to that of the Nkx-2 family of homeobox genes (Dolle et al., 
1994). In the retina, Rxrg expression is initially similar to ChxlO expression. In 
addition, Rxrg is also expressed in the ventral horns of the foetal spinal cord, where 
ChxlO expression has also been observed (Dolle et al., 1994; Liu et al., 1994a).
Why is Rxrg up-regulated in the ChxlO"A retina? As different studies give contrasting 
evidence of the function of Rxrg (with one study showing the necessity for Rxrg in 
green cone photoreceptor differentiation, and another study showing a bias toward 
rod photoreceptor differentiation in the presence of predominant Rxrg expression 
(Janssen et al., 1999; Kelley et al., 1995b), it is difficult to asses what the effect of 
Rxrg up-regulation might be, and how it may be controlled by ChxlO. Perhaps 
ChxlO is required to limit Rxrg expression early during development,. to prevent
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premature differentiation of photoreceptors. However, this would mean that one 
would expect to see an excess of photoreceptors in the ChxlO'A retina, and that 
photoreceptor differentiation occurs at an earlier time point. This does not seem to be 
the case, as rod, and possibly cone, photoreceptor differentiation seems to be delayed 
(Rutherford et al., 2004)( see also chapter 5).
Perhaps photoreceptor differentiation is only one role for Rxrg. It is initially 
expressed in retinal progenitor cells, as is ChxlO, and thus may function together 
with ChxlO in retinal progenitor cells before causing photoreceptor differentiation, in 
the same way that ChxlO seems to play a role both in retinal progenitor cell 
proliferation and subsequently bipolar cell differentiation. Other retinoid signalling 
molecules showing a change in expression in the ChxlO'1' retina include Crabpl and 
Cnot7 (see Table 3.4 in Chapter 3). Thus ChxlO exerts a significant effect on retinoid 
signalling in the developing retina. However, it is unclear how this is done, as no 
ChxlO binding sites were found in the Rxrg promoter region, suggesting Rxrg is not 
a direct target for ChxlO regulation.
There is little indication that Rxrg is an up-regulated RPE gene in the same way that 
Dct and Si are. No Rxrg expression has been observed in the RPE, and in fact, no 
retinoic acids of any kind are expressed in the RPE, although their precursor retinols 
are (Hoover et al., 1998). However, there is some link between the RPE and Rxrg 
expression in the retina. Levels of the selected retinoid receptor transcripts are 
differentially affected by short- or long-term culture and in the latter case, an 
attached RPE seems to play a protective role (Azadi et al., 2002).
4.3.2 Another homeobox transcription factor down-regulated in the ChxltT' 
retina
Dlx2 plays a role in cell fate determination during development. Dlx2 is best-known 
for its role in forebrain and branchial arch development, where it regulates patterning 
and differentiation. In one study of forebrain development, Dlx2 was shown to be 
expressed in the same cells as Mash-1, a bHLH gene and marker of relatively 
undifferentiated cells, but in a reciprocal fashion to Map-2, a marker of terminal 
neuron differentiation. Thus, like ChxlO in the retina, Dlx2 was thought to be
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expressed at the transition from proliferation to terminal differentiation (Porteus et 
al., 1994). It has been suggested that alternate cell fate choices in the developing 
telencephalon are controlled by coordinated functions of bHLH and homeobox 
transcription factors through their differential effects on Notch signalling (Yun et al., 
2002). This echoes studies in the retina, where Mash-1 and Math-3 (bHLH genes) 
and ChxlO are required to direct bipolar cell differentiation (Hatakeyama et al., 
2001) and the combination of Notch and bHLH transcription factor signalling are 
generally thought to be a mechanism in which retinal cell type specification occurs 
(Perron and Harris, 2000a).
One study examines the expression of Dlx2 at various stages during mouse retinal 
development. Dlx2 can be detected in retinal progenitors at E l2.5 and this was 
confirmed in the current study (Figure 4.9B). At E13.5 expression of Dlx2, Brn3b, 
Pax6 and ChxlO define distinct yet overlapping domains in the retinal 
neuroepithelium (de Melo et al., 2003). The Dlxl and Dlx2 double knock out retina 
shows reduced cellularity in the ganglion cell layer, whilst amacrine and horizontal 
cells seem to develop relatively normally, and it has been suggested that Dlx2 is 
required for late-born retinal ganglion cell differentiation (de Melo et al., 2003). In 
the adult, Dlx2 is co-expressed with Brn3b in ganglion cells, Pax6 in amacrine, 
horizontal, and ganglion cells, and ChxlO in some bipolar cells. These data support a 
role for Dlx2 in inner retinal development and in the retinal differentiation and/or 
maintenance of the inner nuclear layer intemeurons and ganglion cells in the adult. It 
has been suggested that a subset of retinal progenitors require Dlxl/2 expression to 
down-regulate ChxlO expression in order to begin their terminal differentiation as 
retinal ganglion cells (de Melo et al., 2003). However, the data obtained here suggest 
that ChxlO is upstream of Dlx2 and is needed for its induction. Perhaps a lack of 
ChxlO arrests the induction of Dlx2 expression, and this may lead to a decreased 
number of retinal ganglion cells in the ChxlO'1' retina.
4.3.3 Neurodl is a candidate for ChxlO regulation
Of the three genes involved in cell fate determination, the third is a bHLH gene 
(where Rxrg was a retinoid receptor and Dlx2 was a homeobox gene). In this study, 
Neurodl seems the most likely candidate for direct ChxlO regulation. Neurodl is
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known to play a role in cell specification in a variety of organs. The role of Neurodl 
in the developing pancreas has been studied in depth, as the Neurodl knock out 
mouse shows abnormal pancreatic islet morphogenesis and overt diabetes. Neurodl 
also plays are role in the proliferation and differentiation of enteroendocrine cells of 
the small intestine. Over-expression of Neurodl leads to cell cycle arrest and 
apoptosis, whilst the re-entry into the cell cycle of normally quiescent cells and 
disrupted cell number are observed in the null (Mutoh et al., 1997). Interestingly, 
cyclin Dl, a gene thought to be down-regulated in the ChxlO'1’ retina, is thought to 
repress Neurodl in enteroendocrine cells, in manner independent of its effects on the 
cell cycle (Ratineau et al., 2002).
Neurodl is also transiently expressed in a subset of neurons in the central and 
peripheral nervous systems at the time of their terminal differentiation. Ectopic 
expression of Neurodl in Xenopus causes conversion of epithelial cells into neurons 
(Lee et al., 1995). Mice homozygous for a Neurodl deletion fail to develop a granule 
cell layer within the dentate gyrus. Whilst early cell populations in the dentate gyrus 
are present and normally organised, and migration of dentate precursor cells and 
newly bom granule cells from the neuro-epithelium to the dentate gyms remains 
intact, a dramatic defect in proliferation of precursor cells is observed once they 
reach the dentate gyms and a significant delay in the differentiation of granule cells 
occurs (Liu et al., 2000a). It seems Neurodl is required for the differentiation of 
granule cells in the cerebellum and hippocampus and is critical for postnatal 
neurogenesis in the mouse brain (Miyata et al., 1999).
In the retina, Neurodl is expressed in areas of undetermined retinal cells as well as in 
developing photoreceptors and amacrine cells (Morrow et al., 1999b). Strong 
expression is first observed at E l7, although expression of Neurodl is strong 
elsewhere in the CNS from E l3. In the current study weak Neurodl expression was 
observed at E l2.5 in the wild type. Expression is maintained in a subset of mature 
photoreceptors in the adult (Morrow et al., 1999a). Neurodl is thought to be a critical 
regulator of neuronal versus glial fate, a regulator of intemeuron development, 
favouring amacrine over bipolar differentiation, and essential for the terminal 
differentiation and survival of a subset of photoreceptors (Inoue et al., 2002; Morrow 
et al., 1999a; Pennesi et al., 2003). A loss of Neurodl results in age-related
200
degeneration of rods and cones (Pennesi et al., 2003). It has also been found to 
suppress glial differentiation and stimulate some cells from the toxin damaged 
chicken retina to acquire some neuronal phenotypes (Fischer et al., 2004).
Like Rxrg and Dlx2, Neurodl is expressed in retinal progenitors and then becomes 
localised to a subset of retinal neurons. Both Rxrg and Neurodl seem to be required 
for normal photoreceptor differentiation and Dlx2 seems to be required for a subset 
of retinal ganglion cell differentiation. A change in expression in all three of these 
genes is therefore likely to significantly affect the proportions and morphology of 
retinal neurons, going some way to explaining the apparent lack of properly 
differentiated cells observed in the Chxl&' retina. An examination of when and how 
well the various retinal cell types begin to differentiate in the ChxlO’A retina may 
lead to further insights in how ChxlO regulates retinal development, and forms the 
subject of the following chapter.
4.3.4 RPE genes up-regulated in the Chxlff/m retina
Two of the genes examined here are known to be expressed in the RPE. Silver and 
dopachrome tautomerase are expressed in all developing melanocytes. Silver 
encodes a pigment cell-specific transmembrane protein that resides in the 
melanosomal matrix and is a diagnostic marker for melanoma (Adema et al., 1996; 
Kobayashi et al., 1994; Kwon et al., 1991). The carboxyl terminus of silver is 
truncated in the classical coat colour mutant silver, resulting in dilution of hair 
coloration (Kwon et al., 1991; Martinez-Esparza et al., 1999). Silver can accelerate 
melanin synthesis in vitro and direct melanosomal matrix assembly (Berson et al., 
2001; Lee et al., 1996b); however a complete understanding of the function of silver 
in melanocytes remains elusive. Dct converts L-dopachrome into 5,6- 
dihydroxyindole-2-carboxylic acid. Mutations in the Dct gene are responsible for the 
phenotype of the classic pigmentation mutation slaty (Budd and Jackson, 1995; 
Jackson et al., 1992). Dct can be detected in migratory melanocytes as early as 10 
days of gestation and is also expressed in the neuroectoderm destined to become RPE 
(Steel etal., 1992).
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Silver is expressed in the presumptive RPE starting at E9.5 and in neural crest- 
derived melanoblasts starting at E10.5. Its expression in dorsal regions precedes 
dopachrome tautomerase expression, suggesting it identifies melanoblasts at an 
earlier developmental stage than Dct. (Baxter and Pavan, 2003). Silver expression is 
not detectable in embryos mutated for microphthalmia associated transcription factor 
(Mitf), demonstrating transcriptional dependence of Silver on Mitf in the RPE. 
Interestingly, another gene shown to be differentially expressed in the microarray 
study, Trpml, is also transcriptionally dependent on Mitf. Mutations in Mitf in the 
mouse cause RPE to thicken, lose pigmentation and expression of a number of 
pigment epithelium transcription factors, and eventually trans-differentiate into a 
laminated second retina (Bumsted et al., 2001; Mochii et al., 1998; Nakayama et al., 
1998; Packer, 1967; Scholtz and Chan, 1987). It is thought that the progressive 
restriction of Mitf expression to the future RPE is instrumental for the separation of 
the mammalian optic vesicle into NR and RPE (Nguyen and Amheiter, 2000).
Two other published studies have also identified the expression of RPE-specific 
genes within the ChxlO'1' retina. Horsford et al. suggested that ChxlO is not 
necessary for the initial specification of the neural retina, but is required for its 
maintenance (Horsford et al., 2005). They report ectopic expression of Mitf in the 
ChxlO'A retina, and by using ChxlO and Mitf transgenic mice to misexpress these two 
genes in the NR and RPE, show an antagonistic interaction between ChxlO and Mitf. 
It was suggested that ChxlO repression of Mitf ensures the maintenance of the neural 
retinal identity, and that in its absence, ectopic expression of Mitf results in cells 
previously specified as NR to transdifferentiate to RPE cells. (Horsford et al., 2005). 
In the second study, electroporation of ChxlO into chick optic vesicles resulted in 
strong down-regulation of Mitf and other RPE-specific genes. In addition, the authors 
of this study used a ChxlO BAC reporter mouse to perform cell lineage studies in the 
ChxlO"A retina in mixed genetic backgrounds, and demonstrate that neural retinal 
cells transdifferentiate to RPE (Rowan et al., 2004). Mitf was not found to be up- 
regulated in the microarray study performed here however, but the up-regulation of 
RPE-specific genes, some of which are dependent on Mitf expression, does support a 
role for ChxlO in maintaining a boundary between RPE and NR. The early time 
point used here to examine expression makes it unclear whether this change in gene 
expression is a result of an early misspecification event or a gradual trans­
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differentiation event. A change in expression of these genes suggests that ChxlO 
seems to play a greater role in retinal cell specification than in the actual cell cycle of 
retinal progenitor cells, and exerts its effects through various transcription factors 
that control exit from the cell cycle and commitment to a differentiation pathway, 
rather than through the regulation of cell cycle machinery.
4.3.5 Cadherin 8 may be involved in bipolar cell fate specification
Finally differential expression for cadherin 8 was observed between the wild type 
and ChxlO'A retina. In the developing central nervous system, cadherins are thought 
to play a role in neural connectivity: based on their preferential homotypic binding 
and the localisation of cadherins in synaptic junctions (Honjo et al., 2000; Korematsu 
and Redies, 1997; Uchida et al., 1996). Cadherin 8 expression is restricted to 
particular subdivisions of early central nervous system and the thalamus. Korematsu 
et al studied cadherin 8 expression in the central nervous system in detail from early 
during embryogenesis to postnatal stages and suggest its expression pattern indicates 
that Cdh8 is involved in the formation of striatal compartmentalised structures during 
brain development (Korematsu et al., 1998; Korematsu and Redies, 1997). No report 
was made of cadherin 8 expression in the eyes in these studies.
Few studies have examined cadherin 8 expression in the developing retina. Wohm et 
al examined cadherin 6B and cadherin 7 expression during chicken retinal 
development, and studies of R-cadherin, N-cadherin and B-cadherin have been 
reported (Wohm et al., 1998 and references therein). A study of five cadherins (N- 
cad, R-cad, cad-6, cad-8, cad-11) in the mouse postnatal retina suggests each may be 
expressed in a restricted population of retinal cells (Honjo et al., 2000). Cadherin 8 is 
expressed in the ganglion cell layer and the inner nuclear layer between postnatal 
days 0 and 3 (P0-P3). By P7 it is expressed in a deeper zone of the INL and by P14 
expression in the INL is prominent, whilst expression in the GCL is diminished. A 
similar pattern is observed in the adult, but overall less Cdh8 expression is observed. 
It is thought that these Cdh8 positive cells may be bipolar cells, as they do not co­
label with calbindin-D, a horizontal and amacrine cell marker (Honjo et al., 2000). 
Here, the first report of expression of Cdh8 within the early embryonic wild type 
retina was made, and microarray, in situ, and RT-PCR data support an early function
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in the retina which is disrupted by a lack of ChxlO. Its down-regulation in the 
ChxlO'f' retina may be an early indication that bipolar cell specification is not 
occurring normally.
4.3.6 Conclusions
Real time PCR and in situ hybridisation have confirmed the changes in expression 
observed in the microarray study described in the previous chapter of all six genes 
chosen for further examination. In addition, the in silico study performed here 
suggests Neurodl may be a target for direct ChxlO regulation. Further functional 
studies will be required to confirm or refute this interaction. The microarray study 
and the further investigation of some of the genes showing a change in expression 
have revealed that as well as affecting the transcript levels of proteins regulating 
proliferation, ChxlO also seems to exert early effects on genes thought to be 
important for retinal cell differentiation and cell fate specification. As all cell types, 
with the exception of bipolar cells, are present in the ChxlO'A retina (Burmeister et 
al., 1996), little investigation has been done into how cell differentiation has been 
affected by a lack of ChxlO. Thus, one of the aims of the following chapter is to 
examine how early proliferation and differentiation of retinal neurons is affected by a 
lack of ChxlO.
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CHAPTER 5
C h x l ( T A  retinal progenitor cells exhibit altered 
properties during retinal development
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5.1. Introduction
ChxlO is essential for RPC proliferation. DNA synthesis in the ChxlO'f' mutant has 
been examined by quantifying incorporation of the thymidine analogue 
bromodeoxyuridine (Kee et al., 2002). A large reduction in BrdU labelling was found 
at the periphery of the embryonic retina but labelling indices were not significantly 
altered in the central retina (Bone-Larson et al., 2000; Burmeister et al., 1996). Lack 
of proliferation in the ChxlO'A mutant is partially rescued by deletion of the cell cycle 
regulatory gene p27Klpl (Green et al., 2003). It is clear that proliferation of RPCs is 
affected by an absence of ChxlO; however it is unclear how this occurs.
The microarray data described in Chapter 1 shows a relationship between ChxlO and 
regulation of expression of cell cycle proteins. Altered regulation of a single cell 
cycle protein could be all that is necessary to reduce proliferation, as has been 
observed when a decrease in proliferation was observed in cyclin D1 knock out mice 
(Fantl et al., 1995). However, data does not currently exist showing that lack of, for 
example, Gas2 or Ccne2 causes small eyes. In addition, genes of cell cycle proteins 
were in the minority amongst the genes identified by the microarray study.
Instead, the picture that emerged was that ChxlO affects a variety of transcription 
factors involved in the specification of the neural retina and the surrounding RPE, 
and in regulating RPC development. A variety of transcription factors are known to 
affect eye size. Over-expression of several eye-specific transcription factors results in 
giant eyes (Kobayashi et al., 2001; Zuber et al., 2003). Lack of other transcription 
factors reduce eye size(Chow and Lang, 2001; Fantl et al., 1995; Lee et al., 1996a). 
However, none of the transcription factors identified in the microarray study are 
known to regulate proliferation levels or eye size.
Conversely, ChxlO is known to be important for differentiation and maintenance of a 
specific cell type, the bipolar cell (Burmeister et al., 1996; Liu et al., 1994b). Other 
transcription factors, such as Crx and Brn3b are important for differentiation of other 
specific retinal cell types, photoreceptors and retinal ganglion cells respectively 
(Furukawa et al., 1999; Liu et al., 2000b). The relationship between the effects on 
RPC proliferation and differentiation in the ChxlO retina is unclear. Perhaps changes
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in cell cycle that result in a smaller retina are a secondary effect of transcriptional 
regulation of retinal progenitor cell development.
As described in Chapter 1, the aims of this thesis are to understand the causes of the 
ChxlO'1' phenotype, and the disease aetiology of microphthalmia. The microarray 
study was designed to do this at a molecular level, through examination of the 
genetic pathway in which ChxlO is involved. The studies described in this chapter 
were performed to better characterise the abnormal behaviour of RPCs in the absence 
of ChxlO, and thus examine the ChxlO'1' phenotype at a cellular level. Elucidating 
how RPCs behave differently in the ChxlOv" retina should offer clues to how the 
small eye phenotype is caused. The studies described here were designed to further 
elucidate how lack of ChxlO affects RPC behaviour and examined two hypotheses:
1. The cell cycle of RPCs is altered in the ChxlO'A retina
2. Differentiation of retinal cell types is affected by a lack of ChxlO.
In order to examine cycling behaviour, three studies were undertaken. Firstly, anti- 
phosphohistone H3 and proliferating cell nuclear antigen (Kurki et al., 1988) 
immuno-labelling was used to examine the distribution of mitotic/cycling cells in the 
wild type eye and in the ChxlO'A mutant eye during embryonic development.
Secondly, flow cytometry was used to examine what proportions of retinal 
progenitor cells were in various stages of the cell cycle. Flow cytometry is a common 
approach to monitor the cell cycle of mammalian cells. It can measure DNA content 
of individual cells at a great speed, and thus conveniently reveal cell distribution over 
DNA content, which indicates the locations of cells in the cell cycle. Dyes such as 
propidium iodide (PI), which bind DNA, provide a rapid and accurate means for 
quantitating both total nuclear DNA content and the fraction of cells in each phase of 
the cell cycle. The fluorescence signal intensity of the PI is directly proportional to 
the amount of DNA in each cell. DNA content distribution of a typical exponentially 
growing cell population is composed of two peaks of G1/G0 and G2/M phase and a 
valley of S phase. G2/M phase cells have twice the amount of DNA of G1/G0 phase 
cells, and S phase cells possess varying amounts of DNA between G1 and G2 cells 
(Krishan, 1975; Nicoletti et al., 1991).
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Thirdly, I examined the dividing behaviour of newly bom cells. Investigations in the 
rat and chick retina have indicated that the mitotic spindle orientation during cell 
division is associated with whether an RPC divides asymmetrically, to give one 
daughter that remains as a progenitor and one that adopts a differentiation pathway, 
or symmetrically, giving rise to two daughter cells that divide again (Cayouette and 
Raff, 2003; Cayouette et al., 2001; Silva et al., 2002). RPCs with horizontal spindle 
orientations (i.e. parallel to the ventricular surface) tend to produce daughters that 
become the same cell type (symmetric cell division) whereas RPCs with vertical 
spindles (i.e. perpendicular to the ventricular surface) tend to produce daughters that 
with different fates (asymmetric) (Cayouette et al., 2001). Based on the hypothesis 
that the types of divisions are important for expansion and initiation of differentiation 
of the RPC pool I compared the mitotic spindle orientations in El 1.5 mutant and 
wild type retinae.
Finally, in order to examine how cell differentiation is affected in the ChxlO'1' retina, 
and test the second hypothesis, various markers of immature and mature neural 
retinal cells were used in order to compare their initiation of expression. 03 tubulin is 
an early pan-neuronal marker that labels maturing retinal cells (Snow and Robson, 
1994; Watanabe et al., 1991). In addition, cell-type specific markers were used at 
various stages of early retinal development, between El 1.5, when the first ganglion 
cells are bom and begin to differentiate, until P20, when differentiation of the latest 
bom cells, the rod photoreceptors, is occurring. In addition, the numbers of nuclei in 
the various cell layers of the P12 wild type and ChxlO'1' were counted to examine 
whether there is a difference in the relative numbers of various types of cells.
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5.2. Results
5.2.1 Mitotic cells in the Chxltf' mutant retina fail to amplify the size of the 
retinal progenitor cell population
To examine the cycling behaviour of Chx 10-expressing RPCs in the central retina, 
anti-phospho-histone H3, which strongly labels cells during mitosis, was used to 
compare the distribution of mitotic cells in the wild type eye and in the ChxlO'1' 
mutant mouse, during embryonic development. The anti phospho-histone H3 
antibody used here is highly specific for the phosphorylated form of histone H3, 
whose phosphorylation at SerlO initiates at the end of G2, and is complete just prior 
to the formation of prophase chromosomes at the beginning of mitosis. 
Dephosphorylation begins in anaphase and is completed just as detectable 
chromosome decondensation occurs in telophase (Hendzel et al., 1997).
H3-positive mitotic cells located at the ventricular edge of the neuroblastic cell layer, 
where mitosis occurs (see Figure 5.4), were detected in the wild type and ChxlO'f' 
retina at various points of development, from E ll .5 toE18.5. At E ll .5, wild type 
and ChxlO'1' central retinal sections are roughly similar in size, and a similar number 
of cells are undergoing mitosis at the ventricular edge (two examples each of wild 
type and ChxlO'A El 1.5 retinal sections are shown in Figure 5.1A-D). By E13.5 the 
ChxlO'f' retina is visibly smaller and thinner than the wild type retina (compare 
Figure 5.IE and F). Fewer cells seem to be undergoing mitosis and a lack of H3 
labelling was observed in the periphery of the mutant retina (Figure 5. IF) which is 
consistent with previous reports of reduced BrdU incorporation at the periphery 
(Bone-Larson et al., 2000; Burmeister et al., 1996). The same phenomenon was 
observed during the rest of embryogenesis - no H3-labelled cells are observed in the 
periphery ChxlO'/* retina at E l5.5 or E l8.5 (Figure 5.2C and D). By contrast H3- 
positive cells were detected in the central retina of both genotypes throughout 
embryogenesis.
Whilst H3-labelled cells were observed along the entire ventricular edge of the wild 
type retina at later stages of embryogenesis (Figure 5.2A, B), few labelled cells were 
observed in the E l5.5 and El 8.5 C h x lO retina, and these were limited to the central
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Figure 5.1: H3-labelled cells in the developing ChxlO‘A retina at El 1.5 and E l3.5. 
Midline sections from wild type (.A,C,E,) and ChxlO/_ (B,D,F) eyes at El 1.5 (A-D) 
and E l3.5 (E,F), labelled with H3 antibody (green) and counter-stained with 
Hoechst nuclear dye (blue). At El 1.5, wild type (A,C) and ChxlOf~ (B,D) retina 
show a similar number of mitotic H3-positive cells along the ventricular surface. 
At E l3.5, the wild type retina (E) is larger than the ChxlOA (F). More cells were 
labelled in the wild type retina than in the ChxlO1' retina, and no cells were 
labelled in the periphery of the ChxlO1' retina (dashed white lines demarcating 
central retina in F). Scale bars =100 pm, scale bar in A applies to A-D.
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Figure 5.2: H3-labelled cells in the developing CbxlOr/' retina at E l5.5 and E l8.5. 
Midline sections from wild type (A,B,E,F) and ChxlOr1' (C,D,G,H) eyes at E l5.5 
(A,C,E,G) and E l8.5 (B,D,F,H), labelled with H3 antibody (green) and 
counterstained with Hoechst nuclear dye (blue). A-D show mitotic cells in whole 
retinal sections of the El 5.5 (A,C) and El 8.5 (B,D) ChxlO'/' and wild type central 
retinae. Fewer labelled cells are present in the ChxlO"/' retinae, and mitotic cells 
tend to be located more dorsally in the E l8.5 ChxlOr/' retina (D). High 
magnification views of retinal sections are depicted in (E-H). H3-positive cells 
displaced from the ventricular surface were seen in the in the ChxlO"1' retina at 
both E l5.5 (G) and E l8.5 (H) (arrowheads) retina. Scale bars = (in A) 200 pm for 
A and B and 100 pm in C and D, (in E) 50 pm for E-H.
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retina. In addition, at E l8.5, H3-lablled cells tended to be located more specifically 
towards the dorsal area of the central retina (Figure 5.2C, D). High magnification 
images of wild type and ChxlO'1' retina at El 5.5 and El 8.5 (Figure 5.2E-H) revealed 
abnormal positioning of mitotic cells was in the ChxlO'f' retina. H3 labelling was 
found not only in cells at the ventricular edge, but also in cells displaced towards the 
vitreal edge (Figure 5.2G, H, arrowheads).
To compare the number of mitotic cells in ChxlO'f' and wild type retina, the mitotic 
labelling index was estimated at each stage from midline retinal sections (Figure 
5.3A-C). A count of total cell numbers in central retinal sections reveals a significant 
increase in total cell number in the wild type retina at each time point during 
development. In contrast, there is no significant increase in total cell number per 
section in the ChxlO'f' retina from time point to time point up to E l5.5. A significant 
increase in average total cell number per section is observed from El 1.5 to E l8.5, 
but it is only a 3-fold increase compared to a 13-fold increase in the wild type retina 
(Figure 5.3A). Numbers of H3-labelled cells were counted and divided by total cell 
counts to estimate the mitotic labelling index. At El 1.5, a similar proportion of the 
total cells in the wild type and mutant are undergoing mitosis (p = 0.16) (Figure 
5.3C), whereas there is a significant difference between genotypes at each 
subsequent stage analysed (p < 0.001). In both the mutant and the wild type, the 
mitotic index decreased significantly from El 1.5 to E13.5 (Figure 5.3C). When the 
absolute numbers of H3-labelled cells were compared during this period it was 
observed that there is a significant increase in dividing cells in the wild type retina 
whereas the number is constant in the mutant, over the same period (Figure 5.3B).
At El 5.5 and El 8.5, the wild type pattern of growth (significantly increasing total 
cell number) and significantly decreasing mitotic index continued (Figure 5.3A-C). 
By contrast, no significant change is observed between the mitotic index at E l3.5 
and El 8.5 in the mutant retina; a small increase in both total cell number and the 
number of H3 labelled cells was observed (Figure 5.3A-C). Despite the presence of 
mitotic cells throughout embryogenesis in the mutant, in numbers similar to the 
number of mitotic cells present at El 1.5 in the wild type (compare El 8.5 mutant with 
El 1.5 wild type in Figure 5.3B), a large expansion in the size of the pool of dividing 
RPCs was not observed in the mutant.
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Figure 5.3: Comparison of total cell number and H3 labelled cells in wild type 
and Chxlfr^ retina. (A) Total cell number of wild type retina increases steadily in 
the wild type retina during development. Significant increases in total cell number 
were observed between every time point in the wild type (*p<0.001). In the 
ChxlO'/' retina, a small but significant overall increase is observed between El 1.5 
and E l8.5 (**, pO.OOl). (B) The number of H3-labelled mitotic cells in the wild 
type retina increases significantly between El 1.5 and El 8.5 (*p<0.001) and 
between E ll .5 to E13.5 (p=.024). In the ChxlO'/~ retina, no overall significant 
increase is observed in H3-labelled cells between El 1.5 and E l8.5. (Q  The 
number of H3-labelled cells was divided by the total number of cells per section, 
to create the mitotic labelling index. Early in development, at El 1.5, a similar 
proportion of cells are undergoing mitosis in the ChxlO'/' and wild type retina. At 
E l3.5 there is a significant decrease in the mitotic index of both the ChxlO'f' and 
wild type retina (*p=0.002,**p=0.008). This trend continued in the wild type 
retina throughout development, with a significant difference in mitotic labelling 
index between E l3.5 and E l8.5 (*p=0.003), but no significant change was 
observed in the mitotic labelling index from E l3.5 onwards in the ChxlO'A retina. 
Columns indicate means, error bars = sd. n = nine midline sections taken from 
three eyes.
215
Em
bryonic 
day
o
% H3 labelled cells, per section
O ^  M U t  Ui
M
j  i i i i___
= ■ ■  ■<
w
5
■ d
00
l/l
b J
? ■
Em
bryonic 
day
>
Number o f H3 labelled cells per section
Total number o f cells per section
w
3cr
3
o o o o o o o oo o o o o o o oo o o o o o o o o
J I I I
■
J
5.2.2 PCNA labelling confirms a lack of proliferation at the periphery
Immunostaining with PCNA (proliferating cell nuclear antigen), which labels cells 
during the G1 and S phases of the cell cycle (Kurki et al., 1988), Figure 5.4) 
confirmed the pattern of reduced proliferation at the retinal periphery compared to 
central retina. At E l3.5, a differentiating cell layer has developed along the vitreal 
edge of the retina, where cells have exited the cell cycle to differentiate to their final 
retinal cell types. The RPCs still cycling are located in the neuroblastic layer towards 
the ventricular edge of the retina. PCNA staining can be observed throughout the 
neuroblastic layer of the retina, particularly, along the ventricular edge of the retina, 
where cells are undergoing mitosis, and in the vitreal edge of the neuroblastic layer - 
adjacent to the differentiated cell layer - where most cells are thought to be in S 
phase (Figure 5.5A). PCNA staining is seen in both the central retina and the 
periphery (Figure 5.5A, C). In contrast, PCNA staining in the ChxlO"A retina is 
restricted to the central retina (Figure 5.5B, D). PCNA labelled cells are located 
throughout the retina, from the ventricular edge to the vitreal edge (Figure 5.5D), in 
contrast to labelling in the wild type retina. This suggests that no differentiating cell 
layer has become established yet at this point.
A similar pattern of staining can be observed at E l5.5 (Figure 5.5E-H). PCNA 
labelled cells in the wild type retina are restricted to the neuroblastic layer, where 
cells are proliferating, whilst no PCNA labelling is observed in the differentiated cell 
layer toward the vitreal edge (Figure 5.5G). As was observed at E l3.5, staining 
seems brightest at the ventricular edge of the neuroblastic cell layer, (Figure 5.5E). In 
the ChxlO'f' retina, however, PCNA labelled cells are again observed from the 
ventricular edge to the vitreal edge of the entire retina, suggesting that differentiating 
cells are not forming a separate layer to RPCs (Figure 5.5H). PCNA staining is 
limited to the central retina, and no PCNA labelled cells are observed in the 
periphery (Figure 5.5F).
By E l8.5, PCNA labelling in the wild type retina is becoming fainter in the 
neuroblastic layer. Although staining can still be observed in the neuroblastic layer of 
the wild type retina (Figure 5.6A, C), the strongest staining is confined to cells along 
the ventricular edge of the retina (Figure 5.6C). A high power confocal microscope
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Figure 5.4: Localisation of cells in various phases of the cell cycle in the 
developing retina. Cells underoing mitosis are situated at the ventricular 
edge of the neuroblastic layer, and as they progress through G1 and S 
phase, they migrate toward the vitreal edge of the neuroblastic layer. Cells 
that exit the cell cycle and go on to differentiate migrate further towards 
the vitreal edge, away from the neuroblastic layer, whilst cells that will 
divide again migrate back toward the ventricular edge.
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Figure 5.5: PCNA labelling of wild type and Chxl&' retina at various time points 
during development. At E13.5 (A-D) PCNA labelling (red, with blue Hoechst 
nuclear counter-stain) in the wild type retina (A,C) can be observed throughout the 
proliferating neuroblastic layer from the centre of the retina to the very periphery 
(Q . In the ChxlOr1' retina, PCNA labelling is observed in the central retina (B, D) 
from the vitreal layer to the ventricular layer, but no staining is observed in the 
periphery (B, arrows indicate boundaries of staining). A similar pattern is observed 
at E l5.5 (E-G), where PCNA staining is still observed in the neurobalstic layer of 
the wild type retina (E,G, NBL), with no staining in the differentiated cell layer (G). 
In the ChxlO'/_ retina, PCNA labelling remains confined to the central retina (F, 
arrows indicate boundaries of PCNA labelling) and is still present from the vitreal 
to the ventricular edge of the retina (H). Scale bar in A = 100 pm for A, 50 pm for 
B and C; scale bar in D = 50 pm; scale bar in E = 100 pm for E and F, 50 pm for 
GandH.
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Figure 5.6: PCNA labelling (red, with blue Hoechst nuclear counter-stain 
in A-D) of wild type (A,C,E) and ChxlOr' (B,D,F) retina at E l8.5. PCNA 
labelling in the wild type retina is strongest at the ventricular edge of the 
retina and is observed in the proliferating neuroblastic layer (C, NBL), 
whilst the postmitotic cells toward the vitreal edge (v) of the retina no 
longer express PCNA. In the Chclfr^ retina, PCNA labelling still occurs 
throughout the retina (D ). E and F are confocal images. Strong PCNA 
staining is observed in mitotic cells at ventricular edge of wild type retina 
(E, arrows), and in both mitotic cells at the ventricular edge of the retina 
(F, arrow) and in nuclei of proliferating cells throughout the ChxlOrf' 
retina (F, arrowheads). Scale bar in A = 200 pm for A and B; scale bar in 
C = 50 pm for C and D. 221
image of the wild type retina at this time point shows bright PCNA labelling in 
dividing cells along the ventricular edge of the retina (Figure 5.6E, arrows). In 
contrast, PCNA labelling is observed throughout the width of the C h x lO retina, 
although staining again is confined to the central retina, and in particular the dorsal 
area of the retina (Figure 5.6B). Both mitotic cells at the ventricular edge of the 
ChxlO'f' retina and cycling cells in the rest of the retina are strongly labelled (Figure 
5.6D, F, arrows point to mitotic cells and arrowheads to cycling cells). Thus PCNA 
labelling confirms that there is a lack of proliferation occurring in the periphery of 
the ChxlO'A retina from E l3.5 onwards, and suggests that a greater proportion of 
cells are cycling in the ChxlO'f' retina than in the wild type retina at later time points, 
mirroring the H3 data.
5.2.3 Apoptosis does not contribute to the cell number deficit or differentiation 
delay in the early embryonic Chxltf' retina
TdT-mediated dUTP nick end labelling (TUNEL) was used to assess whether 
increased levels of apoptosis were occurring during development of the ChxlO'f' 
retina, which could explain the low level of retinal growth in the ChxlO'1' retina. 
Between El 1.5 and E18.5 the total cell number has increased 13 times compared to 
less than 4 times in the mutant (Figure 5.3A). The TUNEL procedure was used to 
examine whether this difference might have resulted from an increase in apoptosis in 
the ChxlO'f' retina.
7 retinal sections from 4 eyes were examined from the wild type retina. Very few 
apoptotic cells were observed in most sections (Figure 5.7), with the exception of 
sections from the ventral retina including the optic fissure, where an increased 
number of apoptotic cells were observed. On average, 9.8 +/- 5.0 apoptotic cells were 
observed per midline retinal section in the wild type retina. Similarly, only a very 
small number of apoptotic figures were observed in the ChxlO'1' retina. In fact, fewer 
apoptotic cells were observed in the ChxlO'1' retina than in the wild type. On average, 
only 3.4 +/- 2.2 apoptotic cells were observed per retinal section, counted in 17 
sections from 2 eyes. A significant difference (p<0.015 student’s t-test) was observed 
between the number of apoptotic cells in central El 1.5 in the wild type and mutant 
retina. This corresponds with previous data on apoptosis in the ChxlO'1' retina (Robb
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Figure 5.7 TUNEL labelling (green) of El 1.5 wild type (A) and ChxW'- (B) 
retina. Apoptotic bodies can be observed in the central area of the wild type retina 
(A, arrow), whilst apoptotic bodies seem to be localised at the periphery of the 
ChxlO~ ~ retina (B, arrow)
et al., 1978; Theiler et al., 1976). Thus changes in apoptosis are unlikely to be 
involved in the reduced size of the retina, as fewer apoptotic cells were observed in 
the ChxlO'A retina than in the wild type.
Interestingly, the positioning of the apoptotic figures in the ChxlO'A retina was 
different to that of the apoptotic cells in the wild type. In the wild type retina, 
apoptotic figures were generally observed in the central retina (Figure 5.7A, arrow). 
In contrast, apoptotic figures in the ChxlO'A retina were observed in the periphery of 
the retina (Figure 5.7B, arrow). As this is the same area in which cell proliferation is 
observed to be reduced, this difference is particularly striking.
5.2.4 Changes in the cell cycle
The H3 data indicated that RPCs in the ChxlO'1' retina do seem to proliferate, do not 
die, but also do not expand in number. In order to investigate in what ways RPCs of 
the ChxlO'/' retina differed from those of the wild type retina, flow cytometry was 
used to measure the DNA content of dissociated RPCs and compare the percentage 
of cells at G1/G0, G2 and S stage of the cell cycle. Neural retinae from 3 pools of 
El 1.5 wild type and 3 somite matched pools of ChxlQ'/~ mouse embryos were 
dissociated, labelled with propidium iodide and analysed using an Epics XL flow 
cytometer (Beckman Coulter). For each sample, 30,000 events were collected on the 
flow cytometer, using doublet discrimination to exclude clumps of cells. The data 
was analysed using Expo32 software (Beckman Coulter) to only select single cells in 
the cell cycle (i.e. excluding dead or fragmented cells). The data was subsequently 
modelled using Multicycle software (Phoenix flow systems), using an appropriate 
modelling system (the ‘aggregates’ modelling system). The data closely fit this 
model, used for analysis of single cells, and this was verified by low Chi squared 
values upon fitting the data to the model.
The graphs obtained using Multicycle software are shown in Figures 5.8. Each graph 
shows an initial G1/G0 peak, and a final G2 peak, with an S phase curve between the 
two. This S phase curve is visibly smaller in the ChxlO‘A retina.
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Figure 5.8: Flow cytometry data of retinal progenitor cells at El 1.5. Graphs 
representing proportions of retinal progenitor cells in the various stages of the 
cell cycle at El 1.5 in the wild type (A,C,E) and Chxlfr1' (B,D,F) retinae. Gl/GO 
phase is shown in grey, S phase in red, and G2 phase in blue. A larger proportion 
of cells reside in the Gl/GO phase of the cell cycle in the ChxlOr'' retina than in 
the wild type, whilst a smaller proportion reside in S phase (compare cell cycle 
data of B, D, F to A, C, E).
On average, 51.4 +/- 1.8 % of cells were in G1 in the wild type compared to 60.3 +/- 
0.5% in the ChxlO'f~ retina, 38.6 +/- 1.4% of cells in S in the wild type compared to
26.5 +/- 1.7% in the ChxlO''A retina and 10 +/- 3.2% of cells in G2 in the wild type 
compared to 13.2 +/- 1.8% in the ChxlO'1' retina. These data showed that a 
significantly higher proportion of cells were in G1 in the ChxlO'A retina than in wild 
type retina (student t-test, p = 0.001, Figures 5.8 and 5.10E). Conversely a decreased 
number of RPCs were in S-phase in the ChxlOm/' retina compared with the wild type 
(p < 0.001). No significant difference was observed between the proportions of cells 
in G2 phase. Thus, at the stage when the retinae are largely undifferentiated and 
similar in size between the ChxlO'/' mutant and the wild type, the cycling properties 
of the RPCs differ considerably.
Three pools of wild type and ChxlO'A retinae were also collected at El 3.5 and run on 
the flow cytometer (Figure 5.9A-F). The proportions of cells in the various stages of 
the cell cycle have not changed significantly between El 1.5 and E13.5 in the wild 
type. However, two out of the three pools showed a markedly reduced proportion of 
cells undergoing G2, and there was a corresponding increase in cells in the Gl/GO 
and S phases. At this point in development, a proportion of retinal cells have exited 
the cell cycle and are thus in the GO phase of the cell cycle. It is not possible to 
distinguish between cells in the G1 phase and the GO phase of the cell cycle using 
this method. Thus it is not clear whether a decrease in the proportion of cells in G2 
phase and a corresponding increase in the proportion of cells in Gl/GO compared to 
El 1.5 is a result of cells differentiation or a change in the relative lengths of the 
various phases of the cell cycle.
Again there is a significant difference between the proportion of cells residing in 
Gl/GO phase and in S phase (p = 0.02 and 0.001 respectively) between the wild type 
and the ChxlO_/' retina. By this point, in the ChxlO'/' retina, an even larger proportion 
of the retinal progenitor cells tested (70.6 +/- 3.0%) were in Gl/GO (Figure 5.9 and 
5.10B) than at El 1.5, whilst a smaller proportion of RPCs are in S phase (19.8 +/- 
3.4%). It is possible that the G1 phase of the cell cycle is extended in the ChxlO'A 
retina, or that a large proportion of cells have exited the cell cycle and are residing in 
GO.
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Figure 5.9: Flow cytometry data of retinal progenitor cells at E13.5. Graphs 
representing proportions of retinal progenitor cells in the various stages of the 
cell cycle at E13.5 in the wild type {A,C,E) and ChxlO’' (B,D,F) retinae. Gl/GO 
phase is shown in grey, S phase in red, and G2 phase in blue. A larger proportion 
of cells reside in the Gl/GO phase of the cell cycle in the ChxlOr' retina than in 
the wild type, whilst a smaller proportion reside in S phase (compare cell cycle 
date of B, D, F to A, C, E). 227
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Figure 5.10: Flow cytometry data o f retinal progenitor cells. A-D: Graphs 
representing proportions o f retinal progenitor cells in the various stages o f the cell 
cycle at E15.5 (A, B) and 18.5 (C, D ) in the wild type (A ,Q  and ChxlOr'- (.B,D) 
retinae. Gl/GO phase is shown in grey, S phase in red, and G2 phase in blue. A  
larger proportion o f  cells reside in the Gl/GO phase o f  the cell cycle in the 
C h xlO r1 retina than in the wild type at E15.5, whilst the proportions are similar at 
E l8.5. No cells reside in the G2 phase of the cell cycle in the wild type retina by 
E l8.5 (C). E-F: Summary o f flow  cytometry results for retinal progenitor cells at 
E l 1.5 (E) and El 3.5 (F) in the wild type and C h xlO 1 retina. A comparison o f wild 
type versus ChxlOr1 RPCs shows that a higher proportion o f cells reside in the 
Gl/GO phase of the cell cycle in the C hxlO 7 retina at both time points.
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Finally, wild type and ChxlO''A RPCs were examined at E l5.5 and E l8.5 (examples 
shown in Figure 5.10A-D). By E l8.5, virtually no cells are in G2 anymore and most 
cells are in Gl/GO phase in the wild type retina. In the ChxlO'f~ retina, the 
proportions of cells in the various cell cycle stages are similar to those at E l3.5. 
Although no statistical analysis was carried out at these time points as only 1-2 pools 
of retinae were collected for each, it seems that there is little change in the 
proportions of cells at various stages of the cell cycle from about E13.5 onwards in 
the ChxlOv‘ retina. In contrast, the proportion of cells undergoing Gl/GO and S phase 
increased steadily in the wild type retina, whilst the proportion of cells undergoing 
G2 decreases over the same time period. This may be an indication of the increasing 
proportion of cells exiting the cell cycle and differentiating to the various neural 
retinal cell types.
5.2.5 The orientation of cell division is altered in the Chxltf' retina
Some studies, in particular in the developing cortex but also in the retina, have 
suggested that proliferating cells with horizontal spindle orientations (i.e. parallel to 
the ventricular surface) tend to produce daughters that become the same cell type 
(symmetric cell division) whereas those with vertical spindles (i.e. perpendicular to 
the ventricular surface) tend to produce daughters that have different fates 
(asymmetric) (Cayouette and Raff, 2003a; Chenn and McConnell, 1995; Zamenhof, 
1987). Perhaps the types of divisions are important for expansion and initiation of 
differentiation of the RPC pool. To examine this hypothesis, the mitotic spindle 
orientations of dividing cells were classified and counted in the El 1.5 wild type and 
ChxlO'A retinae.
Retinal sections were stained with 4’6-diamidino-2-phenylindole (DAPI), which 
allows the identification of cells in late anaphase and telophase when condensed 
chromosomes are separating (Hamada and Fujita, 1983; Otto and Tsou, 1985). As in 
section 5.2.1, mitotic figures were localised and counted along the ventricular edge 
of the retina. If a line drawn through the spindle of a mitotic figure was 0° +/- 45° to 
the ventricular surface of the retina, the division was classified as horizontal (Figure 
5.9A). If the line through the mitotic spindle was 90° +/- 45° to the ventricular 
surface, the mitotic figure was classed as a vertical division (Figure5.1 IB). Only
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Figure 5.11: Examining symmetry of division of retinal progenitor cells. A,B: 
DAPI staining of the El 1.5 retina -  cells dividing with a horizontal (A, dashed 
lines) and a vertical (B , dashed lines) mitotic spindle orientation were observed in 
both the wild type and mutant retinae of El 1.5 mice. C: Percentage vertical 
spindles observed in the wild type retina, the Chxlfr' retina, the ChxlOr1' / 
p27Kip+/' and the C hxl& Ip27Kipl~ double knock out, +SE. All mutant genotypes 
differ significantly from the wild type (asterisks, p<0.01 Mann Whitney U test) 
but not from each other. D-F: Numb staining of dissociated wild type (D-F) and 
ChxlOr' retinal cells. D and G are phase images of the dissociated cells, E and H  
show red numb staining and blue Hoechst nuclear counter stain. In both cases, 
numb staining appears to be localised on one side of the mitotic cells, 
perpendicular to plane of cleavage (indicated by dashed lines). This is more 
clearly visible in F, where only numb staining is shown. Scale bar = 10 pm.
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figures where both daughter cells were clearly visible were counted. Overall, mitotic 
figures were clearly identifiable as horizontal or vertical, with only the rare mitotic 
figure requiring angle measurement.
Wild type and ChxlO'1' embryos were cut in 7 pm sections, and all mitotic figures on 
all high-quality retinal sections were counted. There was no significant difference 
between the number of cells per section in the wild type retina and the ChxlO'f' retina 
(p = 0.4). In total, 191 mitotic figures were analysed in 6 wild type eyes. Of these, on 
average 54.5% were classed as vertical divisions (Figure 5.11C). In contrast, of the 
100 mitotic figures counted in 4 ChxlO'A eyes, only 27.7% of divisions were classed 
as vertical (Figure 5.11C). This difference was statistically significant (p<0.01, 2- 
tailed Mann Whitney U test).
In addition to examining wild type and ChxlO'1' eyes, spindle orientations of RPCs in 
mice generated by intercrossing Chxl0'f' and Kipl'1' mice were also examined. It has 
been shown that growth of the retina in the ChxlO*/‘ mutant is rescued by deletion of 
the cell cycle regulatory gene p27Kipl (Green et al., 2003). This study was carried out 
to examine whether p27Kipl could contribute to the reduced levels of cells dividing 
vertically in the Chxl0'A retina. Mitotic figures of the eyes from both the Chxl0'f' 
p27Kip'/~ double knockout, and the ChxlO‘f  p27Kip+/' retinae were counted. Both 
showed a significant bias towards horizontal cell divisions. In the C h xlO ^ 'p ll^ ' 
mice, 95 mitotic figures were counted from 4 eyes, and only 25.49% of these were 
vertical divisions (Figure 5.11C). Similarly, in the ChxlO’1' p27Kip*/' mouse, 74 
mitotic figures from 4 eyes respectively were counted, and 31.75% of these were 
vertical divisions (Figure 5.11C). These results were not significantly different from 
those obtained from the ChxlOf^ mouse eyes (p = 0.39 for ChxlO'/'p27Kip'/' and 0.34 
for ChxlO'/'p27Kip*/'), but significantly different to those obtained from the wild type 
mouse eyes (p < 0.006 for Chxl0'f'p27Kip'/' and < 0.005 for ChxlO'1'p27Kip*/', 2-tailed 
Mann Whitney U test). This indicates that the difference in cell division type 
between wild type and ChxlO'A RPCs was not ameliorated by lack of p27Kipl 
suggesting that it is independent of the proliferation defect.
To further examine the orientation of division, anti-numb antibody was used on 
dissociated retinal progenitor cells. In previous studies, a correlation was observed
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between asymmetric localisation of numb, an intrinsic factor that regulates cellular 
competence through the Notch pathway, and cellular competence to differentiate. 
Cells with an asymmetric numb distribution differentiated more readily in culture 
(Dooley et al., 2003). In the rat retina, cells that divided with their mitotic spindles 
perpendicular to the ventricular edge showed asymmetrical numb distribution, with 
the more vitreal cell inheriting numb (Cayouette et al., 2001; Cayouette and Raff, 
2003b; Dooley et al., 2003). RPCs from wild type and ChxlO'A developing retinae 
were dissociated and allowed to remain in culture for 24 hours. Cells were then fixed 
and mitotic figures were examined for numb localisation. Very few mitotic figures 
were observed amongst the dissociated cells, and thus only a few observations could 
be made. Figure 5.11D-H show examples of both wild type and ChxlO'A dissociated 
RPCs, with numb staining perpendicular to the mitotic spindles (dashed lines in 
Figure 5.1 IE, H). Thus, numb would be distributed between both daughter cells in 
these instances. In other mitotic figures, it was difficult to ascertain whether numb 
staining was distributed evenly across two dividing cells or not. In no case was numb 
staining observed in only one pole, away from the mitotic spindle. As the aim of this 
experiment was to compare the number of cells with different numb distributions 
between mutant and wild type, it was not pursued here due to a low number of numb- 
labelled mitotic cells observed in culture.
5.2.6 Altered profile of cell fate determination
A mutation in the p27Kipl gene has previously been shown to rescue the proliferation 
defect in the ChxlO'A mouse. However, it does not seem to ameliorate the bias 
toward horizontal divisions observed in the ChxlO_A retina. If the orientation of cell 
division is related to what fate the daughter cells will assume, the question arises 
whether onset of differentiation of retinal neurons is affected in the ChxlO'A retina. 
To test this idea, I used immunostaining for p3 tubulin on El 1.5 retina. p3 tubulin is 
a marker of maturing neurons, first expressed around El 1.5 when the first ganglion 
cells are bom (McCabe et al., 1999);(Snow and Robson, 1994; Watanabe et al., 
1991).
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Retinae from wild type, ChxlOv‘, and C hxlO '^pU ^' mice were examined by P3 
tubulin labelling at El 1.5. In the wild type retina, P3 tubulin labelling could be 
observed in the central retina, in particular at the vitreal edge, where ganglion cells 
first mature (Figure 5.12A, B arrow). Processes could be observed projecting radially 
from the ganglion cells toward the ventricular edge. In contrast, no p3 tubulin 
labelling was observed in the ChxlO'f' retina at El 1.5 (Figure 5.12C). Similarly, no 
p3 tubulin staining was observed in the ChxlO~/~p27Kip~/~ retina at the same time point 
(Figure 5.12D). Together these data suggest that the decrease in vertical cell division 
is associated with delayed differentiation of retinal neurons.
A lack of P3 tubulin staining suggests that the maturation of the earliest-born retinal 
cells, the retinal ganglion cells, is delayed. The question arises as to whether other 
neural retinal cell types are similarly affected. Is an effect observed in later-born 
cells? To examine this, a number of retinal markers were used at various points 
during development. Antibodies against syntaxin and VC 1.1 were used to examine 
the development of amacrine and horizontal cells (the same antibodies were used in 
Chapter 6, with amacrine and horizontal cells in the adult wild type retina serving as 
clear positive controls), which begin to become postmitotic shortly after retinal 
ganglion cells begin to exit the cell cycle and differentiate (see Figure 1.2). At E l3.5, 
syntaxin-labelled cells can be observed at high magnification in the wild type retina 
(Figure 5.13A, C, arrows). In contrast, no syntaxin labelling can be observed in the 
ChxlO'/' retina at the same point during development (Figure 5.13B, D). By E15.5, 
syntaxin labelling is still widespread throughout the wild type retina (Figure 5.13E, 
G, arrowheads), whilst in ChxlO‘A eyes only a few cells in the central retina are 
labelled with the syntaxin antibody (Figure 5.13F, H, arrows).
A similar pattern of expression can be observed using the anti-VC 1.1 antibody. 
VC 1.1 is expressed in both amacrine and horizontal cells (Arimatsu et al., 1987), 
whilst syntaxin is more restricted to amacrine cells (Barnstable et al., 1985). At 
E l3.5, VC 1.1 labelling can be observed in several cells in the wild type central 
retina, especially in the most central retinal areas, which are the first to mature, and 
towards the ventricular edge, where cells exit the cell cycle and begin to differentiate 
(Figure 15.14A, C, arrows). Mirroring observations made using anti-syntaxin
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Figure 5.12: Immunostaining for |33-tubulin (red, with blue Hoechst nuclear 
counter-stain in A,C,D) in the wild type shows differentiating neurons in the 
El 1.5 wild type central retina (A, B arrows), but not in the El 1.5 C hxl&  retina 
(C) or the El 1.5 ChxlOr'/p27Kip~'~ double knock out (D). Scale bar = \00pm .
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Figure 5.13: Syntaxin labelling (red, with blue Hoechst nuclear counter-stain) of 
wild type (A,C,E,G) and ChxlO'' (B,D,F,H) retina at E13.5 (A-D) and E15.5 (E-H). 
At E l3.5 (A-D) syntaxin labelling in the wild type retina is difficult to discern at 
low magnification (A) but can be observed in larger areas of the retina at higher 
magnification (C, arrows). In the ChxlOr/m retina, no syntaxin labelling can be 
observed, either at low (B) or high magnification (£>). At E l5.5, syntaxin labelling 
can still be observed in large areas of the wild type retina (G, arrowheads) and is 
also seen in a few cells of the ChxlOA retina (F,H, arrows). Scale bars =100 pm in 
A and B; scale bar in C = 50 pm for C and D; scale bar in E = 100 pm  in E, 50 pm  
in F; scale bar in G = 50 pm for G and H.
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Figure 5.14: VC1.1 labelling (red, with blue Hoechst nuclear counter-stain) of 
wild type (A,C,E,G) and ChxlOrA (B,D,F,H) retina at E13.5 (A-D) and E15.5 (E-H). 
At E l3.5, VC1.1 labelling in the wild type retina can be observed at low and high 
magnification (A, C, arrows), whilst no VC 1.1 staining can be observed in the 
ChxlOr1' retina (B,D). At E15.5, VC1.1 labelling can still be observed in large 
areas of the wild type retina (G, arrows) and is also seen in a few cells of the 
ChxlOr/' retina (H, arrows). Scale bar in A = 100 pm in A, 50 pm in B; scale bars 
in C and D = 50 pm; scale bar in E = 100 pm in E, 50 pm in F; scale bars in G and 
H = 50 pm.
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antibody, no VC 1.1 staining can be observed in the ChxlOm/~ retina at the same time 
point. At E l5.5, differentiating amacrine and horizontal cells can be observed in the 
differentiating layers of the wild type retina (Figure 5.14E, G, arrows), and VC 1.1 
labelling can also be observed in the ChxlO'A retina, although to a lesser extent than 
in the wild type retina. Both syntaxin and VC 1.1 labelling suggest that the birth 
and/or differentiation of amacrine and horizontal cells may be delayed in the ChxlO'1'' 
retina.
To examine whether there is a change in photoreceptor differentiation in the ChxlO'1' 
retina compared to the wild type, recoverin labelling was examined at El 8.5 
(Dizhoor et al., 1991). At this point during development, a small number of 
differentiating photoreceptors can be observed at the ventricular edge of the wild 
type retina (Figure 5.15A, C, arrows). This is not the case, however, in the ChxlO/‘ 
eye; no recoverin labelling can be observed anywhere in the retina at El 8.5 (Figure 
5.15B, D). This again suggests that differentiation of a variety of neural retinal cell 
types is delayed or disrupted in the ChxlO'1' retina.
Previous data indicate that the development of photoreceptors is disrupted in the 
ChxlO'1' retina, and that expression of the Crx gene, a gene necessary for 
photoreceptor differentiation, is delayed (Rutherford et al., 2004). However it is not 
clear whether both rods and cones are similarly affected. As cones are generated 
early along with amacrine and ganglion cells and rods and bipolars are late bom 
cells, it is of interest to examine whether both types of photoreceptor are disrupted 
and whether early and late-bom cells are differentially affected. Cone cell-specific 
peanut agglutinin (PNA)-rhodamine staining and immunostaining for the blue short 
wave-sensitive “S” cone opsin gene were used to compare cone development in the 
post-natal ChxlO'A and wild-type retina. Immunostaining for rhodopsin was also 
performed to compare rod development at the same stages (Molday, 1989).
PNA labels all developing cone types (Zhang et al., 1994). By P14 in both the wild 
type and the mutant retina distinct cone outer segments were detected with PNA 
(Figure 5.16B and E). Blue cone opsin-positive outer segments were detected in both 
the ChxlO1' (Figure. 5.16J) and the wild-type retina at P7 (Figure 5.16G) and at later 
stages (Figure 5.16H, I, K, L), consistent with previous reports of wild-type
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Figure 5.15: Recoverin labelling (green, with blue Hoechst nuclear counter-stain) 
of wild type (A,C) and ChxlO 'A (B,D) retina at E l8.5. In the wild type retina, a 
few recoverin-labelled cells can be observed at the ventricular edge of the retina 
(A,C , arrows), where developing photoreceptors are located. No recoverin 
labelling can be observed in the ChxlO~/~ retina (B,D). Scale bar =100 pm for A, 
200 pm for B, and 50 pm for C and D.
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Figure 5.16. Examination of photoreceptor differentiation in the postnatal retina. 
Cone photoreceptors of both wild type and ChxlOr1' mutant retina were labelled 
with PNA (A-F, red) and blue cone opsin (G-L, red) at postnatal days 7,14-15 and 
20. PNA staining of cone pedicles is first observed at P14 in both the wild type (B, 
arrowheads), and ChxlOr/_ (E, arrowheads) retina, and cones seem to be present at 
similar densities. By P20 it is clear that the outer segments of the cone 
photoreceptors of the ChxlO'1' retina are shorter and abnormal looking compared to 
the cones of the wild type retina at the same stage (compare F, arrowhead with C, 
arrowheads). Labelling with blue cone opsin labels blue cone outer segments as 
early as P7 in both the wild type and ChxlO'/' retina and expression persists at later 
stages (H I ,  K, L) in both. By contrast, rhodopsin labelling (M-R, green) was 
observed at P7 in the developing outer segments of rod photoreceptors (M, 
arrowhead) and remains expressed in the outer segments of the wild type retina at 
later stages (N, O), but is not expressed in the mutant retina until P20 (R), where it 
is only sparsely distributed (arrowheads). Hoechst 33258 nuclear dye was used to 
label the nuclei of the photoreceptor layer blue in all sections. Scale bars = 20 pm.
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expression patterns. The cones were present at similar densities within the ChxlO' 
and the wild-type retinae (Figure 5.16B and E). At P20 the cone outer segments were 
reduced in length in the ChxlO'/' retina (Figure 5.16F) compared with the wild-type 
(Figure 5.16C). By contrast, rhodopsin was localised in the developing outer 
segments at P7 (Figure 5.16M) and P I5 (Figure 5.16N) in the wild-type but similar 
expression was markedly absent in the ChxlOr/‘ retina (Figure 5.16P, Q). At P20 the 
rhodopsin was specifically localised throughout the rod outer segment layer in the 
wild-type retina (Figure 5.160). By this stage the mutant retina showed more 
sparsely distributed rhodopsin positive outer segments with an abnormal truncated 
appearance (Figure 5.16R). These data show that the cone photoreceptors are being 
generated relatively normally in the absence of ChxlO, suggesting that generation of 
early bom photoreceptors is less dismpted than late bom photoreceptors. It follows 
that the reduction in cell number in the outer nuclear layer is due to a rod deficit. 
These data also indicate that lack of ChxlO is affecting the differentiation of 
photoreceptors as outer segment morphogenesis is abnormal for rods and cones. It 
seems likely that this phenotype could result from the delay in Crx expression in the 
ChxlO'1' mutant.
5.2.7 Cell numbers are decreased in both the inner and outer nuclear layers of 
the Chxltf' retina
Use of specific retinal cell type markers indicated that the differentiation of several 
cell types is affected by a loss of ChxlO. However, expression of Brn3b and Pax6, 
markers of postmitotic retinal ganglion cells and amacrine cells/retinal ganglion cells 
respectively, in the ChxlO_/' retina suggest cells of the inner retina were being bom in 
early embryonic stages (Rutherford et al., 2004). To address whether the reduced size 
of the C h x lO retina was due to a reduction in specific types of cells, for example of 
rod photoreceptors, semithin histological sections of wild type and ChxlO'A retinae 
were examined. These sections offer the advantage of being only one cell layer thick, 
allowing relative cell counts in the various cell layers. All retinal layers are present in 
the wild type retina by P12 (Figure 5.17A, B). Each layer is of an even thickness 
throughout the retina (Figure 5.17B) and the retina tapers off towards the periphery, 
and the ciliary body has a characteristic folded shape (Figure 5.17C). The P12 
ChxlO’f' retina, however, is far less organised and of variable thickness. Thick areas
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Figure 5.17: Semithin sections of wild type (A^C,J,K) and ChxlOr1' (D-I, L) retina 
stained with toluidine blue. The P12 wild type retina is of an even thickness 
throughout, tapering towards the periphery and ciliary body (A-C), and contains 
three well-organised cell layers. The P12 ChxlO1' retina, in contrast, shows 
variable thickness and organisation, with some well organised thick areas of retina 
(D,E, arrows and F,H) and some thin areas where retinal cell layers are far less 
organised (D,E arrowheads, and G,1). J-L show P12 wild type and ChxlOA retinae 
compared to an adult wild type retina, all at the same magnification. The wild type 
P12 retina is slightly smaller than the mature adult retina, and the photoreceptors 
are less well developed. The P12 ChxlO1' retina is about half as small as the wild 
type retina at this time point -  a relatively thick, well-organised area of ChxlOA 
was used for this comparison.
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(Figure 5.17D, E arrows) are interspersed with thin areas (Figure 5.17D, E, 
arrowheads). Figure 5.17 F-I show four different high magnification views of P12 
ChxlO'A retinae. The various cell layers are present, especially in the thicker areas 
(Figure 5.17F, H) but are far less organised, and in some areas, only one cell layer 
can be distinguished (Figure 5.171). A direct comparison of the adult and P12 wild 
type and P12 ChxlO"A retinae is shown in Figure 5.17J-L. All images were taken at 
the same magnification. The P12 wild type retina is slightly thinner than the adult 
retina, but all cell layers are present and the most significant differences are in the 
photoreceptor layers: the cells are not fully differentiated in the P I2 retina, and the 
inner and outer segments are significantly smaller than in the adult. At its thickest 
and most organised, the ChxlO"/' P12 retina is only about half the size of the wild 
type P12 retina. Morphologically distinct cell types are present in both, but the cell 
layers of the ChxlO'A retina are thinner than in the wild type and the plexiform layers 
between the cell layers are greatly reduced.
A comparison was made of the thickness of the inner and outer nuclear layers by 
making replicate counts of the number of nuclei along the length of each nuclear 
layer. Table 5.1 summarises the cell nuclei counts. Both layers show a significant 
reduction in cell number, with a more marked reduction in the outer nuclear layer. It 
seems likely that a lack of cells in the outer nuclear layer is due to a low number of 
mitotic RPCs being present in the ChxlO*A retina around birth, the normal peak of 
rod genesis.
Genotype Nuclear Cell layer
(no of nuclei)
Inner Outer
+/+ 8.8+/-1.2 11.7+/-0.8
-/- 4.0+/-0.9 4.2+/-1.4
Table 5.1. Comparison of thickness , by nuclei, of retinal tissues from wild type (+/+) and 
ChxlO1' (-/-) mice. Observations were made on four eyes in each category. Numbers refer 
to the mean values +/- SD.
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5.3. Discussion
5.3.1 A decrease in proliferation in the periphery of the C h x lO retina may be 
due to misspecification of neural retina
The aim of the study described here was to examine if and how the properties of 
retinal progenitor cells in the ChxlO'A retina are affected by the lack of ChxlO during 
early retinal development. Previous studies, using the cell cycle marker BrdU, have 
indicated that there is an apparent decrease in proliferating cells in the periphery of 
the retina from E l0.5 onwards. However, proliferation seemed to occur normally in 
the central retina, as there was no apparent difference in the percentage of BrdU- 
labelled cells in this area (Bone-Larson et al., 2000; Burmeister et al., 1996).
The results obtained here correlate to some extent with these studies. H3 and PCNA 
labelling confirm that the apparent number of cycling cells is diminished in the 
periphery of the retina. Thus far, no real Explanation has been put forth for this 
phenomenon. Why should a lack of ChxlO affect a population of RPCs in the 
periphery of the retina in a different manner? However, in the previous chapter, it 
became clear that RPE markers are expressed in the periphery of the ChxlO'A retina. 
It seems likely that the decrease in proliferation observed in the periphery of the 
ChxlO'A retina may not occur as a result of ChxlO directing some aspect of the cell 
cycle, but of a possible misspecification of the peripheral retina.
The neural retina and the RPE are adjacent tissues and are both patterned from the 
optic vesicle. However, total cell number of the neural retina is much larger than that 
of the RPE, due primarily to differential regulation of proliferation, which first 
occurs during optic vesicle morphogenesis to form the optic cup (Green et al., 2003). 
It is possible that a lack of ChxlO causes the border between RPE and neural retina, 
at the periphery of the retina, to become less accurately specified. A proportion of the 
RPCs at the periphery of the retina may in this way acquire some RPE-like 
characteristics, such as expression of RPE- markers and a decrease in proliferation 
compared to the rest of the retina. This would explain why this area of the retina 
seems to be most severely affected by a lack of proliferation.
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Interestingly, the few apoptotic cells observed in the ChxlO_/' retina early on in 
development are located in the periphery of the retina, in contrast to the wild type, in 
which a few apoptotic cells are located in the central retina, but most are located 
around the optic fissure. Although rare, and unlikely to be playing a direct role in the 
apparent decrease in cell number compared to the wild type, this cell death in the 
periphery of the ChxlO‘A may reflect a certain level of disorganisation, where the 
border between RPE and neural retina is ‘blurred’.
5.3.2 H3 labelled cells and orientation of cell division offer clues to how ChxlO/' 
RPCs proliferate
In addition to a decrease in the proliferation of RPCs in the periphery of the ChxlO'1' 
retina, RPCs are not cycling in a manner similar to that of the wild type throughout 
the entire retina. In the wild type retina, cells undergo a highly proliferative phase 
between E9.5 and E l0.5, resulting in a thickened presumptive neural retina and a 
thinner presumptive RPE. By El 1.5, a small proportion of cells start to differentiate 
whilst other cells continue to cycle. If cell orientation during division is a reflection 
of the proportion of cell undergoing symmetric and asymmetric divisions (Chenn and 
McConnell, (Cayouette and Raff, 2003b), our data suggest that about 50% of 
divisions are symmetric (horizontal divisions), resulting in two daughter cells that 
will divide again. About 50% of divisions are asymmetric (vertical divisions), 
resulting in one daughter cell that will exit the cell cycle and differentiate, and one 
daughter cell that will go on to divide again.
In this model, as development continues, the proportion of dividing cells that divide 
asymmetrically will increase, whilst symmetric divisions resulting in two 
proliferative daughter cells will decrease. Instead, more symmetric divisions will 
result in two post-mitotic cells, which will go on to differentiate. This shift from 
symmetrical divisions resulting in two further dividing daughter cells to 
asymmetrical divisions or symmetrical divisions resulting in two post-mitotic cells 
would result in the proportion of H3-labelled cells in the wild type retina decreasing 
throughout development, even as total cell number increases.
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However, this pattern of proliferation is not observed in the ChxlOv" retina. The H3 
study revealed that following an early decrease in proliferation in the mutant 
compared with the wild type retina, between El 1.5 and E l3.5, later, a small 
population of RPCs continues to proliferate steadily in the mutant. The H3 study 
suggests that rather than a steady decrease in the proportion of mitotic cells during 
development, as one might expect if cells are not proliferating normally, a small 
population of progenitors seem to cycle continually, maintaining a stable mitotic 
labelling index that does not decrease with development as observed in the wild type 
retina. These cycling cells, however, do not expand the RPC population in a 
significant manner.
In addition, at El 1.5 a larger proportion of cells are undergoing horizontal divisions 
than in the wild type, which may suggest that a larger proportion of divisions are 
symmetrical. This seems counter-intuitive, as a larger proportion of symmetrical 
divisions, over time, should result in larger numbers of cells. Thus, the data do not fit 
a model in which symmetric divisions are important for expansion of the RPC 
population in the early optic cup. At present, there is some controversy over whether 
this model represents the events occurring in the early retina. Studies by Cayouette 
and Raff suggesting the orientation of division reflects the types of divisions cells 
undergo in the developing retina (Cayouette and Raff, 2003b) have been questioned 
by other groups, who have found no evidence for a relationship between spindle 
orientation and type of cell division (Silva et al., 2002; Tibber et al., 2004).
It is possible that the increased horizontal divisions suggest that a proportion of cells 
are dividing symmetrically to become post-mitotic and subsequently differentiate. 
This would explain why there is no apparent expansion in the RPC population from 
early on in development, but might be expected to involve early onset of expression 
markers of cell differentiation. However, this explanation is not supported by 
labelling with the marker P3-tubulin for differentiated neurons, which suggested that 
differentiation is delayed, not advanced, in the ChxlO'1' retina, and this was 
confirmed with the use of retinal specific markers, which indicated that the 
differentiation of most, if not all, retinal cell types is delayed. Thus, it is unlikely that 
at this early point in development, these increased putative symmetrical divisions 
result in two post-mitotic cells which differentiate.
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A relative increase in the proportion of cells dividing symmetrically in the ChxlO'A 
retina at El 1.5 may mean that cells that should be dividing asymmetrically and 
producing daughter cells that will go on to differentiate are actually dividing 
symmetrically and thus a delay in cell differentiation would be observed. This is 
supported by a relative lack of p3-tubulin expression at this time point in the ChxlO'A 
retina compared to the wild type. A subsequent delay in expression of other retinal 
cell type markers was similarly observed. Such a delay in differentiation of various 
cell types has also been observed in various other studies (Bone-Larson et al., 2000; 
Burmeister et al., 1996). It is possible that these symmetrically dividing cells produce 
daughter cells that arrest in G1/G0, and therefore do not go on to either further 
proliferate or differentiate. This would explain why there is no apparent expansion of 
the RPC population whilst a small proportion of cells appears to be proliferating 
throughout development, and in addition, why there is an apparent delay in retinal 
cell differentiation in the ChxlO'1' retina. In order to draw firmer conclusions, it will 
be necessary in future work to identify the fate of cells resulting from the different 
types of division, for example through the use of time lapse microscopy.
The presence of continually dividing cells throughout development raises the 
question as to what becomes of these proliferating cells. Do they continue 
proliferating after development, in similar proportions? This question forms the basis 
of the following chapter.
5.3.3 The cell cycle of the Chxl(TA RPCs is likely to be increased in length
If cells are proliferating constantly, RPC number should, as a consequence be 
growing steadily as well. However, there is some evidence that in addition to a 
change in the pattern of cycling, there is also an increase in the length of the cell 
cycle, such that the number of cycles over time is decreased in the ChxlO‘A retina. 
Studies using 3H thymidine have indicated that the length of G1 may be increased in 
the ChxlO'■' RPCs (Konyukhov and Sazhina, 1971). In addition, a recent study 
suggests that cyclin Dl, a G1 regulator, is decreased in the ChxlO'A retina (Green et 
al., 2003). It was suggested that this decrease in cyclin Dl allows p27Kipl to be
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ectopically localised in retinal progenitor cells, and that p27Kipl lengthens the cell 
cycle by causing an extension of the G1 phase (Green et al., 2003).
The flow cytometry data obtained in this study indicate that a larger proportion of 
RPCs are in the G1/G0 phase of the cell cycle in the ChxlO"A retina than in the wild 
type retina. One interpretation of this is that in the ChxlO‘A RPCs, the length of G1 is 
increased as suggested by Konyukhov (Konyukhov and Sazhina, 1971). However, an 
increase in the length of the cell cycle alone would be insufficient to explain the 
small size of the ChxlO'A retina. If proliferation is merely decreased, a full 
complement of cells ought to be produced, only over a longer period of time. 
However, if cells arrest in the G1 phase of the cell cycle, and neither proliferate or 
differentiate, as suggested above, this may result in an abnormally small retina.
Cell death certainly does not seem to contribute to the decreased retinal size of the 
ChxlO"A eye. In accordance with various earlier studies, cell death does not seem to 
be increased in the developing ChxlOA retina (Burmeister et al., 1996; Robb et al., 
1978; Theiler et al., 1976). In fact, as noted in these earlier studies, apoptotic cell 
death seems to be decreased in the ChxlO_/' retina. This seems to be particularly true 
around the optic fissure area, and may relate to the abnormal development of the 
optic nerve, another feature of the ChxlOA eye (Burmeister et al., 1996).
5.3.4 Conclusions
In summary, the results obtained in this study suggest that ChxlO'A retinal cells do 
indeed exhibit an abnormal pattern of proliferation. Not only does this study to some 
extent support an increase in the length of Gl, through flow cytometry analysis, but 
an abnormal pattern of proliferation was observed throughout development. A 
difference in the orientation in cell divisions observed at El 1.5 between the wild type 
and ChxlO'A retina could suggest that this abnormal pattern of proliferation is a result 
of a change in the proportion of symmetrical and asymmetrical divisions occurring 
throughout development.
251
CHAPTER 6
Absence of ChxlO causes embryonic neural 
progenitor-like cells to persist in the adult retina
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6.1. Introduction
The data from the studies described thus far indicate that retinal progenitor cell 
proliferation is severely disrupted in the ChxlO'A retina (Chapter 5), and that this 
disruption is in part caused by misregulation of transcription factors necessary for 
retinal cell fate determination and/or differentiation (Chapters 3 and 4). The 
abnormalities in RPC behaviour are associated with a severe decrease in retinal cell 
number, as well as improper differentiation and structure of various retinal cell types, 
such as bipolar cells and rod photoreceptors, by the time the C h x lO mouse reaches 
adulthood. As the normal pattern of histogenesis is disrupted in the ChxlO'1' retina, 
are there any compensatory mechanisms to correct for it? This question was of 
particular interest in view of the small population of dividing cells observed to be 
cycling throughout development (Chapter 5). The mitotic cells present in the slow 
growing ChxlO''' retina during embryonic development could be primitive 
neuroepithelium cells, perhaps self-renewing stem or precursor cells, which require 
ChxlO for expansion and/or transition to a pool of RPCs that undergo a finite number 
of divisions before differentiating. If this model is correct, one might expect that the 
cells cycling consistently throughout embryogenesis persist into adulthood in the 
ChxlO''’ retina.
Of further interest is that the ciliary epithelium (CE) at the periphery of the adult 
retina has recently been shown to harbour cells which when isolated and cultured in 
vitro exhibit stem cell properties of multi-potentiality and self-renewal (Ahmad et al., 
1999; Tropepe et al., 2000). The CE, which forms part of the ciliary body and 
consists of both pigmented and non-pigmented layers, is derived during development 
from the neuroepithelium at the periphery of the optic cup. Adult CE cells cultured in 
conditions that promote stem cell propagation (neurosphere cultures) express ChxlO 
and the neural progenitor marker nestin and can be differentiated to express retinal 
neuron specific markers (Ahmad et al., 1999). Notably, more neurospheres arose 
from the CE of the ChxlO''' mouse compared to wild type cultures (Tropepe et al., 
2000). The question arises as to why more of such presumptive stem cells would 
reside in the CE of the ChxlO''' mouse than in the wild type. Does reduced 
proliferation of RPCs, caused by the absence of ChxlO in the microphthalmic 
embryonic retina, lead to increased number of ‘stem cells’ in the adult?
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As discussed in Chapter 1, it has long been known that most of the retina in fish and 
amphibians is formed by the addition of new retinal neurons from a growth zone at 
the retinal margin, the ciliary marginal zone (CMZ), rather than during 
embryogenesis (Figure 6.1)(Moshiri et al., 2004). The CMZ of teleost fish and frogs 
continue to generate new retinal neurons throughout life (Johns, 1977; Johns and 
Easter, Jr., 1977; Wetts et al., 1989), and accordingly, this region of stem cells 
persists. Recently it has been shown that the post-hatch chicken retina has ongoing 
neurogenesis at the retinal margin, similar to that in lower vertebrates. Although 
most of the chick retina is derived from embryonic RPCs (Figure 6.1), the CMZ cells 
of the chicken are capable of generating new retinal neurons that are incorporated 
into the retina (Fischer and Reh, 2000). In all these species, cells in the CMZ 
expressed retinal progenitor cell markers such as nestin and Pax6, suggesting they 
formed a colony of self-renewing progenitor cells derived from the embryonic neural 
cells. They were also able to generate neurons, and thus they satisfy the criteria for 
neural retinal stem cells set out in Chapter 1. No such stem cell-like cells are thought 
to exist in the mammalian ciliary margin, and it has been suggested that the CMZ has 
decreased over the course of evolution with lower vertebrates possessing a large 
CMZ, capable of renewing retinal cells throughout life, and mammals lacking a 
CMZ altogether (Figure 6.1) (Perron and Harris, 2000b). Yet the possibility that the 
CE may harbour such cells is intriguing, especially if this population of putative stem 
cells is expanded in the ChxlO'1' retina. They may offer some hope to an otherwise 
bleak prospect for replacing damaged retinal neurons in adult mammals.
In this chapter, a series of experiments were designed to explore whether reduced 
proliferation of RPCs, caused by the absence of ChxlO in the microphthalmic 
embryonic retina was associated with an increased number of ‘stem cells’ in the 
adult. A BrdU study was performed to identify any cycling cells in the adult wild 
type and Chxl0'/m retina in vivo. In addition, retinal cultures were set up to examine 
whether cells from the adult wild type and ChxlO'A neural retina, ciliary epithelium, 
or RPE were able to proliferate and form neurospheres in vitro.
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Figure 6.1: The relative contribution of the CMZ to retinal growth has 
been progressively reduced in homeothermic vertebrates and is shown in 
drawings of the adult eyes. The region of retina generated in the 
embryonic/neonatal period is shown in blue, while that generated by the 
CMZ is shown in yellow for various vertebrate classes. The CMZ itself is 
indicated in red the show the relationship to the ciliary body, coloured 
green. Figure adapted from Moshiri et al., 2004.
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6.2. Results
6.2.1. Proliferation of cells in the Chxlff^' central retina persists into adulthood
To examine whether any dividing cells were present in the adult retina, and to test 
the hypothesis that persisting embryonic RPC-like cells/stem cells continue cycling 
in the adult ChxlO"A retina, I used a schedule of repeated BrdU injections that 
allowed me to observe both slowly dividing cells and/or cells that divide infrequently 
in the postnatal and adult retina. Wild type and ChxlO'1' mice were given 
intraperitoneal injections every other day from P15-P29 and culled at P30. Previous 
birthdating studies have indicated that retinal histogenesis is normally completed by 
the end of the second postnatal week (around PI 1) (Young, 1985a; Young, 1985b), 
and thus, in the wild type retina, all cells should have exited the cell cycle by the time 
the first BrdU injection was administered.
As expected, little or no BrdU staining was observed in the central or peripheral wild 
type retina (Figures 6.2 and 6.5A-C). Two examples of sections from Brdu-treated, 
wild type retinae are shown in Figure 6.2. No BrdU labelled cells are observed in the 
central retina (6.2B and F), and only a few BrdU labelled cells are observed in the 
ciliary body, specifically in the non-pigmented ciliary epithelium (Figure 6.2G and 
H, arrows). Of the 28 sections analysed (7 eyes, 4 sections each), an average of 0-2 
labelled cells were found per retinal section. The site of such rare, labelled cells was 
often within the inner layers of the retina (an example of this is shown in Figure 
6.5B).
The ChxlO'1' retina showed a remarkable contrast. A relatively large number of cells 
were labelled throughout the central retina (Figures 6.3, 6.4 and 6.5D and E). Three 
ChxlO'A sections are shown in Figures 6.3 and 6.4. The arrows in Figure 6.3 indicate 
the BrdU labelled cells present throughout the central retina as well as in the ciliary 
body. These sections also show that the ciliary body (CB) is considerably enlarged in 
the ChxlO’/' eye compared to the wild type. More BrdU labelled cells are highlighted 
in the retinae of the sections in Figure 6.4C and E by arrows, whilst BrdU labelled 
cells in the ciliary bodies are highlighted with arrowheads in Figure 6.4B and E. It is
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Figure 6.2: Two sections of wild type retina taken from mice injected with 
BrdU between P I5 and P29. Plates A and E show phase views of the whole 
retinal sections. These were labelled with anti-BrdU antibody (green) and 
counterstained with Hoechst nuclear dye (blue). B-D are higher magnification 
views of the central (B) and peripheral (C,D) areas of the section shown in A. 
No cells were labelled with BrdU antibody in this section. F-H are high 
magnification views of the central (F) and peripheral (G,H) areas of the section 
shown in E. No cells were labelled for BrdU in the central retina, and only 1-2 
BrdU-labelled cells were observed in the non-pigmented ciliary epithelium of 
the ciliary body at the periphery of the retina (arrows). Scale bar = 400 pm for A 
and E, 100 pm for B-D and E-G, 50 pm in H, L = lens.
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Figure 6.3: Section of CbxlOr/_ retina taken from mouse injected with BrdU 
between P I5 and P29. A is a phase view of the whole retinal section. The 
pigmented ciliary epithelium of the ciliary body is greatly expanded in the 
ChxlQr1' retina, and there is very little vitreous space between the lens and the 
retina. The section was labelled with anti-BrdU antibody (green) and 
counterstained with Hoechst nuclear dye (blue), shown in B. A large number of 
BrdU labelled cells could be observed along the length of the retina (arrows), as 
well as in the ciliary body, although it is difficult to discern whether labelled 
cells are in the pigmented or non-pigmented epithelium. Scale bars = 500 pm in 
A , 100 [Am in B, L = lens, CB = ciliary body.
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Figure 6.4: Two sections of ChxlOr/' retina taken from mice injected with BrdU 
between P I5 and P29. Plates A and D show whole retinal midline sections, B 
and C are high magnification views of green and purple boxed areas in A 
respectively, E is a high magnification view of boxed area in D. A number of 
BrdU labelled cells can be observed in both the ChxlO'/' retina (C and E, arrows) 
and in the ciliary body (B and E, arrowheads). Scale bar in A — 500 pm in A and 
Z), in B = 100 pm in others, L = lens.
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Figure 6.5: Sections of wild type (A, B, C) and ChxlOr^ (D, E) retina, taken 
from mice injected with BrdU between PI5 and P29, were labelled with anti- 
BrdU antibody (green) and counterstained with Hoechst nuclear dye (blue). 
Very few cells were labelled in the wild type retina (A \ and any labelled cells 
tended to be located in the inner nuclear (B) or ganglion cell layer. A small 
number of cells were labelled in the ciliary body, in most cases in the non- 
pigmented ciliary epithelium (C, arrowheads). In the Chxlfr/m retina, many cells 
were labelled throughout (Z)), indicating that proliferation is occurring between 
PI5 and P29. The expanded pigmented epithelium of the mutant ciliary body 
(with its vitreous edge marked by dashed line, E) contains a small number of 
labelled cells as well. (ONL - outer nuclear layer, INL - inner nuclear layer, gcl - 
ganglion cell layer, scale bars = 1 0 0 pm)
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difficult to ascertain whether labelled cells in the ciliary bodies of ChxlO'1' eyes are 
located in the pigmented or non-pigmented epithelia. Figure 6.5 is a comparison of 
BrdU treatment of wild type eyes and ChxlO'A eyes. A dramatic difference is 
observed between the wild type (A, B) and ChxlO/' (D) central retinae, in which a 
substantial number of cells are labelled with BrdU. BrdU labelling can be observed 
in the ciliary bodies of both the wild type (C) and ChxlO'A (E) eyes, but those in the 
wild type are clearly residing in the non-pigmented ciliary epithelium, whilst it is 
difficult to discern whether this is also the case in the ChxlO'A ciliary body.
To quantify the number of BrdU-labelled cells observed in ChxlO'1' and wild type 
retinae, four to six midline sections were examined from three to seven eyes of each 
genotype and the average number of BrdU-labelled cells per section were compared 
using student’s t-tests. The number of BrdU-labelled cells counted in the ChxlO‘/' 
retinae was substantially higher (p = 1.75 x 10'5) than the occasional labelled cell 
observed in the wild type retina (Figure 6.6A, 4 weeks), but the variation in the 
number of labelled cells per section was highly variable in the ChxlO'*' retina, as can 
be seen in a graph of the raw cell counts (Figure 6.6C). In addition to an increase in 
BrdU-labelled cells in the central retina of the ChxlO'f~ eye compared to the wild 
type, a significantly larger number of cells were BrdU-labelled in the ChxlO'1' ciliary 
body as well (Figure 6.6B; p = 0.01).
In order to examine whether proliferation in the ChxlO1’ retina continues further into 
adulthood, a follow-up set of injections was performed between 3 to 5 weeks and 6 
to 8 weeks after birth. In the wild type retina, few or no dividing cells were detected 
at either additional time point (Figure 6.6A, C). In the ChxlO'1' retina, a significantly 
larger number of cells (p = 0.02) divide during both two-week periods compared to 
the wild type retina (Figure 6.6A, C). A similar range of BrdU labelled cell numbers 
was observed in the ChxlO_/‘ retina at three to five weeks of age as at two to four 
weeks. However, fewer cells were labelled at six to eight weeks than at two to four 
weeks of age. Examples of ChxlO'1' retinal sections at each time point are shown in 
Figure 6.7. BrdU labelled cells are still present throughout the central retina, from the 
periphery to the centre (arrows). These data indicate that a population of cells in the 
retina continues to proliferate well into adulthood.
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Figure 6.6: Mice were injected with BrdU for two weeks before culling at 4, 5 
or 8 weeks, and labelled cells were counted in midline retinal sections and 
compared. Labelled cells in the ChxlO'/' and wild type retina were counted. 
Quantitative results were obtained in the central retina at 4 and 8 weeks (A), and 
in the ciliary epithelium at 4 weeks (B). At 4 weeks, less than five cells per 
section were labelled in the wild type retina, whereas more than 20 cells per 
section were labelled in the C hxltf' retina on average - a highly significant 
difference. By 8 weeks, very few BrdU labelled cells were observed in the wild 
type retina, whilst a significantly higher average of 12 labelled cells per section 
was observed in the ChxlO‘/  retina (A). A small but significant difference 
between the number of labelled cells in the ciliary epithelia of the wild type and 
mutant retinae was observed in sections from 4 week old mice (B). Columns 
indicate means and error bars = sd. Numbers in brackets denote number of 
sections examined. At four weeks, sections were taken from 7 wild type and 6 
mutant mouse eyes, at 8 weeks, sections were taken from 3 wild type and 7 
mutant mouse eyes.(C) Raw data of cell counts of BrdU-labelled cells in the 
central retina at 4, 5 and 8 weeks. Each point indicates a cell count in a single 
section.
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Figure 6.7: Sections of Chxl0"A retina taken from mice injected with BrdU 
every other day for two weeks, from three to five weeks of age (A) and from six 
to eight weeks of age (5). In both sections BrdU-labelled cells can be observed 
throughout the central retina (arrows). It is difficult to discern any BrdU labelled 
cells in the ciliary bodies of the retinae. Scale bar =100 |im, L = lens, CB = 
ciliary body.
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In order to verify that cells continued to cycle in the adult ChxlO'1' retina, H3 
immunostaining was also carried out on a series of postnatal retinal sections. 
Whereas H3-positive mitotic cells were not detected at P20 in the wild type retina, in 
the ChxlO'A eye occasional H3-positive cells were seen at the ventricular surface in 
the central retina (Figure 6.8), confirming that cell cycling is taking place in the 
ChxlO'1' well after histogenesis is complete in the wild type retina. This study 
identified a unique feature of the pattern of proliferation in the Chxl 0'f' retina that is 
very different to that of the wild type retina.
6.2.2. Pattern of proliferation after birth
In addition to the injection schedule described above, 2 other types of injection 
schedules were followed, and these are listed in Table 6.1. These schedules were 
designed to examine the pattern of proliferation that occurs at the end of wild type 
retinal cell histogenesis and how this compares to the pattern of proliferation 
occurring in the ChxlO'A retina.
Schedule Age at first injection Injected Culled
1 P15, P21, or P42 Every other day for two 
weeks
Culled on day after last 
injection
2 P7, P10, P13 or P15 Once CulledP8, Pll, P14, or 
P16
3 P10, PI5, P20, or P25 Injected every other day 
for five days (3 times)
Culled on day after last 
injection (PI 5, P20, P25 
or P30)
Table 6.1: BrdU injection schedules employed to examine cell proliferation in the postnatal 
wild type and ChxlO'1' retina
Schedule 2 was designed to examine how proliferation changed from day to day in 
the last few days of normal retinal histogenesis (completed at P ll). It is clear from 
raw data of BrdU labelled cell counts in Figure 6.9A  that in the wild type retina, the 
number of cells synthesizing DNA decreases fairly drastically from P7 to PI 5. At P7 
and P10, many cells are still cycling in the periphery of the retina, the last part of the 
retina to mature, and a few BrdU-labelled cells can also be observed in the central 
retina (Figure 6.10A, C, F). By P I5, histogenesis is complete, and only a few cells 
can be observed in the wild type retina (Figure 6.9A, 6.10, H). In the ChxlO'A retina, 
fewer cells have incorporated BrdU at P7 than in the wild type, and the pattern of
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Figure 6.8: H3 labelling in the wild type (A) and ChxlO'/_ (B) retina at postnatal 
day 20. N o H3 labelling can be observed in the wild type retina, only some auto­
fluorescence caused by the outer segments o f  the photoreceptor cell layer. In the 
ChxlOr/' retina, an occasional H3 labelled cell can be observed near the 
ventricular edge o f  the retina (B, arrow). Scale bar = 100 pm in A, 200 pm in B.
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Figure 6.9: BrdU labelled cell counts o f  midline retinal sections from m ice 
injected overnight and culled the following day (A) or injected every other 
day for five days and culled on the day after last injection (B). Each data 
point represents a count o f  one section. Age corresponds to day o f  culling.
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Figure 6.10: BrdU labelled cells in retinae of mice injected once and culled the following day. 
A and B : BrdU labelled cells in section of wild type (A) and ChxlCt/' (B) retinae injected at P7. 
In the wild type retina, BrdU labelled cells tend to be located at the periphery of the retina, the 
last area of the retina to fully mature, whilst BrdU labelled cells are observed throughout the 
retina in the Chxl0'/~ eye. C-H: BrdU labelled cells in wild type retinae injected at P10 (C, F), 
P I3 (D,G) and P I5 (E, H). BrdU labelled cells slowly diminish in number in the periphery of 
the retina with increasing age (C-E). In the central retina (F-H), a decrease of BrdU labelled 
cells with age is also readily apparent. Few BrdU labelled cells remain in the retina at P10 (F), 
only one can be observed at P I3 (G, arrow), and no BrdU labelled cells can be observed at P I5 
(H) in the central retina. BrdU labelled cells are green and the sections are counterstained with 
Hoechst nuclear dye (blue). Scale bar in A = 500 pm, in B = 100 pm, and in C = 100 pm for C- 
H.
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BrdU labelling is different: BrdU-labelled cells are present throughout the retina, not 
restricted to the periphery (Figure 6.1 OB). By PI 0, a similar amount of BrdU labelled 
cells were observed in the ChxlO''A retina as in the wild type (Figure 6.9A), after 
which the number of BrdU labelled cells is higher in the ChxlO'A retina than in the 
wild type, a pattern that subsequently seems to carry on into adulthood, as the 
number of BrdU-labelled cells are similar to those observed after 2-4 weeks of BrdU 
injections, described above.
Mice were also injected every other day for five days. The purpose of this was to 
examine whether any relatively short burst of proliferation was taking place in a 
specific window of development that could account for the large numbers of BrdU 
labelled cells observed in the ChxlO'A retina during the two-week injection periods. It 
is possible, for instance that a large burst of proliferation takes place between PI5 
and P21, and that cell cycling diminishes after this point. This is illustrated to some 
extent in the wild type retina. Between P10 and PI 5, a large number of cells seem to 
be cycling and are therefore labelled with BrdU. Most of the labelled cells will have 
divided at P10, at the periphery of the retina, where the last retinal progenitor cells 
divide and mature. This can be seen from the overnight injection and culling 
treatments described above, and after P10, cell cycling diminished substantially 
(Figure 6.9B, Figure 6.11 A). At all later time points, BrdU labelling is rarely 
observed (Figure 6.9B, 6.1 IB), consistent with the observation that retinal 
histogenesis is complete by PI 1.
In the ChxlO'A retina, large numbers of BrdU labelled cells are observed at every 
time point (Figure 6.9B), both in the first five days of the two-week period and in the 
last five days. Only between P20 and P25 can a decrease in cycling cells be 
observed. BrdU-labelled cells are spread throughout the retina, as originally observed 
after two weeks of BrdU injections (Figure 6.11C). This suggests that, in contrast to 
the pattern of proliferation observed in the wild type retina, the BrdU labelling 
observed in the ChxlO'A retina is a result of regularly cycling cells. As fewer BrdU 
labelled cells are observed later in adulthood, even after two weeks of BrdU 
injections, this could indicate cell cycling decreases slowly through adulthood, with 
large numbers of cells cycling between P10 and P20 and fewer cells cycling six to 
eight weeks after birth. Cycling cells also do not seem to become restricted to the
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Figure 6.11: BrdU labelled cells in retinae of mice injected every other day for 
five days before culling. A: wild type retina injected from P15-P20. A few BrdU 
labelled cells can be observed towards the periphery of the retina (arrows), the 
last area of the retina to fully mature. B and C: Retinae of wild type (B) and 
ChxlO'1' (C) mice injected from P25-P30. No BrdU labelled cells can be observed 
in either the periphery or the central area of the retina of the, by now, adult wild 
type eye. By contrast, BrdU labelled cells are observed throughout the ChxlO'/' 
retina at the same time point (C, arrows). BrdU labelled cells are green and the 
sections are counterstained with Hoechst nuclear dye (blue). Scale bar in A = 100 
pm in A , 200 pm in B, scale bar in C = 100 pm.
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periphery of the retina in the same way that the final cycling cells observed during 
wild type retinal histogenesis are.
Statistical significance was not tested for data obtained from schedules 2 and 3, as 
sections were only counted from 1-2 eyes. The data described in section 6.2.1, 
however, show that the number of BrdU labelled cells in ChxlO_/* retinal sections is 
highly variable (see raw cell count numbers, Figures 6.6C and 6.9), and even 
between sections of the same eye, and that variability is higher between sections of 
the ChxlO'A eye than the wild type eye.
6.2.3. Some BrdU labelled cells differentiate and form new neurons in the adult 
C hxltf' retina
The presence of cycling cells in the ChxlO'/' retina is interesting and raises the 
question of what type of cells they are. Are they retinal progenitor cells? Retinal stem 
cells? Can they differentiate to become retinal neurons? In order to examine the 
phenotype of the dividing BrdU labelled cells I examined whether the BrdU labelled 
cell would co-label with a variety of RPC and retinal cell markers (Table 6.1).
Nestin is a marker for neural progenitor/stem cells (Ahmad et al., 1999; Ahmad et 
al., 2000; Messam et al., 2000). Nestin-labelled retinal progenitor cells can be 
detected in the early postnatal wild type retina. Typically nestin-labelled progenitors 
project radially across the retinal laminar axis (Insua et al., 2003). Figure 6.12A-C 
shows BrdU labelled cells in wild type P8 mice (BrdU injected at P7 and mice culled 
at P8). Co-labelling of BrdU with nestin was observed in the periphery of the retina, 
the last area of the retina to mature and cease proliferation, where nestin staining can 
be observed to project across the whole of the retina (Figure 6.12A and B), but no 
double labelling was detected in the central retina which is largely post-mitotic 
(Figure 6.12C) and where nestin-labelled cells are restricted to the ganglion cell layer 
and inner plexiform layer. BrdU labelled cells are observed in the neuroblastic layer, 
where retinal progenitor cells reside before they become post-mitotic. By four weeks 
of age in the wild type, no nestin labelling of RPCs was observed (Figure 6.12D), 
and BrdU labelled cells were rarely detected, as described above. By contrast, nestin 
labelling was widespread in the ChxlO'A retina at four weeks of age. Nestin-labelled
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Figure 6.12: Sections from wild type and ChxlO- * eyes double labelled for BrdU (green) and 
nestin (red). A-C: At postnatal day 8  (P8 ), after a single BrdU injection on P7, BrdU labelling 
is observed primarily in the periphery of the retina (A,B), and decreases towards the central 
retina (C). Nestin labelling is observed radially across the retina at the periphery, where it 
double labels with a few BrdU labelled cells (box in A magnified in B, arrows), but in the 
central retina is restricted primarily to the ganglion cell layer and the inner plexiform layer, 
and is rarely observed to double label with cycling BrdU labelled cells (C). D: By four weeks 
of age, after two weeks of BrdU injections, BrdU labelled cells are rarely observed in the 
wild type retina, and nestin labelling is no longer apparent (bright red areas caused by auto­
fluorescence of outer segments and vasculature). In contrast, nestin labelling is observed in 
cells projecting radially across the retina in 4 week old ChxlO-  retinae (E, F, G), and 
occasionally double labels with BrdU labelled cells (F and G, arrows, box in G magnified in 
H), more abundant in the ChxlO" retina than in the wild type. (OPL - outer plexiform layer, 
IPL - inner plexiform layer, GCL/NFL - ganglion cell layer/nerve fibre layer, all scale bars = 
50 pm, apart from scale bar in G which = 100 pm in G, 15 pm in H).
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cells were observed projecting radially across the retina (Figure 6.12E-H) in a similar 
manner to nestin-labelled cells of the early wild type retina. Co-localisation of BrdU 
and nestin was detected in a small number of cells (Figure 6.12F, G, H), although the 
majority of BrdU labelled cells did not co-label with nestin.
To further examine whether the cycling cells observed in the ChxlO'f' adult retina are 
retinal progenitor-like cells another marker for RPCs was employed. CRALBP is 
often used as a Muller cell and RPE marker in adult retinae (Bunt-Milam and Saari, 
1983), but is also known to be a retinal progenitor cell marker (Walcott and Provis, 
2003). Co-labelling of BrdU-labelled cells with CRALBP, in conjunction with the 
co-labelling observed with nestin, would suggest that the BrdU labelled cells 
observed in adult ChxlO'1' have RPC-like properties. It is important to keep in mind, 
however, that co-labelling with CRALBP could equally suggest that the cycling cells 
observed are Muller or RPE cells. In addition, the marker would also allow 
investigation of the expanded ciliary epithelium, which can be observed in the adult 
retinal sections.
CRALBP staining is observed in the Muller cells and RPE of the wild type adult 
retina (Figure 6.13 A, B). Bright labelling is observed in the inner nuclear layer of the 
retina, where Muller cell bodies reside. The end-feet of the Muller cells are brightly 
labelled at the vitreal edge of the ganglion cell layer/inner limiting membrane, and 
processes running from the Muller cell bodies to the inner segments of the 
photoreceptors can be observed throughout the outer plexiform layer, outer nuclear 
layer and in the inner segments. Labelling can also be seen in the RPE, but is less 
bright. Muller cell and RPE labelling is seen throughout the wild type retina, but 
ends abruptly at the periphery of the retina, and no CRALBP labelling can be 
observed in either the pigmented or non-pigmented epithelium of the ciliary body 
(Figure 6.13B). In the C hxltf' retina, CRALBP labelling is abundant, disorganised 
and difficult to examine. However, a small number of double labelled cells were 
observed (Figure 6.13E, F, and box in F magnified in G). F and G are confocal 
images depicting a BrdU labelled cell with CRALBP-labelled processes.
Were the co-labelled BrdU/CRALBP cells retinal progenitor cells or cycling Muller 
glial cells? To examine this further, another glial marker, GFAP, was used. GFAP
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Figure 6.13: Sections from wild type (A an d  B) and ChxlO' eyes (C-G) labelled for 
CRALBP (red) and BrdU (E-G, green) at four weeks of age. CRALBP staining in the wild 
type central retina (A) is observed in the Muller cells of the inner nuclear layer, their 
processes extending toward the ventricular edge of the retina, their endfeet at the vitreal 
edge of the retina, and in the RPE. No CRALBP staining is observed in either the 
pigmented or non-pigmented ciliary epithelium of the wild type retina (B). In the ChxlO' 
retina, CRALBP staining can be observed in the central retina of the ChxlO' retina and 
the RPE, which extends beyond the expanded ciliary epithelium of the ChxlO' retina (C, 
arrow). In a phase photograph of CRALBP staining of the ChxlO' retina (D), it is clear no 
CRALBP staining is observed in the ciliary epithelium of the ChxlO' retina. The retinae 
have been injected every other day with BrdU for two weeks, and some BrdU labelled 
cells in the ChxlO' retina are co-labelled with CRALBP (E, arrow, F, box in F magnified 
in G). Scale bar in B = 50 pm in A and B, scale bar in C = 200 pm for C and 50 pm for D 
and E, scale bar in F = 100 pm, in G = 25 pm.
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labelling can normally be observed in the outer plexiform layer and, to some extent, 
the ganglion cell layer of the wild type retina (Figure 6.14A, B). Some staining in the 
inner nuclear layer can be seen in the very periphery of the retina (Figure 6.14A). 
GFAP labelling in the ChxlO'f' retina is far less organised, less discretely localised, 
and seems more widespread (Figure 6.14C, D). However, no double labelling of 
BrdU and GFAP was observed, suggesting the BrdU/CRALBP double-labelled cells 
described above are more likely to be retinal progenitor cells than Muller glial cells.
Interestingly, CRALBP staining was not observed in the majority of the ChxlO~f~ 
ciliary epithelium. As can be observed in Figure 6.13C and D, CRALBP staining is 
localised to the RPE along the outer edge of the retina (arrow) and extends past the 
expanded ciliary epithelium at the peripheral edge of the ciliary body. However, 
CRALBP labelling does not extend into the ciliary body (Figure 6.13D), which 
suggests that the pigmented cells observed in the expanded CE of the ChxlO'1' retina 
do not express this particular RPE marker. Rowan et al recently proposed that the 
expanded ciliary body is a result of transdifferentiation of neural retina to RPE, 
associated with expansion of RPE gene expression (Rowan et al., 2004). However 
the CRALBP staining showed that at this point, these cells are not expressing the full 
complement of RPE markers.
To examine whether dividing cells differentiate and give rise to new neuronal cells in 
the adult retina, retinal sections from BrdU injected animals were double-labelled 
with the neuronal markers P 3-tubulin and NeuN, both markers of mature neuronal 
cells. At P8, a large proportion of cells in the wild type retina, specifically those in 
the ganglion cell layer and many in the inner nuclear layer, will have fully matured 
into retinal neurons. Accordingly, p3-tubulin is strongly localised in the ganglion 
cell/nerve fibre layer, the inner plexiform layer, and in a proportion of cells of the 
inner nuclear layer (Figure 6.15A-C) and weakly detected in the photoreceptor layer 
at this time point. Cycling cells are localised in the neuroblastic layer of the retina, 
toward the ventricular edge, and thus BrdU-labelled cells are localised in this area of 
the retina. A few BrdU-positive cells with p3-tubulin labelled processes are located 
toward the vitreal edge of the inner nuclear layer, especially in the periphery of the 
retina, where the last of cycling cells are differentiating (Figure 6.15 A, box in A
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Figure 6.14: Sections from wild type (A and B) and ChxlOh/' (C and D) eyes 
labelled for GFAP (red) and BrdU (green) at four weeks of age. GFAP staining in 
the wild type periphery (A) and central retina (B) is limited to astrocytic cells 
within the inner plexiform layer, and no double labelling with BrdU is observed. 
In the ChxlO'/' retina, GFAP staining is more extensive throughout, as is clear in 
both examples of central retinal sections depicted here (C, D) but as was the case 
for the wild type retina, no GFAP and BrdU double labelling was observed. L = 
lens, scale bar = 80 pm.
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Figure 6.15: Sections from wild type and ChxlO" eyes double labelled for BrdU (green) and (33 
tubulin (red). At P8 , after a single BrdU injection on P7, (33 tubulin is localised to the ganglion 
cell and the inner plexiform layers of the wild type retina, and to a proportion of cells in the inner 
nuclear layer (A-C). BrdU labelled cells that contribute to the inner nuclear layer are double 
labelled with (33 tubulin (box in A magnified and rotated in B and C, arrows). In the adult wild 
type retina, (33-tubulin labelling can be observed in all layers of the retina in an organised pattern 
(Z)). In the mutant retina, [33 tubulin labelled cells are observed at 4 (E-F), 5 (G-7), and 8  (J-L) 
weeks of age in an apparently disorganised pattern. After two weeks of BrdU injections 
administered every other day before culling, BrdU labelled cells are observed in the retina at all 
time points and some cells label for both (33 tubulin and BrdU at each time point (arrows in 
F.H.IKL). Scale bar = 50 pm in all but F,H, I K  L where it = 2 0  pm
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rotated and magnified in B and C). It is possible that these cells took up BrdU during 
their final cell cycle before becoming post-mitotic and differentiating into retinal 
neurons. p3 tubulin staining in the adult wild type retina is observed in every cell 
layer, with the strongest staining in the ganglion cell/nerve fibre layer (Figure 
6.15D). The cells expressing (33-tubulin in the adult ChxlO'A retina are disorganised 
compared to the highly organised pattern of p3-tubulin expression observed in the 
adult wild type retina. Using confocal microscopy I detected BrdU-positive cells in 
the adult ChxlO"A retina with p3-tubulin labelled processes, examples are shown at 
four (Figure 6.15 E-F), five (Figure 6.15G-I) and eight (Figure 6.15J-L) weeks of 
age. This suggests that some of the cycling cells observed in the adult ChxlO'A retina 
exit the cell cycle and differentiate to become neurons.
NeuN labelling was also used to examine mature neurons in the wild type and 
ChxlO'A retina, offering the advantage of labelling cell nuclei rather than the cell 
bodies and process labelled by p3-tubulin. In the adult wild type retina, NeuN is 
restricted to the ganglion cell and inner retinal cell layer, but photoreceptors are not 
labelled by NeuN (Figure 6.16A, B). In the ChxlO'A retina, NeuN labelling is not 
widespread, but a few NeuN labelled cells can be observed in various retinal sections 
(Figure 6.16C-E). BrdU and NeuN co-labelled cells were only observed in a few 
sections (Figure 6.16E, magnified in F, arrow), much less frequently than the p3- 
tubulin and BrdU co-labelled cells, which may reflect cell immaturity, as NeuN is a 
late neuronal marker, or the fact that a smaller proportion of cells are labelled with 
NeuN in the adult retina.
No nestin, CRALBP, GFAP, p3-tubulin, or NeuN localisation was observed within 
the ciliary body of either the ChxlO'A or the wild type eye.
6.2.4. New amacrine-like cells develop in the adult Chxl ^ ‘retina
To determine whether the neurons generated from RPCs in the adult ChxlO‘A retina, 
expressed markers characteristic of specific retinal neurons, immuno-labelling with a 
range of antibodies was carried out on BrdU injected mouse retinae. To extend the 
time for BrdU labelled cells to differentiate, a final BrdU injection schedule was
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Figure 6.16: Sections from wild type and ChxlO'/' eyes double labelled for BrdU 
(green) and NeuN (red). In the adult wild type eye (A,B), cells in the ganglion cell 
layer and towards the vitreal edge of the inner nuclear layer are most brightly 
stained for NeuN (A, B, arrows), whilst cells in the rest of the inner nuclear layer 
and the outer nuclear layer are less brightly labelled (B). C-E are examples of 
sections taken from ChxlOr'retinae at 4 weeks of age after two weeks of BrdU 
injections. NeuN labelling is disorganised and scattered in all three sections. Higher 
magnification views of the box in E , (F) show one BrdU labelled cell that does not 
co-label with NeuN (arrowhead) and one BrdU labelled cell that does co-label with 
BrdU (arrow). ONL = outer nuclear layer, INL = inner nuclear layer, GCL = 
ganglion cell layer, L = lens, scale bars = 50 pm.
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devised. Cells were injected every other day from P25 to P29 and then culled three 
weeks after the last injection. Sections were then examined for BrdU and cell marker 
co-labelling. Bm3b (Pou4f2) was used as a marker for ganglion cells, blue cone 
opsin for cones, rhodopsin for rods, recoverin for photoreceptors, protein kinase C 
(PKC) for bipolar cells, and syntaxin and the VC 1.1 epitope for amacrine and 
horizontal cells (Alexiades and Cepko, 1997; Rutherford et al., 2004; Xiang et al., 
1993). Calbindin was also used as a marker for horizontal cells (Chu et al., 1993).
As expected, whilst bipolar cells in the adult wild type retina stained brightly with 
PKC (Figure 6.17A), no PKC staining was observed in the Chxl0'f' retina, 
confirming that bipolar cells are not present in the Chxl0'f' retina (Figure 6.17D). 
Labelling with cone opsin and rhodopsin proved to be problematic. Both markers 
label the outer segments of the respective photoreceptors, whilst BrdU labels the 
nuclei of dividing cells. The adult ChxlO'^ retinal cell layers are relatively 
disorganised compared to the wild type retina, thus making it very difficult to match 
the nuclei of any photoreceptors to their respective outer segments, a task that is 
already difficult in the organised wild type retina. Thus, the photoreceptor marker 
recoverin was also employed. All cells in the outer nuclear layer, where the 
photoreceptors reside, are brightly labelled in the adult wild type retina (Figure 
6.17B). Recoverin also labelled cells towards the ventricular edge of the ChxlO'A 
retina, however, no double staining of BrdU and recoverin was observed (Figure 
6.17E). Bm3b labels ganglion cells (Figure 6.17C), but as was observed with 
recoverin labelling, no Bm3b/BrdU double labelling was observed in the adult 
ChxlO'1' retina. This suggests that the neurons observed to be double labelled with 
P3-tubulin and BrdU are unlikely to be ganglion cells or photoreceptors.
Whilst no BrdU-labelled cells co-labelled for ganglion cell layer or outer nuclear 
layer cell markers, some BrdU labelled cells in the adult ChxlO'1' retina, however, did 
express inner nuclear layer cell markers. Figure 6.17F shows a BrdU-labelled cell co­
labelled with calbindin; a cross section through a confocal image of a ChxlO'*' retinal 
section, taken at 0.2 pm increments. The green BrdU-labelled nucleus indicated by 
the arrows is surrounded by red calbindin staining, causing a yellow area where the 
two markers overlap. BrdU-labelled cells also co-labelled for both VC 1.1 (Figure 
6.18) and syntaxin (Figure 6.19). In the adult wild type retina, VC 1.1 is expressed in
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Figure 6.17: Sections from wild type eyes (A-C) or ChxlOr/m eyes (D-F) 
labelled with a variety of retinal cell markers (red) and (in D-F) BrdU 
(green). A - C  are wild type sections from 4-week old wild type mice. PKC 
(A) labels the bipolar cells located in the inner nuclear layer of the retina and 
their processes towards the ganglion cell layer. Recoverin (B, rec) labels all 
the photoreceptors in the outer nuclear layer of the retina. Bm3b (C) labels 
the ganglion cells in the ganglion cell layer. D-F  are sections of retina from 
4-week old CkxlO’/~ mice that have been injected with BrdU every other day 
for two weeks before culling. No PKC labelling can be observed in D , 
confirming that no bipolar cells are present in the mutant retina. Some 
recoverin labelled cells can be observed towards the ventricular layer of the 
retina (E), but no recoverin and BrdU double-labelling can be observed. F  is 
a view through a series of 0.2 pm increments through the retinal section 
taken with a confocal microscope. The cross hairs indicate the position of a 
BrdU labelled cell that seems to be co-labelled with calbindin (cal). Views 
through the section at the level of the cross hairs, show an overlap of some of 
the red and green labelling (yellow areas, arrows).ONL = outer nuclear layer, 
INL = inner nuclear layer, GCL = ganglon cell layer, scale bars = 100 pm 
except in F where it = 25 pm.
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Figure 6.18: Sections from wild type and C h xltf' eyes labelled for VC1.1 (red) 
and (in B-E) BrdU (green). VC 1.1 staining in the 4-week old wild type retina is 
localised to the inner plexiform layer, some of the inner nuclear layer cells, and the 
outer plexiform layer. B-E are two sections of retinae of 4-week old Chxl O'7' mice 
injected with BrdU for two weeks before culling. B and E are views through a 
series of 0.2 pm increments through the retinal sections taken with a confocal 
microscope. The cross hairs indicate the position of a BrdU labelled cell. In B, 
views through the section at the level of the cross hairs, shows some overlap of the 
red and green labelling (yellow areas, arrow). In E, BrdU-labelling more clearly 
overlaps with VC1.1 labelling. This is confirmed by C and D, an average projection 
of the 0.2 pm increments (C), and a view of only the VC 1.1 labelling (D), where 
the BrdU labelled cell is clearly stained red (arrow). ONL = outer nuclear layer, 
INL = inner nuclear layer, GCL = ganglion cell layer, scale bar = 50 pm in A, 20 
pm in B, 25 pm in C  and D, 25 pm in E.
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Figure 6.19: Sections from wild type and ChxlO'/' eyes labelled for syntaxin (red) 
and (in B-F) BrdU (green). Syntaxin staining in the 4-week old wild type retina is 
localised to the inner plexiform layer and some of the inner nuclear layer cells. B- 
F  are two sections of retinae of 4-week old ChxlOr/' mice injected with BrdU for 
two weeks before culling. C and D  are high magnification views of the section in 
B, with (C) and without (D) the BrdU labelling imposed, showing clearly that the 
BrdU labelled cell (arrows) is also labelled with syntaxin. F  is a high 
magnification view of the section in E, and shows a cell double labelled for BrdU 
and syntaxin (arrow), giving it a yellow colour. ONL = outer nuclear layer, INL = 
inner nuclear layer, GCL = ganglion cell layer, scale bar in A = 50 pm, in B and E 
= 100 pm, in C  = 25 pm and in F  = 30 pm.
the inner and outer plexiform layers and the vitreal cells of the inner nuclear layer, 
the amacrine and horizontal cells (Figure 6.18A). Two examples of BrdU/VCl.l co­
labelled cells are shown in Figure 6.18B-E. B and E show cross sections through 
confocal images of ChxlO''' retinal sections, taken at 0.2 pm increments. Yellow 
labelling indicates overlapping red and green staining from VC 1.1 and BrdU 
labelling respectively. Syntaxin, like VC 1.1, is expressed in the inner plexiform layer 
and amacrine cells of the inner nuclear layer, but unlike VC 1.1, is not detected in the 
outer plexiform layer of the adult wild type retina (Figure 6.19A). Figure 6.19B-F 
show two examples of BrdU/syntaxin co-labelled cells, with the high-magnification 
images C, D and F clearly depicting the yellow staining caused by the overlapping 
green BrdU and red syntaxin labelling. These experiments suggest that some of the 
cycling cells observed in the ChxlO'1' retina not only differentiate to become neuronal 
cells, but acquire specific retinal cell type markers.
Immuno-staining for neuronal markers was not detected in the ciliary body of the 
ChxlO"'' eye in these experiments.
6.2.5. Labelling of dissociated cells
To confirm double-labelling of BrdU and retinal neuron markers and to attempt to 
quantify the types of cells, immunostaining was performed on dissociated retinal 
cells from BrdU injected ChxlO''' and wild type mice. A similar injection schedule 
was used to the one described in 6.2.4; mice were injected every other day for five 
days from P25-P29 and left for three weeks after the first injection. The retinae were 
dissociated and spun using a cytospin, onto microslides, for immunolabelling. 
Antibodies against p3-tubulin, CRALBP, VC 1.1, syntaxin, Bm3b, calbindin and 
recoverin were used together with anti-BrdU antibodies.
Whilst wild type retinae were relatively easy to dissociate and spin down, ChxlO''' 
retinae tend to be very difficult to both dissect and dissociate. This, coupled with 
their decreased size compared to the wild type retina, meant that only a small number 
of ChxlO''' retinal cells were recovered for analysis. Labelling with p3-tubulin and 
Bm3b was unsuccessful. In addition, no cells were co-labelled with CRALBP or
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Figure 6.20: Dissociated ChxlOr' retinal cells from BrdU injected mice, co­
labelled for BrdU (green) and VC 1.1 (red, A-C), syntaxin (red, D-F) or 
recoverin (G-l). C, F, and I are overlays of the green and red figures to their left. 
Arrows indicate co-labelled cells. Scale bar = 30 pirn.
291
calbindin. BrdU labelled cells were, however, found to be co-labelled with VC 1.1 
(Figure 6.20A-C) and syntaxin (Figure 6.20D-F). This supports the observation made 
in the retinal sections and suggests cycling cells are capable of differentiating to 
inner nuclear layer cells of the retina. In addition, co-labelling with recoverin was 
observed (Figure 6.20G-I). Due to the very small amount of dissociated retinal cells 
being recovered, no analysis could be made of the relative amount of labelled cells.
6.2.7. BrdU labelled cells in the adult wild type form part of the retinal 
vasculature
Occasionally BrdU labelled cells were observed in the adult wild type retina (Figure 
6.5B). These cells did not double label with either nestin or p3-tubulin and were 
restricted to the inner layers of the retina. Based on their location, it is possible that 
these cells may be part of the developing capillary plexus of the inner retina, which 
develops during the first few postnatal weeks (Feeney et al., 2003; Friedlander et al., 
1996).
In order to discover if these cells were part of the retinal vasculature, retinal sections 
were examined for expression of the endothelial marker, P 1 -integrin. In the adult 
wild type retina, pi-integrin labelling can be observed in vascular cells of the inner 
nuclear layer (Figure 6.21 A, C). Whilst no BrdU labelled cells expressed pi-integrin 
in the adult ChxlO'A retina (Figure 6.2IB) occasional BrdU labelled cells observed in 
the adult wild type retina also expressed pi-integrin (Figure 6.21C, magnified in 
inset), confirming that these cells are more likely to be associated with the retinal 
vasculature than persisting dividing progenitor cells.
6.2.6. Cell death is not a common fate of cells in the Chxltf' retina
As not all BrdU labelled cells observed in the ChxlO'A retina co-labelled with nestin 
or p3-tubulin, it still remains unclear what the identity is of the majority of cycling 
cells observed. One possibility is that the cells continue to cycle beyond normal 
development but are unable to contribute to the retina as fully functioning cells. 
Thus, it is possible that these cells eventually stop cycling and die.
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Figure 6.21: Sections from wild type (.A,C) and C h x l O (B) eyes double 
labelled for BrdU (green) and pi integrin (red). Eyes were injected every 
other day from PI5 to P29 and culled on P30. In the wild type retina, pi 
integrin labels cells of the vasculature, mostly within the inner nuclear 
layer {A). A few cells incorporate BrdU during the time of BrdU injection 
(C, arrow) and these cells co-label for p 1 integrin (arrow C and magnified 
in inset), suggesting these cells are part of the retinal vasculature. BrdU 
labelled cells observed in the ChxlOr/_ retina do not co-label for pi 
integrin (B). Scale bars = 50 pm.
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Figure 6.22: Sections from 4-week-old wild type (+/+, A, B) and ChxlO''' 
C ,D) eyes stained with the TUNEL detection kit for apoptotic bodies 
(green) and counterstained with Hoechst nuclear dye (blue). Both in the 
wild type and ChxlOr' retina, few apoptotic bodies can be seen in the 
retina, either in the periphery (A and C (p)) or in the central retina (B and 
D). Some faintly labelled green bodies can be observed wild type retina (B, 
arrow), but these are faint, compared to brightly labelled apoptotic bodies 
in other areas of the sections (C, arrows), suggesting little or no cell death 
is occurring in either the wild type or ChxlOr' retina. Scale bar = 200 pm 
in A, 100 pm in B and D, 400 pm in C.
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In order to discover whether cell death is occurring in the adult ChxlO'*' retina, 
TUNEL labelling of retinal sections at postnatal week four and eight (after BrdU 
labelling according to schedule 1) was performed in both the wild type and ChxlO'*' 
retina. In both cases, apoptotic cell death was not detected in the central or peripheral 
retina (Figure 6.22). This suggests that cell death was not a common fate in the 
ChxlO'/_ retina.
6.2.8. Cell cultures of adult retinal cells suggest retinal progenitor-like cells are 
present in the ChxlO’/~ central retina
The presence of BrdU labelled cells in the ChxlO"A retina suggests there is a 
population of cycling cells in the ChxlO'A central retina. If this is the case, it should 
be possible to observe this phenomenon in culture. Previous studies have indicated 
that no neurosphere cultures can be grown from ChxlO"A retinae (Tropepe et al., 
2000), whilst such cultures can be grown from the CE of both wild type and ChxlO'A 
eyes. In view of the BrdU results presented here, I re-examined whether progenitor 
cells could be cultured from the central retina.
At varying time points, four primary cultures were set up, using defined conditions 
for neurosphere propagation (Ahmad et al., 1999; Kelley et al., 1995a), made up of 
the central neural retina of both wild type and ChxlO"A retinae, as well as cultures of 
the CE and RPE. Cells were treated with growth factors EGF and FGF-2. In all 
cases, dissociated wild type cells had a tendency to remain unchanged in the culture 
dishes (Figure 6.23A, B). The cells rounded up and showed no processes for several 
days. Trypan blue staining at 32 days in vitro indicated the cells did not die, 
however, they did not divide or show any signs of being mature neurons (Figure 
6.23B). This state lasted for three weeks and seemed unchanged.
In the ChxlO'1' retina, a remarkable difference was observed. Cells dissociated from 
the central neural retina started to proliferate and form small spheres, neurospheres, 
within days of being in culture (Figure 6.23C). The neurospheres grew to various 
sizes, and by approximately 15 days in culture, the neurospheres began to look 
darker and necrotic in their centres (6.23D). After 28 days in vitro, the spheres were 
passaged -  dissociated and replated. Fewer neurospheres seemed to arise from the
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Figure 6.23: Cell cultures of dissociated wild type (A and B) and ChxlOr/_ (C- 
F) retinal cells. A. Dissociated wild type retinal cells after 1 day in vitro. Cells 
are small and round and don’t have any processes. After 32 days in vitro (B), 
cells show no change in phenotype and trypan blue staining indicates cells are 
still viable, as no trypan blue can be observed inside the cells. Cells of the 
ChxlO’/' retina proliferate to form neurospheres, observed in C after 7 days in 
vitro. Neurospheres grow progressively larger, as observed in D  after 15 days in 
vitro, and the centres begin to look necrotic. Neurospheres from the ciliary 
epithelium (E) are both pigmented and non-pigmented. After 28 days in vitro, 
neural retina-derived neurospheres are dissociated and placed in differentiating 
conditions (F) and flatten and adhere to the culture dish. Scale bar = 50 pm.
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passaged cells, suggesting that either a substantial number of cells were lost during 
passaging, or the capacity to self-renew in the cycling cells was depleting. In 3 
separate experiments, neurospheres were maintained for 60 days and passeaged 2-3 
times during this period. However with each passage, cells were lost and eventually 
no neurospheres were observed.
Cells dissociated from the RPE, did not grow in neurosphere culture conditions either 
from the wild type eye or the ChxlO'1' eye. Some neurospheres were observed in the 
cultures dissociated from the CE of the ChxlO'*' eyes (Figure 6.23E). However, these 
cultures included cells from the periphery of the retina and so the possibility that 
these neurospheres arose from retinal cells cannot be ruled out. Separating the ciliary 
epithelium from the retina is a difficult dissection. Neurospheres arising from the 
ciliary margin cultures tended to contain pigmented cells (Figure 6.23E). However, 
the observation that CE-derived neurospheres started out pigmented and showed a 
gradual change to a non-pigmented state, as observed in previous literature (Tropepe 
et al., 2000) was not made here.
Upon passaging, some of the cells were transferred to differentiating conditions, 
where growth factors were replaced with fetal calf serum. In these conditions, cells 
showed a tendency to adhere and flatten to the culture dishes, and on some 
occasions, processes were observed (Figure 6.23F). However, immunostaining 
results were not conclusive for these cultures, and thus future experiments will be 
needed to ascertain whether the cells could differentiate to specific neural retinal cell 
fates.
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6.3. Discussion
6.3.1 An aberrant pattern of proliferation observed in the Chxl(fA retina during 
development continues after birth
The data obtained in this study show that when ChxlO function is disrupted, cells 
with RPC-like behaviour persist in the adult retina. In accordance with the results 
obtained in Chapter 5, cells seem to be cycling steadily from birth onwards into 
adulthood. Interestingly, these RPC-like cells in the adult mutant retina are present in 
both central and peripheral regions. Putative stem-cell like cells have thus far only 
been isolated from the ciliary epithelium (CE) at the very periphery of the retina 
(Ahmad et al., 2000; Tropepe et al., 2000), whilst cells taken from the neural central 
retina apparently did not proliferate to form neurosphere colonies (Tropepe et al., 
2000).
In this study, dividing cells were identified in vivo in the CE of the wild type and 
Chxl0'A eye, and in the neural retina of the ChxlO'1’ eye. The only other examples of 
neurogenic progenitor-like cells present in the central retina of adult vertebrate 
organisms are the rod-precursor lineages of teleost fish (Reh and Levine, 1998) and 
Muller glial cells in postnatal chicks (Fischer and Reh, 2001). In damaged gold fish 
retina, the rod-precursor cells regenerate all types of retinal neuron, whereas acute 
damage of the postnatal chick retina induced Muller glial cells to undergo a single 
round of cell division and express markers characteristic of retinal progenitors and 
occasionally retinal neurons. Similar progenitor-like cells have not been observed in 
mammalian retina which does not regenerate following injury, although in other 
regions of the nervous system evidence exists that glial cells can give rise to neurons 
(Doetsch et al., 1999). Transdifferentiation of the RPE to neural retina, can also 
provide a source of new neurons after retinal damage, and has been shown to occur 
in amphibians, and in chick and mammalian embryonic eyes (Reh and Levine, 1998).
That single genetic changes can result in the presence of RPC-like cells in the mature 
retina of mammals is a novel concept and supported by recent studies that identified 
persistent progenitors at the retinal margin of adult Shh receptor patched (ptc) +/- 
mice (Moshiri and Reh, 2004) and in the central retina of p27Kipl null and
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p27Kipl/pl9 INK4d double-null mice at P I8 (Cunningham et al., 2002). Like ChxlO, 
these genes affect proliferation of retinal progenitors but their deficiency has 
different effects on the adult retina. In the Ptc+/- mice, which have constitutively 
activated Shh signalling, proliferating cells were present in the retinal margin and in 
the CE, and only those at the margin generated new photoreceptors in response to 
retinal degeneration (Moshiri and Reh, 2004). Whereas loss of the cyclin dependent 
kinase inhibitors, p27Kipl and pl9 INK4d which mediate cell cycle exit, prolonged the 
normal period of retinal cell proliferation and caused retinal dysplasia including an 
increase in the number of horizontal cells (Cunningham et al., 2002).
The analysis of the profile of mitotic cells during development performed in the 
previous chapter, using H3 labelling, supports a model in which lack of ChxlO 
extends the longevity of a population of embryonic RPCs. The H3 study revealed 
that following an early decrease in proliferation in the mutant compared with the 
wild type retina, later, a small population of RPCs continues to proliferate steadily in 
the mutant. These cells are a possible source of the dividing cells observed in the 
adult retina. Previous studies concluded that RPCs have a limited life-span, as neuro­
sphere colonies could not be isolated from the adult neural retina (Tropepe et al., 
2000). By contrast here we find that in retina lacking ChxlO, RPC-like cells persist 
into adulthood. Although one cannot exclude a non-neuroepithelial source for the 
BrdU-positive cells, the expression data make this unlikely. Since ChxlO is not 
expressed in the retinal pigmented epithelium (RPE) and BrdU-labelled cells were 
not observed in the RPE, migrating RPE cells are an unlikely alternative source. 
Moreover, a recent analysis of expression using a ChxlO-GFP BAC reporter 
transgene in ChxlO null retina showed that in the P14 retina, GFP-positive cells 
expressed the Muller glial/progenitor markers CRALBP and Pax6 (Rowan and 
Cepko, 2004). Although the data do not exclude the possibility that the dividing cells 
initially have a Muller glial origin, the rarity of BrdU and CRALBP double labelling 
suggests instead that they may be occasionally adopting a glial or RPE fate after 
division. These findings are consistent with the idea that RPC-like cells persist in the 
absence of ChxlO.
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6.3.2 Misspecification of the retina through the absence of ChxlO may 
contribute to the continued cycling of retinal progenitor cells
Two recent studies and the results in chapters 3 and 4 give insight to the data 
obtained in these BrdU experiments. Crossing the ChxlOorJ/ 129/Sv into a mixed 
genetic background produced a more severe phenotype, with a progressive 
appearance of ectopic pigmentation in the neural retina (Rowan et al., 2004). 
Labelling with a ChxlO-GFP BAC transgene suggested that these pigment cells arose 
from cells in the neural retina, and the authors concluded that these arose by direct 
transdifferentiation of neural retinal cells. In addition, ectopic RPE gene expression 
(of Tfec and Dct) was also found in the neural retina from early embryonic stages 
(Rowan et al., 2004), mirroring the results of chapters 3 and 4, in which both silver 
and dopachrome tautomerase were upregulated in the ChxlO'1' developing retina. A 
recent study by Horsford et al, discussed in detail in Chapter 4, suggests that ChxlO 
acts to maintain the neural retina by repressing expression of RPE determinants such 
as the Mitf transcription factor (Horsford et al., 2005). This study, however, did not 
explore whether the adult mutant retina contains proliferating cells. The presence of 
proliferating cells in the adult retina likely reflects this instability of neural retinal 
identity in the absence of ChxlO. Nestin, VC 1.1 and CRALBP immuno-staining of 
BrdU-positive cells is consistent with their progenitor state as these markers have 
been used to label neural progenitors (Alexiades and Cepko, 1997; Walcott and 
Provis, 2003). It remains possible that the observed cells are neural retinal cells that 
may be dividing as part of a process of transdifferentiation, but the altered pattern of 
proliferation observed throughout development and into adulthood suggests this is 
unlikely. In addition, proliferating cells were observed throughout the retina whereas 
studies suggesting that transdifferentiation may be taking place in the ChxlO'A retina, 
report that this process occurs at the periphery (Rowan et al., 2004). Alternatively, 
the dividing cells may have failed to complete normal retinal histogenesis due to 
RPE gene expression, and therefore retain progenitor-characteristics.
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6.3.3 RPC-like cells maintain neurogenic potential, but are unable to expand 
retinal cell numbers
The data obtained here suggest that neurons are being generated in the adult mutant 
retina, albeit in small numbers and expressing only a subset of retinal neuron 
markers. Previous work has shown that over expression of ChxlO increased 
generation of all types of inner nuclear layer (INL) cells in mouse and suppressed 
photoreceptor development in chick, whereas lack of ChxlO prevents bipolar cell 
development (Burmeister et al., 1996);(Hatakeyama et al., 2001; Toy et al., 2002). 
That RPC-like cells in the adult mutant preferentially express INL markers (syntaxin, 
VC 1.1) may relate to ChxlO’s role in providing INL-identity. One possibility is that 
progenitors that were predestined in part to produce amacrine cells selectively 
persisted in the mutant retina post-natally. Consistent with this idea, we found no 
evidence of ganglion cell, bipolar cell, or photoreceptor production, with the 
exception of an occasional recoverin-labelled cell seen upon retinal dissociation and 
immunolabelling. No recoverin-labelled cells were observed in retinal sections, 
which is more likely to be an indication of the rarity of such double-labelled cells 
than of a difference between data obtained from sections and data obtained from 
dissociated cells, as retinae were treated in an identical manner. However, the finding 
that the adult mutant retina is apparently permissive for neurogenesis is surprising 
and suggests that the environment is not inhibitory.
While the ChxlO null adult retina contains RPCs with neurogenic potential, it 
remains markedly deficient in cell number. In the previous chapter it has been shown 
that, consistent with other studies, very low levels of apoptosis were detected in the 
embryonic wild type retina (Pequignot et al., 2003), and we found that apoptosis is 
not likely to contribute to the cell number deficit in the mutant during development 
(Green et al., 2003; Robb et al., 1978). The data obtained from this study suggest that 
the same is true in the adult retina. In both the wild type and ChxlO'A mature retina, 
very few apoptotic bodies were observed, suggesting that there is no widespread cell 
death resulting from the absence of ChxlO. This suggests that the ChxlO null adult 
RPC-like cells thus seem to harbour the same proliferative defects found in the 
embryonic RPCs and are unable to drive cell number expansion and growth of the 
retina.
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6.3.4 In vivo demonstrations of stem-cell like properties of cycling cells in the 
adult retina
Properties of multi-potentiality and self-renewal have been demonstrated in vitro for 
putative stem cells isolated from the adult CE of the rodent retina (Ahmad et al., 
1999; Tropepe et al., 2000). In this study, cells isolated from the ChxlO"A retina have 
also exhibited self-renewing properties, although their multi-potentiality has not been 
tested. In addition, this study has identified cycling cells in the CE of the ciliary body 
in the adult wild type mouse eye in vivo. These cells are a likely source of the CE 
stem cells characterised in vitro. Cycling cells were not identified however, at the 
peripheral edge of the retina (the ciliary margin). By contrast, proliferating RPCs in 
the ciliary margin have been identified in adult chickens (Fischer and Reh, 2000), 
and in quail and opossum (Kubota et al., 2002) which show similarities with 
embryonic RPCs, such as expression of both Pax6 and ChxlO.
An increased number of dividing cells was observed in vivo within the adult CE of 
the ChxlO'A eye, compared with the wild type. Likewise, in a previous in vitro study, 
ChxlO mutant CE produced more neurospheres containing fewer cells than the wild 
type CE (Tropepe et al., 2000). Both mutant and wild type neurosphere colonies 
differentiated to produce neurons (Tropepe et al., 2000). However, in vivo, the adult 
CE showed no evidence of neurogenesis, in contrast to the dividing cells in the 
mutant central retina. The different behaviours of these dividing cell populations are 
likely influenced by differences in their extracellular environments. The relationship 
between the progenitor-like cells observed here in the CE and the central retina, the 
putative retinal stem cells isolated from the CE (Ahmad et al., 1999; Tropepe et al., 
2000), and the transdifferentiating pigment generating cells (Horsford et al., 2005; 
Rowan et al., 2004) have not been established and will be the subject of future 
investigation. These findings are of interest as they suggest that manipulation of 
ChxlO expression and/or extracellular factors could influence the number of cells 
with neurogenic potential within the mature retina.
302
CHAPTER 7 
Final Discussion
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7.1 Identification of genes previously not known to be under ChxlO control
The first aim of this study was to identify genes that are controlled, either directly or 
indirectly by the transcription factor ChxlO. It was hoped more could be learned 
about the genetic pathway in which ChxlO is involved, and thus discover the 
molecular basis for the ChxlO'A retinal phenotype. The microarray system employed 
for this purpose was an ideal tool for examining the expression of thousands of genes 
simultaneously in the ChxW/' and wild type retinae early in development. It has 
resulted in the identification of 293 genes whose expression is changed in the 
ChxlO'A retina, of which 34 are characterised genes that are significantly up- or 
down-regulated at least 1.5-fold in the absence of ChxlO. Although many of these 
genes are expressed in the developing eye, few of these genes would have been 
chosen for examination as potential ChxlO targets, either because loss-of-function 
mutants do not show a significant phenotype, or because very little is as yet known 
about their function in the developing eye.
7.1.1 Cell cycle proteins affected by the absence of ChxlO
One group of genes of particular interest with regards to our understanding of ChxlO 
function, is the group of genes known to play a role in the cell proliferation. These 
include the cell cycle machinery-regulating genes growth arrest specific 2 (Gas2) and 
cyclin E2 (Ccne2). The role of ChxlO in cell proliferation in general, and its 
involvement in the cell cycle in particular, has been under a great deal of scrutiny, as 
a markedly reduced retinal cell number is one of the major phenotypic effects of its 
absence. As described in Chapter 1, ChxlO has been shown to interact with the pRB 
family of proteins, and the levels of both cyclin D1 and p27Klpl in retinal progenitor 
cells are thought to be influenced by ChxlO. The results obtained in this study 
indicated that both Gas2 and Ccne2 are down-regulated in the ChxlO_A retina.
Gas2 and other growth arrest specific genes were initially identified due to their high 
level of expression in murine fibroblasts under growth arrest conditions followed by 
down-regulation after re-entry into the cell cycle (Schneider et al., 1994). In contrast, 
Gas2 was found to be expressed more strongly in proliferative murine keratinocytes 
than in differentiating cells, and there was a higher expression of Gas2 during
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exponential growth than during growth arrest in this cell population, suggesting 
regulation of Gas2 is cell specific (Manzow et al., 1996). In this study, Gas2 down- 
regulation as a result of ChxlO absence (Chapter 3) is observed in conjunction with a 
decrease in exponential growth, suggesting Gas2 may be regulated in a similar 
manner in the retina. In addition, Gas2 has been shown to be involved in the 
execution of the apoptotic program in hindlimb interdigital tissues by acting as a 
death substrate for caspase enzymes (Lee et al., 1999). These data are of interest in 
light of the findings in Chapter 5 and previous studies, suggesting apoptosis is 
reduced in the ChxlO'A developing retina. It raises the possibility that a decrease in 
Gas2 expression as a result of ChxlO absence affects the apoptotic process.
CCne2, together with other E cyclins, is expressed during the late G1 phase of the 
cell cycle until the end of the S-phase. The activity of cyclin E is limiting for the 
passage of cells through the restriction point which marks a "point of no return" for 
cells entering the division cycle from a resting state or passing from G1 into S-phase 
(Moroy and Geisen, 2004). It has been shown that Cc«e2-associated kinase activity 
is regulated in a cell cycle dependent manner with peak activity at the G1 to S 
transition and that ectopic expression of cyclin E2 in human cells accelerates Gl, 
suggesting that it is rate limiting for Gl progression (Payton and Coats, 2002). The 
data obtained in Chapter 5 suggest that the length of Gl is increased in the ChxlO'1' 
retina, and thus the down-regulation of Ccne2 in response to ChxlO may be 
associated with this phenomenon.
Figure 7.1 summarises the interactions of various cell cycle proteins shown to be 
affected by the absence of ChxlO (see Chapter 1 for details), and also highlights the 
cell cycle proteins identified in this study. Neither of these cell cycle proteins has 
previously been shown to play a significant role in eye development, but their 
apparent change in expression in response to ChxlO, and the fact that the human 
homologue of Gas2 maps to a microphthalmia locus (Chapter 4) provides strong 
reasons to further examine their role in the progression of RPC proliferation and 
differentiation.
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Figure 7.1: Interactions of cell cycle proteins known to interact with ChxlO or 
showing a change in expression in the ChxlO'A retina. Members of the pRB 
family are known to bind to ChxlO, and thought to inhibit its binding to DNA. 
Cyclin D1 and E2 expression are down-regulated in the ChxlO'/_ retina, whilst 
p27Kipl protein is up-regulated in the ChxlOr1' retina, which may result in a 
failure to make the transition from Gl to S phase, even if cells don’t enter GO 
and differentiate. G asl has been shown to be up-regulated in the ChxlO'/' retina 
(Rowan et al, 2004), whilst Gas2 expression is decreased. These factors are also 
important during Gl. Cell cycle figure adapted from Livesey and Cepko, 2001.
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7.1.2 Cell differentiation factors affected by a loss of ChxlO
A second large group of genes identified in the microarray study are involved in 
various aspects of retinal cell type differentiation. A large number of transcription 
factors and other genes involved in cell fate specification or differentiation seem to 
be affected by a lack of ChxlO (see Table 3.5). Of the six genes examined in detail as 
a result of the microarray data, three are thought to play a role in retinal cell 
differentiation. Neurodl has been shown to be a regulator of intemeuron 
development, favouring amacrine over bipolar differentiation, and is essential for the 
terminal differentiation of a subset of photoreceptors (Inoue et al., 2002; Morrow et 
al., 1999a; Pennesi et al., 2003). Dlx2 has a role in the retinal differentiation and/or 
maintenance of the inner nuclear layer intemeurons and ganglion cells in the adult 
retina (de Melo et al., 2005). Finally it is thought that differentiation of 
photoreceptors may be mediated through Rxrg (Kelley et al., 1994). In addition, 
genes such as Fgf9 and Foxcl are known to be expressed in specific retinal cell 
types, Fgf9 in photoreceptors and Foxcl in retinal ganglion cells (Alizadeh et al., 
2003; Pratt et al., 2004). As discussed in Chapter 3, the expression of additional 
transcription factors shown here to be affected by the absence of ChxlO, have been 
shown to be important for differentiation of various other cell types.
The microarray data, in combination with real-time PCR and in situ hybridisation 
suggest both Neurodl and Dlx2 are positively regulated by the presence of ChxlO, as 
they are both down-regulated in the C h xN X retina. In contrast, Rxrg seems to be 
negatively regulated by ChxlO, as both microarray and real-time PCR data suggest 
its expression is increased in the ChxlO'1' retina. How do these changes in gene 
expression result in the Chxl0'f' phenotype? A decrease in retinal cells from all three 
retinal cell layers of the retina is observed in the ChxlO'A retina (Chapter 5). In 
addition, differentiation of many of the retinal cells types has been shown to be 
delayed. A significant proportion of genes known to affect retinal cell differentiation 
are down-regulated in the ChxlO_/‘ retina (Neurodl, Dlx2, Fgf9, and Foxcl), and it 
follows that a down-regulation of expression of genes required for retinal cell 
differentiation results in a delay in differentiation. In addition, retinal cells such as 
rod photoreceptors show abnormal morphology in the ChxlO'1' retina, and this may 
be caused by a lack of expression of genes required for normal differentiation.
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Figure 7.2 summarises some of the changes in gene expression observed as a result 
of ChxlO absence in the ChxlO'A retina, and where in the retina they are usually 
expressed.
7.1.3 Genes expressed in the RPE are up-regulated in the Chxltf' retina, 
suggesting a novel role for ChxlO in maintaining compartment boundaries
Of particular interest is that subsets of the cell specification genes identified in this 
study were RPE-specific genes. Both Si and Dct are usually expressed in the RPE, 
whose border with the retina is normally clearly defined. Silver expression is 
dependent on expression of the microphthalmia associated transcription factor (Mitf), 
a gene whose progressive restriction to the future RPE is thought to be instrumental 
for the specification of the mammalian optic vesicle into NR and RPE (Nguyen and 
Amheiter, 2000). In addition, three more genes expressed in the RPE, Fgf9, ApoE 
and Trpml, are also up-regulated in the ChxlO'1' retina, and the human homologue of 
Trpml maps to a microphthalmia locus (Chapter 4).
Whilst the roles of ChxlO in cell proliferation and bipolar cell specification have 
been established through various studies (Bone-Larson et al., 2000; Burmeister et al., 
1996), two of the recent studies examining the ChxlO phenotype have focused on a 
novel role for ChxlO in the maintenance of compartment boundaries in the peripheral 
retina (Horsford et al., 2005; Rowan et al., 2004). These studies suggest that ChxlO, 
required for neural retinal specification, and Mitf ] required for RPE specification, are 
components of a pathway that determines and maintains the identity of the neural 
retina, and that the loss of ChxlO results in the progressively increased expression of 
RPE genes over time, and possibly transdifferentiation of the neural retina to RPE 
(Figure 7.3). The data obtained in Chapters 1 and 2 suggest that a loss of neural 
retinal identity may indeed have occurred early in development, or is occurring 
during development, resulting in the expression of RPE-specific genes at El 1.5.
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Figure 7.2: Cascade of progressive differentiation of retinal progenitor cells to 
the seven different cell types of the neural retina in the ChxlO’' retina. ChxlO 
and genes showing a change in expression as a result of lack of ChxlO are 
highlighted in red. Changes in gene expression of genes required for retinal 
differentiation are seen in all layers of the neural retina, which may contribute to 
the delayed differentiation and poor morphology of the different cell types, 
especially photoreceptors, as various genes affected by a lack of ChxlO are 
required for photoreceptor differentiation. In addition, an increase in RPE 
specific genes may lead to an expansion of the RPE-cell population, either early 
in development or through transdifferentiation. RPE = retinal pigmented 
epithelium, RPC = retinal progenitor cell, GCL = ganglion cell layer, INL = inner 
nuclear layer, ONL = outer nuclear layer. Compare to Figure 1.3.
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Figure 7.3: Mitf- and ChxlO-mediated retinal tissue specification. In the wild 
type eye {A), all parts of the optic vesicle have the potential to become either 
neural retina or RPE, until the onset of ChxlO and M itf expression, induced by 
signals such as FGF1 and 2 or Otxl and 2 respectively, when the inner layer of 
the optic cup acquires a retinal pigment epithelium identity (green), and the 
outer layer a neural retinal identity (yellow). The boundaries between the two 
cell layers are clearly defined by the inhibitory effect of the two genes on each 
other. In the ChxlOr/_ retina (B), the absence of ChxlO reduces the inhibitory 
effect on M itf expression, ‘blurring’ the boundaries between the presumptive 
neural retina and the presumptive RPE. As differentiation progresses, the 
periphery of the retina is seen to be expressing RPE-specific gene, suggesting it 
has acquired, or is acquiring, RPE identity. Figure adapted from Horsford et al, 
2004.
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7.1.4 Microarray studies in the Chxl(f/' mouse
Microarray analysis of the ChxlO’1' retina has recently been performed using spotted 
cDNA microarrays (Rowan et al., 2004). It is of interest to compare this study to the 
study carried out here. Although the study carried out here was performed at an 
earlier time point (El 1.5 compared to E12.5 and E l3.5), and Affymetrix GeneChips 
were employed rather than spotted cDNA microarrays, some intriguing similarities 
were observed between the two experiments. In both studies, RPE-specific genes 
were shown to be up-regulated in the ChxlO’'’ retina. The transcription factor EC 
(Tfec), a bHLH leucine-zipper transcription factor of the Mitf family was the most 
up-regulated gene observed in the study carried out by Rowan et al (2004). In 
addition, Neurodl was shown to be down-regulated in both studies. Cell cycle 
inhibitors such as p57 and Gasl were shown to be up-regulated, whilst two markers 
of cell cycle progression, cyclin D1 and E2fl, were shown to be down-regulated. 
Although changes in these genes were not observed in the study performed here, it is 
intriguing that cell cycle proteins have been shown to be affected in both studies.
In the study performed by Rowan et al, 26 genes were shown to be up-regulated 
above an arbitrarily assigned 1.7-fold difference cut-off, whilst 21 were shown to be 
down-regulated at least 0.5-fold. The spotted microarray employed was composed of 
about 12,000 cDNA clones, comparable in number to the 12,000 genes/ESTs of the 
Affymetrix GeneChip. Thus 47 out of 12,000 cDNA clones showed what was 
considered to be a significant change in expression, compared to the 34 out of 12,000 
genes/ESTs reported here.
Only two genes, Neurodl and Stathmin-like 2 (Stmn2), were shown to be 
significantly down-regulated in both studies, and only one gene, UDP-glucose 
ceramide glucosyltransferase (Ugcg), was shown to be significantly up-regulated in 
both studies. Taking into account the variation between the two studies, including a 
difference in time point and the use of different chips, such a small overlap is not 
particularly surprising. This overlap, together with the observation that similar 
groups of genes are represented, e.g. RPE-specific genes or cell cycle protein genes, 
and show similar changes in expression, lends validity to the results of the studies.
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Microarray studies are becoming a more common tool for trying to elucidate how 
various eye phenotypes result from changes at a molecular level (Corbo and Cepko, 
2005; Hollbom et al., 2005; Jones et al., 2000; Qian et al., 2005; Rattner and 
Nathans, 2005). It is encouraging that two experiments with similar aims and using 
similar tissues for examination, despite some fundamental differences, produce 
similar results. Both have resulted in the novel finding that RPE genes are up- 
regulated in the periphery of the ChxlO'1' retina - suggesting a role for ChxlO in 
maintenance of compartment boundaries -  and complement each other well. Such 
data are an indication of the power of array technology to reveal previously 
undiscovered molecular pathways and relationships.
7.2 Misspecification at the border between the neural retina and RPE may 
contribute to a decrease in proliferation in the periphery of the retina
The H3 and PCNA data obtained in Chapter 5 suggest that the periphery of the 
ChxlO*A retina is most seriously affected by a lack of proliferation, and the 
microarray and expression data presented in Chapters 3 and 4 indicate that 
expression of genes normally localised to the RPE expands into this area. Previously, 
a lack of proliferation has been reported in the periphery of the ChxlO'1' retina (Bone- 
Larson et al., 2000; Burmeister et al., 1996), but it has thus far been unclear as to 
why this area of the retina was most seriously affected. It has been suggested that this 
phenomenon might be related to the central to peripheral gradient in which the retina 
matures, with cells of the central retina being the first to become post-mitotic and 
differentiate (Bone-Larson et al., 2000).
Whilst an effect on the central to peripheral gradient of maturation has not been 
excluded in this study, the data produced here suggest a correlation between the lack 
of proliferation observed in the ChxlO'/_ retina and the expansion of RPE gene 
expression into this same area. If tissue in the periphery of the retina is expressing 
RPE-specific genes, it may be acquiring an RPE identity, and its decreased rate of 
proliferation may be another manifestation of this process, as the RPE proliferates at 
a slower rate than the neural retina during development of the optic cup (Packer, 
1967). Thus, the data obtained in this study support a model in which a decrease in 
proliferation observed in the periphery of the ChxlO'A retina is the result of a lack of
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identity exhibited by RPCs in this area. This establishes a link between the role of 
ChxlO in proliferation of retinal progenitor cells and its role in 
establishing/maintaining neural retinal identity.
7.3 An altered pattern of proliferation in the ChxlO retina results in fewer 
retinal cells and a delay in their differentiation
In addition to identifying genes controlled by ChxlO, in order to understand the 
molecular basis of the microphthalmia phenotype, a second aim of this study was to 
further characterise aspects of the phenotype at a cellular level. Specifically, I sought 
to examine how RPC proliferation is affected in the ChxlO'A retina. Several new 
observations were made in the studies discussed in Chapter 5:
1. The proportion of cells undergoing mitosis in the ChxlO'A retina changes little 
throughout development, and does not result in the exponential expansion of 
cell number observed in the wild type retina;
2. a larger proportion of RPCs in the ChxlO'1' retina appears to reside in Gl 
phase of the cell cycle than is the case in the wild type retina;
3. a larger proportion of horizontal cell divisions occurs in the ChxlO'A retina 
compared to the wild type retina at E11.5; and,
4. differentiation of most retinal cell types is delayed in the ChxlO'A retina.
Whilst a decrease in proliferation has previously been observed in the periphery of 
the retina, as is observed in Chapter 5, the proportion of cells cycling in the central 
Chxl 0'A retina is reported to be no different from that of the wild type (Bone-Larson 
et al., 2000; Burmeister et al., 1996). Why then, is the ChxlO'A retina so severely 
depleted of cells? Suggestions as to how this may be the case have included the 
following possibilities:
1. That increased cell death might result in a smaller population of RPCs;
2. a smaller number of cells are initially specified to become neural retinal cells, 
and that this, coupled with a decrease in proliferation in the periphery of the 
retina, inhibits the retina from attaining its full complement of cells (Bone- 
Larson et al., 2000); and,
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3. there is a decrease in the rate of proliferation, through the extension of Gl of 
the cell cycle (Bone-Larson et al., 2000; Green et al., 2003).
It is unlikely that an increase in cell death in the ChxlO"A retina is the cause of the 
severely depleted RPC number. This and other studies have shown that apoptotic cell 
death is not a widespread phenomenon in the ChxlO"A retina, and that its occurrence 
may in fact be decreased (Robb et al., 1978; Theiler et al., 1976)( Chapter 5.2.7). The 
second possibility, that fewer cells are specified to become neural retina initially, is 
supported in this study by an increase in expression of RPE-specific genes, 
suggesting that, at least at the periphery of the retina, a proportion of cells might be 
specified to become RPE rather than neural retina. An increase in the length of Gl is 
also supported by this study. Evidence from the flow cytometry experiment 
performed in Chapter 5 suggests that a greater proportion of cells in the El 1.5 
ChxlO"A retina are in Gl phase of the cell cycle, compared to the wild type retina 
(Chapter 5.2.3).
If the cell cycle is merely delayed in the ChxlO"A retina, why does the retina not grow 
to its full size over a longer period of time? One model that is supported by the data 
obtained in these studies is that RPCs of the developing Chxl0'A retina are unable to 
expand in number due to an arrest in Gl of the cell cycle. The microarray data 
indicate that the cell cycle proteins affected by a lack of ChxlO are mainly important 
for the transition from Gl to S or from Gl to GO and differentiation. If this 
mechanism is disrupted, it is possible that cells are temporarily unable either enter S 
phase to continue proliferating, or become post-mitotic and differentiate, reflected by 
a delay in the appearance of retinal neuron-specific markers. This model is illustrated 
in Figure 7.4.
7.4 Stem-cell like properties of cells proliferating in the adult C h x lf fretina
A final aim of this study was to confirm whether stem cell-like cells reside in the CE 
of the eye, and whether more of these are present in the ChxlO'A retina than in the
314
o
RPCs Post-mitotic 
differentiating cells
Bo
o No proliferative expansion Delayeddifferentiation
Cells arrested in G1/G0
neither proliferate or differentiate
Figure 7.4: Model of how an arrest in G1/G0 of the cell cycle in RPCs of the 
ChxlO'/_ retina might result in a smaller population of retinal cells and delayed 
differentiation. A: In the wild type developing retina, RPCs proliferate 
symmetrically to produce an exponentially expanding population of RPCs, 
which will divide asymmetrically, and in time symmetrically, to produce post­
mitotic differentiating cells in an organised manner, with various cell types 
being bom at clearly defined times. B: In the ChxlO'/' retina, RPCs may become 
arrested in G1/G0, and thus although they may divide symmetrically, long 
periods of time may exist between one division and the next, inhibiting 
proliferative expansion of RPCs. In a similar manner, differentiation of retinal 
cells may be delayed due to post-mitotic RPCs becoming arrested in GO. 
Whether this arrest is temporary or occurs in a certain percentage of the 
population of cells remains to be seen.
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wild type, as suggested by previous studies (Ahmad et al., 2000; Tropepe et al., 
2000).
An area of stem cell research now offering real possibilities of therapy for previously 
incurable diseases is that of neural stem cells. Over recent years, a number of 
approaches have evolved for using neural progenitor cells in cell therapy, approaches 
that are very attractive for clinical translation. Many involve transplantation of one or 
more types of stem cells into the brain. In treating disorders of myelin, such as 
multiple sclerosis, transplantation of oligodendrocyte progenitor cells is an attractive 
approach. They have been assessed in a variety of models of demyelinating disease 
and show promise for the treatment of a fairly wide spectrum of demyelinating 
disorders (Pluchino et al., 2004; Windrem et al., 2002; Windrem et al., 2004; 
Yandava et al., 1999). To treat diseases of discrete loss of a single neuronal 
phenotype, such as Parkinson’s disease, transplantation of phenotypically restricted 
neuronal progenitor cells have booked varied results (Bjorklund and Lindvall, 2000; 
Hagell et al., 2002; Olanow et al., 1996). Finally, implantation of mixed progenitor 
pools has been examined for potential treatment of conditions characterized by the 
loss of several discrete phenotypes, such as spinal cord injury (Brustle et al., 1999; 
Han et al., 2004; Nistor et al., 2005; Ogawa et al., 2002). In addition, therapies have 
been directed to mobilise endogenous neural progenitor cells to restore neurons lost 
as a result of neurodegenerative diseases, in particular Huntington’s disease (Chen et 
al., 2004; Curtis et al., 2003; Magavi et al., 2000). Together, these may present 
compelling strategies and near-term disease targets for cell-based neurological 
therapy.
Stem cells have also been characterised in the eye, where limbal stem cells replenish 
the cornea (Davanger and Evensen, 1971; Schermer et al., 1986; Tseng, 1989), and 
pigmented epithelial cells of the iris have been shown to re-enter the cell cycle and 
transdifferentiate to lens (Eguchi, 1988; Eguchi and Shingai, 1971; Imokawa and 
Brockes, 2003). Recently, the transplantation of limbal epithelial cells cultivated on 
amniotic membrane has been developed treatment for limbal stem cell deficiency, 
with encouraging results (Santos et al., 2005; Song et al., 2005). However, thus far, 
there has been no evidence that the mammalian retina can regenerate, or that any 
neural retinal progenitor-type cells exist in the mammalian retina, even though such
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cells have been observed in lower vertebrates (see Chapter 1). Studies into 
transplant-based approaches for treatment of retinal degenerative conditions have 
been limited to the use of ES cells rather than more eye-specific cells (Banin et al., 
2005; Meyer et al., 2005). Thus, the discovery that the CE of the mammalian eye 
might harbour self-renewing cells that could be induced to differentiate to various 
retinal cell types offers the first hope of developing therapies for retinal degenerative 
diseases.
Surprisingly, a large number of proliferating cells were observed throughout the 
ChxlO'A retina, and this is the first observation of proliferating cells in the adult 
mammalian retina in vivo. These cells seemed to continue to proliferate well into 
adulthood and showed self-renewing properties in culture. Moreover, they seemed to 
retain neurogenic properties, not only labelling with markers for neural progenitor 
cells and neuronal cells, but also with markers for the retinal specific amacrine cells.
No such cells were observed in the wild type retina. Proliferating cells were observed 
in the CE of both wild type and ChxlO'A retina, with a larger number seen in the 
Chxl0'f' CE, but these did not co-label with any neurogenic markers, suggesting they 
have different properties to those proliferating cells observed in the ChxlO'A retina 
and that their ability to differentiate to various cell types, as shown in culture, may be 
restricted in vivo. The discovery of these cells, and their self-renewing and 
neurogenic properties, opens perspectives for devising mechanisms in which retinal 
cells can be regenerated after injury or degeneration. Further work needs to better 
define the properties of these cells. How is the ChxlO'1' retina different to the wild 
type? Why do cells continue to proliferate in that environment? Can the properties of 
the ChxlO_/' retina be utilised for the development of stem cell therapies for retinal 
degeneration or injury?
7.5 Considerations for future work
The work described here has revealed a variety of novel findings that pertain to the 
ChxlO'f' phenotype. A number of genes that may be under ChxlO control have been 
identified, and the importance of ChxlO in directing retinal cell fate has been
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highlighted by this study. In addition, proliferating cells with RPC-like qualities and 
neurogenic potential have been identified in the central retina of the ChxlO'1' retina. 
Of course, these findings raise many new questions about the mechanisms in which 
ChxlO exerts its control, both on the RPC cell cycle and retinal cell differentiation.
Whilst a number of genes have been identified that are clearly under ChxlO control, 
whether this control is direct or indirect remains to be seen. Neurodl has 5 ChxlO 
binding sites within 5 kb of its start codon, and Dlx2 has 3. Binding studies using 
ChxlO need to be carried out to examine whether ChxlO actually binds to these sites, 
which might suggest its direct, rather than indirect, control of these genes. Functional 
studies are also required, for example by manipulating the amount of these factors in 
cell culture of Chx 10-deficient RPCs and examining whether they in some way 
rescue aspects the phenotype.
Thus far, only six of the 34 characterised genes that have shown a significant 1.5- 
fold change in expression in the microarray study performed here have been 
examined further. A number of other genes would be of interest to pursue, such as 
Gas2 and Ccne2, with respect to ChxlO’s control of the cell cycle, or ApoE, another 
gene normally expressed in the RPE. Fgf9 also shows a change in expression and as 
Fgfs are involved in various aspects of cell proliferation and differentiation, it would 
also be interesting to examine how Fgf9 might be controlled by ChxlO. A number of 
the genes showing a change in expression are currently being examined in this 
laboratory.
Many questions also remain unanswered as to how ChxlO regulates the cell cycle. 
The data suggest that the length of Gl is increased or cells are arrested in Gl, and 
that ChxlOv' RPCs cycle abnormally during development, leading to a persistence of 
cycling cells after birth. However the mechanisms through which this occurs remain 
elusive. The cell culture studies initiated here should be expanded in order to further 
characterise how ChxlO'1' RPCs are different to wild type, and how they respond to 
their environment, through the addition of growth factors for example. In addition, it 
would be beneficial to isolate the cycling cells observed in the adult ChxlO'f' retina in 
culture, and compare them to embryonic RPCs in order to examine whether they are 
similar in nature and behaviour.
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Finally, a population of proliferating cells has been identified in the adult ChxlO'f' 
retina. This novel finding is of interest in light of the various stem cell studies that 
have been conducted on the mammalian retina. As described earlier, self-renewing 
cells with neurogenic potential have not previously been found in the mammalian 
retina. Stem cell-like cells have thus far only been isolated from the ciliary 
epithelium of the mammalian eye (Ahmad et al., 1999; Tropepe et al., 2000). Such 
cells are of great interest, as they may offer clues as to how cells in the mammalian 
retina might be regenerated after, for example, injury or degeneration. If the 
proliferating cells found in the ChxlO'A retina can self-renew and differentiate to 
specific retinal cell types, can they also integrate into the existing retinal structure? 
Can such cells be cultured indefinitely and be transplanted into an injured retina? 
Such questions are of great interest with respect to finding novel therapies for retinal 
degeneration, and cell culture and transplantation studies of these cells have been 
initiated in this and collaborating labs.
7.6 Final Thoughts
The study conducted here has produced a number of interesting and novel findings 
and offered some valuable clues as to how ChxlO affects retinal progenitor cell 
proliferation and differentiation. In addition, it has raised a number of new and 
interesting questions, which will form the basis of further work in this fast-evolving 
field. It is hoped this work will contribute to the current knowledge of eye 
development in general, and ChxlO’s involvement in this process in particular.
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Appendix 1
List of 293 genes that showed a greater than 1.5-fold expression between wild type 
and ChxlO'A El 1.5 retinae in the experiment described in Chapter 3. ‘Trend’ 
indicates an increase (+) or decrease (-) in expression in the ChxlO'/‘ retina as 
compared to the wild type, and ‘Fold-change’ indicates the fold change in 
expression. Of the 293 genes, 54 are expressed sequence tags (‘EST’) and 235 are 
characterised genes (eight genes are represented twice, these are marked with an 
asterisk).
Gene Title
Actin, beta, cytoplasmic (Actb)
Adenylosuccinate synthetase like 1 (Adssll) 
Aortic preferentially expressed gene 1 (Apegl) 
Apolipoprotein E (Apoe)
ATPase, Ca-H--sequestering {Atp2cl)
ATP synthase, H+ transporting, mitochondrial FI 
complex, delta subunit (Atp5d)
ATP synthase, H+ transporting, mitochondrial FO 
complex, subunit g (Atp51)
UDP-GlcNAc:betaGal beta-1,3-N- 
acetylglucosaminyltransferase 1 (B3gntl) 
Biglycan (Bgn)
Basic helix-loop-helix domain containing, class 
B2 (JBhlhbl)
Brain and kidney protein (Bk)
BMP2 inducible kinase (Bmp2k)
Budding uninhibited by benzimidazoles 1 
homolog (S. cerevisiae) (Bubl)
Nuclear DNA binding protein (Cld)
Calcium binding protein, intestinal {Cai)
Catenin alpha 2 (Catna2)
Chromobox homolog 3 (Drosophila HP1 gamma) 
(iCbx3)
Cyclin E2 (Ccne2)
Copper chaperone for superoxide dismutase (Ccs) 
CD8 antigen, beta chain 1 (Cd8bl)
Cadherin 4 (Cdh4)
Cadherin 8 (Cdh8)
Cyclin-dependent kinase inhibitor IB (P27)
(<Cdknlb)
C. elegans ceh-10 homeo domain containing 
homolog {ChxlO)*
C. elegans ceh-10 homeo domain containing 
homolog {ChxlO)*
Creatine kinase, mitochondrial 1, ubiquitous 
{Ckmtl)
Claudin 1 {Cldnl)
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Trend Fold- Genbank Accession 
________Change_______ Number
- 3.50 J04181
+ 1.92 M74495
+ 2.03 U57098
+ 4.70 D00466
- 1.75 AV356516
+ 1.69 AV217314
- 2.17 Y17223
+ 2.46 AV315957
+ 2.18 X53928
+ 2.95 Y07836
+ 2.26 AW046243
- 1.79 AA673486
- 1.70 AI428843
1.83 X95591
+ 1.89 Y00884
- 1.73 D25281
- 1.82 X56683
_ 2.44 AF091432
+ 2.11 AV267263
- 1.60 X07698
- 2.53 X69966
- 5.99 X95600
+ 1.50 U09968
- 2.61 L34808
- 2.70 AV246437
- 1.59 Z13969
2.75 AI604314
Gene Title
Claudin 6 (CldnS)
CCR4-NOT transcription complex, subunit 7 
(CnotT)
Coactosin-like 1 (Dictyostelium) (Cotll)
Carnitine palmitoyltransferase la, liver (Cptla) 
Cellular retinoic acid binding protein I (Crabpl) 
cAMP responsive element binding protein 1 
(Crebl)
Cellular repressor of ElA-stimulated genes 1 
(Cregl)
Casein kinase 1, gamma 2 (Csnklg2)
Chondroitin sulfate proteoglycan 2 (Cspg2) 
Cathepsin C (Ctsc)
Cytochrome P450, family 1, subfamily b, 
polypeptide 1 (Cyplbl)
Cytochrome P450, family 4, subfamily v, 
polypeptide 3 (Cyp4v3)
DNA segment, Chr 2, ERATO Doi 93, expressed 
CD2Ertd93e)
DNA segment, Chr 6, Wayne State University 
176, expressed (D6Wsul76e)*
DNA segment, Chr 6, Wayne State University 
176, expressed (D6Wsul76e)*
Death-associated kinase 3 (Dapk3)
D site albumin promoter binding protein (Dbp) 
Dopachrome tautomerase (Dct)
DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 
(Ddx6)
DEK oncogene (DNA binding) (Dek) 
Diacylglycerol kinase, alpha (Dgka)
Distal-less homeobox 2 (Dlx2)
DnaJ (Hsp40) homolog, subfamily B, member 9 
(Dnajb9)*
DnaJ (Hsp40) homolog, subfamily B, member 9 
(Dnajb9)*
Dual specificity phosphatase 16 (Duspl6)
ER degradation enhancer, mannosidase alpha-like 
1 (Edeml)
Eukaryotic translation initiation factor 1A (Eifla) 
Elongation of very long chain fatty acids 
(FENl/Elo2, SUR4/Elo3, yeast)-like 2 (ElovlT) 
Enamelin (Enam)
Enolase 2, gamma neuronal (Eno2) 
Ectonucleoside triphosphate diphosphohydrolase 
4 (Entpd4)
Eph receptor A4 (Epha4)
Epoxide hydrolase 2, cytoplasmic (Ephx2) 
Endogenous retroviral sequence 4 (with leucine t- 
RNA primer) (Erv4)
Exocyst complex component 8 (Exoc8)
Fatty acid binding protein 3, muscle and heart 
(Fabp3)
Famesyl diphosphate synthetase (Fdps)
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Trend Fold- Genbank Accession
________Change_______ Number
- 2.43 AF087824
+ 3.31 AI931748
+ 3.05 AI837006
+ 2.78 AF017175
- 2.29 X15789
- 2.53 X67719
+ 2.01 AF084524
+ 1.79 AW121446
- 1.83 D45889
+ 1.82 U74683
- 3.41 X78445
+ 3.35 AA212964
- 1.94 C77278
+ 1.59 AA733372
- 2.07 AA733372
_ 1.80 AB007143
+ 1.97 AW047343
+ 4.80 X63349
- 5.65 D50494
_ 2.12 AA733594
+ 1.76 AF085219
- 13.83 M80540
- 1.61 AI835630
- 2.48 AW120711
_ 1.85 AV234570
- 1.95 AW212878
_ 2.73 U28419
- 1.90 AI317360
_ 1.48 U82698
+ 2.28 AC002397
+ 1.69 AI851172
_ 1.70 X65138
+ 1.81 Z37107
- 1.44 Y12713
+ 1.67 AI591555
+ 2.88 X14961
_ 1.83 AW045533
Gene Title Trend Fold- Genbank Accession
 ___ Change_______ Number
Fibroblast growth factor 9 (Fgf9) - 2.75 U33535
Fibroblast growth factor 15 (Fgfl5) - 2.48 AF007268
Fibroblast growth factor receptor 2 (Fgfr2) + 1.74 AV363696
Fragile histidine triad gene (Fhit) + 1.80 AF047699
Forkhead box Cl (Foxcl) - 2.33 AF045017
Forkhead box C2 (Foxc2)* - 2.29 X74040
Forkhead box C2 (Foxc2)* - 2.61 AV251191
Forkhead box G1 (Foxgl) - 3.57 U36760
Friend virus susceptibility 4 (Fv4) - 2.12 C78850
Frizzled homolog 4 (Drosophila) (Fzd4) + 2.07 AW122897
Growth arrest and DNA-damage-inducible 45 - 2.00 U00937
alpha (Gadd45a)
Growth arrest specific 2 (Gas2) - 2.15 M21828
GATA-binding protein 3 (Gata3) - 2.27 X55123
Glia maturation factor, beta (Gmfb) - 2.12 AA756568
Guanine nucleotide binding protein, beta 2 + 1.31 U34960
(Gnb2)
G protein-coupled receptor 49 (Gpr49) - 2.95 AF110818
G protein-coupled receptor 143 (Gprl43) + 3.91 X98352
G protein-coupled receptor 175 (Gprl75) + 2.50 AI842363
G-rich RNA sequence binding factor 1 (Grsfl) + 1.78 AV293460
Glutathione S-transferase, alpha 4 (Gsta4) + 1.80 L06047
Glutathione S-transferase, theta 2 (Gstt2) + 2.06 X98056
Hyaluronan synthase 2 (Has2) - 2.39 U52524
Histone 1, H2ba {Histlh2ba) - 1.58 X90778
Histone 2, H3c2 (Hist2h3c2) - 3.25 Z30939
Histone 2, H3c2; histone 1, H3g; histone 1, H3f; - 3.70 M32459
histonel, H3c; histonel, H3d; histone 1, H3b; 
histone 1, H3e; histone 1, H3h; histone 1, H3i; 
histone 1, H3a (Hist2h3c2, Histlh3g, Histlh3f 
Histlh3c, Histlh3d, Histlh3b, Histlh3e, 
Histlh3h, Histlh3i, Histlh3a)
Hexokinase 1 (Hkl) - 3.79 J05277
Homeo box C4 (Hoxc4) - 1.79 X69019
Heparan sulfate (glucosamine) 3-0- + 2.32 AF019385
sulfotransferase 1 (Hs3stl)
Heat shock protein 1A {Hspa la) + 2.76 M12571
Heat shock protein IB (Hspalb) + 3.22 AF109906
Intracistemal A particles, 113 linked {lap 11-1) - 1.85 X04120
Inhibitor of DNA binding 1 (Idbl) - 1.95 M31885
Interferon gamma inducible protein 30 (Ifi30) + 1.88 AI844520
Insulin-like growth factor binding protein 5 + 2.41 LI2447
CIgfbpS)
Inner centromere protein (Incenp) - 1.50 AW045530
Indolethylamine N-methyltransferase (Inmt) + 3.26 M88694
Insulinoma-associated 1 {Insml) - 2.14 AF044669
IL2-inducible T-cell kinase (Itk) - 1.58 D14042
Integrin alpha 4 (ltga4) - 1.71 X53177
Integrin alpha V (Itgav) + 2.97 U14135
Potassium voltage-gated channel, subfamily Q, - 2.21 AB000503
member 2 {Kcnq2)
K+ voltage-gated channel, subfamily S, 1 (Kcnsl) + 1.78 AF008573
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Gene Title
Keratin complex 1, acidic, gene 10 (Krtl-10) 
Kinectin 1 (Ktnl)
Laminin B1 subunit 1 {Lamb 1-1)
Lamin A (Lmna)
Leukotriene B4 12-hydroxydehydrogenase 
(Ub4dh)
Mannosidase 1, alpha {Mania)*
Mannosidase 1, alpha {Mania)*
Maternal embryonic leucine zipper kinase {Melk) 
Microsomal glutathione S-transferase 1 {Mgstl) 
Mitochondrial ribosomal protein L54 {Mrpl54) 
MutS homolog 6 (E. coli) (Msh6) 
Metastasis-associated gene family, member 2 
{Mta2)
Myeloblastosis oncogene {Myb)
Myosin, heavy polypeptide 9, non-muscle {Myh9) 
Myosin X {MyolO)
Myelin transcription factor 1 {Mytl)
N-acetyl galactosaminidase, alpha {Naga)
NADH dehydrogenase (ubiquinone) 1 alpha 
subcomplex 11 {Ndufall)
Neurogenic differentiation 1 {Neurodl) 
Neuroblastoma myc-related oncogene 1 {Nmycl) 
Neuronatin {Nnat)
Non-POU-domain-containing, octamer-binding 
protein {Nono)
Notch gene homolog 1, (Drosophila) {Notchl) 
Nuclear protein 1 {Nuprl)
Osteoglycin {Ogn)
One cut domain, family member 1 {Onecutl) 
OTU domain, ubiquitin aldehyde binding 1 
{Otubl)
Paired box gene 9 {Pctx9)
Purkinje cell protein 4 {Pcp4)
Paternally expressed 10 {Peg 10)
Pleckstrin homology-like domain, family A, 
member 1 {Phldal)
Plakophilin 2 {Pkp2)
Pleiomorphic adenoma gene-like 1 {Plagll)* 
Pleiomorphic adenoma gene-like 1 {Plagll)* 
Phospholipase D3 {Pld3)
Polo-like kinase homolog, (Drosophila) {Plkl) 
Polo-like kinase, pseudogene 1 {Plk-psl) 
Polyamine-modulated factor 1 {Pmfl)
Peroxisome proliferator activated receptor alpha 
{Ppara)
Peroxisome proliferative activated receptor, 
gamma, coactivator 1 alpha {Ppargcla) 
Peroxiredoxin 6
peroxiredoxin 6, related sequence 1 {Prdx6 
Prdx6-rsl)
Pituitary tumor-transforming 1 {Pttgl)
Trend Fold- Genbank Accession
________Change_______ Number
+ 1.76 V00830
- 3.18 A V380640
+ 1.83 AV357656
+ 1.72 D49733
+ 1.84 AA596710
+ 1.67 AI021125
+ 2.05 U04299
- 2.06 L76158
+ 1.84 AW124337
- 1.34 AW060257
- 1.37 AF031087
- 1.62 AW048332
_ 2.31 Ml 2848
+ 1.68 AW125698
+ 2.81 AJ249706
- 1.79 AF004294
+ 2.18 AJ223966
- 2.11 AI843074
_ 8.26 U28068
- 1.82 M12731
- 2.39 X83569
- 1.81 AI316087
_ 1.72 AV374287
- 4.20 AI852641
- 1.62 D31951
- 2.22 U95945
+ 1.65 AI838318
_ 2.56 X84000
+ 1.67 X17320
- 1.75 AI836610
- 3.04 U44088
_ 1.53 AW208938
- 1.97 X95504
- 1.63 X95503
+ 2.12 AF026124
- 1.47 AV305987
- 2.67 U73170
- 1.78 AW060657
- 1.75 X57638
+ 1.90 AF049330
1.86 AF093853
1.89 AF071209
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Gene Title
Prospero-related homeobox 1 (Proxl)
Prostate tumor over expressed gene 1 (Ptovl) 
Protein kinase C, alpha (Prkca)
Protein kinase C, beta 1 (Prkcbl)*
Protein kinase C, beta 1 {Prkcbl)*
Protein kinase C, delta binding protein {Prkcdbp) 
PRP19/PS04 homolog (S. cerevisiae) (Prpl9) 
Protein tyrosine kinase 9 (Ptk9)
Protein tyrosine kinase 9-like (A6-related protein) 
(Ptk9l)
Protein tyrosine phosphatase, receptor type, S 
(Ptprs)
Purine rich element binding protein A (Pura) 
RAB7, member RAS oncogene family (Rab7) 
RAD51 homolog (S. cerevisiae) (Rad51)
RAN GTPase activating protein 1 (Rangapl) 
RNA binding motif protein 4 {Rbm4)
REST corepressor 1 {Rcorl)
Regenerating islet-derived 2 (Reg2)
Reelin {Rein)
Renin-binding protein {Renbp)
Ring finger protein 13 {Rnfl3)
Ring finger protein 138 {Rnfl38)
Roundabout homolog 3 (Drosophila) {Robo3) 
Rho-associated coiled-coil forming kinase 1 
{Rockl)
Ribosomal protein L27a {Rpl27a)
Ribosomal protein SI5a {Rpsl5a)
Ribosomal protein S28 (Rps28)
Reticulon 1 {Rtnl)
Retinoid X receptor gamma {Rxrg)
SI00 calcium binding protein A1 {SlOOal) 
Sarcoma amplified sequence {Sas)
Secretory carrier membrane protein 3 {Scamp3) 
Stearoyl-Coenzyme A desaturase 1 {Scdl)* 
Stearoyl-Coenzyme A desaturase 1 {Scdl)* 
Syndecan 4 {Sdc4)
SEC63-like (S. cerevisiae) {Sec63)
Selenium binding protein 1 
selenium binding protein 2 {Selenbpl 
Selenbp2)
Selenoprotein P, plasma, 1 {Seppl)
Sarcoglycan, gamma (dystrophin-associated 
glycoprotein) {Sgcg)
SIC domain binding protein 1 (tetratricopeptide 
repeat containing) {Sh2bpl)
Silver {Si)
Solute carrier family 2 (facilitated glucose » 
transporter), member 4 {Slc2a4)
Solute carrier family 19 (sodium/hydrogen 
exchanger), member 1 {Slcl9al)
Solute carrier family 22 (organic cation
Trend Fold- Genbank Accession
________Change_______ Number
- 1.98 AF061576
+ 1.41 AI838337
- 2.35 M25811
+ 2.56 X53532
+ 2.50 X59274
+ 2.03 AW048944
+ 1.74 AW122465
- 1.77 U82324
+• 1.81 Y17808
+ 1.43 X82288
+ 2.00 U02098
+ 1.64 X89650
- 1.78 D13803
- 1.89 U20857
- 1.77 U89506
- 2.07 AV356223
- 1.53 AV051312
+ 3.90 AV263736
+ 2.46 AA600645
- 1.80 AF037205
- 1.80 AW209763
+ 3.29 AF060570
- 1.75 AA647393
_ 3.41 X05021
- 2.27 AF085809
+ 1.81 U11248
- 2.43 AW123115
+ 17.93 X66225
+ 4.50 AF087687
+ 1.56 AI844321
+ 1.97 AF005036
- 2.05 M21285
- 1.90 M21285
+ 2.80 D89571
- 1.98 C76102
+ 1.71 AV366872
- 1.61 AF021345
- 1.53 AB024922
- 2.03 AV375731
+ 3.54 U14133
+ 2.18 M23383
+ 1.86 L23755
+ 2.16 AB012808
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Gene Title Trend Fold-
Change
Genbank Acces: 
Number
transporter), member 17 (Slc22al7)
Solute carrier family 23 (nucleobase transporters), + 1.65 AV222871
member 3 (Slc23a3)
Solute carrier organic anion transporter family, - 1.93 AA407151
member 5A1 (Slco5al)
SWI/SNF-related, matrix-associated actin- - 1.69 AV381829
dependent regulator of chromatin, subfamily a,
containing DEAD/H box 1 (Smarcadl)
Sphingomyelin phosphodiesterase, acid-like 3A + 2.42 Y08135
(iSmpdl3a)
Small nuclear ribonucleoprotein polypeptide G - 2.14 AW060597
0Snrpg)
Sphingosine kinase 1 (Sphkl) + 2.95 AF068748
Secreted phosphoprotein 1 (Sppl) + 2.38 X13986
Small proline-rich protein 2F (<Sprr2j) - 2.03 AJ005564
Serine racemase (Srr) - 1.68 AI840579
Signal sequence receptor, gamma (Ssr3) - 1.98 AW227650
ST8 alpha-N-acetyl-neuraminide alpha-2,8- - 2.25 X80502
sialyltransferase 3 (St8sia3)
START domain containing 10 (<StardlO) + 1.72 AW049732
Signal transducer and activator of transcription 1 - 1.37 U06924
0Statl)
Signal transducer and activator of transcription 6 + 3.02 L47650
(Stat6)
Stathmin-like 2 (Stmn2) - 2.21 AI839868
Suppressor of zeste 12 homolog (Drosophila) - 1.88 AA797843
(Suzl2)
Synaptotagmin binding, cytoplasmic RNA - 1.72 AF093821
interacting protein (Syncrip)
Synaptotagmin 11 (Sytll) - 1.60 AB026808
Tubulin cofactor a (Tbca) - 1.96 U05333
Transcription elongation factor B (SIII), - 1.79 AA795613
polypeptide 2 (Tceb2)
Transcription factor 20 (Tcf20) + 1.99 AI847906
T-complex-associated testis expressed 2 (Tcte2) - 1.38 U46151
T-complex-associated testis expressed 3 (Tcte3) - 1.96 U21673
Cytoplasmic tyrosine kinase, Dscr28C related + 2.38 X55663
(Drosophila) (Tec)
Endothelial-specific receptor tyrosine kinase + 1.72 X71426
(Tek)
Transferrin receptor (Tfrc) - 1.47 X57349
Thioesterase superfamily member 2 (Them2) + 1.92 AW060827
THO complex 4 (Thoc4) + 1.62 U89876
Thimet oligopeptidase 1 (Thopl) + 1.80 AW047185
Thymocyte protein thy28 (Thy28) 1.55 AI050598
Transducin-like enhancer of split 1, homolog of - 2.48 U61362
Drosophila E(spl) (Tlel)
Transmembrane 4 superfamily member 8 + 2.18 AI843488
(Tm4sf8)
Transmembrane protein 30B (Tmem30b) + 2.13 AA619554
Thymosin, beta 10 (TmsblO) - 2.64 AI852553
Tenascin C (Tnc) - 2.30 X56304
Transient receptor potential cation channel, + 3.34 AF047714
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Gene Title Trend Fold- Genbank Accession
________Change_______ Number
subfamily M, member 1 (Trpml)
Thyroid stimulating hormone receptor (Tshr) - 5.75 U02602
Tubulin, beta 2 (Tubb2) - 1.64 AV351758
Ubiquitin-like 5 (Ubl5) - 1.80 AW124386
UDP-glucose ceramide glucosyltransferase 
(Ugcg)
+ 2.30 D89866
Vascular endothelial growth factor B (Vegfb) + 1.84 U43836
WAP four-disulfide core domain 2 (Wfdc2) + 1.93 AW121336
Zinc finger protein 54 (Zfp54) + 2.12 AF080070
Zinc finger protein 101 (ZfplOl) - 1.78 U07861
Zinc finger protein 106 (Zjpl06) - 1.39 AF060245
Zinc finger protein 260 (Zfp260) - 1.93 D45210
Zinc finger protein 281 {Zfy281) - 1.70 AI850113
EST + 2.73 AI606967
EST + 2.60 AA266467
EST + 2.51 AA607758
EST + 2.50 AA717225
EST + 2.39 AI845874
EST + 2.33 AF015811
EST + 2.26 W40747
EST + 2.22 AV251613
EST + 2.20 AV240248
EST + 2.09 AA691628
EST + 2.08 AA656550
EST + 2.07 AI839150
EST + 2.00 AV303935
EST + 1.96 AI020029
EST + 1.89 AV339602
EST + 1.84 AA763466
EST + 1.79 M31649
EST + 1.70 C80138
EST + 1.63 AV347226
EST + 1.49 AI846236
EST - 4.18 AW214136
EST - 3.51 AW122834
EST - 3.41 AW123796
EST - 2.33 AA867778
EST - 2.28 AW061337
EST - 2.26 AV027707
EST - 2.18 AV293047
EST - 2.12 AA738737
EST - 2.12 AV293047
EST - 2.09 AW 125284
EST - 2.09 AI153421
EST - 1.98 AI645050
EST - 1.94 AA600542
EST - 1.93 AW228316
EST - 1.87 AA189811
EST - 1.83 AA607053
EST - 1.82 AV279579
EST - 1.80 AA674798
EST - 1.75 AI604097
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Gene Title Trend Fold- Genbank Accession
_______________________________________________Change_______ Number
EST - 1.75 AW259499
EST - 1.75 X16670
EST - 1.74 AA691185
EST - 1.73 C77386
EST - 1.66 AI850846
EST - 1.62 AI854606
EST - 1.54 AW047329
EST - 1.52 D10627
EST - 1.48 AV062425
EST - 1.48 AW045808
EST - 1.47 AU045946
EST - 1.47 W91754
EST - 1.45 AW047921
EST - 1.36 AJ003132
EST - 1.36 AI852409
EST - 1.31 AV365271
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Appendix 2
Amplification curves for RT-PCR experiments described in Chapter 4.
RT-PCR amplification curves for silver and dopachrome tautomerase. Amplification curves depicted as cycle number versus Delta Rn 
(baseline corrected normalised fluorescence). Amplification curves shown for cDNA from all 3 cDNA pools. ChxlQr/_ amplification 
curves are consistently to the left of the wild type curves. With the exception of silver, Pool 1, all PCRs were run as duplicates. ChxlQ'/~ 
amplification curves are consistently to the left of the wild type curves.
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amplification curves are consistently to the right of the wild type curves.
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RT-PCR amplification curves for Neurodl. Amplification curves depicted as cycle number versus Delta Rn (baseline 
corrected normalised fluorescence). Amplification curves shown for cDNA from all 3 pools. ChxlO~f- amplification curves 
are consistently to the right of the wild type curves. cDNA from pools 2 and 3 were run twice (top right and bottom left) 
and the RT repeated for both pools and run as well (bottom right). H20  controls were used in all experiments, with 
fluorescence above the threshold level considered as contamination. H20  controls are shown on bottom left graphs.
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